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Controversies surrounding Patient-Reported Outcome Measures (PROMs) and the 
cumbersome-nature of movement analysis-based (MAB) methods for shoulder function 
evaluation make the exploration of alternatives needed. Research aimed at the 
simplification of MAB outcome measures had demonstrated previously that the B-B 
Score, which relies on two movements only, was valid for out-of-laboratory evaluations 
of shoulder function. Nevertheless, further investigations were needed to optimise 
testing procedures, test the B-B Score’s capability of acquisition using a user-friendly 
device, and critically evaluate its measurement properties in comparison to current 
methods. 
Objective 
The aim of this thesis was to develop and assess the simplest possible MAB shoulder 
function scoring procedure for clinical measurement. 
Methods 
The research included four steps: 1) Optimisation of the B-B Score testing procedure 
(Phase 1 study [data-driven]), 2) Comparison of measurements using a smartphone or 
an inertial sensor system (Phase 2 study [data-driven]), 3) Validation in frequently-
occurring pathologies (rotator cuff conditions, instability, fracture, capsulitis) (Phase 3 
study [data-driven]), 4) Benchmarking of the new approach with concurrent MAB 
outcome measures and PROMs (literature review). 
Results 
Amongst the tested methods, the B-B score was optimised by using the mean of three 
replicates in the computation of the range of accelerations by angular velocities. The 
comparison of easily-used smartphone and reference device showed non-significant 
differences and excellent relationships between measurements (Intraclass Correlation 
Coefficient [ICC=0.97]). The smartphone’s B-B Score intra-rater and inter-rater 
reliability was excellent (ICC=0.92), but limits of agreement could reach up to ±19.4%. 
The score was responsive (area under the curve [AUC≥0.70]) and demonstrated 
excellent discriminative power between patients and controls (AUC≥0.90), except for 
shoulder instability (AUC=0.67). The correlations with PROMs were moderate to high. 
The benchmarking established that the measurement properties of the B-B Score 
 
II. 
compared equivalently with those of PROMs and MAB outcome measures, except for 
shoulder instability. 
Conclusion 
Shoulder function can be efficiently evaluated using a simple scoring procedure 
performed with a smartphone, which facilitates its objective assessment. Further 
research is needed to understand how best to reduce the effects of variability 
associated with single measurements in order to optimise clinical applicability and to 
explore the B-B Score’s properties in other situations requiring functional assessments 
of the shoulder. 
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 Epidemiology of shoulder conditions 
Shoulder problems are a frequent cause of pain and disability. Prevalence of shoulder 
problems ranges in-between 7% and 35% in the general population (Yamamoto et 
al., 2010; Green et al., 2003), which represents the second most frequently affected 
musculoskeletal area in the body (Picavet and Schouten, 2003). This results in 
substantial disability at work or in daily living activities and impaired quality of life 
(Green et al., 2003). The quality of tools for the evaluation of shoulder function is of 
primary interest to adequately address the problems of this large population and 
therefore limit the impact of shoulder pathologies on patients and society. 
  Impact of main shoulder conditions on 
function 
A large variety of conditions may lead to shoulder function alteration. However, each 
one of them has to be considered separately for evaluation, as each impairs the 
function of the shoulder specifically. Pain, stiffness or weakness might for example be 
present to a variable degree according to the pathology. Thus, the items of a patient-
rated outcome measure (PROM) must be adequate to target the specific shoulder 
function alterations induced by a condition, and a kinematic outcome measure must 
account for the fact that each pathology affects the movement in a specific way. 
Therefore, measurement properties of a shoulder function measure are valid only in 
the population in which they were tested (Robertson et al., 2017; Collins and Roos, 
2016; Riddle and Stratford, 2013). 
In addition to issues related to shoulder conditions, the evaluation of surgically or 
conservatively treated populations should be differentiated for the same reason. The 
size of the conservatively treated population is much larger than that of the surgically 
treated one. Overall, only one in every 10 patients presenting with shoulder pain 
requires surgery (Colvin et al., 2012).  
Patients with rotator cuff conditions, proximal humerus fractures, adhesive capsulitis, 
and shoulder instabilities are frequently encountered in shoulder consultations (van 
der Windt et al., 1996; Yamamoto et al., 2010; van der Windt et al., 1995; Court-Brown 
Chapter one 
3. 
and Caesar, 2006; Liavaag et al., 2011; Owens et al., 2007). It is thus essential to 
have efficient tools to evaluate shoulder function as a priority for these conditions, of 
which the main characteristics are developed hereafter.  
1.1.1.1.1. Characteristics of rotator cuff conditions  
Conditions associated with the shoulder’s rotator cuff musculature are the most 
common source of shoulder pain (65%). The notion of a rotator cuff condition is non-
specific, as the pain may come from several causes that are difficult to differentiate in 
practice, like rotator cuff tendinopathy, rotator cuff tears, subacromial impingement or 
subacromial bursitis (Mitchell et al., 2005). Rotator cuff tendinitis affects 29% of 
patients presenting with shoulder pain in general practice (van der Windt et al., 1995). 
Rotator cuff tear prevalence is also very high and is strongly related to age. Tears are 
present in 2.5% of the general population in their 30’s, 25% in their 60’s, and 50% in 
their 80’s (Yamamoto et al., 2010). A painful arc during arm elevation is typical of 
rotator cuff conditions (O'Kane and Toresdahl, 2014). However, clinical presentation 
of rotator cuff conditions varies considerably. Range of motion (ROM) limitations may 
or may not be observed, and tears may remain asymptomatic despite the anatomical 
lesions (Yamaguchi et al., 2006; Yamamoto et al., 2010; Moosmayer et al., 2009).  
1.1.1.1.2. Characteristics of adhesive capsulitis 
Adhesive capsulitis, also named frozen shoulder, represents the second most 
prevalent cause of shoulder pain (22%) (Yamamoto et al., 2010). It is an idiopathic 
disease of the joint capsule causing mainly pain and stiffness (Mitchell et al., 2005). 
The adhesive capsulitis is usually considered a 12- to 18-month self-limiting process, 
but mild symptoms may persist longer (Kelley et al., 2013).  
1.1.1.1.3. Characteristics of proximal humerus 
fractures  
Proximal humeral fractures are also common, as they account for 6% of all adult 
fractures (Court-Brown and Caesar, 2006). The incidence of this type of fracture in 
Western countries is growing, due to the increasing age of the population. The 
movement is altered during the rehabilitation phase by pain, stiffness, and loss of 
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strength. The recovery at one year is generally good and equivalent for the 
conservative and the surgical approach (Handoll et al., 2012). 
1.1.1.1.4. Characteristics of shoulder instability 
Shoulder instability is also a frequent cause of medical consultation in younger 
populations. It is characterised by the inability to maintain the humeral head in the 
glenoid fossa of the scapula, so that the humerus slides partially or completely out of 
its socket. The shoulder instability’s incidence rate reaches 56.3 per 100 000 person-
years in the general population, but 2.8% in a physically active young population 
(Liavaag et al., 2011; Owens et al., 2007). Instability is problematic because it 
frequently leads to recurrent shoulder dislocation, apprehension, and loss of quality 
of life (Handoll et al., 2004; Rouleau et al., 2010). The movement is altered in the less 
stable positions of the glenohumeral joint. Typically, the patient experiences 
apprehension at the end of ROM, while undertaking combined movements, but can 
perform activities without problem in stable glenohumeral joint positions. 
 Evaluation of shoulder function 
 Patient-reported outcome measures 
Shoulder function is most frequently evaluated using PROMs  questionnaires. Up to 
thirty-nine shoulder function evaluation tools have been audited within reviews, but 
most have not undergone a full validation process that would be expected to underpin 
good quality research (Kirkley et al., 2003; Oh et al., 2009; Huang et al., 2015; Harvie 
et al., 2005). Thus, the measurement of the shoulder functional outcome using 
PROMs remains a contemporary and controversial issue. Consequently, no 
questionnaire has been widely recognised as a standard (Fayad et al., 2005; Oh et 
al., 2009; Placzek et al., 2004; Roy et al., 2009). The use of a large variety of outcome 
measurements tools and assessment tools in research limits the development of 
evidence about treatments of shoulder conditions, as the results are hardly 
comparable between studies that rely on different PROMs (Green et al., 2003; Harvie 
et al., 2005; Makhni et al., 2015; Page et al., 2015).  
Clinical questionnaires have essentially the advantages of handiness and low cost. 
Conversely, they present intrinsic limitations related to language and cultural issues, 
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respondents’ interpretations and content validity (Ragab, 2003; Olley and Carr, 2008). 
The validation of questionnaires’ translations into various languages is a time-
consuming and cumbersome process. Moreover, the delineation between objective 
and subjective aspects of evaluation is sometimes ambiguous in questionnaire-based 
assessment. This is all the more important as objective and subjective approaches 
generally produce different results (Krueger et al., 2011; Moustgaard et al., 2014).  
Despite the questionnaires’ limitations, PROMs represent the current standard in 
clinical shoulder function evaluation. Actually, as there has rarely been a direct critical 
comparison of PROMs and alternative measurement methods (e.g movement 
analysis, physical testing or observation), no concurrent measurement method has 
demonstrated its superiority or inferiority over PROMs to date. In the current context, 
the development of a new questionnaire based from its conception on recognised 
methods would probably have limited added value, as it would face the same 
difficulties as its predecessors in overcoming methodological pitfalls in order for it to 
be considered as a standard. There is therefore a need to investigate alternatives to 
provide clinicians and researchers with well-recognised and convenient measurement 
tools that would not present the same drawbacks as PROMs. This could ideally lead 
to the development of new clinimetrically-relevant measurement tools with the 
capability for delivery within a clinical environment. The role of these innovative 
approaches should also be explored to understand if they mainly concur with or 
complement the results of current approaches.  
 Movement analysis-based (MAB) 
assessment 
Computerised movement analysis produces a purely objective outcome, and could 
potentially be recognised as a standard for shoulder function evaluation due to its 
accuracy and precision (Pandyan, 2002). It could also overcome limitations related to 
language and cultural issues, respondent interpretations and content validity 
associated with questionnaires (Ragab, 2003; Olley and Carr, 2008; Kirkley et al., 
2003). It has thus been largely used in research studies aiming at the characterisation 
and evaluation of shoulder motion.  
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Although three-dimensional laboratory motion analysis systems have assumed a 
growing importance in research, their application in clinical settings has remained 
limited to date. Most motion laboratory analysis studies have mainly addressed the 
development of innovative measurement' models or have investigated differences 
between healthy and pathological participants’ groups. This led to a better 
understanding of shoulder movement and its alterations, but has rarely resulted in the 
development of measurement tools that could be used in clinical research, let alone 
in clinical practice. No laboratory-based research had proposed a MAB outcome 
measure for shoulder function that could be possibly used to monitor patient's clinical 
change in routine practice, to the best of the author’s knowledge. 
Most laboratory-based approaches for shoulder movement analysis rely on infrared 
cameras, ultrasounds systems, electromagnetic systems or electromyography (Coley 
et al., 2009). Constraints of location, time, complexity and costs of laboratory 
measurement restrict its use in clinical practice, and research (Aminian and Najafi, 
2004; Clark et al., 2017). Therefore, embedded systems, like inertial measurement 
units (IMU) using gyroscopes and accelerometers have also been developed for 
shoulder evaluation, as their portability and practicality facilitates the procedures for 
measurement. Ambulatory systems may represent a well-balanced compromise 
between practicality and reliability. While they are highly correlated to laboratory 
measurements and display adequate accuracy, measurement completion is easier 
and application is not restricted to laboratory-based environments (Coley et al., 
2007a). 
Embedded sensors have been applied with promising results to measure arm and 
shoulder movement in various conditions (Luinge et al., 2007; Wong et al., 2007; 
Coley et al., 2008b; Coley et al., 2008a; Teece et al., 2008; Ludewig and Cook, 2000; 
Borstad and Ludewig, 2002; Rundquist et al., 2003; Rundquist and Ludewig, 2004; 
Rundquist and Ludewig, 2005; Ludewig et al., 2009; Ludewig and Reynolds, 2009; 
Duc et al., 2013; Duc et al., 2014). These studies demonstrated the potential of 
movement analysis based on body-worn sensors to characterise healthy and 
pathological shoulder movement. Thus, several research teams have proposed 
scoring methods that could potentially be used to evaluate shoulder function in clinical 
settings (Korver et al., 2014a; Coley et al., 2007a; Duc et al., 2014; Yang et al., 2014; 
Jolles et al., 2011; Pichonnaz et al., 2015c) (please see literature review Chapter five). 
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Nevertheless, despite the simplification of the measurement procedures provided by 
body-worn sensors, their use for shoulder function evaluation has remained limited in 
clinical settings. Several barriers, including for example access to the device, time 
constraints, familiarity with the technology, still hinder the widespread use of such 
devices among health professionals. Though apparently self-evident, the 
requirements for the routine application in clinical practice are very demanding as, in 
addition to measurement properties, time, practicability, user-friendliness and cost are 
of higher concern than when used for research’ purposes. 
Several of the existing scoring methods are based on Coley’s work, who proposed a 
relatively simple shoulder function score based on three dimensional measurements 
of a power-related metric by accelerometer and gyroscopes (P score) (Coley et al., 
2007a). The procedure relied on a sequence of seven functional movements based 
on the Simple Shoulder Test functional score (Lippitt, 1993). This approach 
demonstrated clinical relevance, as the score was clearly capable of discriminating 
healthy from pathological subjects, was correlated to clinical questionnaires and 
displayed adequate responsiveness after shoulder surgery (Coley et al., 2007a). 
However, the full test procedure needed around 20 minutes to perform, which 
precluded routine application in clinical settings. 
The latter limitation of the P Score to shoulder function assessment was addressed 
in a QMU MSc dissertation project in physiotherapy that  investigated whether it was 
possible to simplify Coley’s testing procedure (Pichonnaz, 2010; Pichonnaz et al., 
2015c) (Appendix I). This preliminary work aimed at selecting only essential 
movements that should be performed during the measurement protocol, and this 
research ultimately acted as a forerunner for the research questions addressed within 
this PhD thesis. A simplified score was developed based on multivariate statistical 
approaches of principal component analysis and multiple regressions of P Score raw 
data at baseline and at 3, 6 and 12 months after surgery. Principal component 
analysis allowed identifying two main constituent dimensions: an “arm elevation” and 
an “arm rotation” dimensions. Therefore, simplified scoring systems were developed 
based on multiple regressions of two movements, representative of these dimensions, 
and focusing on their ability to predict the P Score. Several possibly relevant 
movement associations were investigated (hand to the back + reach back of head 
with hand; hand to the back + 90° abduction; hand to the back + touch opposite 
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shoulder with hand ; hand to the back + lift arm as if changing a bulb). The most 
efficient statistical model for a simplified score arising from the multiple regressions 
was found to be 16.71 + (0.32 x hand to the Back) + (0.45 x lift arm as if changing a 
Bulb). This two-movement combination was therefore selected as the best possible 
alternative to the P Score and named B-B Score (B-B Score meaning Back-Bulb 
Score). It was demonstrated that the testing procedure limited to only two essential 
movements instead of seven, did not induce any significant information loss (R2 > .97). 
The outcomes of this simplified scoring procedure were then compared to the P score 
outcomes in the same sample at baseline and at 3, 6 and 12 months following surgery. 
The mean results closely matched and the correlation between the simplified and the 
reference score was excellent regardless of stage of rehabilitation. The simplified 
score demonstrated measurement properties similar to those of the reference score 
for the study population and the responsiveness for both assessment approaches was 
comparable. Moreover, the discriminative power between patients and controls of the 
simplified approach was excellent with 97% sensitivity and 94% specificity, indicating 
that the score was able to detect the function loss in patients following rotator cuff 
surgery or shoulder arthroplasty. 
All other things being equal, the main advantage of the simplified scoring system 
resides in its clinical practicality. Moreover, the simplified scoring procedure can easily 
be repeated, which can potentially contribute to increased reliability of measurement 
by taking the mean of several replications into consideration when calculating the 
score. 
Concurrent studies investigated another two-movement combination including “arm 
to the back” and “arm behind the head” movements (Korver et al., 2014a; Korver et 
al., 2014b). These movements were selected because they represented motion tasks 
related to activities of daily living that are part of several standard clinical 
questionnaires. This score required less than 5 minutes to perform and demonstrated 
high intra- and inter-rater reliability, with intraclass coefficient of correlation (ICC) of 
0.95 and 0.91, respectively. The diagnostic sensitivity was 98% and the specificity 
81%. However, the relationship to shoulder function evaluation was limited, as 
correlations with the DASH (Disabilities of the Arm, Shoulder and Hand) questionnaire  
and SST (simple shoulder test) clinical score were weak (Pearson r < 0.25) (Lippitt, 
1993; Hudak et al., 1996). As stated by the authors, this score’s outcome cannot thus 
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be considered to be representative of shoulder function as it has been conceptualised 
within these PROMs. So, these kinematic scores cannot be considered as a potential 
substitute to shoulder function PROMs. 
Conversely to the scores developed by Korver et al., who used similar PROMs and 
inertial sensor system outcome measures for patients suffering shoulder disorders, 
the correlations of the B-B Score with current PROMs ranged from 0.51 to 0.77, 
indicating that the B-B Score had good criterion-based validity for shoulder function 
evaluation (Pichonnaz et al., 2015c). Despite these promising preliminary results, 
further research would nevertheless be required to establish extensively the 
measurement properties of the B-B Score. It would also be necessary to precisely 
standardise its measurement procedure, to determine healthy subjects’ performance 
and to evaluate applicability to populations presenting with other shoulder conditions 
than rotator cuff surgery or arthroplasty surgery that were investigated in previous 
works (Coley et al., 2007a; Pichonnaz et al., 2015c). 
Though the testing movements are kept to their simplest expression in the B-B Score, 
this simplicity might not prove sufficient for routine clinical application if a complex 
movement analysis device is needed for the score’s completion. More research would 
therefore also be needed to investigate if the score can be usefully measured using 
an accessible and affordable device. Using a smartphone for evaluation purposes 
might contribute to meeting these requirements and facilitating the transfer of 
objective movement analysis-based functional outcome in current practice. This 
approach is conceivable nowadays because, like embedded measurement systems, 
most smartphones are fitted with built-in accelerometers and gyroscopes. If used in 
conjunction with a dedicated but as yet to be developed application, they could thus 
potentially be used for shoulder function analysis. 
 Smartphone applications for shoulder 
evaluation 
The use of a smartphone for the B-B Score measurement might further improve the 
practicability of the evaluation procedure. In case the measurement properties are 
acceptable, smartphones may offer a cost-effective and straightforward clinical 
outcome measurement, provided that a simple measurement procedure is applied. 
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Cost and training might be considerably reduced and this could favour routine 
objective function measurement of the shoulder.  
However, there are also limitations in the use of smartphones for scientific 
measurement. For instance, the precise features of the device are not fully disclosed 
due to commercial sensitivities. Furthermore, the smartphone results might possibly 
differ from inertial-based systems, as the sensors’ features have not been specifically 
designed for scientific measurement. Users should also remain conscious that 
measurement properties might be device-dependent, because the characteristics will 
differ according to smartphone version and brand. 
Smartphone-based evaluation in clinical conditions is thus valuable only provided that 
the measurement properties have been previously be verified to meet necessary 
clinical criteria - which was still to be completed for a possible smartphone version of 
the B-B Score. This is a prerequisite to any clinical implementation because important 
decisions are taken based on delivered clinical outcome, for example about treatment 
continuation, hospital stay or intervention needs (Roe et al., 2013; Michener, 2011). 
Considering these issues, the results on which the decision is based must previously 
have proven to be valid, responsive and reliable. Extensive verification studies of 
clinimetric utility would thus be needed before clinical implementation of a 
smartphone-based approach, whether it is in general or more specifically for shoulder 
function evaluation.  
The exploration of the literature shows that smartphone applications are taking 
growing importance for patient evaluation, patient education or to assist health care 
professionals in their practice. Concerning the shoulder, most applications address 
the assessment of shoulder range of motion (ROM), generally finding reliable results 
(Werner et al., 2014; Shin et al., 2012; Mitchell et al., 2014; Cuesta-Vargas and 
Roldan-Jimenez, 2016; Johnson et al., 2015; Brophy et al., 2005). The results on 
shoulder function may possibly differ from these research outcomes, as ROM is only 
one component of shoulder function evaluation, which is a more complex concept 
than merely an end-range mobility evaluation. One study on healthy subjects showed 
that the analysis of accelerations was achieved generally with adequate precision 
when using a smartphone (Cuesta-Vargas and Roldan-Jimenez, 2016). However, to 
the best of the knowledge of this thesis’ author, no smartphone-based software 
application to assess shoulder function is currently available, let alone validated. The 
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verification of a smartphone application for functional outcome measurement using 
the B-B Score would thus be novel and of paramount importance, especially when 
considering the high prevalence of shoulder conditions, the existing controversy about 
shoulder function questionnaires and the complexity of current computerized 
movement analysis methods.  
 Thesis aim 
The combination of a score that includes only essential movements and a device 
whose use has entered into daily life reduces the testing procedure to its simplest 
expression. However, the transfer into practice is indicated only if this minimalist 
approach has previously proven its validity and has been compared with alternative 
approaches, that is PROMs questionnaires and measurement using movement 
analysis dedicated body-worn sensors.  
The general aim of this thesis was thus to validate the simplest possible kinematic 
shoulder function scoring procedure applicable in clinical practice and research, and 
compare it with alternative approaches. 
The research process included four phases: 1) Definition of the testing procedure, 2) 
Comparison of B-B Score measurements derived from a specifically developed 
smartphone application and an inertial measurement system 3) Validation of the 
smartphone B-B Score in current shoulder pathologies (rotator cuff conditions, 
humerus fracture, capsulitis, instability), 4) Benchmarking of the new approach with 
concurrent kinematic- and questionnaire-based methods  
The Phase 1 study of the research programme centred on the precise definition of the 
research plan and the determination of the most efficient score calculation method of 
the B-B Score measured with an inertial measurement unit (IMU). At this stage, the 
variability in measurement was analysed and sources of variability in scores were 
tracked. Attention was focused notably on the influence of the measurement device, 
the subjects’ characteristics, the feasibility issues and the inconsistencies in the 
measurement protocol. Recommendations were made accordingly about the 




The thesis’ Phase 2 study aimed at the comparison of the outcomes and 
measurement properties of the B-B Score acquired using a dedicated IMU (inertial 
measurement unit) Physilog II system (Physilog®, Gait Up, Lausanne Switzerland) 
and an iPod (iPod®, Apple, Cupertino, USA) with a dedicated software measurement 
application.  
The thesis’ Phase 3 study aimed at establishing the measurement properties of the 
B-B Score derived from a smartphone, as delivered within the thesis’ Phase 2 study, 
by critically evaluating the scope and effectiveness of its application within four 
prevalent shoulder pathologies encountered in physiotherapy: rotator cuff condition 
treated conservatively, shoulder instability treated conservatively, proximal humerus 
fracture treated surgically or conservatively, and capsulitis treated conservatively. 
Normal performance and score reliability over 6 months were investigated in a healthy 
population. At the end of the Phase 3 study, the convergent validity of the B-B Score 
in comparison with the current clinical function questionnaires was established for 
each shoulder pathology, as well as its discriminative power between healthy and 
pathological participants, intra- and inter-rater reliability, responsiveness, 
measurement error and interpretability aspects . 
Data for Phase 2 and Phase 3 studies were collected simultaneously. The 
measurement method defined in the Phase 1 study was used in these phases to 
establish the measurement properties of B-B Score based on the calculation method 
that we had found to be the most efficient. 
With the measurement properties of the B-B Score using a smartphone having been 
established, a benchmarking of the new approach with concurrent kinematic- and 
questionnaire-based methods was made in Phase 4, to contextualise the B-B Score 
measurement properties with regard to other methods used for shoulder function 
measurement. 






Figure 1.1: Steps in the development process of a measurement instrument. From: 
DE VET, H. C., TERWEE, C. B., MOKKINK, L. B. & KNOL, D. L. 2011. 
Development of a measurement instrument. In: TERWEE, C. B., KNOL, D. L., DE 
VET, H. C. W. & MOKKINK, L. B. (eds.) Measurement in Medicine: A Practical 
Guide. Cambridge: Cambridge University Press.  
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 Definition of central concepts 
 Framework for the definition of shoulder 
function 
Shoulder function is not a straightforward concept and no unequivocal definition is 
commonly accepted (Roe et al., 2013). In contrast to lower limb function that has 
locomotion as its main purpose, delineating the domains that describe upper limb 
function is much more complex because of the increased diversity of its possible 
actions.  
The International Classification of Functioning, Disability and Health (ICF) could serve 
as a reference to delineate what encompasses the notion of shoulder function (World 
Health Organization, 2001; Michener, 2011; Roe et al., 2013). The ICF that was 
developed in 2001 by the World Health Organisation to serve as the international 
standard to describe and measure health and disability, classifies functioning within 
the components of body functions, body structures, activities & participation and 
environmental and personal factors. It promotes then an approach from a bio-psycho-
social perspective and is largely recognised as a reference to conceptualise 
rehabilitation using a shared framework.  
As such, using the ICF for shoulder function evaluation implies considering the 
problem from within a large perspective. The latter would include investigating 
impairments at the origin of dysfunction, while recognising the influence on the 
activities undertaken and the global consequences on a patient’s life. A review about 
the measures of shoulder pain and function showed that the most currently addressed 
concepts were related to activities and participation, that is the execution of a task or 
action by an individual and his/her involvement in life situations. (Roe et al., 2013). 
Conversely, psychosocial functioning and environmental factors were more scarcely 
investigated. Overall, the most frequent items covered in questionnaires concerned 
pain, movement related body functions and structures, sleep, hand and arm use, self-
care, household tasks, work and employment, and leisure activities. 
These aspects are thus commonly considered as important components of shoulder 
function. However, they obviously do not encompass all aspects covered by the ICF. 
Though suitable from a conceptual point of view, covering exhaustively the ICF 
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framework would imply investigating a very large panel of items, because body 
structures and environmental factors should be included. While this extensive process 
may be required to investigate the determinants of shoulder function fully, it might not 
be necessary when only the functional outcome is the parameter of interest. The 
extent of the domains that should be covered by shoulder function evaluation tools 
remains a focus for debate (Beaton et al., 2001b; Michener, 2011). However, when 
designing a shoulder function evaluation based on the ICF framework, it seems 
reasonable to focus on the specific domains that characterise the person functioning 
(that is body function, activities and participation), like most instruments do. A broader 
rationale that accounts for all ICF domains would be necessary only when the 
determinant and consequences of dysfunction are of concern. 
In the absence of a precise and universally accepted definition of shoulder function, it 
was nevertheless necessary to produce one that might be acceptable for the purpose 
of this thesis. Based on the aforementioned considerations, shoulder function should 
be understood in this thesis to be the ability of the shoulder to perform the movement 
and hold the positions required for the management of activities and life situations 
that are significant for the person. 
This is an operational definition to facilitate the PhD’s goals being pursued effectively, 
i.e. to develop a kinematic score for shoulder function evaluation. It stems from a 
logical reasoning based on the ICF framework and as such, remains focused on this 
reference. Other frameworks like the Disability Creation Process (Fougeyrollas et al., 
1998) could have been considered as references. However, they are far less accepted 
worldwide, and it was more appropriate to propose a consensual than an innovative 
definition of shoulder function in the context of this thesis. 
 PROMS and clinical questionnaires 
1.1.3.2.1. Definition of function in clinical 
questionnaires 
It is challenging to envisage a measurement tool that remains easily usable while 
successfully encompassing all important and requisite clinimetric aspects. The 
absence of a universally accepted definition of function partly explains the controversy 
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surrounding the content of clinical questionnaires. In a review that investigated the 
aspects investigated in measures of shoulder pain and functioning, Roe et al. 
concluded that there are huge differences in the content of the condition-specific multi-
item measures (Roe et al., 2013). The lack of an unequivocal definition has thus 
contributed to the manifold attempts made to create questionnaires that are more 
efficient in encompassing shoulder function (Fayad et al., 2005; Oh et al., 2009; 
Placzek et al., 2004; Roy et al., 2009). Consequently, the variety of rationales that 
sustained the conception of clinical questionnaires have led to the creation of a 
multitude of instruments that aim at the measurement of shoulder function (Huang et 
al., 2015; Harvie et al., 2005). 
In the field of shoulder function evaluation, almost all clinical questionnaires are 
PROMs, i.e. patient-reported outcome measures, a type of clinical questionnaire in 
which the patient acts as his/her own rater. Note that for the sake of simplification, 
PROMs (for example SST, DASH, UCLA, WOSI) and composite scores that include 
patient-reported and clinical measurements items (for example Constant, ASES) will 
be mentioned as “PROMs” within the rest of this work. Indeed, both types of 
questionnaires adopt the same approach, which consists in collating the necessary 
amount of relevant information in a pool of items chosen to encapsulate shoulder 
function as it has been conceived.  
In spite of this shared approach within PROMs, variations exist in the underlying 
conceptual-frameworks leading to the inclusion of items. Differences in PROMS lie in 
the fact that the evaluation may have condition-generic/specific, population 
generic/specific, shoulder-specific/upper limb, subjective/mix of subjective and 
objective or patient centred/standardised emphases. Each approach has his 
advantages and drawbacks, which are discussed hereafter.  
This variety hinders the comparison between studies using different instruments and 
the syntheses within meta-analyses but nevertheless allows the choice of a targeted 
instrument in line with the measurement purpose (Green et al., 2003; Harvie et al., 




1.1.3.2.2. Shoulder function PROMs types 
The degree of specificity of a questionnaire has an influence on its validity for shoulder 
function evaluation and its measurement properties. Typically, the SF-36 quality of life 
generic instrument has been used in several studies in conjunction with shoulder 
function PROMs (Hudak et al., 1996). It was consistently shown to be to be less 
responsive than shoulder PROMs and compared to the strength of correlation 
amongst the PROMs, showed lower magnitude relationships (Beaton and Richards, 
1996; Angst et al., 2008; MacDermid et al., 2006). This illustrates that a generic 
instrument, which is only marginally affected by variations in shoulder function, does 
not effectively target this outcome. Conversely, it can prove useful to assess the 
broader impact of shoulder dysfunction on patients’ lives. 
A very specific instrument may have the advantage of circumscribing very precisely 
the condition and functional needs in a given population of patients. This results in 
greater validity for the instrument within the population of interest. Conversely, 
PROMs adapted to the general population may suffer from a marked ceiling effect 
when applied to an athlete population for example, which precludes the functional 
performance differentiation between them. This type of problem was illustrated by the 
SPORTS score for shoulder instability in athletes showing a lower ceiling effect than 
shoulder function PROMs designed for the general population (Blonna et al., 2014). 
However, very specific PROMs suffer from low adaptability, as they are adapted for 
the evaluation of precisely defined patients’ populations. As these instruments are 
reserved for situations in which current PROMs have demonstrated their limitations, 
their use, and consequently the experience acquired about them, has remained 
marginal to date (Makhni et al., 2015; Gartsman et al., 2015). The development of a 
variety of specific PROMs for each condition, patient population and intervention (for 
example conservative and surgical) is conceptually sound, as instruments are valid in 
the population for which they were tested. However, the latter may result in the 
creation of an overwhelming number of new instruments for clinicians and 
researchers (Slobogean et al., 2011). 
Actually, the most frequently used PROMs are situated in-between the two latterly 
described extremes, though to different degrees (Makhni et al., 2015; Gartsman et 
al., 2015). Some instruments for the general population were designed either for 
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shoulder function in specific pathologies (for example WORC, WOSI), generic 
shoulder function (for example Constant, ASES) or generic upper extremity function 
(for example DASH). However, despite their possible applicability in different clinical 
contexts, users should remain conscious that measurement properties found in one 
context are not transferable into a different one (Slobogean and Slobogean, 2011). 
Though the instrument is generic to some extent, the measurement validity 
associated with it remains specific to the context in which it was tested. 
Another issue in shoulder function evaluation is the degree of subjectivity or objectivity 
of the instrument. The differentiation is apparently simple, subjective measurement 
being influenced by feelings and ideas, whereas objective measurement is not. 
However, the delineation is actually more complex to establish, as the definition of 
“subjective” is ambiguous in the scientific literature, the term being used to mean 
either rater-dependent, patient-reported or only assessable by the patient 
(Moustgaard et al., 2014).  
Concerning shoulder PROMs, some are clearly subjective, for example investigating 
the perceived difficulty to successfully complete tasks, while other ones are composed 
of a mix of subjective and objective items, like the Constant that gathers perceived 
limitations and clinical measurements. Sometimes, the delineation between 
subjective and objective is ambiguous, as for example in the SST in which the patient 
is asked if he/she is capable of successfully undertaking an activity. The answer is 
subjective if the patient thinks that he is able to achieve it and objective if he can really 
perform it. The subjective or objective character of the results is important to define 
as both approaches investigate different aspects of function that are complementary 
(Matsen et al., 2017; Krueger et al., 2011; de los Reyes-Guzman et al., 2014). Thus, 
the delineation between subjective and objective outcomes is important for the 
understanding of the issue at stake and for correctly combining measurement tools in 
an evaluation. 
Patient-centred evaluation tools, like for example the Patient Specific Functional 
Scale (PFSF) are clearly subjective, as they investigate the activities that are 
specifically of interest to the person. They have the advantage of focusing the 
questions on the ones that make sense in the context of the person being treated, but 
the generalisation of the results is therefore difficult, because the items investigated 
are different for each patient. Although there are some exceptions, patient-centred 
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evaluation tools have been rarely used in shoulder function research (Hurd et al., 
2017; Hefford et al., 2012; Horn et al., 2012).  
1.1.3.2.3. Implications for the thesis 
In summary, though all PROMs are generally considered together and contrast with 
clinical or laboratory measurements, a large variety of approaches have been used to 
substantiate their conception. Therefore, it must be kept in mind that each PROM 
investigates a particular aspect of function that is slightly different from other PROMs 
and that to date, none of these approaches has demonstrated its superiority over any 
other.  
This situation is suboptimal for clinicians and researchers, as it is complex and hardly 
applicable to choose several complementary PROMs to get a broad view of all 
aspects of shoulder function (Christie et al., 2009).  
This discussion about shoulder function PROMs has implications for the PhD design. 
The criterion validity evaluation of the B-B Score, i.e. the demonstration that it actually 
measures shoulder function similarly to an established reference instrument, can only 
be relative to the conditions and environment in which it was assessed. As no gold 
standard PROM exists, no comparison can be made between the new kinematic 
score and a unique and strongly established reference. The best that can be done is 
to evaluate its convergent validity, that is the relationship with several other 
instruments that aim at the evaluation of the same outcome, though the comparators 
may also have their own limitations (McDowell, 2006). To be able to draw the most 
robust conclusions from the research on the validity of the B-B Score to truly measure 
shoulder function, it will be necessary to challenge it with several currently used 
shoulder function PROMs with different characteristics. Similarly, a comparison with 
the most frequently used PROMs will be needed in the literature review that will 
complete the PhD programme of research with a benchmarking of the calculated B-B 
Score’s measurement properties against those of contemporary assessment tools 
with which it might represent an alternative. 
It might be that the relationship varies according to the characteristics of each PROM, 
but these variations will also be informative about the aspects of shoulder functions 
that are measured by the B-B Score and the respective advantages of each approach. 
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 Movement analysis-based methods 
1.1.3.3.1. Validity issues 
Computerised movement analysis offers useful practical advantages over PROMs. 
Notably, they overcome the intrinsic limitations of PROMs related to content validity, 
language and cultural issues and respondents’ interpretations (Olley and Carr, 2008; 
Ragab, 2003; McDowell, 2006). Unlike questionnaires, no time-consuming and 
cumbersome process is needed for the translations into various languages. It has 
therefore a better potential for universal recognition than PROMs.  
Moreover, the advantage of the computerised movement analysis approach - of which 
the different variations in methods will be presented hereafter - is to measure 
movement objectively. While PROMs capture by essence an interpretation of what 
happens, movement analysis captures the movement as it is, provided that the 
measurement error is contained. Fundamentally, computerised movement analysis 
translates the primary function of the shoulder, which is to orient the upper limb in the 
visual work space, in terms of biomechanical parameters (for example range of 
motion, accelerations, speed, power…)(Culham and Peat, 1993). 
Nevertheless, and similarly to questionnaire-based approaches, it is a challenge to 
evaluate shoulder function using computerised movement analysis. As for PROMs, 
the imprecise definition of the term “function” means that various notions referring to 
different levels of the ICF classification have been used by researchers, leading to an 
absence of consensus about what should be measured to adequately reflect shoulder 
function (De Baets et al., 2017).  
Actually, the fact that some movement parameters are captured does not imply that 
they are representative of function as defined in this thesis 1 . A biomechanical 
parameter cannot be considered to reflect shoulder function as defined above until its 
                                               
1 Shoulder function: the ability of the shoulder to perform the movement and hold the 
positons required for the management of activities and life situations that are 
significant for the person. 
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convergent validity has been demonstrated by an adequate correlation between it and 
recognised shoulder function measurement tools (de los Reyes-Guzman et al., 2014). 
This is usually done in contemporary research by investigating its correlation with 
PROMs that target the same outcome.  
Due to the aforementioned controversies, convergent validity but no gold standard 
validity, can be established in the absence of a universally recognised PROM for 
shoulder function evaluation (McDowell, 2006). However, they currently represent the 
best available references, as similarly to PROMs, no movement analysis-based 
method has established itself as a reference for the assessment of shoulder function. 
Thus, when a new computerised movement analysis-based method shows an 
adequate correlation to PROMs, it is considered as valid for shoulder function 
evaluation. Conversely, when the correlation is weak, the unclear definition of function 
also makes for a situation in which it may be considered that complementary 
dimensions of function to those associated with PROMs are being investigated by 
movement analysis parameters (Korver et al., 2014a; Matsen et al., 2017). This 
illustrates that in the present situation, more research is needed to understand the 
degree to which shoulder function evaluation using PROMs or computerised 
movement analysis produce concurrent or complementary outcomes.  
 Data collection approaches 
The capture of shoulder function using computerised movement analysis implies 
successfully identifying which representative movements and which relevant 
parameters should be measured to describe accurately the limits of the shoulder’s 
capacity for functional motion. Two approaches have mainly been used for this 
purpose, an approach aimed at synthesis using short-time measurements and an 
extensive approach using long-time measurements (De Baets et al., 2017).  
The rationale of the approach aimed at synthesis has been to identify a parameter 
indicative of shoulder function and analyse it over a limited number of movements 
(Coley et al., 2007a; Korver et al., 2014a; Jolles et al., 2010). The assumption of this 
approach is that the alterations of selected movements measured over a limited time 
can be representative of the variety of difficulties encountered in functional tasks. If 
so, the advantage of such an approach would be that rapidly acquired measurements 
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are able to provide information on a large range of functional difficulties faced by the 
patient in his/her activities of interest. 
Conversely, the extensive approach has aimed at the acquisition of a revealing 
parameter over several hours to identify how the shoulder operates in unconstrained 
conditions of daily life, taking advantage of the portability of a dedicated measurement 
system (Coley et al., 2008b; Duc et al., 2014; Wylie et al., 2016). The assumption of 
this approach is that, provided that the parameters revealing the difficulty has 
previously been identified, the long measurement time makes it possible to capture 
the patient’s functional difficulties when they happen. If so, such an approach would 
provide an objective picture of shoulder function in conditions that are very close to 
those within the patient’s life. However, it is challenging to identify parameters that 
consistently reveal the functional alterations of patients independently of the great 
variety of situations potentially encountered within an unconstrained environment 
(Duc et al., 2013). 
1.1.3.3.2. Definition of normal movement 
A difficulty of upper limb movement analysis resides in the fact that each person has 
his own dynamic of movement (Khadilkar et al., 2014; Wickham et al., 2010; Linkel et 
al., 2017). Among others, the speed, range of motion and developed power are highly 
dependent of the person physical and psychosocial characteristics, as well as the 
conditions in which the task is executed. Movement, notably mobility and 
accelerations, is affected by age (Patel et al., 2007; Cutti et al., 2014; Roldan-Jimenez 
and Cuesta-Vargas, 2016). This dependency makes it difficult to parameter values 
from one person to the other and to determine with precision from which threshold an 
alteration is problematic. 
The use of the healthy side as the reference may help overcoming this shortcoming. 
In this case, the healthy side is considered as the reference for normal movement and 
the magnitude of the difference between sides is considered as representative of the 
dysfunction, with the patient acting as his/her own control. An advantage of between-
sides comparison is that age-related modification of movement is accounted for by 




A condition for the comparison with the healthy side to be valid is that the range of the 
normal difference between sides must be previously known for the results to be 
interpreted. Importantly, the difference between the dominant and non-dominant side 
has to be established, or demonstrated to be negligible, for the comparison between 
sides to be valid. Another condition is that one of the sides has to be healthy. In case 
of bilateral problems, no shoulder can represent the normal performance that serves 
as a reference. This may be particularly limiting in older people, due to the increasing 
prevalence of shoulder rotator cuff tears with age (Yamaguchi et al., 2006; Yamamoto 
et al., 2010; Moosmayer et al., 2009). 
1.1.3.3.3. Objective measurement vs. patient 
perception 
The purely objective character of computerised movement analysis might be 
considered as an advantage, as the real performance and not an interpretation of the 
performance, is recorded. However, it is now commonly accepted that subjective and 
objective outcomes should be considered as complementary aspects of function 
evaluation, without hierarchy between them (Matsen et al., 2017; de los Reyes-
Guzman et al., 2014). Subjective measures give insights into matters of human 
concern such as pain and suffering, while physical measures allow the quantification 
of function (McDowell, 2006). Moreover, the fact that the measurement is objective 
does not mean that the patient’s subjectivity has no influence on the outcome. For 
example, kinesiophobia (which is a subjective feeling) may influence the course of the 
movement and consequently, the measured outcome. Thus, some subjective aspects 
that influence shoulder function are also accounted for when proceeding to an 
objective measurement. This is more an advantage than a disadvantage when 
measuring shoulder function, as the subjective aspects that influence the function will 
be also reflected in the outcome. 
Conversely, it should be considered that biomechanical parameters do not reflect the 
perceived functional importance of the movement for the person until that has been 
formerly specified. A challenge in movement analysis is the translation from a 
technical to a clinically valuable tool that is relevant for both the therapist’s and the 
patient’s perspectives (De Baets et al., 2017). For example, it might be highly 
important to be able to lift the arm above the head in the professional occupation of 
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one person and of little importance for someone else. Hence, the same objective 
result may have quite a different meaning for each of them. 
1.1.3.3.4. Kinetics and kinematics 
Movement analysis is usually separated into two branches of mechanics, involving 
kinetic or kinematic analyses. The kinetics is the branch of mechanics that concerns 
the effect of forces and torques on the motion of bodies having mass (Encyclopædia 
Britannica Online), while the kinematics concerns the description of the motion of a 
body or system of bodies that is geometrically possible without consideration of the 
forces involved (that is, without focusing on causes and effects of the motions) 
(Encyclopædia Britannica Online). Kinetics addresses either forces when considering 
the linear movement or torque when considering the angular movement. Conversely, 
kinematics addresses positions, linear velocities and accelerations, or angular 
velocities and accelerations. 
Kinematics has been used more often than kinetics for shoulder function analysis, as 
functional outcome is related to the ability to perform a movement rather than about 
causational explanations. Kinetics may offer a supplementary insight when the 
reasons for alterations in movement are of concern, but offer little added value when 
the aim is to evaluate function as an outcome. Moreover, they are more complex to 
acquire, as they require additional information compared to kinematics, such as mass 
or intensity of muscular activity. Thus, the possibility of applying a ‘lighter’ 
measurement procedure that is sufficient to analyse shoulder function explains why 
kinematics is more frequently used in the literature for the evaluation of shoulder 
function. In this context, kinematic analysis based on inertial sensor devices that 
record accelerations and angular velocities is increasingly used in the assessment of 
shoulder characteristics, due to their portability, and relative ease of use (Cutti et al., 
2008). 
1.1.3.3.5. Issues in the measurement of shoulder 
function 
The shoulder’s primary function is to orient the upper limb in visual work space, which 
will then allow, in contribution with the other upper limb joints, to place the hand in a 
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favourable condition for the execution of tasks (Culham and Peat, 1993). The 
respective role of the shoulder, elbow, wrist and fingers are the general upper limb 
orientation, distance adjustment, hand orientation and the handling of objects 
(Kapandji, 1971). 
The shoulder structure is designed to meet two apparently conflicting conditions for 
the great variety of possible tasks in human activity to be achievable: to have sufficient 
upper limb mobility for the target point to be reached and sufficient stability for the 
shoulder to remain steady when it is put under physical constraints and stress during 
a task’s execution (Veeger and van der Helm, 2007). This is made possible by the 
distribution of the movement over a complex structure composed of four different 
joints, the glenohumeral, acromioclavicular, sternocostoclavicular and 
scapulothoracic joints (Culham and Peat, 1993). The glenohumeral joints and 
surrounding muscles are in charge of the motion of the arm in relation to the shoulder 
girdle, while the four other joints regulate the motion of the shoulder girdle in relation 
to the trunk.  
This construction has the advantage of adding the mobility to the movement of the 
scapula over the thorax, which contributes to approximately one third of the motion, 
to the movement of the humerus in relation to the scapula. The thoracohumeral 
mobility, which reflects the global mobility of the arm in relation to the thorax, results 
from the addition of these two mobilities (Veeger and van der Helm, 2007). A 
harmonious scapulohumeral rhythm, that is distribution of movement between the 
humerus and the scapula, is necessary to reach the full possible motion without 
overloading the joints and surrounding soft tissues (Ludewig and Reynolds, 2009). 
Alterations of the scapulohumeral rhythm are frequently described in the case of 
pathologies, because pain or decreased mobility of one of the shoulder joints induces 
compensatory movements in the other ones. 
The shoulder complex enables large movements in the three space dimensions that 
is flexion-extension, abduction-adduction, medial-lateral rotations. Importantly, the 
spontaneous movements are rarely executed in one of the orthogonal planes, as the 
joints’ physiological orientations and shapes predispose to the execution of three 
dimensional movements. When the shoulder motion is not sufficient, additional upper 
limb mobility can be found by adding trunk movements to shoulder movements. Large 
mobility being intrinsically linked to increased instability, the coordination of the 
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seventeen muscles surrounding the shoulder is very important to avoid dislocation 
while providing power for three dimensional motions (Nordin and Frankel, 2001). 
Notably, the rotator cuff muscles acts as a stabilising sleeve around the glenohumeral 
joint.  
The complexity of the shoulder has meant that several approaches have been 
envisioned for its functional evaluation. Some authors underline the importance of 
separate analysis of each segment to be able to identify the source of a movement 
alteration (De Baets et al., 2017). This is sustained by the fact that coordination of the 
scapular and humeral movements is of importance for shoulder good functioning and 
is frequently altered in shoulder pathologies (Kibler et al., 2009; Ludewig et al., 2009; 
Ludewig and Reynolds, 2009; Lopes et al., 2015). However, this approach has 
technical implications, as it implies the need to use a complex model that accounts 
for the trunk, scapula and humerus movements, as well as their intersegmental 
coordination.  
Running this kind of analysis is challenging because of the controversies about the 
reliability of scapula movements (van den Noort et al., 2014; De Baets et al., 2013) 
and of the relation between pattern variations and clinical symptoms (Littlewood and 
Cools, 2017; Kibler et al., 2013). From a practical point of view, the correct placement 
of the markers on the flat surface of the scapula, which is surrounded by muscles, 
remains a limitation to reliable movement analysis due to the difficulty of managing 
skin-movement artifacts (Lefèvre-Colau et al., 2017; Matsui et al., 2006). Moreover, 
asymptomatic dyskinesia or compensatory movements between segments may mean 
that the observed alterations in a single joint do not automatically induce an alteration 
in upper limb function (Littlewood and Cools, 2017). 
Thus, a multisegmental model offers an insight into the intersegmental biomechanics 
that may be useful to understand some causes of altered function. Conversely, when 
only the functional outcome is of interest, without consideration for the underlying 
causes, a multisegmental model also induces an increased complexity that does not 
necessarily produce useful information for this purpose. 
Therefore, some authors have adopted a minimalist approach aiming at the design of 
a simple model based on the minimal number of markers or sensors. In this way, they 
have relied on the measurement of the thoracohumeral motion, a virtual joint between 
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the shoulder and the trunk that does not consider the involvement of a complex 
multisegmental structure in the movement (Coley, 2007; Korver et al., 2014a; Duc et 
al., 2013). This model has obvious limitations for the precise investigations of the 
causes and locations of shoulder problems. Conversely, it may be efficient in 
capturing the arm motion in relation to the trunk, which is the resultant of the motion 
produced by each shoulder joint, when shoulder function is the outcome of interest. 
In this case, the investigations of the integrity of each single joint are omitted in favour 
of the investigation of the shoulder function, defined as the ability to perform the 
shoulder movements required for the management of activities. This model targets 
solely the functional consequences of the problems that affect the shoulder function, 
without consideration for the origins or for the intrinsic biomechanical alterations. 
Despite these limitations, this concept of shoulder evaluation has advantages for 
routine clinical assessment of outcome, as it relies on a limited number of 
markers/sensors and produces data that is less complex to analyse than a 
multisegmental model. 
1.1.3.3.6. Implications for the thesis 
The aforementioned discussions about computerised movement analysis have 
theoretical implications for the scope of the results and practical implications for the 
research methods.  
In the absence of a universally recognised definition of shoulder function, it was 
necessary to define one that serves as a common thread for the thesis 2. Thus, the 
statement that the B-B Score is or is not a measurement of shoulder function will be 
made with reference to this definition that is an operational one but one which could 
be challenged, as any definition might be.  
As the kinematic approach analysis captures the movement by its essence, it will then 
be necessary to investigate if the B-B Score is actually representative of function. If 
                                               
2 Shoulder function: the ability of the shoulder to perform the movement and hold the 
positons required for the management of activities and life situations that are 
significant for the person. 
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the correlations with reference PROMs are low, it will imply that it does not measure 
function as conceptualised in these scores. 
In the absence of a gold standard for shoulder function evaluation, either as a PROM 
or as a computerised movement analysis method, it will be possible to assess the 
convergent validity of the B-B Score but not its gold standard validity. The convergent 
validity will thus be estimated using the correlations of the B-B Score with currently 
used PROMs, which represent the most established references to date for assessing 
shoulder function. 
Choices will have to be made in line with the thesis’ aim to validate a score that is 
applicable within routine practice. However, the pursuit of this aim also implies that 
the score will be incorporating some of the intrinsic limitations of the method that will 
be used.  
The B-B Score belongs within the category of the approach aimed at synthesis of 
shoulder function outcome measurements, which attempts to identify a limited 
number of movements and parameters that are representative of function. In pursuing 
the design of a simple approach to assessment, a thoracohumeral measurement is 
used in this score to minimise the sensors’ configuration. As previous researchers 
have shown that one sensor was sufficient for function evaluation within measurement 
conditions in which the trunk movements can be controlled, only one IMU or 
smartphone will be fixed on the arm segment (Coley et al., 2007a; Jolles et al., 2011; 
Korver et al., 2014a). A limitation of this approach lies in the fact that no insight will 
be possible into the causes and precise location of the shoulder movement 
alterations.  
The B-B Score is based on the comparison of a power-related metric (multiplication 
of angular velocities by accelerations) between sides (Pichonnaz et al., 2015c). This 
represents the patient’s ability to control the humerus’ velocity by its acceleration 
during the execution of the movement (Coley et al., 2007a).  
The patient acts as his own control within this approach, with the healthy shoulder 
representing the normal performance of the person. This implies that the score will 
not be applicable in cases of bilateral shoulder pathologies, as no normal performance 
can be determined on either side when both sides are affected.  
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The B-B Score is based on accelerations and angular velocities, because it is 
preferable to refer to dynamic rather than static kinematics like end ROM, to capture 
shoulder function (Coley, 2007; Lopez-Pascual et al., 2017a). This may be explained 
by the fact that in some patients, the full ROM can be reached, but with difficulty. In 
these cases, the end ROM is normal, while the difficulty in executing the movement 
is captured by dynamic parameters, which are therefore indicative of the altered 
function of the shoulder. This approach proved to be discriminative for the P Score, 
which uses the same metric as the B-B Score (Coley et al., 2007a). Due to the three-
dimensional aspect of functional shoulder movements, a 3D data capture will be 
needed.  
A technical advantage of the use of IMU fitted with accelerometers and gyroscopes is 
that accelerations and angular velocities are measured directly, without the need for 
differentiation or integration calculations. Thus, the drift that affects inertial 
measurement remains negligible, as no calculation process amplifies it. This directly 
contrasts to the situation for angular measurements made using an IMU, which may 
be effected by drift in this case, but will not be used for the purpose of shoulder 
function assessment in this thesis (Amasay et al., 2009; Rowe, 1999). To ensure the 
soundness of this argument, this point was investigated and confirmed by preliminary 
measurements that preceded the start of the thesis. 
 Clinimetrics 
To be recognised as validated, any new score needs to undergo an extensive 
validation process based on current requirements. The scientific discipline that deals 
with the establishment of the measurement quality has been referred to by various 
terms with corresponding definitions, including psychometrics, metrology or 
clinimetrics.  
Subtle nuances that are subject to controversies exist between the delineations of 
these terms, about which further discussion is beyond the scope of this thesis 
(Streiner, 2003). For the purpose of this thesis, the term clinimetrics was adopted for 
its focus on clinical measurement. Clinimetrics is a methodological discipline that 
deals with the quality of clinical measurement (Feinstein, 1983). It thus encompasses 
both the quality of the instruments and the quality of the actual measurements, while 
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also accounting for errors induced by human factors and the environment (de Vet et 
al., 2003). 
Multiple qualities are expected from a measurement instrument to ensure that the 
result gives a correct representation of the reality. These qualities are encapsulated 
by the concepts of validity, reliability and responsiveness (Mokkink et al., 2010d). In 
addition, the determination of normal performance and interpretability aspects is of 
importance for the interpretation of the results (Tubach et al., 2007). Some practical 
aspects like accessibility, interpretability and affordability are also of importance for 
clinical implementation. These notions will be defined immediately hereafter, as well 
as a discussion of their implications for validating a measurement tool. 
The definitions and relations between concepts for measurement are difficult to obtain 
in essence and are thus subject to controversies. Although every definition might be 
considered disputable, the definitions provided by the COSMIN study represent a 
sustainable taxonomy of measurement properties of HR-PROs (health-related 
patient-reported outcomes), as they are based on an international consensus of 
experts using a systematic methodology (Mokkink et al., 2010d). This COSMIN 
terminology will thus be used to structure this chapter and to determine the 
measurement properties to be used in the measurement property study. An overview 
of the COSMIN classification that summarises the domains, measurement properties 
and aspects of measurement properties that define the quality of an instrument is 




Figure 1.2: COSMIN classification that summarises the domains, measurement 
properties and aspects of measurement properties that define the quality of an 
instrument. Source: MOKKINK, L. B., TERWEE, C. B., PATRICK, D. L., ALONSO, J., 
STRATFORD, P. W., KNOL, D. L., BOUTER, L. M. & DE VET, H. C. 2010. The 
COSMIN study reached international consensus on taxonomy, terminology, and 
definitions of measurement properties for health-related patient-reported outcomes. J 





The validity is the degree to which an instrument measures the construct(s) it purports 
to measure (Mokkink et al., 2010d). It is thus a fundamental quality, because there is 
no point in running further studies to establish the measurement properties of an 
instrument that would not effectively measure the outcome it is intended to measure. 
Validity includes three measurement properties, which are content validity, construct 
validity and criterion validity.  
 Content validity 
Content validity refers to the degree to which the content of an instrument is an 
adequate reflection of the construct to be measured (Mokkink et al., 2010d).  
Content validity also encompasses the aspect of face validity, which is the degree to 
which (the items of) an instrument indeed look as though they are an adequate 
reflection of the construct to be measured (Mokkink et al., 2010d). The establishment 
of face validity is based on a subjective assessment of the content of the instrument 
(De Vet et al., 2011e). It relies on the impression of persons that are recognised as 
knowledgeable about the concept to be measured, considering their experience and 
the related literature in their field of competence. Though rather basic in its 
conception, face validity is a fundamental initial step to consider before the initiation 
of complex validation studies (De Vet et al., 2011e). 
Content validity implies the need to investigate the content of the instrument in more 
detail than face validity to assess whether it adequately represents the construct being 
scrutinised (De Vet et al., 2011e). It requires the assessment of the relevance and the 
comprehensiveness of the items for the construct to be measured (McDowell, 2006). 
Thus, the clear definition of the concept of interest is a prerequisite for content validity 
evaluation. After the concept has been circumscribed, it can be assessed if the items 
of the instruments are in close relationship to it and cover all its dimensions. The 
content validity is assessed by the persons who are concerned with the instrument. 
For PROMs, these persons can be patients, who have become knowledgeable 
through their experience of the disease, or health professionals, who have become 
informed through their training and encounters with patients. So, content validity is 
based on expert opinion rather than on statistical testing. This measurement property 
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is relative to the context of the measurement and the population, and should therefore 
be assessed specifically for each population in which the instrument is used. A 
positive rating for content validity can be given if a clear description is provided about 
the instrument’s wider development process. This includes the reporting of the 
measurement aim, the target population, the concepts that are being measured, and 
the items’ selection. Furthermore, the target population and/or experts should have 
been involved in the instrument’s construction process (Terwee et al., 2007). 
The determination of content validity is central for clinical measurement as it relates 
to the fundamental issue of what is measured. In some cases, the content validity is 
rather straightforward to establish, as the relation between the concept and the 
instrument is obvious. For example, the relationship between the knee joint mobility 
and its range of motion is evident in an osteoarthritic population. Conversely, some 
concepts are more difficult to define are they give more scope for subjective 
interpretation. The latter concern has been addressed previously within this 
introduction to the thesis when issues and controversies related to the measurement 
of shoulder function had been discussed. Nevertheless, measures of subjective 
aspects are sometimes irreplaceable in clinical evaluations, as they provide an insight 
into matters of human concern that cannot be investigated from physical 
measurements (McDowell, 2006). 
Specifically concerning the B-B Score, its face validity has been determined by its 
close relationship to the P Score, which itself measured objectively the movements 
described in the SST, a commonly used shoulder function PROM (Pichonnaz et al., 
2015c). The two movements “hand to the back” and “hand to the ceiling as to change 
a bulb” are also reported as being problematic by patients suffering shoulder function 
loss (van der Windt et al., 1995; Magermans et al., 2005). This endorses the face 
validity of the B-B Score, as it shows an a priori link to shoulder function. 
The content validity of the B-B Score has not been determined by a systematic 
investigation of expert opinion, though the two selected movements are currently used 
for clinical evaluation of the mobility of the shoulder. Conversely, the choice of the 
movements was justified by statistical methods that relate to construct validity 
(Pichonnaz et al., 2015c). Further investigations conducted within this thesis will 
examine to which degree the score content – that is the measurement of a power-
related metric for the two movements – is congruent with the measurement aim that 
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is to grasp shoulder function in various pathologies. The conclusions will have to be 
drawn separately for each pathology, because the content validity is specific for each 
population (De Vet et al., 2011e). Therefore, specifically for this score, the content 
validity of the score is sustainable, but has been determined using different methods 
than the ones that are currently used for item selection in PROMs questionnaires (i.e. 
statistical approach instead of expert opinion). 
 Floor and ceiling effect 
Floor and ceiling effects are classified within “Content validity” in the COSMIN 
taxomony, as these effects are related to the distribution of the items over the scale. 
They are also related to interpretability aspects, as information about the floor and 
ceiling effects are important for the interpretation of the performance or the change of 
a score. 
The sensitivity of an outcome measure may not be homogeneous along all the 
possible scale values, especially at the scale’s end ranges. Such a phenomenon is 
indicative of a limitation in content validity of a scale (Terwee, 2007). For example, a 
scale containing overly challenging items will not be responsive to the deterioration of 
patients with low performance, if they have already exhibited the minimum score 
before the deterioration. Such a scale offers insufficient scoring sensitivity at its lower 
echelons in particular. This phenomenon is called the floor effect. Conversely, a 
ceiling effect is observed when the outcome measure’s items are not challenging 
enough for the evaluated population. In this case, the improvement of patients who 
perform high will remain undetected, as they have already achieved the maximum 
outcome measure value, before displaying further improvement. Such a scale offers 
insufficient scoring sensitivity at its higher echelons in particular. Therefore, when floor 
effect is present, patients with the lowest possible score cannot be distinguished from 
each other, even though their performances may differ. The same reasoning apply for 
patients with the highest possible score when ceiling effect is present. For example, 
an outcome measure designed for patients, will typically show a ceiling effect in 
athletes, and will thus be unable to discriminate the performance level among the 
latter group. Floor and ceiling effects are thus contextual to the population for which 
they were determined (Terwee et al., 2007). 
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It is generally considered that floor and ceiling effects exist when more than 15% of 
the patients get the minimum or maximum value on the score, respectively (Terwee 
et al., 2007; McHorney and Tarlov, 1995). However, this approach does not account 
for possible measurement errors. Therefore, it has also been proposed to use the 
minimum scale value + MDC (minimal detectable change), as a threshold for floor 
effect, and the maximum scale value - MDC, as a threshold for ceiling effect. This 
approach accounts for the fact that a change below the MDC value is unlikely to be 
detected if it is close to one of the extremes (van der Linde et al., 2015; van der Linde 
et al., 2014). 
The commonly accepted approach, which consists in taking 15% of patients as a 
threshold for floor and ceiling effect determination, is somewhat arbitrary and implies 
a dichotomous conception of floor and ceiling effects that can only be considered 
“present” or “absent”. However, when the measurement properties of several 
outcome measures are compared within a study, the proportion of outcomes at the 
minimum and maximum scale values is also informative about the respective trend of 
each outcome measure towards floor and ceiling effects, regardless of the 15% 
threshold. 
 Construct validity 
In contrast, to content validity, construct validity implies the need for statistical 
analyses to determine objectively to what extend the instrument is coherent with the 
construct of be measured. It encompasses several measurement properties, which 
are structural validity, hypotheses testing, and cross-cultural validity (Terwee et al., 
2007). 
Structural validity is concerned with the degree to which the scores of an instrument 
are an adequate reflection of the dimensionality of the construct to be measured 
(Mokkink et al., 2010d). For abstract concepts, gold standards do not exist and thus 
validity testing is more challenging. Some analyses need to be done to investigate if 
a single score can really summarise several variables into a coherent single result 
(McDowell, 2006).  
When an instrument is unidimensional, it uses several items or measurements that 
should all be related to the targeted concept. In cases where a measurement contains 
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several scales to produce a resulting score that combines different subscores, each 
of those should be unidimensional. For example, a score that aims to measure a 
complex clinical phenomenon might have a physical, a mental and a psychosocial 
dimension, which should be clearly differentiated in a multidimensional instrument. 
The scale dimensionality can be assessed using factor analysis (FA), which is an 
advanced statistical approach used to reduce a large number of variables into fewer 
numbers of factors corresponding to dimensions. It calculates the maximum common 
variance from all variables and indicates if it is relevant to condense them into a single 
score. Exploratory factor analysis is used in case no a priori hypothesis is made about 
the concept. It shows how the measured variables cluster together to represent an 
underlying construct (McDowell, 2006). Exploratory FA aims thus to identify groups of 
variables that form a dimension that is related to the concept. Confirmatory FA is used 
to test hypotheses regarding the factor structure that has been previously formulated 
based on a theoretical approach (Terwee et al., 2007).  
Hypothesis testing is another aspect of construct validity. Some theoretical relations 
are hypothesised, when a score is developed based on a construct. These theoretical 
hypotheses have to be confirmed to be real by statistical analyses for the score to be 
considered valid. Hypothesis testing relates thus to the degree to which the scores of 
an instrument are consistent with hypotheses based on the assumption that the 
instrument validly measures the construct to be measured (Mokkink et al., 2010e; 
McDowell, 2006). 
Many hypotheses requiring various research designs can be envisaged when an 
outcome measure is to be validated. Most important types of hypotheses can be 
grouped into the notions of convergent, divergent or known-groups validity. 
Contextualising these notions in the context of shoulder function, a new shoulder 
function outcome measure would be expected to be correlated to other outcome 
measures pursuing the same aim (convergent validity), and negatively correlated to 
dysfunction outcome measures (divergent validity). It would also be expected that the 
results are related to the shoulder health status, that is, there would typically be 
significant differences between patients and healthy controls (known-groups validity) 
(Mokkink et al., 2010e; McDowell, 2006). 
The translation of a questionnaire into various languages is not a straightforward 
issue, because some subtle nuances may be hard to translate and because the idea 
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underlying a question can be diversely interpreted according to the cultural 
background and lifestyle of different populations. A rigorous translation process with 
forward and backward translation by several translators is required to ensure the 
language and cultural equivalency of the translated and original version of an outcome 
measure (Wild et al., 2005; De Vet et al., 2011e). Nevertheless, a thorough translation 
is not sufficient to ensure that the equivalency is reached. Cross-cultural validity (that 
is the degree to which the performance of the items on a translated or culturally 
adapted instrument are an adequate reflection of the performance of the items of the 
original version) has to be established. This implies that by using various statistical 
approaches (confirmatory factor analysis, logistic regression and item response 
theory), it must be demonstrated that the questionnaire structure, item difficulty and 
measured performance are similar to those of the original version for the 
measurement of similar populations (De Vet et al., 2011e). It may also be sound to 
check that reliability and responsiveness are equivalent between versions.  
The confirmation of the outcome measures’ equivalency is of first importance for the 
realisation of meta-analyses that compile results from various countries. Yet, it is a 
very cumbersome process that limits the possibility of using a questionnaire 
universally. A long time is needed until valid translations are available in major 
languages and there is a high risk of excluding the numerous populations that speak 
local idioms. Quantified evaluation has a clear advantage over questionnaires on this 
issue, as numbers are more universally shared language. 
 Criterion validity 
Criterion validity is the degree to which the outcomes acquired using an instrument 
are an adequate reflection of a “gold standard” (Mokkink et al., 2010e). It considers 
thus whether outcomes on the instrument agree with another measurement of the 
same outcome that is an undisputable reference. This property is typically 
investigated when a new instrument is developed as an alternative that could 
potentially be simpler, cheaper or more convenient to use than an established 
measurement. Criterion validity is sometimes called concurrent validity when the 
criterion refers to a current state, and predictive validity when it refers to the 
anticipation of a future state (McDowell, 2006). 
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In the situation of shoulder function, no criterion validity can be established due to the 
lack of a gold standard, because no indisputable measurement of shoulder function 
exists and the definition of one in the future is hardly conceivable. In this scenario, the 
establishment of convergent validity, that is the testing of hypotheses that state that 
the results are correlated positively with the results of other instruments that measure 
the same concept, is the best approach that can be envisaged (McDowell, 2006). 
Thus, for shoulder function, its evaluation requires the calculation of the strength of 
correlation of the tested instrument with other recognised measurements of shoulder 
function, in order to explore how far the tested instrument actually reflects shoulder 
function. 
For diagnostic tests, criterion validity comes from discriminating correctly those who 
have from those who do not have a disease, as would be demonstrated by a gold 
standard that classifies relevant people without mistake. A test is considered as 
sensitive when it identifies all the people with the condition of interest, and it is specific 
when the people identified by the test as having the condition, really have it. 
Therefore, if the test lacks sensitivity some people with the condition will miss being 
identified. A negative sensitive test is particularly useful for ruling out with minimal 
doubts the people without the disease, and thus for avoiding unnecessary 
interventions. A positive specific test is particularly useful for ruling in with minimal 
doubts, the people with the disease, and thus for undertaking necessary measures 
for them (Nendaz and Perrier, 2004; Christe, 2017).  
Considering computerised shoulder function analysis, movement alterations have not 
been shown to be pathognomonic of specific shoulder conditions to date. So, this 
approach cannot be used to diagnose shoulder conditions. Conversely, it can be used 
to discriminate patients with shoulder function alteration from patients with healthy 
shoulders (Korver et al., 2014a; Pichonnaz et al., 2015c). Though unable to identify 
precisely the medical diagnosis, a good outcome measure of the shoulder function 
should be able to separate people who probably have a functional decrease from 
those who have not. 
In contrast to a disease diagnosis, which is dichotomous (the disease is either present 
or absent), a shoulder function outcome measure fits in a continuum that ranges from 
a completely absent to a normal function. Thus, there is a requirement to have 
identified a cut-off score that represents the best balance between sensitivity and 
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specificity, knowing that an increase in sensitivity is almost always associated with a 
decrease in specificity (McDowell, 2006). The receiver operating characteristic (ROC) 
curve that plots true-positive (sensitivity) against false-positive (1-specificity) results 
can be calculated to illustrate the trade-off between sensitivity and specificity. 
Therefore, the cut-off score that represents the optimal balance between sensitivity 
and specificity and the area under the curve (AUC), indicates the amount of 
information provided by the test, which can be calculated. An AUC value of 0.5 
indicates that the outcome measure is no better than merely guessing to identify if 
someone has a shoulder function loss, while a value of 1 means that the outcome 
measure discriminates without mistake those who have from those who do not have 
a shoulder function loss (McDowell, 2006; Hanley and McNeil, 1982). 
1.1.3.4.2. Reliability and agreement 
The notion of reliability relates to the degree to which the measurement is free from 
measurement error (Mokkink et al., 2010e). It is defined by the proportion of the total 
variance in the measurements, which is due to “true” differences between the patients. 
It expresses thus how well patients can be distinguished from each other despite the 
presence of measurement error (McDowell, 2006). Ideally, an instrument is expected 
to produce the same results for repeated measurements of patients who are stable. 
This should be the case when using different sets of items from the same instrument 
(internal consistency), over time (test-retest), by different persons on the same 
occasion (inter-rater) or by the same person (that is, rater or responder) on different 
occasions (intra-rater) (Mokkink et al., 2010e) 
 Internal consistency  
Internal consistency refers to the interrelatedness of the items (Cortina, 1993). This 
measurement property is evaluated using a statistical construct involving the 
computation of Cronbach’s alpha, which is indicative of the degree of inter-correlation 
between the items, and thus their consistency in measuring a latent trait. A 0.70 to 
0.90 value is generally considered as a measure of good internal consistency. A lower 
Cronbach’s alpha indicates a lack of homogeneity between the items, which makes 
summarising them into a single score unjustified. Conversely, a higher Cronbach’s 
alpha is an indication of redundancy between the items (Terwee et al., 2007).  
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Despite an existing controversy about its ability to determine the internal structure of 
an outcome measure, Cronbach’s alpha remains the most frequently used statistics 
for this purpose and is considered an adequate evaluation by the COSMIN 
(COnsensus-based Standards for the selection of health Measurement Instruments) 
initiative (Mokkink et al., 2010c). Cronbach’s alpha refers to Classical Item Theory 
(CTT), but an alternative approach is to use Item Response Theory (IRT). IRT is a 
more complex approach that does not assume that each item is equally difficult and 
incorporates this information in the analysis using item characteristic curves that 
reveal the item’s difficulty (van Alphen et al., 1994). A different reliability coefficient 
will thus be calculated for each item, implying that no single reliability result exist for 
a measurement (McDowell, 2006). This topic will not be considered further as it has 
limited implications within the context of the thesis. 
 Test-retest, intra- and inter-rater reliability  
Conversely, test-retest, intra- and inter-rater reliability have strong implications for the 
work to be done. These three aspects of reliability have in common that they share a 
focus relating to the degree of error in repeated measurements. Classical test theory 
considers that the result is a combination of the underlying true score and error to 
some degree (McDowell, 2006). In test-retest reliability, the errors are only due to day-
to-day variations or to the instruments. In intra-rater reliability, the error introduced by 
the variations that a rater makes between his/her measurements is added to the 
previously mentioned sources of error. In inter-rater reliability, the error introduced by 
the variations between raters is added to all previously mentioned sources of error 
(De Vet et al., 2011b). 
Intraclass correlation should be ≥ 0.75 to be considered as good and should be ≥0.90 
to ensure reliability in clinical measurements (Portney and Watkins, 2015). 
Intraclass coefficient of correlations (ICCs) is the most frequently used statistic to 
evaluate the reliability of continuous variables, while the Kappa coefficient is used for 
dichotomous variables and the weighted Kappa for ordinal variables (De Vet et al., 
2011b; Kottner et al., 2011).  
ICCs will be used to evaluate continuous variables within this thesis. ICC is indicative 
of the ability of a test to differentiate between individuals (Weir, 2005). It has the 
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advantage of being sensitive to systematic differences, in contrast to the Spearman 
correlation, and thus, it’s an estimator of agreement and not just consistency (i.e. the 
actual similarity of measurements rather than just an estimate of their association) 
(McDowell, 2006). This might be of importance in the detection of training- or fatigue-
related effects when proceeding to repeated measurements, for example. Several 
forms of ICCs have been described to adapt to various testing conditions, for example 
the number of replications and raters (Shrout and Fleiss, 1979). All formulas for ICCs 
consist of a ratio of the variance due to systematic differences between the “true” 
scores of patients and the total variance (summing true and error variance) (De Vet 
et al., 2011b). Thus, ICCs have been criticised because of their tendency to be low 
when the sample variance is low and high when the sample variance is high, 
independently of the measurement error (Russek, 2004). Thus it implies that reliability 
is a characteristic of an instrument used in a population, and not just an intrinsic 
property of an instrument (McDowell, 2006). Another limitation of ICCs is that they 
provide a global indicator of reliability but do not give indications on the potential error 
magnitude between measurements (Bland and Altman, 1986b). 
An alternative to the calculation of ICCs, is the calculation of the concordance 
correlation coefficient (CCC), which indicates the agreement between the observed 
data and a 45° slope (line of identity) (McDowell, 2006). Both methods are considered 
as equivalent and produced results are comparable (Feng et al., 2014; Carrasco and 
Jover, 2003) 
 SEM 
The standard error of measurement (SEM) is an indication of the precision of an 
outcome measure, that allows the construction of confidence intervals around the 
measured values (Weir, 2005). Though SEM is abbreviated similarly to the standard 
error of the mean, it should not be confused with it. The standard error of the mean is 
not related to reliability, as it is defined as the standard deviation of the sampling 
distribution around the mean (McDowell, 2006). 
The SEM is representative of the “typical error” of a measurement, as it quantifies the 
precision of individual outcome measures on a test. It defines the boundaries within 
which a subject’s true outcome probably lies (Weir, 2005). It is indicative of the amount 
of error that may be expected, due to chance alone. Ideally, the SEM would be zero 
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when using a perfectly reliable instrument and all variation would reflect true 
differences (McDowell, 2006). The SEM95 is generally reported (indicating 95% 
confidence limits within which the true outcome is expected to lie), though some 
authors report it using the less stringent 90% interval. Using the SEM95, a clinician 
can be 95% confident that the patient’s true outcome lies within the ‘±’ error 
boundaries specified for this parameter. As such, this is an important indication of the 
margin of error of a result in constructing the clinical interpretation of an outcome. For 
example, a rater can be reasonably confident that a patient improved only if the 
difference between the initial and follow-up measurement is larger than the SEM95 
(Michener, 2011).  
The SEM is calculated using the standard deviation of errors amongst repeated 
measurements (De Vet et al., 2011b). There are SEMagreement and SEMconsistency 
versions of the SEM that accounts or does not account for systematic errors, 
respectively. However, as a limited amount of repetitions of measurements is 
generally available in practice, the SEM is rarely determined using the SD of repeated 
measurement. It more frequently estimated using SD of the difference between two 
raters ( 	
   


 √2  ) or the formula based on the ICC 
(	
     √1  ), which represent an estimate of SD of errors 
for the data available (De Vet et al., 2011b; Portney and Watkins, 2015). Applying the 
second formula, it should also be kept in mind that, for the SEM to be estimated and 
relevant, the ICC used in the calculation should originate from the same population 
as the one in which the SEM will be used (De Vet et al., 2011b).  
 Minimal Detectable Change 
When a difference is observed between two measurements, the issue for the rater is 
to differentiate between the difference caused by error in the value measured by the 
instrument, or by a real difference between measurements, knowing that both are 
combined to a variable and unknown extent. The Minimal Detectable Change (MDC), 
also sometimes called SDC (smallest detectable change), MDD (minimal detectable 
difference) or SDD (smallest detectable difference), can be calculated to evaluate the 
value beyond which the difference can be considered as true (Beaton et al., 2001a). 
The MDC is linked to the SEM value as the mathematical expression to calculate 
MDC is: MDC (95% confidence level) = 1.96 * √2* SEM 
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The 95% confidence interval is generally used, though the less stringent MDC at 90% 
confidence interval (MDC90) is sometimes reported (Beaton et al., 2001a; Membrilla-
Mesa et al., 2015a; Michener, 2011). It is considered that values larger than the MDC 
at 95% confidence level (MDC95) have 95% probability to be due to a real difference 
(van Kampen et al., 2013). 
The MDC is an important property for the interpretation of differences for the clinician. 
However, it should be kept in mind that, though real, a change could be of little 
importance for the patient’s subjective state (de Vet et al., 2006a; Michener, 2011). It 
should also be considered that the MDC is population dependent (Schuller et al., 
2014). 
 Bland and Altman analysis 
Bland and Altman (B&A) have proposed a procedure to plot the values of the 
differences between measurements against the measured value, as well as to 
calculate the limits of agreement (LoA) and the bias (Bland and Altman, 1986b). They 
proposed this approach to overcome some shortcomings of the correlation and 
regression analyses that are indicative of the strength of the relationship but do not 
provide values on the systematic and random error of measurements. Conversely, 
the 95% limits of agreement and bias inform the user on the range that contains 95% 
of random measurement differences and the systematic measurement difference, 
respectively. In addition, while calculated correlations tend to be higher when the 
study sample heterogeneity is high, agreement parameters are independent of the 
data dispersion (de Vet et al., 2006b; Russek, 2004). The B&A analysis can be 
performed for test-retest, intra-rater, and inter-rater measurements. The magnitude of 
the LoA is closely related to the magnitude of the SEM, as the LoA represent 1.96 * 
SD of the difference between measurements, and the SD of the difference can be 
estimated using the formula: SDdiff = (√2 ∗  !"#"$! %&. 
When performing a B&A analysis, it is important to check the assumption that the 
differences between the measurements do not change as a function of measured 
values (De Vet et al., 2011b; Giavarina, 2015). For example, it can be useful to check 
if the errors increase with the measured value. In addition to using calculations, Bland 
and Altman proposed that graphical analyses of the differences be performed to allow 
for a visual inspection of their characteristics (Bland and Altman, 1986b). The B&A 
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graph consists in plotting the values of the differences between measurements 
against the measured value, and tracing the lines that indicate the bias (mean value 
of the differences between measurements) and the 95% LoA (range from the bias ± 
1.96 standard deviation of the differences). When further analysis is required, the 
relationship between errors and measured values can also be characterised using 
regression analysis and the randomness of their distribution can be checked using 
graphs and inferential statistics. 
LoA and bias can be expressed as absolute values when the error on the scale is of 
interest, or as percentages when the proportion of error is of interest. The degree of 
precision of the bias and LoA estimations can also be determined calculating the 95% 
confidence interval (Giavarina, 2015). Illustrations of Bland and Altman plots with the 






Figure 1.3: a) Bland and Altman plot with the representation of the limits of agreement 
(dotted line), from -1.96 standard deviation to +1.96 standard deviation and bias 
representing the mean of the differences between measurements. b) Bland and 
Altman plot including regression line and its confidence interval limits. From: 
Giavarina, D. (2015). Understanding Bland Altman analysis. Biochemia Medica, 
25(2), 141-151. 
1.1.3.4.3. Responsiveness 
The responsiveness is defined as the ability of an instrument to detect change over 
time in the construct to be measured (Mokkink et al., 2010e). This definition implies 
that the instrument must not only be able to measure a change that happened, but 
also that the measured change has to be in close relationship with the outcome 
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targeted by the instrument. Considerable controversies surround the delineation of 
what responsiveness encompasses and which are the appropriate methods to 
measure it (Terwee et al., 2003; Mokkink et al., 2010e; Angst, 2011). The above 
definition was adopted in this thesis because it results from a consensus. Methods for 
the evaluation of responsiveness in measurement instruments that have been used 
in current practice will be described, without entering into the conceptual debate on 
the definition of responsiveness. 
Responsiveness is an important measurement property, considering that the 
assessment of the change in patient’s status is crucial for health interventions aiming 
at improving the patient’s condition (De Vet et al., 2011c). Two facets are of interest 
when investigating the responsiveness of an instrument: its ability to detect a 
treatment-induced change over a given time period, and also the relationship between 
the change that the instrument measures and the change in an external standard 
(Husted et al., 2000; Terwee et al., 2003). Based on the latter stated expectations and 
the methods currently used in the literature (as stated in the literature review 
performed in this thesis), the following characteristics for responsiveness’ evaluation 
will be presented: the statistical difference between groups/stages, effect size, 
standardised response mean, correlation between change scores and ROC curves 
analysis.  
 Statistical difference between groups or 
stages 
The calculation of the statistical significance of the difference between groups, when 
differences are expected between the groups, or of the difference between 
measurement times for treatments of known efficacy, are currently used to evaluate 
the ability of an instrument to detect differences. This constitutes a fundamental step 
for responsiveness evaluation, as an instrument that would fail this test would have 
limited value in measuring the patient’s state and change. However, the collected 
information is limited because the significance of the differences provides neither 
information on the magnitude of the change, nor on the quality of the tested instrument 
compared to an external standard (De Vet et al., 2011c; Mokkink et al., 2010b). The 
ability of an instrument to discriminate between groups and between measurement 
times is merely a prerequisite of a responsiveness evaluation, and is also sometimes 
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classified within hypothesis testing for the evaluation of construct validity (Mokkink et 
al., 2010e). 
 Effect size 
The Cohen’s effect size (ES) is a relative and without unit indicator of responsiveness 
that is calculated as the mean change score in a group, divided by the pooled 
standard deviation (SD) (McDowell, 2006). It is thus influenced by the magnitude of 
the change and the variance in scores. An effect size of ≤ 0.20 represents a small, 
0.50 represents a moderate and ≥ 0.80 represents a large change (Portney and 
Watkins, 2015; Husted et al., 2000). However, these values should not be considered 
as standards applicable regardless of the context, as is discussed hereafter. 
The criteria for the qualification of effects sizes are useful to provide an insight about 
the efficacy of a treatment. For example, a statistically significant difference compared 
to baseline status might have limited clinical interest if the ES is small or lower than 
that of a concurrent treatment. The comparison of the effect sizes of several 
measurement instruments that measure the same construct in the same conditions is 
also instructive about their respective sensitivity to capture the change that happened. 
The most responsive instrument will have a higher ES than the other ones for the 
measurement of the same phenomenon. Conversely, the ES of a single instrument 
or the longitudinal comparison of effect sizes across several studies has little interest 
for the evaluation of measurement properties, because it is as much influenced by the 
treatment effect as by the quality of the instrument (Angst, 2011; De Vet et al., 2011c). 
The determination of the ES is also of interest to calculate the sample size that is 
required for a study. In general, the higher the effect size, then, the smaller the sample 
size need to be in order to reach the desired study power (generally 0.80) (Portney 
and Watkins, 2015; McDowell, 2006). 
 Standardised response mean 
The standardised response mean (SRM) is based on a statistical approach that is 
close to that of the ES. Its calculation is based on the mean change score in a group, 
divided by the SD of this change. As a ratio of change relative to the standard 
deviation of the change in scores, it is thus influenced by the variability in the degree 
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of change, rather than by the sample’s degree of homogeneity both prior to and after 
an intervention (as the ES is). Cohen's criteria for small, moderate and large effect 
sizes apply for this index as well (Portney and Watkins, 2015). 
 Correlation between change scores 
When a reference instrument exists, the correlation between the change score 
measured on this reference and on the tested instrument can be used as an indicator 
of responsiveness. A significant correlation means in this case that the sensitivity to 
change of the tested outcome measure is related to that of an outcome measure that 
is known to be responsive for the same construct. As would be expected for a 
construct validity evaluation, a priori relevant hypotheses should be formulated on the 
level of correlation, although in this case, evaluations should be focussed on change 
scores (Mokkink et al., 2010b). The magnitude of the correlation amongst change 
scores is generally lower than the correlation between scores at a given timepoint, 
because each measurement has a certain degree of measurement error (De Vet et 
al., 2011c). 
A limitation of correlation amongst change scores lies in the fact that frequently, no 
gold standard exists for a measurement. A solution is to measure the change 
correlation simultaneously alongside another previously validated instrument that 
aims to measure the same construct, though it might not perfectly measure it. A good 
correlation demonstrates that the measured change of the tested instrument is related 
to that of an instrument that has previously demonstrated to be responsive (De Vet et 
al., 2011c). However, the degree of correlation will be relative to the reference 
instrument only, and it might even tend to decrease when the tested instrument is 
more responsive than the reference instrument. An alternative would be to calculate 
the change correlation in comparison with a global rating scale (GRS). At follow-up, 
patients are then asked in a single question, to indicate how much they have changed 
on the construct of interest. However, the reliability and validity of such retrospective 
measures of change is debated (De Vet et al., 2011c). 
 Receiver operating characteristic curves 
A receiver operating characteristic (ROC) curve can be used to evaluate the 
responsiveness when the gold standard is a dichotomous variable. In this context, the 
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curve illustrates the trade-off between sensitivity and specificity for the classification 
of patients as improved or non-improved. The specificity (that is, the probability of the 
measure correctly classifying patients who do not demonstrate change on the external 
criterion, in this context) and sensitivity (i.e. probability of the measure correctly 
classifying patients who do not demonstrate change on the external criterion, in this 
context) can also be assessed for each score value, and the optimal detection 
threshold (cut-off presenting the highest sensitivity-specificity ratio) can also be 
determined using a ROC curve (McDowell, 2006; Husted et al., 2000). 
The area under the ROC curve (AUC) is used to measure the ability of an instrument 
to discriminate between participants who are considered to be improved and those 
who did not improve, according to the gold standard (De Vet et al., 2011c). An AUC 
value of 1 would be found for an instrument that perfectly discriminates improved from 
non-improved participants, and a 0.50 value for an instrument that would not help 
discriminate amongst them at all. AUC values of 0.6 to 0.7 represent thus poor 
accuracy, 0.7 to 0.8 fair, 0.80 to 0.90 good and >0.90 excellent accuracy (Pines et al., 
2012; Terwee et al., 2007; De Vet et al., 2011c). A score of 0.70 is usually considered 
appropriate (De Vet et al., 2011c; McDowell, 2006; Jimerson, 2007).  
A disadvantage of the ROC curve analysis is that the external clinical change score 
must be dichotomised between improved and unimproved. So, the information, which 
is provided about the magnitude of change by the external criterion, is lost in the 
process of dichotomisation (Husted et al., 2000). 
 MCID/MCII 
Many measurement properties are determined based on statistical calculations that 
do not account for the patient’s point of view. It might happen that a treatment makes 
a significant difference from a statistical point of view while the patients consider that 
the treatment effect is not large enough to induce a meaningful change for them. 
Conversely, the Minimal Clinically Important Difference (MCID) is a measurement 
property that indicates from beyond which pre-post treatment difference, the change 
of his/her state is meaningful for the patient (Michener, 2011; de Vet et al., 2006a). 
MCID includes patients who improved and patients who worsened, though the extent 
of change that patients consider clinically important is not the same in these two 
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populations. Thus, the concept of MCII (Minimal Clinically Important Improvement) is 
more specific, as it provides information about the magnitude of the improvement on 
the scale expected by the patient, for the treatment to be considered as valuable by 
him (Tubach et al., 2012). 
There is a controversy about the best method to use for the determination of 
MCII/MCID (Tubach et al., 2005c). This is problematic as the use of different methods 
leads to the determination of varying MCII/MCID values (Beaton et al., 2011). Several 
distribution-based methods, which are related to a distribution of scores and several 
anchor-based methods, which use an external criterion to define clinical importance, 
have been used to define important change (Portney and Watkins, 2015). Anchor-
based methods are generally preferred, as they imply that what is considered as 
minimally important has previously been defined (de Vet et al., 2006a; Tubach et al., 
2012). 
An example of a calculation process on which a consensus has been reached for the 
determination of MCID/MCII (Tubach et al., 2007) is presented hereafter. The 
definition of MCID/MCII implies discriminating the patients who improved from those 
who remained unchanged and those who worsened, using a simple question. 
Focusing attention on only patients who report improvement, those patients are then 
asked to rate the importance of the improvement on a Likert scale that uses 
standardised wording. The MCID/MCII is then calculated based on the 75th percentile 
of those who consider themselves as at least slightly improved, as reported by 
themselves on the Likert Scale (Tubach et al., 2005c).  
The MCID/MCII is relative to the population in which it was calculated (Schuller et al., 
2014; King, 2011). It must be larger than the MDC to be considered as valid, as it 
would be contradictory to define a value that is supposedly important but is below the 
change detection threshold for an individual patient (van der Linde et al., 2017; De 
Vet et al., 2011a). 
 PASS 
Another measurement property that accounts for the patient point of view is the 
Patient Acceptable Symptom State (PASS). Despite the effect of the treatment, it 
might happen that the change is not sufficient for the patient to think that the level of 
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symptoms is sufficiently satisfying for him/her to feel well. The PASS indicates from 
which value the patients estimate that the result is acceptable, according to their 
standard (Tubach et al., 2005a). This is important information to fix treatment 
objectives or for deciding about the continuation of therapy, for example. 
As for the MCID/MCII, the best approach for this measurement property’s use has 
been debated. Relying on an established consensus, the PASS is based on the 
calculation of the 75th percentile among patients who report an acceptable level of 
symptoms (Tubach et al., 2007; Tubach et al., 2005c; Tubach et al., 2005b). 
1.1.3.4.4. Synthesis on clinimetrics 
A considerable quantity of information needs to be generated before it can be 
asserted that a new instrument has undergone an exhaustive validation process. This 
has important implications for this thesis, as it should be anticipated that there will be 
an investigation of many of the expected properties within its component related 
research projects, including the clinical validation projects that will aim at the 
investigation of many relevant aspects of the validity, reliability and responsiveness 
of the B-B Score, using a smartphone and a dedicated IMU system (Chapter two: 
Optimisation of scoring procedure and measurement method development; Chapter 
three: devices’ comparison; Chapter four: B-B Score measurement properties study). 
Consecutively, there will be a literature review project that will compare the newly 
investigated measurement properties of the B-B Score with those of well-established 
contemporary PROMs (Chapter five: literature systematic review challenging the 
measurement properties of patient-reported and movement analysis-based outcome 
measures for shoulder function evaluation).  
Despite efforts made to standardise the approaches to determine the measurement 
properties, it has been frequently mentioned above that there are controversies about 
the appropriate methods to use. This is problematic for users of assessment tools and 
researchers because the comparisons of results between studies may be subject to 
amplified caution, due to the dependency of results on the applied and potentially 
idiosyncratic methods of calculation.  
Moreover, it was also frequently mentioned within this review of introductory concepts 
that results are population-dependent. This implies that any new measurement 
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method proposed within this thesis will have to be validated separately for several 
populations of patients with shoulder complaints and that similarly, the measurement 
properties of shoulder function will have to be analysed separately for each population 
of interest within the systematic literature review. Though the population dependency 
of results is largely acknowledged, no precise definition of the degree of similarity 
amongst populations has been found. The populations considered in validation 
articles in the literature offer very diversified characteristics, for example a common 
pain location (e.g. shoulder pain), specific shoulder condition (e.g. shoulder 
instability), treatment approach (e.g. shoulder surgery/conservative treatment), stage 
of treatment, and so on. Therefore, it is difficult for users to estimate to what degree 
a particular set of results apply to their specific situation of interest. A corollary of this 
is the importance of studies that compare the results from several instruments within 
the same population, to allow for a benchmarking. The latter aspects will thus be taken 
into consideration in this thesis. 
 Practical issues 
While the quality of measurement properties is fundamental in order to guarantee the 
soundness and trustworthiness of measurements, some validated outcome measures 
may be rarely used due to practical barriers. It is thus important to consider 
accessibility, cost, feasibility and interpretability at the outcome measure’s stage of 
inception, to account for the fact that most measurements are realised within contexts 
in which time, cost and burden matter (Valderas et al., 2008). 
 Accessibility and cost 
Accessibility and cost are frequently related. The accessibility of questionnaires can 
easily be handled today, by presenting them within the original publications and/or on 
dedicated websites. Numerous questionnaires are thus immediately accessible at no 
cost. However, their unrestricted use may be limited by existing copyrights in some 
cases. Their access is conditional on a simple request for authorisation or a payment, 
as the case may be.  
The accessibility to measurement devices is more problematic because it implies a 
physical access to the device. The accessibility may be limited by the cost of the 
device or the absence of availability and its diffusion throughout the countries of 
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potential use. When the device is not transportable, the access to the device location 
may also be complicated for the participants, especially for people with reduced 
mobility. 
 Practicalities 
If a measurement instrument is accessible, practicalities enter then into consideration. 
Time, number of items or steps, administrative burden, complexity of instructions, 
availability of language-translated versions may be barriers to routine questionnaire 
use (De Vet et al., 2011d). Specifically in relation to measurement devices, issues of 
maintenance, breakdowns, compatibility and obsolescence also enter into 
consideration. Some instruments are straightforward to use while others require 
training before they can be used by patient and/or professionals.  
 Interpretability 
Every measurement instrument produces by essence a result, but the meaning of this 
result may not be straightforward to understand. The outcome measure’s 
interpretation, that is “the degree to which one can assign qualitative meaning to an 
instrument’s score or change score” is thus an important characteristic to consider 
(Mokkink et al., 2010e; De Vet et al., 2011a). Ideally, a result should be readily 
available and interpretable by the user for clinical use. More complex data 
management is possible in a research context. 
The ability of an outcome measure to be readily interpreted and placed in context 
(interpretability) relies also on the prior determination of several measurement 
properties that have been previously presented (sub-sections 1.1.3.4.2.1 ff p. 42 - 50), 
for example, in the defining of MDC, MCID/MCII, PASS, LoA and bias, floor/ceiling 
effect and the determination of a normal performance (De Vet et al., 2011a). 
Importantly, these properties must have been established in the population of interest 




 Implication of practical issues for the thesis 
The objectives of this thesis centred not only on developing and testing an innovative 
measurement method, but also on ensuring that practical issues do not hinder the 
routine use of this instrument. The quality of the measurement properties are 
nevertheless of prime importance, as a practical but otherwise invalid measurement 
would be useless.  
A preliminary step along the procedure simplification has been accomplished by the 
development of the B-B Score, which includes only two upper limb movements. This 
score has been developed using inertial sensors that are much less cumbersome to 
use than laboratory-based devices for movement analysis, but are still not easily 
accessible and affordable for clinicians. Therefore, there is an intention to test to what 
extent a smartphone might replace inertial sensors for the measurement of the B-B 
Score in patients. Accordingly, a concurrent evaluation of the measurement properties 
of assessment approaches using inertial sensors and smartphones was envisaged. 
Importantly, in the scenario where the measurement properties are deemed 
equivalent between the two approaches, the smartphone will inevitably be considered 
superior, due to its greater practicality.  
The overview of the planned thesis process issued from the notions presented in sub-
section 1.1.3 “Definition of central concepts” p. 14 - 51 and section 1.1.4 “Practical 
issues” p. 51 - 53, within this Chapter is available in Figure 1.4  
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Figure 1.4:  Overview of the planned thesis process 
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 Potential impact of the results 
 Scientific significance of results 
This study might contribute to the further use of movement analysis methods in clinical 
research and even in clinical practice. This could possibly facilitate routine application 
of more efficient measurement approaches for delivering objective outcomes of 
shoulder treatment in physiotherapy, surgery and rehabilitation.  
The project is related to the latest technological development in embedded movement 
analysis systems. The conjunction of the simplification of testing procedure with the 
recent development of wireless ambulatory movement analysis systems, makes 
measurement much easier to perform, while keeping sound measurement properties. 
Complexity of technology of movement analysis systems, time in setting them up, 
training in their correct use and their high cost have prevented their routine application 
within movement analysis to date. However, several of these barriers can probably 
well be overcome with the progress of wireless technology, lessening of the cost of 
electronic componentry and the development of user-friendly software. Typically, 
most middle segment smartphones are fitted with built-in accelerometers and 
gyroscopes, which makes technology that had previously been confined to use within 
leading scientific laboratories, accessible to almost everyone nowadays.  
In terms of future developments, applications within telemedicine may also be 
envisaged for a patient’s routine follow-up and surgery complications detection, as 
the testing procedure is quite simple to execute and has been well tolerated by 
patients (Jolles et al., 2011). Therefore, the study topic anticipates possible future 
developments in healthcare. 
 Significance for health professionals 
The reliability of measurement methods is of importance for physiotherapists and 
medical doctors. Effective methods are needed to evaluate if therapeutic interventions 
are economical and efficient (LaMal, 1994). The development of evidence-based 
practice also relies on efficient measurement tools. 
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As stated within this introduction, shoulder function measurement remains a 
controversial issue. Researchers and clinicians have to face the dilemma of 
attempting the selection of a measurement tool in the absence of a gold standard. 
This situation has ongoing consequences on the health professionals’ capacity to 
produce therapeutic evidence of treatment effectiveness in shoulder conditions 
(Green et al., 2003; Harvie et al., 2005). Undetermined validity and a proliferation of 
outcome measures contribute to the deficit in scientific evidence supporting some 
shoulder physiotherapy treatments (Green et al., 2003; Harvie et al., 2005; Page et 
al., 2015). Therefore, there is a need for research to provide clinicians and 
researchers with extensively validated and convenient measurement tools. 
 Significance for patients 
Improvements in the quality of measurement tools is of interest for the patient, as 
important decisions concerning him or her are taken on the basis of outcome 
measures. Quality of outcome measurement influences fairness and equity of 
decisions toward patients. For example, the decisions to continue or stop the patient’s 
treatment, or for him/her to return to work, are linked to measured functional outcome. 
Therefore, validity and reliability of measurement is a prerequisite for fair decision-
making concerning the patient. Correct evaluation also contributes to the allocation of 
relevant resources according to patients’ needs.  
Consequently, trustworthy and straightforward measurement methods are needed to 
assist clinicians and clinical scientists in their decisions concerning patients.  
 Significance of results for clinical partner 
Shoulder conditions are frequently encountered in orthopedic practice. Around 250 
patients attend a medical consultation every month at the Département de l’Appareil 
Locomoteur (DAL), due to shoulder conditions. Therefore, the development of valid, 
reliable and convenient functional outcome measurement methods is of primary 
interest for the department. This is in direct relationship with the ambitions of the 
present study that aims to validate a straightforward measurement method. The score 
could potentially be integrated within the routine patient assessment procedure of the 
specialised medical consultation.  
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Around 15 - 20 patients suffering shoulder conditions are also treated every month in 
the physiotherapy department of the DAL. The developed measurement method is 
therefore also of interest in this field. It could contribute to patient follow-up and 
development of evidence-based practice in physiotherapy. As part of a university 
hospital, the physiotherapy department has the mission to participate actively in 
research. The project is a contribution to the fulfilment of this mission. 
The DAL-CHUV has been active for more than ten years in the development of clinical 
evaluation using ambulatory measurement analysis, in partnership with the 
Laboratory of Movement Analysis and Measurement of the EPFL. The present project 
plays a strategic role in the pursuit of this long-term research orientation. 
 Study resources and implementation 
Paradoxically, the validation of a simple kinematic approach to measure shoulder 
function involves a complex multistage process that rely on a great variety of 
resources and competencies. This includes methodological and statistical guidance, 
technological support, patient access and funding access. 
Besides the resources available at Queen Margaret University (QMU), the required 
resources were accessible in the candidate’s environment. In addition to his MSc 
study on the simplification of kinematic shoulder scores, which is related to this thesis, 
the author has had previous opportunities to collaborate in several projects of the 
Laboratory of Movements Analysis and Measurement of the Swiss Institute of 
Technology (LMAM-EPFL) that were related to shoulder function analysis (Coley et 
al., 2007a; Coley et al., 2008b; Duc et al., 2013; Duc et al., 2014; Jolles et al., 2010; 
Jolles et al., 2011; Pichonnaz et al., 2015b). 
In conjunction to his main 70% employment as an assistant professor in the 
Physiotherapy Department of the Haute Ecole de Santé Vaud, a school of the 
University of Applied Sciences of Western Switzerland (HESAV//HES-SO), the author 
also worked as a clinical specialist physiotherapist at a 30% employment rate in the 
Physiotherapy Service of the Department of Musculoskeletal Medicine of the 
University Hospital of Lausanne (DAL-CHUV). Therefore, access to the required 
methodological, technological and clinical competencies was available in the author’s 
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environment. The author is grateful to both of his employers for having agreed to 
provide partial time and financial support towards the completion of this thesis. 
Thus, it was reasonable to have expected that the resources accessible through the 
author’s work environment and the network of clinical colleagues of the applicant were 
compatible with the thesis’ requirements. 
The access to the required patient population was possible through the author’s 
position at DAL-CHUV. An arrangement was concluded with the medical doctors in 
charge of the specialised shoulder consultation within the hospital and also, with the 
physiotherapy department of the hospital. The author’s position as a staff member in 
the physiotherapy department was also useful to get the involvement of several 
colleagues who facilitated the delivery of the numerous clinical tests required in the 
validation process.  
Through his work at HESAV, the author was entitled to apply for research funding to 
the Swiss National Science Foundation (SNF). At the time of the thesis’ conception, 
an access to a launch fund of the SNF (DORE fund), dedicated to the development 
of research in universities of applied sciences, was possible.  
First, a funding was obtained from the HES-SO University of applied sciences 
“RéSAR” fund to support the preparation work for the submission to the SNF DORE 
fund (Ré-Sa-R 17-10) (Appendix II). Then, a successful application for funding was 
made to the SNF DORE fund (SNF n° 135061). This ensured the financing of the 
clinical research (Phase 2 and 3) and allowed to consolidate the agreements between 
the research partners (HESAV, CHUV and EPFL) (Appendix III and URL 
http://p3.snf.ch/project-135061). 
The Phase 1 study project was submitted and approved by the Ethical Commission 
of the Faculty of biology and medicine of the University of Lausanne (Protocol 205/10) 
(Appendix IV). An amendment to the original protocol was accepted to adapt the 
details of the Phase 2 and 3 protocols to the conclusion of the Phase 1 study 
(Appendix V). 
The study was declared on the ClinicalTrials site (N° NCT01281085) (Appendix VI 
and URL https://clinicaltrials.gov/ct2/show/NCT01281085). It is required that clinical 
trials are registered to prevent selective reporting, identify publication bias caused by 
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unpublished negative results and avoid unnecessary duplication of trials (Costa et al., 









OPTIMISATION OF SCORING 





 Phase 1 study general context 
Some preparatory work had previously been done by Coley et al. and by the author 
in his MSc dissertation to design and simplify a relevant procedure for the kinematic 
evaluation of shoulder function (Coley, 2007; Coley et al., 2007a; Pichonnaz et al., 
2015c). These works led to the proposal for a two-movement score based on the side-
to-side comparison of a power-related metric, as an adequate approach for the 
measurement of shoulder function. 
Nevertheless, several issues needed to be evaluated in the initial phase of the project 
to define the optimal testing procedure for the B-B Score that was to be used in the 
main measurement properties study. The Phase 1 study was also necessary to test 
the applicability and acceptability of the research protocol for patients and colleagues, 
as well as testing for any implementation issues (patient recruitment process, partners 
contribution, administrative process, database implementation, burden and practical 
issues) (Thabane et al., 2010). It also aimed at training all collaborators in the correct 
use of the measurement instruments (inertial sensors, smartphones and clinical 
questionnaires) and towards mastering the study protocol. Finally, the database was 
implemented and tested at this stage of the project.  
 Technical issues to explore in the Phase 1 study 
Though previous studies had given a promising insight into the measurement 
properties of the P Score, and by extension to those of the B-B Score that predicts 
97% of the P Score from which it is derived, several issues were still needing to be 
considered in order to optimise the measurement procedure. Notably, it was shown 
that the B-B Score had an excessive variability for single measurements, with LoA 
with the P Score, taken as a reference, reaching up to ± 21.6% at 6 months post-
surgery (Pichonnaz et al., 2015c). This implies that the measured result on the B-B 
Score of a patient might occasionally differ by more than ± 20% from the performance 
measured by the P Score. It was thus necessary to explore approaches that could 
potentially reduce single measurement variability. 
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As the variability and error in the mean score of several measurements decreases 
with the square root of the number of repetitions (assuming a normal distribution of 
errors), it was thought that test replication and averaging over repeated intra-
individual trials may decrease the possible variability in individual measurements 
(Winer, 1991; Gleeson and Mercer, 1996; Pichonnaz et al., 2015c). One pathway to 
explore was thus to take advantage of the simplicity of the B-B Score procedure to 
acquire the mean score from a series of several intra-individual scores for the two 
movements, which should decrease the B-B Score’s statistical variability. Further 
exploration to see whether or not the B-B Score would be more stable by taking the 
median or the mean of the score replications was then required. Concomitantly, it 
would be necessary to verify if the above approach would be fully applicable, by 
investigating systematic intrusions from carry-over effects such as fatigue, warm-up 
or learning effects, during repeated intra-individual trials. The Phase 1 data would 
thus be used to evaluate the influence of the repetition number on the B-B Score’s 
reliability and to get a first insight into its measurement properties. 
It was also possible that a reason for the variability observed in previous studies was 
linked to the calculation method used for the determination of P and B-B Scores. 
These scores were based on the computation of the product of accelerations by 
angular velocities, to obtain a power-related metric [(deg/s)*(m/s2)] (Coley et al., 
2007a; Coley, 2007; Pichonnaz et al., 2015c). The values used for the calculation 
were determined by the whole range of accelerations and angular velocities during 
the measured movement, calculated for each axis and added to obtain a power-
related parameter called Pr. This approach corresponds to the calculation for each 
dimension of the surface of rectangles that would circumscribe the curve representing 
a whole range of measured values (Figure 2.1). This parameter was then compared 






Figure 2.1: Humerus acceleration as a function of its angular velocity for the patient. 
a) The trace represents the humerus acceleration vs. angular velocity for the healthy 
side. b) The trace represents the humerus acceleration vs. angular velocity for the 
affected (painful) side. The rectangle that circumscribes the curve corresponds to the 
product. From: COLEY, B., JOLLES, B. M., FARRON, A., BOURGEOIS, A., 
NUSSBAUMER, F., PICHONNAZ, C. & AMINIAN, K. 2007. Outcome evaluation in 
shoulder surgery using 3D kinematics sensors. Gait Posture, 25, 523-32. 
It was suspected that calculating a rectangle, of which surface is markedly influenced 
by the maximal and minimal peak values, instead of calculating the effective area 
inside the curve of measured values that is less influenced by peak values, might 
increase the variability. Thus, the variability taking the range or the effective area of 
measured values was compared in the Phase 1 study using both methods, with the 
support of the engineers of the LMAM-EPFL. The surface that is taken into 





Figure 2.2: Surface (red area) taken into consideration when using the area 
calculation method for the B-B Score. 
Conversely, no new try-outs were conducted to explore alternative testing procedures 
and technical features for the score measurement. Exploratory measurements that 
had been previously conducted at the conception stage of the P Score had shown no 
advantage in modifying the speed of movements or adding weights compared to a 
spontaneous movement at a self-selected speed within the pain free range of motion. 
Similarly, the technical features remained unchanged, as they had proven adequate 
in the previous studies. Thus, for the Phase 1 study, the sensors were placed as they 
had been in previous studies and the accelerations and angular velocities were 
amplified and low-pass filtered at a cut-off frequency of 17 Hz to remove any electronic 
noise, before being recorded by a Physilog data-logger (Physilog®, Gait Up, CH), at 
a 200 Hz sampling frequency (Coley, 2007). 
Preliminary study try-outs had shown that the influence of errors in sensor’ 
measurements was negligible in the study context, with an offset < 0.005g and static 
drift of 0.0038g over 5 minutes of measurement, with a maximum error < 0.028g 
(Pichonnaz, 2009). Therefore, the sensors accuracy was not re-tested in the Phase 1 
study. Importantly on this aspect, the accelerometers and gyroscopes provided a 
direct measurement of accelerations and angular velocities, and thus the possible 
errors would not have been amplified by mathematical transformation (Luinge et al., 
2007; Aminian and Najafi, 2004).  
No smartphone measurements were collected at this initial stage. The tests were 
performed using the IMU approach only, which had previously been recognised as 
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relevant. Conversely, it would not have been possible to differentiate amongst the 
sources of variability using the smartphone approach, as the application was still 
under development at this stage of the project. 
Another issue to explore before the start of the Phase 2 and 3 studies was the 
suitability of the B-B Score for the measurement of conservatively treated conditions, 
as the score had been developed based on surgically treated patients only. The 
promising results of the development study might not have been transferable to 
conservative treatment as measurement properties are context and population-
dependent (Robertson et al., 2017; Collins and Roos, 2016; Riddle and Stratford, 
2013). For example, the discrimination between patients and heathy controls might 
have been more difficult, or a ceiling effect might have been observed, as non-surgical 
patients are supposedly less severely affected than surgically treated patients are. 
Due to the small sample size, only the ability to discriminate patients from healthy 
controls was tested at this stage and no subgroup analysis based on pathologies, had 
been planned.  
 Aims 
The aims of the Phase 1 study were: 
- to define the optimal testing procedure for the subsequent Phase 2 and 3 
studies, including the number of B-B Score replications 
- to compare the respective advantages of an alternative score computation 
method (area calculation) to the original method (range calculation) 
- to test the feasibility and applicability of the study protocol 
- to test the organisational issues of the study’s implementation 
 Methods 
 Study sample 
A prospective cohort study was conducted at the Department of Traumatology and 
Orthopaedic Surgery of the University Hospital of Lausanne. Ethical approval was 
granted by the Human Research Ethics Committee of the Canton of Vaud (CER-VD), 
protocol number 205/10. Patients gave their signed informed consent for participation 
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in the study. The patient information sheet and consent form are available in Appendix 
VII that includes the complete baseline patient file. The study was registered under 
Clinicaltrials.gov Identifier NCT01281085 (Appendix VI).   
The inclusion criteria were to be a > 18 year old adult and to present with one of the 
following shoulder conditions, as recorded during their first medical consultation at the 
specialised shoulder consultation unit of the hospital: rotator cuff condition, instability, 
adhesive capsulitis, and proximal humerus fracture.   
Patients with various shoulder pathologies were included to test the applicability of 
protocol in the same populations of interest than in the subsequent Phase 2 and 3 
studies. For the rotator cuff condition, instability or capsulitis, patients were selected 
who required only conservative treatment. As the B-B Score had previously been 
validated after rotator cuff and arthroplasty surgery (Pichonnaz et al., 2015c), it was 
of interest to explore its validity in different populations. Surgical and conservative 
fracture treatment were included in the same group as the expected progress and 
functional prognosis is similar in both populations (Handoll et al., 2012).  
Exclusion criteria were bilateral shoulder conditions, any concomitant pain or 
condition involving the upper limb or cervical spine, medical contraindication to 
execute movements required for score completion, tumour, neurological condition 
interfering with the test and an insufficient local language level to give truly informed 
consent or to understand questionnaires. It was also required to proceed to a Mini 
Mental State score if a decrease in cognitive function was suspected, with exclusion 
criteria at 24 points/30 (ANAES, 2000).  
The patients corresponding to the study criteria were recruited based on the 
notification to the thesis’ author by the medical doctors in charge of the specialised 
consultation of the hospital-based patients. Following this first contact through the 
doctor, a telephone call was made by a PT collaborator of the research team to those 
who had previously agreed to be contacted about this study, as indicated by the 
doctor. Those who accepted to participate received then detailed information and an 
appointment time was arranged with them. The opportunity to ask for further 
clarifications was afforded to them before signing the consent form at the beginning 
of the measurement session.  
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A group of participants without history of shoulder condition/pain was also recruited 
within the professional environment of the applicant to evaluate the performance in a 
healthy population and the stability of the score. Inclusion criteria were to have no 
present pain or shoulder condition/pain on any side and to be < 50 years old. 
Exclusion criteria were any past or present shoulder condition/pain and to be > 50 
years old. Those who accepted to participate followed then the same procedure than 
the patients. 
At this stage, the sample size was determined based on a pragmatic approach 
determined by the needs of the study. It was estimated that around 15 patients and 5 
healthy controls would be sufficient to reach the study objectives, which were to refine 
the testing procedure and test the study protocol without making further inferences 
about the score precise measurements properties. Nevertheless an a priori sample 
size calculation was conducted based on the results of the score development study 
to ensure that the statistical power was sufficient to test the discriminative power of 
the B-B Score, which is the most basic measurement property that is expected from 
an outcome measure. A score that would not be able to discriminate a pathological 
from a healthy group would very likely be useless. 
This calculation showed that, considering that the patients of the Phase 1 study would 
reasonably have a performance approaching either the 3 or 6 months post-surgical 
state, in-between 4 and 5 patients per group were needed to reach a 0.80 power for 
the difference between the patient and the control groups, for a p value at p < 0.05 
[Patients at 3 months mean (SD) 61.8 (16.8); Patients at 6 months mean (SD) 69.0 
(15.9); Controls mean (SD) 102.9 (14.5)] (Pichonnaz et al., 2015c; Soper, 2004). A 
larger sample was included to acquire the required experience for the purpose of the 
subsequent Phase 2 and 3 studies and get estimations of the score properties with 
reasonable confidence intervals. 
Patients residing in the canton were contacted by phone in the order in which they 
attended the medical consultation in the department, upon notification of eligibility by 
the consulting doctor. The patients underwent the baseline measurement session 
within two weeks following medical consultation, with the exception of patients with 
humerus fracture. Measurements were performed 6 weeks post-stabilisation for 




 Measurement device 
The system for body-worn movement analysis was a Physilog system composed of 
two inertial sensors modules and a datalogger system (Physilog®, Gait Up, Lausanne 
Switzerland). Each inertial sensor module included three dimensional accelerometers 
and gyroscopes (Accelerometers: Analog device, ADXL 210, ± 5 g, precision: ± 0.2% 
of Full Scale; Gyroscopes: Analog device, ADXRS 250, ± 400 deg/s, precision: ± 0.1% 
of Full Scale). The device resolution was 16 bits and the sampling frequency was 200 
Hz. An inertial measurement system was used, preferably over concurrent 
measurements analysis systems, because inertial sensors provide direct 
measurements of angular velocities and accelerations used in the score calculation. 
As previously mentioned, preliminary try-outs had shown that the influence of 
measurement errors (offset, sensitivity or drift) was negligible in the study context. 
This try-outs had shown that the errors in sensor’ measurements were < 0.005g for 
offset and < 0.0038g for static drift over 5 minutes of measurement, with a maximum 
error < 0.028g (Pichonnaz, 2009). The magnitude of the error was thus minor 
compared to the magnitude of the within group and between group differences 
observed in the previous study relying on the B-B Score (Pichonnaz, 2009). 
 Measurement procedure 
The inertial sensors modules of the reference system were placed on each humerus, 
3 cm above the midpoint of the line connecting the lateral epicondyle (EL) and medial 
epicondyle (EM). The sensor’s axes were aligned to the anatomical frame of the 
humerus following the ISB recommendations (Wu et al., 2005; Coley et al., 2009): Yh 
on the line connecting the glenohumeral (GH) joint and the midpoint of EL and EM, 
pointing to GH; Xh on the line perpendicular to the plane formed by EL, EM and GH, 
pointing forward; Zh on the line perpendicular to Xh and Yh, pointing to the right 
(Figure 2.3). Similarly to previous work, angular velocities and accelerations in the 
sensor frame have been used to calculate the B-B Score (Pichonnaz et al., 2015c; 
Coley et al., 2007a).  
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a)  b)  c)  
Figure 2.3: Inertial sensors placement and axes (a) The inertial sensor module 
(Physilog® reference system) attached to the arm with medical tape and connected 
by cable to the datalogger carried attached around the participant’s waist. (b) Test 
completion of “hand to the ceiling” (c) Test completion of “hand to the back”. 
After setting-up of the system, the participants watched a video-recorded 
demonstration of the execution of the B-B Score. They were instructed to do the 
movements in the pain free ROM, at their self-selected speed and in their natural way. 
The starting position was the arm alongside the body, in a relaxed position. 
Movements were executed in a standing position following the rater’s instructions. 
The patients undertook five repetitions of the two B-B Score movements on the 
healthy side (put hand to the back + hand to the ceiling as to change a bulb) and then 
repeated the task on the pathological side. The controls executed the same procedure 
beginning with the dominant side. 
The measurement procedure was repeated twice alternating between two raters (the 
author and a physiotherapist colleague, previously trained in B-B Score methods). 
The first rater was randomly assigned. The measurement system was detached after 
each score measurement for inter-rater administration of assessments to account for 




 Clinical questionnaires 
This phase essentially aimed at training all collaborators in the correct use of the 
clinical questionnaires and at testing the feasibility of the study protocol. The 
questionnaires were not interpreted at this stage of the PhD as limited useful 
information could have been drawn from them considering the limited sample size 
and the diversity of pathologies. Thus, the detailed questionnaires’ description has 
been placed in the chapter in which the understanding of them is of most importance 
(Chapter five Literature review, p. 187 - 189). 
Patient-reported outcome measures on shoulder function, pain and quality of life were 
also completed. Three PROMs were selected for shoulder function evaluation: the 
Quick Disabilities of the Arm and Shoulder score (QuickDASH), the Simple shoulder 
test (SST), the Constant Score and its variation, the Constant relative score (based 
on a percentage comparison of the measured value to an age- and sex-matched 
normal populations) (Lippitt, 1993; Constant and Murley, 1987; Fialka et al., 2005; 
American Academy of Orthopaedic Surgeons, 2009). The Constant Score was 
undertaken according to the modified guidelines of Constant (Constant et al., 2008). 
The EuroQol [EQ-5D] quality of life questionnaire and the pain visual analog scale 
(VAS) were also completed to capture a broader picture of patient clinical state 
(EuroQol, 2018). 
The QuickDASH is an shortened version of the DASH, a self-assessment PROM of 
the entire upper extremity symptoms and function  that provides a whole upper-
extremity evaluation, including the shoulder (Hudak et al., 1996). 
The SST is as shoulder function PROM that comprises binary 12 items (yes/no), 
among which two are about function related to pain, seven about function related to 
strength and three about range of motion (Lippitt, 1993; Beaton and Richards, 1998). 
The Constant Score is a composite outcome measure that includes questions on pain 
and activity, and objective measures of range of motion and abduction strength 
(Constant and Murley, 1987). The relative Constant expresses the performance as a 
percentage of the expected value, based on the comparison of the patient’s 
performance to a sex and age matched group (Constant, 1986; Yian et al., 2005; 
Katolik et al., 2005; Fialka et al., 2005; Constant et al., 2008). 
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The EQ-5D is a validated generic quality of life PROM that includes 15 items 
investigating 5 dimensions of the quality of life (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression) and a visual analogue scale to record the 
patient’s self-rated health. 
The VAS pain scale is a very widely used instrument on which the patient has to rate 
his/her pain intensity on a 10 cm scale representing the range between “no pain” and 
“the worst imaginable pain”. 
The PROMs and socio-demographic questionnaire are available in Appendix VII and 
a more detailed description of the selected PROMs is available in sub-section 5.2.7.3 
“Characteristics of selected shoulder function PROMs”, within Chapter five, p. 187 - 
189. 
 B-B Score calculation 
The B-B Score was calculated according to the method described in Pichonnaz et al. 
(2015c) and Coley at al. (2007a). A power-related parameter was extracted from the 
recorded signals: the range of acceleration was multiplied by the range of angular 
velocity, with a measurement unit of [(deg/s) × (m/s2)], for each movement. This 
parameter was calculated for each axis and for each movement of the B-B Score 
(“hand to the Back” movement and “lift hand as to change a Bulb” movement) and 
added, separately for each side and for each movement. The ratio of the performance 
of the affected side relative to the healthy side (or the dominant side relative to the 
non-dominant side for healthy controls), expressed in percentage, was then 
calculated for each of the two movements. The values of the movements were then 
weighted using the equation: B-B Score = 16.71 + 0.32 x hand to the Back + 0.45 x 
lift hand as if changing a Bulb, based on the observed relationship between the B-B 
Score and the P Score which was considered as the reference score (Pichonnaz et 
al., 2015c). 
One hundred percent represents a perfect balance in capability between sides and 
the score decreases in accordance with the severity of functional loss. For example, 
while a typical healthy person performs near to 100%, the average patient might reach 
46% before surgery, 67% at 3 months and 71% at 6 months after surgery. 
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 Feasibility analysis 
The recruitment rate was recorded for this Phase 1 study and this would facilitate a 
projection of the numbers of patients that might realistically be recruited subsequently 
for the Phase 2 and 3 studies to ensure that it achieves appropriate experimental 
design sensitivity and statistical power. The latter would be constrained to some 
extent by the amount of funding that was available to underpin the delivery of the 
following studies within the thesis (Phases 2 and 3), which was based on a two year 
recruitment phase plus six months for follow-up. 
The ethical, technical, clinical measurement, data management and communicational 
issues were recorded systematically and this would facilitate evidence-based and on-
going adjustments to the protocols that would be used subsequently within the main 
research studies of the thesis (Phases 2 and 3), as required. The patients were asked 
to give their impressions about their pain and their difficulties during the testing 
procedure at the end of the measurement session.  
 Statistical analysis plan 
Descriptive statistics including group mean with standard deviation (SD) and median 
with interquartile range were calculated for patients’ characteristics, for each B-B 
Score replication and for the mean of each number of replications. Box plots were 
produced for the visual inspection of data’s dispersion. 
The significance of the differences between the scores obtained with different 
methods (range and area approach; mean and median of replications), different 
numbers of replications (one to five replications), different measurements by the same 
rater and measurements by different raters were calculated using non parametric 
tests (Wilcoxon signed rank test for two related samples, Wilcoxon rank sum test for 
independent samples and Friedman test for more than two related samples). The 
significance level was set at p < 0.05.  
The Cohen’s d effect size was calculated to estimate the magnitude of the differences, 
where significant differences were found. Effect sizes < 0.20 were considered as 
small, < 0.50 as medium and < 0.80 as large (Cohen, 1988).  
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Non-parametric tests were used because the assumption of a normal distribution of 
data was not expected to be met in a sample of patients with various pathologies that 
may imply variable levels of alteration of shoulder function.  
The intraclass correlation coefficient (ICC) (2,1) was calculated to estimate single 
measurement reliability and the strength of the relationship amongst measurement 
replications of the B-B Score (test-retest reliability), between measurements made by 
the same rater (intra-rater reliability) and between measurements delivered by 
different raters (inter-rater reliability), respectively. The ICCagreement for a single 
measurement was recorded, because the absolute agreement for measurements by 
a single rater is of interest in this study’s context (Koo and Li, 2016). The limits of 
agreement (LoA) and bias using the Bland and Altman (B&A) approach were 
calculated for intra- and inter-rater reliability, for the mean and the median of the 
number of replications. 
Several criteria had to be met for the score to be considered as sufficiently efficient to 
employ within the following studies of the thesis (Phases 2 and 3), without any 
modifications to the manner in which the B-B Score is computed or the protocol for 
measurement is delivered. The experimental hypothesis for a difference between the 
B-B Scores for the control and the pathological group should be accepted as indicated 
by a statistically significant finding. However, group mean differences for 
measurements made by the same rater, or by different raters should be statistically 
similar, with retention of the corresponding null hypotheses involving no differences. 
The ICCs should be ≥ 0.90 for intra-rater and inter-rater reliability (Portney and 
Watkins, 2015). No a priori hypotheses were formulated about the other areas of data 
analysis due to their exploratory nature. No subgroup analysis was conducted due to 
the limited sample size.  
For the sake of brevity and relevance, the results are hereafter reported following a 
progressive selection process, based on decisions taken at each step concerning the 
score optimisation. First, the results related to the choice of the range or area 
computation methods for the B-B Score will be reported. After a choice has been 
made based on these results, only the results related to the most suitable computation 
method will be reported in the next steps. Then, the results related to the choice of 
the mean or median of number of replications will be reported for the most suitable 
computation method only, for each number of replications. Finally, the results related 
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to the choice of the most efficient number of replications will be reported for the 
chosen computation method only, using only the most suitable method in-between 
the mean or median of replications. 
 Results 
 Feasibility 
The recruitment of the planned number of participants took 6 months to complete 
successfully.  
No test had to be cancelled and no data was lost due to technical or practical issues. 
The duration of measurement sessions ranged from 45 to 60 minutes, including the 
completion of questionnaires. The data were used to implement the study database 
and test the data extraction process that would be used in the Phase 2 and 3 studies. 
The collaborations involving HESAV, the Lausanne University Hospital and the Swiss 
Institute of Technology were implemented as planned. Liaison meetings amongst staff 
involved in the research were held approximately once per month. 
 Study sample 
Sixteen patients, i.e. one more patient than anticipated in study plan, and seven 
healthy controls i.e. two more than anticipated in study plan were enrolled in the 
Phase 1 study. Patients presenting with the four targeted conditions could be enrolled, 
but patients with rotator cuff conditions represented half of the patients’ sample. The 




Table 2.1 Participants characteristics in the patient and control groups. 
 Patient group Control group 
Sample size, number 16 7 
Gender, number male/female 10/6 4/3 
Age mean (SD), years 56.2 (8.9) 37.1 (7.5) 
Weight mean (SD), kg. 76.4 (17.8) 65.1 (11.5) 




Affected side (right/left) 15/1 - 
Dominance of affected side 
(dominant/non-dominant) 
13/2 - 
Shoulder condition (n)  
Rotator cuff:8 
Instability: 3 
Humerus fracture: 3 
Capsulitis: 2 
 
Legend: SD: Standard Deviation; n: number 
 B-B Score outcomes 
 B-B Score by replication 
The mean score with SD and the median score with interquartile range for each 
replicate of the B-B Score are presented in Table 2.2, and the box plots showing the 
outcomes for each repetition using the range computation method for the B-B Score 
are presented in Figure 2.4.  
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Table 2.2: Mean B-B Scores with standard deviations and median B-B Scores with 
interquartile range for the patient and the control group using the range and the area 
computation method, for each score replication (1 to 5). 
Mean (SD) 
Median (IQR), % 
Patient (n=16) Control (n=7) 
 Range Area Range Area 













































Legend: SD: standard deviation; IQR: interquartile range; * significant difference with 




Figure 2.4: Traditional box plots showing median, lower and upper quartile, range 
and outliers (open circles, 1.5 interquartile range, with case numbers) B-B Scores, 
comparing the control (n= 7) and the patient (n=16) groups according to the number 
of intra-assessment replications (1 to 5*), with B-B Scores computed using the range 
method (* no significant differences across replicates; p >0.05). 
The Friedman test showed no differences between replications of the B-B Score, 
regardless of the group and the computation method: range computation method in 
the patient group (χ2(4) = 9.15, p = 0.06), area computation method in the patient 
group (also χ2(4) = 9.15, p = 0.06), range computation method in the control group 
(χ2(4) = 6.62, p = 0.16) and area computation method in the patient group (χ2(4) = 
0.55, p = 0.97). This indicated that no systematic carry-over effects, such as warm up 
learning or fatigue had intruded during the execution of the manoeuvres associated 
with the B-B Score. 
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 B-B Score determined by range or area of 
computation method 
The Wilcoxon signed-rank test showed no significant difference between the range 
and the area computation methods in the patient group for 1 (Z = -1.71, p = 0.09), 2 
(Z = -1.60, p = 0.11), 3 (Z = -1.55, p = 0.12), 4 (Z = -1.45, p = 0.15) and 5 (Z = -1.60, 
p = 0.11) replications. In the control group, the area B-B Score was significantly 
different from the range B-B Score for 2, 3 and 5 replications (Z = -2.19, p = 0.03 in 
all cases), but not for 1 (Z = -1.69, p = 0.09) and 4 (Z = -1.35, p = 0.18) replications. 
The one-sample Wilcoxon signed-rank test highlighted no significant difference with 
a median B-B Score of 100 in the control group, using either the range or area 
computation method (range computation method: 1st replication (Z = -0.28, p = 0.78), 
2nd replication (Z = -0.28, p = 0.78), 3rd replication (Z = -0.34, p = 0.73), 4th replication 
(Z = -0.66, p = 0.51), 5th replication (Z = -0.28, p = 0.78); area computation method: 
1st replication (Z = 0.72, p = 0.47), 2nd replication (Z = 0.47, p = 0.64), 3rd replication 
(Z = 1.04, p = 0.30), 4th replication (Z = 0.34, p = 0.73), 5th replication (Z = 0.72, p = 
0.47). Thus, this indicated that none of the two methods detected a side-to-side 
asymmetry in healthy controls. 
The effects sizes were of comparable magnitude regardless of the replication 
considered and the range or area computation method for the B-B Score calculation, 
with Cohen’s d ranging from 1.26 to 1.65 (1st replication d = 1.60 for range, d = 1.59 
for area; 2nd replication d = 1.64 for range and for area; 3rd replication d = 1.53 for 
range, d = 1.65 for area; 4th replication d = 1.65 for range, d = 1.55 for area; 5th 
replication d = 1.26 for range, d = 1.45 for area). These results highlight the ability of 
the B-B Score to discriminate correctly two groups that are anticipated to be different, 
regardless of the use of the range of area computation method. 
The ICCs for the evaluation of the reliability between replications using the range and 
the area approaches for computation of B-B Scores showed comparable reliability 
between these approaches, for the patient and for the control group. The ICCs results 




Table 2.3: ICC values with interval at 95 level of confidence for the patient and control 
group for test-retest reliability between replications, using the range and area 
computation methods for the B-B Score calculation.  
ICC [95% CI] Patient (n=16) Control (n=7) 
Range method for the 
computation of B-B Score 
0.90 [0.86 – 0.93] 0.71 [0.50 – 0.87] 
Area approach for the 
computation of B-B Score 
0.90 [0.86 – 0.93] 0.70 [0.50 – 0.87] 
Legend: ICC intraclass coefficient of correlation; 95%CI: limits of interval at 95% 
confidence level 
Based on the rationale for a selective reporting of results announced at the end of the 
statistical analysis plan, only the results obtained using the range B-B Score 
computation method are reported from this point. The exploration of the new area 
computation method showed no advantage on the range method in terms of reliability, 
responsiveness and discriminative power. As the range computation method was the 
original approach for B-B Score computation and as it had been tested in previous 
studies (Coley et al., 2007a; Jolles et al., 2011; Pichonnaz et al., 2015c), it was 
decided to continue to use it in the Phase 2 and 3 studies. These points are further 
detailed in the discussion section. 
 B-B Score determined by mean or median of 
replications 
The B-B Score outcomes determined using the mean or the median of replications 




Table 2.4: Patient and control groups B-B Scores (mean with standard deviation and 
median with interquartile range) for each number of replications (1 to 5), for the mean 




Patient (n=16) Control (n=7) 
 Using mean of replications 
Using median of 
replications 
Using mean of 
replications 









71.5 (40.4-82.7) - 
101.4 (19.0)† 
98.1 (86.4-114.7) - 






























Legend: SD: standard deviation; * significant difference with mean of 5 replications; † 
significant difference with the patient group 
For the patient group, the Friedman test showed a significant difference between the 
B-B Scores obtained using 1 replication or the mean of 2 to 5 replications (χ2(4) = 
10.75, p = 0.03). Post hoc analysis with Wilcoxon signed-rank tests showed a 
significant difference between the B-B Score obtained using 1 replication and the B-
B Score obtained using the mean of 5 replications (Z = -2.33, p = 0.02). However, the 
Cohen’s d was small (d = 0.08). Conversely, for the control group, the Friedman tests 
showed no significant difference between the B-B Scores obtained using 1 replication 
or the mean of 2, 3, 4 and 5 replications (χ2(4) = 1.82, p = 0.77).  
These results indicated that using only one replication, the patient group outcome 
measured using the B-B Score might possibly differ from the performance measured 
using the mean of several replications, which was less likely to be influenced by 




The Friedman test showed no significant difference between the B-B Scores obtained 
using 1 replication or the median of 3, 4 and 5 replications (χ2(3) = 6.13, p = 0.10) for 
the patient group.  It also highlighted no significant difference between the B-B Scores 
obtained using 1 replication or the median of 3, 4 and 5 replications (χ2(3) = 0.83, p = 
0.84) in the control group. This indicated that, for the patient and for the control group, 
using the median of replications, the measured group performance measured on the 
B-B Score was comparable, regardless of number of replications taken into 
consideration. 
The Wilcoxon signed-rank test showed no significant differences between the B-B 
Score determined using the mean and the median of several replications, whether it 
is for 3 replications (Z = - 1.48, p = 0.14), 4 replications (Z = - 1.20, p = 0.23) or 5 
replications (Z = - 1.00, p = 0.32), for the patient group. This highlighted that the 
measured patient group outcome was not influenced by the choice of one or the other 
method for score averaging over replications. 
Similarly, the Wilcoxon signed-rank test showed no significant differences for the 
control group between the B-B Score determined using the mean and the median of 
several replications, whether it is for 3 (Z = - 1.35, p = 0.18), 4 (Z = - 1.15, p = 0.25) 
or 5 replications (Z = - 0.84, p = 0.40). This is indicative that the group performance 
of healthy participants is comparable using the mean or the median of scores 
replications. 
Regardless of the number of replications, the Wilcoxon rank sum test showed 
significant differences between the patients and control groups using the mean or the 
median (for 1, mean of 2,3,4 and 5 replications, median of 3 and 4 replications: Z = -
3.1, p = 0.001, for the median of 5 replications Z = - 2.9, p = 0.02). The effects sizes 
for 1 replication and for the mean and median for the B-B Score replications were of 
comparable magnitudes, regardless of the replications considered, with Cohen’s d 
ranging from 1.60 to 1.70. These results highlight the ability of the B-B Score to 
discriminate with large effect sizes two groups that are anticipated to be different, 
regardless of the use of the mean of the median as an averaging method. 
The ICCs for single-measurement reliability of the B-B Score associated with the B-B 
Score measurements acquired by the same rater, for the mean or median scores 
across varying numbers of replications, are reported in Table 2.5. The intraclass 
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correlation coefficients for single-measurement reliability of the B-B Score associated 
with two separate raters, for the mean or median scores across the varying number 
of replications, are reported in Table 2.6. 
Table 2.5. Comparison of ICC values with intervals at 95 level of confidence for intra-
rater reliability of the measurements acquired by each rater, for each number of 
replications using mean or median of replications. 
ICC (95%CI) Rater Mean Median 
5 replications 
1st 0.96 (0.88 – 0.98) 0.96 (0.88 – 0.98) 
2nd 0.98 (0.95 – 0.99) 0.98 (0.93 – 0.99) 
4 replications 
1st 0.93 (0.83 – 0.98) 0.94 (0.84 – 0.98) 
2nd 0.98 (0.95 – 0.99) 0.97 (0.92 – 0.99) 
3 replications 
1st 0.93 (0.81 – 0.97) 0.93 (0.82 – 0.97) 
2nd 0.97 (0.91 – 0.99) 0.96 (0.88 – 0.98) 
2 replications 
1st 0.91 (0.76 – 0.97) - 
2nd 0.96 (0.89 – 0.99) - 
1 replications 
1st 0.83 (0.57 – 0.94) 
2nd 0.91 (0.77 – 0.97) 
Legend: ICC intraclass coefficient of correlation; 95%CI: limits of ICCs at 95% 
confidence level; 1st: 1st measurement of rater 1 vs. 2nd measurement of rater 1 
reliability; 2nd: 1st measurement of rater 2 vs. 2nd measurement of rater 2 reliability 
There were no significant differences amongst measurements of the patient group B-
B Scores recorded by the same rater using the Wilcoxon signed rank test, for the 
mean of replications: for 1 replications (Z = -0.84, p = 0.40), the mean of 2 (Z = -1.25, 
p = 0.21), 3 (Z = -0.35, p = 0.70), 4 (Z = -0.18, p = 0.85) and 5 (Z = 0.90, p = 0.37) 
replications. Similarly, no significant difference was found for the median of 3 (Z = 
0.06, p = 0.96), 4 (Z = -0.18, p = 0.85) and 5 (Z = -0.15, p = 0.88) replications. The 
effects sizes were small in all cases, with Cohen’d ranging from 0.07 to 0.11.  
In the control group, no significant difference was found for the differences between 
measurements of the same rater using the Wilcoxon signed rank test, for 1 
replications (Z = -0.68, p = 0.50), the mean of 2 (Z = -0.85, p = 0.40), 3 (Z = -0.68, p 
= 0.50), 4 (Z = 0.00, p = 1.00) and 5 (Z = 0.00, p = 1.00) replications, and the median 
of 3 (Z = -0.17, p = 0.87), 4 (Z = -1.35, p = 0.17) and 5 (Z = -0.51, p = 0.61) replications. 
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The effects sizes for the differences between measurements of the same rater were 
small in all cases, with Cohen’s d ranging from 0.01 to 0.15. 
There were no significant differences amongst the patient group mean B-B Scores 
recorded by two raters for increasing numbers of score replications using the 
Wilcoxon signed rank test, for 1 replications (Z = 1.49, p = 0.14), the mean of 2 (Z = -
0.48, p = 0.63), 3 (Z = -1.41, p = 0.25), 4 (Z = -1.50, p = 0.13) and 5 (Z = -1.62, p = 
0.10) replications, and the median of 3 (Z = -1.38, p = 0.17), 4 (Z = -1.23, p = 0.22) 
and 5 (Z = -1.68, p = 0.09) replications. The differences between raters could not be 
calculated in the control group as only one rater proceeded to the measurements. The 
effects sizes of the differences between raters for the patient group were small in all 
cases, with Cohen’s d ranging from 0.07 to 0.11. 
Thus, all the differences between measurements, acquired by the same rater or two 
different raters, were non-significant and of minor magnitude. 
Table 2.6: Comparison of ICC values with intervals at 95 level of confidence for inter-
rater reproducibility for the 1st and the 2nd measurement acquired by the two raters, 






1st 0.96 (0.89 – 0.99) 0.96 (0.90 – 0.99) 
2nd 0.96 (0.90 – 0.99) 0.95 (0.87 – 0.98) 
4 replications 
1st 0.95 (0.86 – 0.98) 0.95 (0.86 – 0.98) 
2nd 0.96 (0.89 – 0.99) 0.95 (0.87 – 0.98) 
3 replications 
1st 0.94 (0.83 – 0.98) 0.93 (0.83 – 0.98) 
2nd 0.96 (0.88 – 0.98) 0.96 (0.89 – 0.99) 
2 replications 
1st 0.96 (0.89 – 0.99) - 
2nd 0.95 (0.86 – 0.98) - 
1 replications 
1st 0.94 (0.85 – 0.98) 
2nd 0.87 (0.68 – 0.95) 
Legend: ICC intraclass coefficient of correlation; 95%CI: limits of ICCs at 95% 
confidence level; 1st: 1st measurement of rater 1 vs. 1st measurement of rater 2 
reliability; 2nd: 2nd measurement of rater 1 vs. 2nd measurement of rater 2 reliability 
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The bias and limits of agreement for intra- and inter-rater reliability are reported for 
the mean and the median of replications of the B-B Score in Table 2.7 and 2.8. The 
Bland and Altman graphs for the intra- and inter-rater reliability are reported in Figure 
2.5 and 2.6. 
Table 2.7: Bias and 95% limits of agreement (%, original units) as estimates of intra-
rater reproducibility of B-B Scores (range method only), recorded for two 
measurements by the same rater (1st; 2nd) using mean or median scores from 1 to 5 
replications 
Bias ± 95% limits of 
agreement 
Rater Mean Median 
5 replications 
1st 1.8 ± 13.8 0.2 ± 13.5 
2nd 1.2 ± 8.7   1.3 ± 10.4 
4 replications 
1st 2.1 ± 16.2 1.7 ± 15.6 
2nd 1.1 ± 9.5 1.3 ± 11.6 
3 replications 
1st 2.3 ± 16.7 1.5 ± 16.5 
2nd 1.2 ± 12.7 0.5 ± 14.6 
2 replications 
1st 3.3 ± 18.9 - 
2nd - 1.0 ± 13.6 - 
1 replications 
1st 5.6 ± 25.8 
2nd - 3.5 ± 21.2 
Legend: 1st: first measurement of rater 1 vs. second measurement of rater 1 reliability; 




Table 2.8: Bias and 95% limits of agreement (%, original units) as estimates of inter-
rater reproducibility of B-B Scores (range method only), recorded across two serial 
assessments (1st; 2nd) acquired by the two raters using mean or median scores from 
1 to 5 replications. 






1st - 3.0 ± 13.5 - 1.8 ± 12.2 
2nd - 0.1 ± 12.3 0.3 ± 13.9 
4 replications 
1st - 2.5 ± 14.8 - 2.5 ± 14.9 
2nd - 0.7 ± 13.1 - 0.6 ± 14.2 
3 replications 
1st - 2.6 ± 16.6 - 2.2 ± 17.2 
2nd - 0.9 ± 13.3 0.2 ± 12.8 
2 replications 
1st - 1.7 ± 14.1 - 
2nd - 0.7 ± 14.2 - 
1 replications 
1st 1.2 ± 17.7 
2nd - 3.3 ± 23 
Legend: 1st: first measurement of rater 1 vs. first measurement of rater 2 reliability; 










Figure 2.5: Bland and Altman plots of bias and 95% limits of agreement (%, original 
units) as estimates of intra-rater reliability of B-B Scores (range method only), 
recorded across two measurements acquired by the same rater, using mean and 
median scores (mean [left panel]; median [right panel]) from 1, 3 and 5 replications 








Figure 2.6: Bland and Altman plots of bias and 95% limits of agreement (%, original 
units) as estimates of inter-rater reliability of B-B Scores (range method only), 
recorded across two serial measurements by two separate raters, using mean and 
median scores (mean [left panel]; median [right panel]) from 1, 3 and 5 replications 
of score’s movements. 
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Based on the rationale for the selective reporting of results announced at the end of 
the statistical analysis plan (sub-section 2.2.7 “Statistical analysis plan”, p. 72 - 74), 
only the results obtained using the mean of several replications using the range B-B 
Score computation method are reported from this point. Though the mean and median 
of replications produce equivalent results, the use of the mean of the replications was 
estimated to be somewhat more intuitive for potential users. 
The evolution of the LoAs as a function of number of replications for the mean of 
replications using the range B-B Score computation is presented in Figure 2.7. 
 
Figure 2.7: The graphical evolution of Bland and Altman 95% limits of agreement 
(%, original units) as estimates of intra- and inter-rater reliability of B-B Scores 
(range method only), as a function of mean score from 1 to 5 intra-measurement 
replications. Graphical plots show responses averaged mathematically over two 







The Phase 1 study showed that the access to patients presenting with the four 
targeted pathologies was possible. Nevertheless, the recruitment of patients with 
rotator cuff conditions was easier than for the other conditions and the latter sub-group 
predominated within the experimental sample.  
The recruitment of patients had improved as the study progressed, and this was 
achieved by means of two strategies. Firstly, systematic recalls to the doctors in 
charge of the specialised shoulder consultations relating to potential patients of 
interest to the study were implemented following further liaison with and, secondly, 
following an addendum procedure that had been approved by the hospital’s ethical 
commission, the recruitment focus was extended to include patients treated in the 
musculoskeletal physiotherapy department of the hospital (for details on the 
addendum pleases see sub-section 3.2.2 “Study sample”, within Chapter three, p. 
101 - 103). 
The absence of any technical and practical issues during the measurement sessions 
confirmed the robustness of the measurement device and the applicability of the 
measurement procedure. The acquired data were all exploitable and contributed fully 
to subsequent statistical analyses.  
Patients who had been assessed were able to undergo the scoring procedure within 
a reasonable amount of time, reaching 45 to 60 minutes. They tolerated the protocol 
well and reported no disagreement at the end of each of the measurement sessions.  
Thus, the results from the Phase 1 study confirmed the feasibility of the subsequent 
Phase 2 and 3 studies of the thesis, with the exception of concerns about of the rate 
of patients’ recruitment which would have been too slow overall to allow the Phase 2 
and 3 studies completion within the anticipated and prescribed amount of time. 
Nevertheless, because the delays in patient recruitment had centred around issues 
of communication at the beginning of the study rather than around an insufficient 
population of targeted patients, it was expected that the adjustment to the process of 
recruitment that had been alluded to earlier (i.e. improved liaison with consultant 
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clinicians and a wider scope for recruitment within the hospital) would allow the 
recruitment for the Phase 2 and 3 studies to be successfully completed within two 
years, plus 6 months for follow-up. 
 Study sample 
The control sample was younger than the patient sample but this had probably a minor 
influence on the B-B Scores. Its calculation is based on a side-to-side comparison, of 
which balance associated with ipsilateral-contralateral performance is not likely to be 
altered by age, in the absence of pathology. The enrolment of younger patients limited 
the risk to include patients with undetected rotator cuff conditions, of which frequency 
increases with age (Yamaguchi et al., 2006; Yamamoto et al., 2010; Moosmayer et 
al., 2009). 
 Score optimisation 
 Influence of number of replications on B-B 
Scoring 
The analyses highlighted no carry-over effect, as was stated by the non-significant 
differences amongst replications for the patient and the control group, both for the 
range and area computation methods. However, the mean outcome of the patient 
group tended slightly to increase in the measured patient sample with each additional 
replication for both computation methods (e.g. from Table 2.2 +1%, +2.1%, +3.2% 
and +3.5% vs. mean of 1st replication for 2nd, 3rd, 4th and 5th replication for range 
approach, respectively). Though these results were non-significant stricto sensu, 
considering the small sample size (16 patients) and the p values in the patient group 
(p = 0.06), a Type II error cannot be fully excluded.   
The box plots of the Figure 2.4 showed that the replication (1st to 5th replication) had 
little influence on the group score, but that extreme results were observable when only 
one replication was accounted for. Thus, performing only one repetition would be 
possible when investigating large samples, as it would have little influence on the 




No robust conclusion could be drawn from the Phase 1 study on the potential 
influence of the number of replications on the score increase over replications. No 
carry-over effect was demonstrated based on the measured patient sample, but this 
effect could nevertheless not be completely excluded, because a trend toward 
increase was observed in the sample and a Type II error was possible. Should a Type 
II error have occurred and the carry-over effect really exist, it would then be a warm-
up effect leading to a progressive increase of the performance, which would induce 
an overestimation of the real patient’s performance. Should a Type II error have 
occurred and the carry-over effect really exist, it would then be a warm-up effect 
leading to a progressive increase of the performance, which would induce an 
overestimation of the real patient’s performance. Nevertheless, since the magnitude 
of the increase remained small compared to the 33 to 39% difference between groups, 
the implications for the accuracy of the evaluation would remain limited.  
It seemed thus reasonable to keep the number of replications to a minimum in the 
next phases of the thesis, provided that the reliability is sufficient using this selected 
number of replications, to avoid a possible artificial increase of the score results by 
the execution of overly high number of replications. 
 Comparison of the range and area methods 
Overall group mean B-B Scores for the patient group computed using the area and 
range methods did not differ in the patient group (p > 0.05) (Table 2.2). The magnitude 
of the difference between range and area mean scores (2.4% – 2.9% difference from 
Table 2.2. results) was limited in comparison to the magnitude of the difference 
between the patient and control groups, which reached 28.9% to 39.4% amongst all 
replications. The responsiveness evaluated using the Cohen’s d effect size was 
comparable using either method (range 1.26-1.65), with no systematic advantage for 
one method amongst replications. 
The differences between the range and area B-B Score computation methods were 
higher in the control group (3.3% – 9.2% from Table 2.2), with significant differences 
(p < 0.05) for the 2nd, 3rd and 5th replication. Though these results highlight that both 
methods may produce different results in this group, none of the results found in this 
study indicated that this difference induced an advantage for either method. Indeed, 
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as presented above, this did not lead to larger effect sizes for the area method though 
the outcomes were higher in the control group for this computation method. 
The difference with a median B-B Score of 100, indicating perfect side-to side 
symmetry, was non-significant (p > 0.05) using either the range or the area B-B Score 
computation method. This implied that there was no need to consider an adjustment 
of the B-B Score outcome as a function of the dominant/non dominant side being 
involved with the pathology, in general and subsequently in Phase 2 and 3 studies.  
ICCs indicating single-measurement reliability for B-B Score measurements showed 
essentially equivalent reliability amongst scores computed using area and range 
methods (Table 2.3). The ICCs were at the threshold between good and excellent for 
scores recorded for the patient group, indicating an adequate reliability between 
replications based on accepted standards for clinical measurement (Portney and 
Watkins, 2015). The ICCs levels were moderate for the control group (Portney and 
Watkins, 2015). The ICCs were expected to be lower in this group, as correlations 
levels are known to be influenced by the data variance (Bland and Altman, 1986a). In 
this study, as in most clinical studies, the group heterogeneity was lower in the control 
than in the patient group, which leads to find higher levels of correlations in the latter 
group. 
Overall, the range and the area approach demonstrated equivalent properties in terms 
of responsiveness, reliability (excellent for the patient group and moderate for the 
control group), side-to-side symmetry in the control group and discriminative power. 
These findings contradict the theoretical advantages of the area computation method, 
which was supposedly less sensitive to peak measurements. As a decision had to be 
taken in the absence of clear statistical advantages in favour of one or the other 
approach, the range approach was retained for the Phase 2 and 3 studies. This choice 
was made because no reason was found to abandon the range method that was the 
original approach used for the B-B Score computation, and because it had previously 
been utilised in several studies in which it had demonstrated acceptable 





 Comparison of the mean and median of 
replications 
The results obtained for each replication (1 to 5) (Table 2.2) and the visual inspection 
of box plots (Figure 2.4) showed that the score was stable over replications. However, 
the presence of outliers using only one replication (box plot of the 1st measurement of 
control group) and the significant difference for the patient group score between the 
1st and 5th replication (Table 2.4) confirmed the importance of averaging the score 
over several replications to contain the influence of diverging measurements. 
The use of the mean or the median of several replications of the B-B Score had no 
significant influence on the group score in the patient and control groups (Table 2.4). 
The differences between the patient and the control group were large (Cohen’s d 1.60 
– 1.70) and significant (p < 0.05), regardless of the number of replications and of the 
calculation of the mean or median of replications. Though no subgroup analysis by 
shoulder condition could be performed at this stage of the project, this result globally 
confirmed the discriminative power of the B-B Score in shoulder conditions, which 
was a prerequisite to any further measurement properties analysis. 
The ICCs calculated for the assessment of the intra-rater reliability were excellent for 
the two raters (ICC ≥ 0.90), regardless of the number of replications, except for the 
reliability of the 1st rater for 1 replication, for which the ICC level was good (ICC = 
0.83) (Table 2.5). Similarly, the ICCs for the assessment of inter-rater reliability were 
all ≥ 0.90, except for the reliability of the 2nd measurement of the raters for 1 
replication, for which the ICC level was good (ICC = 0.87) (Table 2.6). Close data 
inspection showed that this lower ICC was essentially due to a single diverging 
measurement on the 1st replication. This statement, added to the fact that the ICCs 
increased with the number of replications, reinforced the hypotheses that several 
replications were needed to contain the potential influence of measurement variability 
when measuring a patient. 
The calculation of LoAs and the generation of B&A graphs showed a limited bias 
between measurements of the same rater (Table 2.7 and Figure 2.5). It was < 3.3% 
when more than 1 replication was executed, which was minor compared to the 33.0% 
to 37.5% difference between the patient and control group (Table 2.4). The same 
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statements could be made for the inter-rater reliability (Table 2.8 and Figure 2.6), with 
bias always < 3.3%.  
As expected if the measurement errors are randomly distributed, the measurement 
variability decreased with the increase of replications, though in higher proportion for 
the first replications (Winer, 1981, Gleeson and Mercer, 1996).  
Detailed data inspection showed that a few extreme measures had a considerable 
influence on the LoA, especially when one measurement was used instead of the 
mean/median of several. The graph inspection confirmed the similarity of the bias and 
LoA using the mean for the median of scores. No obvious trend in data distribution 
was visually detected from the graphs, indicating that the variability was independent 
of the score value. 
Though the median is theoretically less influenced by extreme values, the use of the 
median in practice did not positively influence the bias, the responsiveness or the 
variability of the measurement in any case. As using one or the other can be 
considered as strictly equivalent from a statistical point of view, it has been decided 
to use the mean of several replications, of which use is somewhat more intuitive for 
clinicians who are the target users of the B-B Score.  
 Influence of the number of replications on 
score variability 
The Figure 2.7 showed that the magnitude of the LoAs decreased with the number of 
replications, but that most of the improvement was obtained during the first 
replications. Observing the curve trend, it can be stated that most of the decrease in 
LoA magnitude was obtained using two replications for the inter-rater LoA and three 
for the intra-rater LoA.  
Considering this, it was decided to use three replications in the Phase 2 and 3 studies. 
This decision was driven by the intention to design an efficient score, presenting a 
good balance between limiting measurement constraints and containing 
measurement variability. However, it was stated that, even using 5 replications, the 
LoAs ranged from 8.7% to 13.9% (Table 2.7 and 2.8), which did not fully guarantee 
that the level of precision of single measurements would be acceptable in clinical 
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situations where the difference between measurements is small (e.g. when a patient’s 
change at follow-up is limited), though the B-B Score reliability was excellent based 
on ICCs values. 
 Conclusion 
 Phase 1 study’s impact on Phase 2 and 3 studies 
The Phase 1 study showed that the main project was reasonably realistic and feasible. 
Adjustment of the recruitment procedure had to be made to prevent a slow recruitment 
rate, which was identified as the main potential risk of failure. 
The Phase 1 study served as a basis to define the optimal testing procedure. The 
range and area score computation methods were found to be equivalent, despite the 
theoretical advantages of the latter one. In addition, none of the method implied to 
use a compensation factor to correct for side-to-side asymmetry between the 
dominant and non-dominant arm to be able to compare the results of patients affected 
on the dominant or on the non-dominant side. If it had been present, this asymmetry 
would have considerably complicated the application and interpretation of the B-B 
Score, (e.g. to compare the performance of a right-handed patient affected on the 
right side to that of a right-handed patient affected on the left side). Based on the 
absence of difference between the range and area computation methods, it was 
decided to use the original range computation method that had already been used in 
previous studies (Coley et al., 2007a; Jolles et al., 2011; Pichonnaz et al., 2015c).  
Five replications of the B-B Score movements were executed in this study. It was 
stated that the score was stable over replications, but that the averaging of the 
replications, using the mean or the median of several replications decreased the 
influence of the measurement variability over replications, and had thus a positive 
influence on the reliability, as demonstrated by increasing ICCs values and 
decreasing magnitude of intra- and inter-rater LoAs over replications.  
The use of the mean or the median had no influence on the measurement properties 
investigated in this study (i.e. LoA, ICCs, effect size between the patient and the 
control group), which were comparable. As most of the decrease of the LoA 
magnitude was obtained in the three first replications, it was decided to use the mean 
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of three score replications. This number appeared to represent good balance between 
measurement constraints and measurement precision. 
A few measurements diverging from the others taken in similar conditions were 
observed in the Phase 1 study, as reported in Table 2.7 and 2.8 and as can be stated 
on the Bland and Altman graphs. This highlighted the need of precision in sensors’ 
placement and patient’s instruction to prevent the occurrence of some extremely 
diverging results in the Phase 2 and 3 studies. 
 General implication of the Phase 1 study 
On a more global level, this study’s results were in line with the measurement 
properties that had previously been reported about the B-B Score and its parent P 
Score from which it is derived (Coley et al., 2007a; Jolles et al., 2011; Pichonnaz et 
al., 2015c; Coley, 2007), though it was the first study that investigated the 
measurement property of the B-B Score in a non-surgical sample. This was of 
importance for the following studies of the thesis, which aimed at the investigation of 
the measurement properties of the B-B Score in conservatively treated patients’ 
populations. 
The score easily discriminated the patients from the control group, and the inter- and 
intra-rater reliability were excellent, provided that the average of more than one 
replication was taken into account for the score calculation. More investigations were 
needed to determine to which extend the score precision was sufficient for single 
measurements,  
These results were nevertheless only indicative, due to the small sizes of the patient 
and control group, and the heterogeneity of the patient sample. Though there is no 
standard recommendation concerning the required sample size for the estimation of 
psychometric properties, the size of the sample has an important influence on the 
precision of the results, larger sample producing estimations that are more precise.  
The sample sizes were sufficient for the exploratory analysis conducted in Phase 1, 
but did not allow drawing precise conclusions on the measurement properties of the 
B-B Score. The precision of the estimation was limited and no information could yet 












The aim of this thesis – validate the simplest possible kinematic shoulder function 
scoring procedure for clinical practice and research – focused on investigating the 
possibility of being able to rely on a simple and accessible device for shoulder function 
scoring, in addition to the investigations that were made to establish the scoring 
properties. Therefore, the relevance of the use of smartphones for the evaluation of 
the B-B Score was investigated and presented within this chapter of the thesis, 
because this device could greatly facilitate the practicality of measurements. 
As a reminder of Chapter one 1.1.2.4 “Thesis aim” p. 11 - 13, the data of Phase 2 and 
3 were collected simultaneously. The data collection protocol was designed to allow 
a two-step analysis, the first step aiming at the assessment of the smartphone 
measurement capacities compared to an inertial sensor system used as a reference 
device, regardless of pathologies (Phase 2, presented in this Chapter), the second 
step aiming at the extensive investigation of the B-B Score measurement properties 
twice at 6 months interval for several frequent shoulder conditions, using the most 
efficient device. This data collection approach only marginally increased the 
complexity of the measurement protocol and contributed to a rational use of 
resources, with respect to patients’, raters’ and ethics committee members’ respective 
solicitations, as well as with respect to the use of premises and measurement 
instruments. 
Aspects of the findings of this Phase 2 study have been published in the peer-
reviewed open-access journal Plos One (Thomson Reuters 2017 impact factor 2.77) 
(Pichonnaz et al., 2017) (Appendix VIII). Note that, though the results of Phase 2 
logically should have been published before those of Phase 3, this was not the case 
due to respective contingencies related to the review process of the submitted articles. 
The rationale for the investigation of a smartphone application were previously 
developed in the points 1.1.2.1 to 1.1.2.3 of the thesis’ Introduction p. 4 - 11. Briefly 
summarised, the evaluation of shoulder function using questionnaires has remained 
a controversial issue (Kirkley et al., 2003; Oh et al., 2009; Huang et al., 2015; Harvie 
et al., 2005). Movement analysis may be a possible alternative to questionnaires for 
shoulder function evaluation. Yet, its use in this respect within clinical practice has 
been limited to date by issues of cost, accessibility, practicality and training (Aminian 
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and Najafi, 2004; Clark et al., 2017). Relying on smartphones to overcome these 
limitations might be an option, as most of them are fitted with built-in movement 
sensors that can potentially be used for shoulder movement analysis (Mark, 2011). 
The studies exploring the smartphone approach have found a good reliability for range 
of motion measurements, but to the best of the author’s knowledge, no study has 
evaluated specifically the measurement properties of smartphones for function 
evaluation, let alone specifically for the B-B Score (Werner et al., 2014; Shin et al., 
2012; Mitchell et al., 2014; Cuesta-Vargas and Roldan-Jimenez, 2016; Johnson et al., 
2015; Brophy et al., 2005). 
A new dedicated application for shoulder function evaluation using the B-B Score was 
developed for the purpose of this study by the engineers of the Laboratory of 
Movement Analysis and Measurement (LMAM) of the Swiss Institute of Technology 
of Lausanne (EPFL), as a parallel venture to the thesis’ Phase 1 study. This facilitated 
assessing the measurement properties and practicalities of a smartphone for the 
evaluation of shoulder function in Phase 2. 
The application was developed using the same algorithm as the one used for the 
Physilog® IMU system (Physilog®, Gait Up, Lausanne Switzerland) deployed within 
the Phase 1 study. Laboratory simulations were conducted before clinical validation 
using the data previously collected from the Physilog to test the correct functioning of 
the application’s algorithm. This initial testing confirmed that the smartphone 
produced similar scores to those from the Physilog reference system when using 
these data.  
A preliminary clinical measurement properties study was then undertaken by the 
engineers on seven healthy controls from within the staff working within the LMAM, 
using the Physilog system and the application simultaneously (Oïhénart et al., 2012; 
Duc, 2013). The differences between the values of the shoulder function scores 
measured using the smartphone application and the Physilog reference system 
reached 0.2 ± 0.8% (max: 1.4%). It was concluded that the smartphone was able to 
measure, process, display and store the kinematic scores effectively and that the 
shoulder function score’ values given by the smartphone were precise and accurate 
compared to the reference system.  
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The latter preliminary study was appropriate to explore if a smartphone could 
potentially be used for the B-B Score measurement, but would have always been 
insufficient to investigate precisely the usefulness of the smartphone for clinical 
measurements in patients with a shoulder condition. Thus, a larger scale study was 
conducted to determine to which degree the smartphone B-B Scores measured on 
patients and healthy controls were comparable to those of the Physilog inertial sensor 
system, used as a reference because it had demonstrated its suitability for this 
purpose in previous studies (Coley et al., 2007a; Jolles et al., 2011; Pichonnaz et al., 
2015c; Duc et al., 2013; Duc et al., 2014; Pichonnaz et al., 2015b). 
 Study aim and hypotheses  
The aims of this study were to investigate the validity and reliability of a smartphone-
assessed kinematic shoulder function B-B Score, and to compare the performance of 
the smartphone to a reference inertial sensor system. 
The results of this study were of clinical importance, as they contributed to explore to 
what extent a tool used in everyday life could be a reasonable substitute to a 
dedicated movement analysis inertial sensor system, potentially making objective 
evaluation of shoulder function more accessible to health professionals. Specifically 
to this thesis, the results were needed to determine which of these devices was the 
most efficient one to measure the B-B Score. It had been anticipated that the Phase 
3 study, which aimed at the extensive validation of the B-B Score measurement 
properties in frequent shoulder pathologies, would then be conducted relying on the 
data acquired using the most efficient of the devices, as stated in Phase 2. It had been 
decided that if the study showed the equivalency of the two devices, the comparison 
would be considered to the advantage of the smartphone, which is more accessible, 
cheaper and more user-friendly. 
The study’s hypothesis was that the B-B Score measured with a smartphone would 
meet the requirements of a valid shoulder function score. This implies that the 
differences between the control and the patient group but not the difference between 
devices should be significant, the statistical reliability involving ICCs would be ≥ 0.90 
for inter-device, intra-rater and inter-rater comparisons, and that the limits of 
agreement (LoA) between devices, raters and measurement would be ≤ ± 10% with 
the bias ≤ ± 5% (Walter et al., 1998; Portney and Watkins, 2015). The B-B Score 
Chapter three 
101. 
results should also be coherent with those of shoulder function PROMs, i.e. show 
similarity in the levels of functional deficiency for patients and show performances that 
would be close to normal as indicated by healthy controls. 
 Methods 
For the sake of concision, only aspects of the methods that differ from Phase 1 are 
detailed hereafter. The full description of the aspects that have been omitted is 
available in sub-section 2.2, “Methods”, within Chapter two, p. 65-74 
 Ethical issues 
Amendments had to be made to the Phase 1 protocol 205/10 that had been previously 
approved by the Human Research Ethics Committee of the Canton of Vaud (CER-
VD), to account for the implications of the results of the Phase 1 study. These 
amendments had been approved by the Ethics Committee, as they were minor and 
did not raise new ethical issues (Appendix V). They could thus be incorporated within 
the current Phase 2 study’s methods. 
The Phase 2 study was registered under ClinicalTrials.gov Identifier: NCT01431417, 
simultaneously to Phase 3 (Appendix IX). 
 Study sample 
One patient and one control groups were enrolled for this study. The patients were 
recruited at the Department of Traumatology and Orthopaedic Surgery of the 
University Hospital of Lausanne and the healthy controls within the working 
environment of this researcher and those that had collaborated for this prospective 
cohort study. 
Based on the difficulties of patient recruitment reported previously within the Phase 1 
study, the recruitment area was widened to include both the patients addressed at the 
specialised shoulder consultations and the patients treated in the musculoskeletal 
physiotherapy department of the hospital. Additionally, a request was made at the 
local Ethics Committee to have the permission to screen the records of patients 
attending the specialised shoulder consultations, which improved the recruitment rate 
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compared to that in Phase 1’s study (Protocol 270/12) (Appendix X Accord éthique 
accès Soarian) (please see sub-section 2.2.1, “Study sample”, within Chapter two p. 
65 - 67, for full details).  Therefore, eligible patients residing in the canton, as indicated 
by the inspection of their medical records, were contacted by phone in the order in 
which they attended the medical consultation in the department. 
The inclusion criteria of patients were the same as those for the study in Phase 1 of 
the research (patients with conservatively treated rotator cuff condition, adhesive 
capsulitis or shoulder instability, and conservatively of surgically treated proximal 
humerus fracture). Exclusion criteria were also unchanged. As presented in the thesis 
aims, the data for Phase 2 and Phase 3 were collected simultaneously, Phase 2 
aiming at the investigation of the measurement performance of a smartphone 
compared to an inertial sensor system used as a reference system and Phase 3 
aiming at the extensive determination of the B-B Score measurement properties for 
various shoulder pathologies using the most efficient of the two systems (please see 
sub-section 1.1.2.4, “Thesis aim”, within Chapter one p. 10 - 12).  
The results for patients with shoulder instability were purposely not included in the 
analyses reported hereafter because of retrospective considerations for the utility of 
the data and a desire to maintain coherence with the overall aims of the thesis 
focusing on the real-world clinical applicability of the B-B Score. It had been 
demonstrated retrospectively and described at a later stage of the thesis that the B-B 
Score has insufficient validity specifically in this population (please see Chapter four, 
p.125-165) (Pichonnaz et al., 2015a). It was thus estimated that it was more relevant 
for potential users of the B-B Score, to report a focused analysis of it on the 
populations for which the score can be used in the future. 
It was specified as a delimitation for this study that the group of participants without 
history of shoulder condition/pain, which was included to evaluate the performance 
and stability of the B-B Score in a healthy population, had to be younger than 35 
years-old. These participants, acting as healthy controls within this study, were 
selected purposefully to be younger than the patients in order to avoid bias related to 
the high prevalence of asymptomatic rotator cuff tear above 40 years old (Yamaguchi 
et al., 2006; Yamamoto et al., 2010; Moosmayer et al., 2009). 
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The sample size calculation was based on the data of the Phase 1 study that had 
included responses from 7 controls and 16 patients. The calculation was made so 
that, with a significance level at p < 0.05, the power of 0.80 was reached when the 
minimal standards for acceptable properties of the score were met. Forty-six patients 
were required considering a lowest acceptable estimate statistically of reliability for 
two measurements (ICC) of 0.80, and an expected estimate statistically of 
measurement ICC of 0.90 (Landis and Koch, 1977; Walter et al., 1998). Nine patients 
per group were required to get the expected power of 0.80 with a significance level at 
p < 0.05 for the difference in B-B Score between the patients and the control group 
(Soper, 2004; Lenth, 2010).  
The number of patients to be enrolled according to these calculations represents the 
minimum sample size required to meet the standards for research design (Portney 
and Watkins, 2015; Soper, 2004). A considerably larger sample was enrolled, 
because the data were to be collected for Phase 2 and 3 together. It was therefore 
needed to anticipate the subsequent subgroup analyses by pathologies at baseline 
and 6 months that had been planned within the Phase 3 of the thesis. The phase 3 
sample size calculations showed that at least 20 participants were required in each 
subgroup (please see sub-section 4.2.1 “Study sample”, within Chapter four p.132). 
Since patients with three pathologies were included in Phase 2, 60 patients and 20 
healthy controls were enrolled, plus a few additional patients needed to account for 
drop-outs at the 6 months follow-up.  
The use of a larger sample size than theoretically required, which had been previously 
approved by the ethics committee, represents therefore an appropriate use of the 
study’s resources and contributed to enhance the precision of the calculated 
estimates in Phase 2. 
 B-B Score calculation 
The B-B Score was calculated using the “range calculation” method, as the Phase 1 
study had demonstrated that the alternative “area calculation” method had no 
advantages over this methods, which had previously been used in previous studies 
(please see sub-section 2.3.3.2, “B-B Score determined by range or area of 
computation method”, p. 78 - 79; sub-section 2.4.3.2, “Comparison of the range and 
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area methods”, p. 91 - 92; sub-section 2.5.1, “Phase 1 study’s impact on Phase 2 and 
3 studies”, p. 95 - 96, within Chapter two). 
The mean of three B-B Score replications was used as it was shown to represent a 
good balance between containing measurement variability and limiting 
measurements constraints (please see Chapter two: sub-section 2.3.3.1, “B-B Score 
by replication”, p. 75 - 77; sub-section 2.3.3.3 “B-B Score determined by mean or 
median of replications”, Tables 2.5, 2.6, 2.7 and 2.8 and Figures 2.4, 2.5 and 2.6 p. 
79 - 88; sub-section 2.4.3.4, “Influence of the number of replications on score 
variability”, p. 94- - 95; sub-section 2.5.1, “Phase 1 study’s impact on Phase 2 and 3 
studies”, p. 95 - 96). 
 Experimental systems: smartphone and reference 
system 
A smartphone (iPod®, Apple, Cupertino, USA) was chosen as the support device for 
the development of the application. This device was adapted to the measurement 
purposes, as it is fitted with 3D built-in sensors (Accelerometers : ± 2 g precision: ± 
0.02 g; Gyroscopes: ± 500 deg./s precision: ± 0.2 deg./s; Sampling frequency: 100 
Hz) (Mark, 2011). An application, called iShould (instrumented shoulder test) was 
programmed in Objective-C (Oïhénart et al., 2012; Laboratory of Movement Analysis 
and Measurement—Swiss Institute of Technology of Lausanne, 2016). This 
application enabled the acquisition of the acceleration and angular velocity signals 
during the movements of the B-B Score and the computation of the B-B Score value, 
as described in the Figure 3.1. The laboratory preliminary testing of the smartphone 
application had shown, previously to the research within the Phase 2 study, that this 
approach was viable, as the measurements were close to those obtained using the 
IMU Physilog system as reference device (Physilog®, Gait Up, Lausanne 




Figure 3.1: Schema of the application steps for the recording of a B-B Score (From: 
Pichonnaz C, Duc C, Gleeson N, Ancey C, Jaccard H, Lecureux E, et al. 
Measurement Properties of the Smartphone-Based B-B Score in Current Shoulder 
Pathologies. Sensors (Basel). 2015;15(10):26801-17). 
On ‘launching’ and initiating the software application, the smartphone provided 
instructions to the user, through the smartphone’s loudspeaker, when to perform a B-
B Score-related movement. For each movement, the application recorded the 
acceleration and angular velocity signals for a predefined period of 10 sec. The 
movements were first performed using the healthy side of the body and then repeated 
with the affected side. At the end of the test, the B-B Score was directly calculated, 
displayed on the smartphone screen and then stored within the smartphone’s internal 
memory. The application enabled exporting of all saved data to an external computer 
for its direct comparison with the data from the inertial sensors of the reference 
system. 
The Physilog measurement system (Physilog®, Gait Up, Lausanne Switzerland) was 
used as the reference system to which B-B Score smartphone measurements were 
compared. The reference system’s set-up was the same as that used in the Phase 1 
study (please see sub-section 2.2.3, “Measurement procedure”, within Chapter two, 
p. 68 - 69). 
 Measurement procedure 
The measurement procedure was identical to used within the Phase 1 study with the 
exception that the smartphone was attached to the back of the arm by means of an 
armband, while simultaneous recordings were made by the reference system. The 
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lower edge of the smartphone was set 3 cm above the upper edge of the inertial 
sensors’ module, which were themselves placed on each humerus, 3 cm above the 
midpoint of the line connecting the lateral epicondyle (EL) and medial epicondyle 
(EM). Thus, the smartphone was on the back of the patient’s arm, the screen facing 
backward, when he/she was standing in the initial testing position with his/her arms 
along the body. Special attention has been paid to ensure that both smartphones were 
strictly at the same height (Pichonnaz et al., 2015a) (Figure 3.2). Similarly to previous 
work, angular velocities and accelerations in the sensor frame were used to calculate 
the B-B Score [11, 28]. 
a)  b)  
Figure 3.2: Inertial sensors and smartphone placement and axes (a) The inertial 
sensor module (Physilog® reference system) attached to the arm with medical tape 
and connected by cable to the datalogger carried on waist. The smartphone is 
attached to the arm by means of the armband. (b) Test completion of the “hand to the 
ceiling as to change a bulb” movement. 
Movements were executed in a standing position following the smartphone-recorded 
instructions. The participants undertook first 3 repetitions of the two B-B Score 
movements on the healthy side (put hand to the back + hand to the ceiling as to 
change a bulb) and the task was then repeated on the pathological side. Preliminary 
trials showed that the smartphone B-B Score procedure completion took around 2-3 




A team of six raters was constituted, from which pairs of evaluators performed the 
assessment sessions, while alternating the order of who undertook measurements. 
The first rater was randomly assigned. All measurement systems were detached for 
inter-rater administration of assessments to account for and incorporate the variability 
amongst measurements induced by possible inconsistent sensors’ placement in 
clinics. All raters were experienced physiotherapists engaged in the project, who had 
been trained in the study protocol completion prior to their involvement in this Stage 
2 study. The constitution of a relatively large team made it possible to adapt to 
controls’ and patients’ availability, and thus facilitated the recruitment.  
Patient-reported outcome measures on shoulder function, pain and quality of life were 
also completed. Three PROMs were selected for shoulder function evaluation: the 
Quick Disabilities of the Arm and Shoulder score (QuickDASH), the Simple shoulder 
test (SST), the Constant Score and its variation, the Constant relative score (based 
on a percentage comparison of the measured value to an age- and sex-matched 
normal populations) (Lippitt, 1993; Constant and Murley, 1987; Fialka et al., 2005; 
American Academy of Orthopaedic Surgeons, 2009). The Constant Score was 
undertaken according to the modified guidelines of Constant (Constant et al., 2008). 
The PROMs and socio-demographic questionnaire are available in Appendix VII and 
a more detailed description of the selected PROMs is available in sub-section 5.2.7.3 
“Characteristics of selected shoulder function PROMs”, within Chapter five, p. 187 - 
189. 
This selection of shoulder function PROMs was made based on published literature 
reviews that investigated their frequency of use and the existence of a formal 
investigation process underlying the validity of the shoulder function outcome 
measures (Gartsman et al., 2015; Makhni et al., 2015; Fayad et al., 2004; Longo et 
al., 2011; Kirkley et al., 2003; Huang et al., 2015; Rouleau et al., 2010). The use of 
these PROMs allowed the evaluation of the convergent validity for the B-B Score but 
not of its validity against a gold standard, due to the controversy surrounding shoulder 
function evaluation. 
The EuroQol [EQ-5D] and the pain visual analog scale (VAS) were also completed to 
capture a broader picture of patient clinical state (EuroQol, 2018). The EQ-5D is a 
validated generic quality of life PROM that includes 15 items investigating 5 
dimensions of the quality of life (mobility, self-care, usual activities, pain/discomfort 
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and anxiety/depression) and a visual analogue scale to record the patient’s self-rated 
health. The EQ-5D test-retest reliability is good to excellent. Some ceiling effects have 
been reported, particularly when used in general population surveys. A validated 
translation is available in the language of the study participants (French) and the form 
is easy to complete (Béthoux, 2003; EuroQol, 2018). 
The VAS pain scale is an instrument on which the patient has to rate his/her pain 
intensity on a 10 cm scale representing the range between “no pain” and “the worst 
imaginable pain”. It is a very widely used tool for subjective pain intensity evaluation, 
that demonstrated adequate reproducibly and responsiveness. The limitations of the 
pain VAS scale is that the pain ratings cannot be compared between patients and that 
the scale is not adapted to young children and to patients with cognitive impairments 
(Béthoux, 2003), which were considered to be minor drawbacks in the context of this 
study. 
 Analysis 
Descriptive statistics including mean and standard deviation (SD) were performed for 
participants’ characteristics and outcomes for the patient and the control group, using 
the reference device and the smartphone. These statistics were also calculated for 
the selected PROMs. In this phase of the thesis, the reporting of PROMs only 
intended to illustrate the performance level of included participants, the determination 
of the specific relationships amongst the PROMs and the B-B Score in each pathology 
being planned in the Phase 3 study. Box plots were also generated to illustrate the B-
B Score outcomes for the patient and the control group, using the reference device 
and the smartphone.  
Parametric tests were used to test the statistical significance of differences when the 
assumption of normality was met, as stated by the Kolmogorov-Smirnov test when  n 
> 50 and the Shapiro-Wilk test when n < 50 (Yap and Sim, 2011), and the assumption 
of homoscedasticity was met, as stated by the Levene’s test for equality of variance 
(p > 0.05). Non-parametric test were used when these assumptions were not met. 
The difference between the B-B Scores measured by each device was evaluated 
using the paired Student t-test. The difference between the patient and the control 
groups were evaluated using the Student t-test when assumption for the use of 
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parametric tests were meet, the Wilcoxon rank-sum test when they were not met and 
the Chi-square (χ2) for nominal data.  
The relationship between the B-B Scores of each device, and the intra- and inter-rater 
reliability were evaluated using the ICC, measurement error (ME: standard error of 
the mean difference), standard error of measurement [SEM: 'pooled SD 
/1  ICC agreement&] and Bland and Altman analysis, including graphs generation 
and bias and LoA calculations. The ICCagreement for a single measurement was 
recorded, because the absolute agreement for measurements by a single rater is of 
interest in this study’s context (Koo and Li, 2016). Intra-rater reliability was calculated 
comparing the 1st with the 2nd B-B Score obtained by the same rater, for the two raters. 
Inter-rater reliability was calculated comparing the score obtained by one rater with 
the score by the other rater, for the 1st and 2nd measurements made by each evaluator.  
The discriminative power of the B-B Score for the detection of shoulder function loss 
was evaluated by the significance level for the differences between groups (Student 
t-test, p < 0.05). This calculation aimed at providing a first insight into the capacity of 
the B-B Score to detect differences that are likely to exist, which should be considered 
as a preliminary investigation. Further calculations related to discriminative power 
analysis were planned in the Phase 3 of the thesis to determine the magnitude of the 
change and the quality of the B-B Score compared to an external standard, 
specifically for each shoulder condition included in the study (De Vet et al., 2011c; 
Mokkink et al., 2010b). 
 Results 
 Study sample 
Twenty healthy controls and 65 patients (20 with rotator cuff condition, 23 with 
fracture, 22 with capsulitis) were included. 
The population characteristics and the significance of the differences between groups 




Table 3.1: Participants’ characteristics for the patient and the control group, with 
indication of the significant differences between groups. 
 Patient (n = 65) Control (n = 20) 
Age mean (SD), years 58.5 (14.2)** 28.2 (6.2) 
Sex (% women) 63 50 
Weight mean (SD), kg 75.2 (15.8) 74.7 (17.4) 
Body mass index mean (SD), kg/m2 26.6 (5.8) 24.2 (3.9) 
Size mean (SD), m. 1.68 (0.10) 1.75 (0.10) 
Hand dominance (% right-handed) 92 90 
Pathology (n) 




Affected side (% dominant side) 43 - 
Legend: ** Significant difference between groups with p-value < 0.01 
The differences between groups were non-significant for the weight (Z =  0.23; 
p = 0.81), height (Z =  1.94; p = 0.05), BMI (Z =  1.25; p = 0.81) but significant 
for age Z =  4.74; p < 0.01), based on the Wilcoxon rank-sum test results. The 
difference between groups were non-significant for sex (χ2(1) = 0.42, p = 0.52) 
and hand dominance (χ2(1) = 0.02, p = 0.90), using the Chi-square test. 
 Score outcome 
The B-B Scores outcomes of the control group and the patient group, for the 
smartphone and the reference system (Physilog), respectively, are presented in Table 




Figure 3.3: Traditional box plots showing median, lower and upper quartile, range 
and outliers (open circles, 1.5 interquartile range, B-B Scores, comparing the healthy 
control (n= 20) and the patient (n=65) groups using the reference system (Physilog, 
blue colour) and the smartphone (green colour) 
Table 3.2: Mean and standard deviation of B-B Score using the smartphone and the 
reference system. Unit of scores are % representing the performance of the 
pathological side compared to the healthy side 
Mean (SD), % 
Reference system Smartphone 
Min;max 
Control  
97.0 (13.8) 94.1 (11.1) 
79.5 ; 125.2 71.9 ; 115.7 
Patient 
54.0 (19.0) 54.1 (18.3) 
21.5 ; 114.5 21.7 ; 108.2 
Legend: SD: standard deviation; Min: minimum measured value; Max: maximum 
measured value 
The visual inspection of the box plots (Figure 3.3) highlighted the similarity between 
the outcomes obtained using the smartphone or the reference device for the patient 
and the control group, and the difference between the outcomes of the patient and 
the control groups, which were then further analysed using inferential statistics. 
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The Kolmogorov-Smirnov test confirmed the normal distribution of data, for the patient 
group using the reference device (df (65) = 0.06, p = 0.08) and the smartphone (df 
(65) = 0.07, p = 0.07), and the Shapiro-Wilk in the control group using the reference 
device (df (20) = 0.94, p = 0.21) and the smartphone (df (20) = 0.97, p = 0.78). All 
assumptions for parametric tests being met, these type of tests were used in further 
calculations. 
The difference between the control and the patient group was statistically significant 
for the reference system (mean (SD) control group 97.0% (13.8) vs. patient group 
54.0% (19.0) t(83) = 9.41, p < 0.01) and the smartphone (mean (SD) control group 
94.1% (11.1) vs. patient group 54.1% (18.3), t(83) = 9.23, p < 0.01) (please see Table 
3.2). These results confirmed the hypothesis that there would be a significant 
difference between the B-B Score outcomes of the patient and the control groups, 
(please see sub-section 3.1.1 “Study aim and hypothesis” of this Chapter, p. 100 - 
101). 
The difference between the reference system and the smartphone was non-significant 
for the control (mean (SD) 97.0% (13.8) for the reference system and 94.1% (11.1) 
for the smartphone, t(19) = 1.39, p = 0.18) and for the patient group (mean (SD) 54.0% 
(19.0) for the reference system and 54.1% (18.3) for the smartphone t(64) = -0.18, p 
= 0.86), as demonstrated by the result of the Student t-test (please see Table 3.2). 
This result confirmed the hypothesis that there would be no difference between the 
smartphone and the reference device when measuring groups (please see sub-
section 3.1.1 “Study aim and hypothesis” of this Chapter, p. 100 - 101).  
 Measurement reliability 
The numerical and graphical presentations of reliability of B-B Score measurements 





Table 3.3: Inter-devices and intra- and inter-rater reliability assessment using ICC, 
LoA, bias, ME and SEM for the B-B Score outcomes (%, original units) acquired 
using the smartphone or the reference system (n = 85). 
 ICC (95% CI) LoA (%) Bias (95% CI) ME (%) SEM (%) 
Inter-devices  0.97 (0.94 - 0.98)  -13.2 – 12.0 - 0.6 (-0.9 – 1.1)  0.7  4.0 
Intra-rater      
Smartphone 0.92 (0.89 - 0.94)  -17.4 – 20.3 1.5 (0.0 – 2.9)  0.7  6.6 
Reference System 0.92 (0.89 - 0.94)  -19.3 – 19.6 0.1 (-1.4 – 1.6)  0.8  6.6 
Inter-rater      
Smartphone 0.92 (0.90 - 0.94)  - 16.9 – 20.0 1.5 (0.1 – 3.0)  0.7  6.6 
Reference System 0.93 (0.91 - 0.95)  - 18.1 – 20.0 1.0 (-0.5 – 2.4)  0.7  6.4 
Legend: ICC: intraclass coefficient of correlation; 95%CI: limits of interval at 95% confidence 
level; LoA: limits of agreement; ME: measurement error; SEM: standard error of measurement 
Intraclass correlation coefficients for inter-device, intra-rater and inter-rater 
assessment presented in Table 3.3 were all above the threshold defined for clinical 
utility (ICC ≥ 0.90; please see sub-section 1.1.3.4.2.2 “Test-retest, intra- and inter-
rater reliability”, within Chapter one, p. 40 - 41). Therefore, the hypotheses that the B-
B Score would have adequate reliability for clinical measurements, regardless of the 
rater, the measurement and the use of a smartphone or an inertial sensor system 
were met (please see sub-section 3.1.1 “Study aim and hypothesis” of this Chapter, 
p. 100). 
The measurement error, that represents the standard error of the mean difference, 
showed that the differences between devices, raters or measurements had minor 
influence on the variability of group scores, as they ranged from 0.7% to 0.8% (Table 
3.3). 
The biases i.e. mean values of the differences between the measurements, indicated 
that the magnitudes of the systematic errors between devices, raters or 
measurements were also minor, as they ranged from -0.6% to 1.5% (Table 3.3 and 
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Figure 3.4. Thus, the hypothesis that the bias would be ≤ ±  5% was met (please see 
sub-section 3.1.1 “Study aim and hypothesis” of this Chapter, p. 100 - 101). 
The LoAs, which represent the ranges that contains 95% of random measurement 
differences, were lower for inter-device (-13.2 – 12.0%) than for intra- or inter-rater 
comparisons (upper limit up to 20.3%) (Table 3.3 and Figure 3.4). Nevertheless, all 
the LoAs were higher than the ≤ ± 10% threshold that had been defined for adequate 
agreement (please see sub-section 3.1.1 “Study aim and hypothesis” of this Chapter, 
p. 100 - 101). The range of error associated with a single measurement should thus 
be taken into consideration when repeated assessments of the B-B Score are 
performed, as the magnitude of error may have a clinically significant influence on the 
measured outcome in some cases. 
The visual inspection of the Bland and Altman graphs showed an increase of the error 






Figure 3.4: Bland and Altman plots of bias and 95% limits of agreement (%, original 
units) as estimates of inter-devices, intra- rater and inter-rater limits of agreement of 
B-B Scores, recorded across two serial measurements by two separate raters, using 
the reference device and the smartphone. 
Legend: LoA: limits of agreement. 
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 Patient-rated outcome measures 
The results of shoulder function, pain and quality of life PROMs are presented in Table 
3.4. 
Table 3.4: Mean group outcomes of patient-reported outcome measures for the 
patient and the control group, with standard deviations, minimum and maximum 
measured values.  
PROMs mean (SD) * 
Min; max 
Patient 
(n = 65) 
Control 
(n = 20) 
Constant Score (SD), points 
42.8 (17.9) 93.7 (6.6) 
10; 85 80; 100 
Relative Constant Score (SD), % 
55.5 (23.9) 97.6 (7.5) 
12; 110 82; 108 
SST (SD), points  
4.6 (3.1) 11.9 (0.2) 
0; 12 11; 12 
QuickDASH (SD), % 
42.8 1.1 (2.5) 
0.0; 86.4 0.0; 6.8 
VAS pain (SD), mm 
40.5 (24.2) 0.9 (2.7) 
0; 81 0.0; 10 
EQ-5D (SD), index 
0.70 (0.19) 1.00 (0.00) 
- 0.18; 1.00 1.00; 1.00 
EQ-5D VAS (SD), points 
74.3 (18.0) 98.4 (44.9) 
10.0; 100.0 85.0; 100.0 
Legend: * Best possible scores: Constant Score100 points, relative Constant Score 
theoretically no limit (scores in % based on an age-and sex-matched normal population for 
Constant Score), SST 12 points; QuickDASH 0, VAS pain 0, EQ-5D 1.00 (index score of a 
value set derived from the general population sample), EQ-5D VAS 100. 
The inspection of Table 3.4 outcomes showed that the patient and control groups 
were representative of the populations that they are supposed to represent. The 
outcome of the patients on the PROMs demonstrated that the patient sample level of 
shoulder dysfunction was realistic, with regard to that encountered in clinical practice 
and in the literature. The outcome of the control group was near from the maximum 





This study investigated the validity and reliability of a smartphone-assessed kinematic 
shoulder function B-B Score, and compared the performance of the smartphone to a 
reference inertial sensor system. Using shoulder function scores derived from a 
dedicated smartphone application, the study aimed at the technical and, to some 
extent at the clinical validation of them within a sample including various shoulder 
pathologies. Provided that the score was valid, it could offer a valuable alternative to 
concurrent MAB outcomes measures of shoulder function, as it was accessible and 
quickly performed. 
 Study sample 
No significant difference was observed between the characteristics of the patient 
group and control group participants, except for age. The control group was 
purposefully younger than the patient group as it was of primary importance that the 
reference population had healthy shoulders. The characteristics of the patient group 
were representative of the population commonly treated for shoulder pain (Picavet 
and Schouten, 2003; van der Windt et al., 1995).  
There were no deviations away from the planned sampling for this study. The study 
sample was sufficient to obtain precise results, as indicated by the narrow 95% 
confidence interval (maximum ± 0.025 for ICC; maximum ± 1.5 for bias) (Table 3.3). 
 Devices’ comparison 
The reference system (Physilog®) and the smartphone produced comparable B-B 
Score outcomes regarding group measurements. Although the specificities of the 
measurement systems were different, for example sensors’ noise, sensors’ ranges 
and sampling frequency, the performance of the smartphone appeared to be sufficient 
for the B-B Scores’ proper measurement (for technical features please see sub-
section 2.2.2 “Measurement device”, within Chapter two, p. 68 for the Physilog and 
sub-section 3.2.4 “Experimental systems: smartphone and reference system” within 
this Chapter, p.103 for the smartphone).  
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The mean differences between the devices were non-significant in the patient (p = 
0.86) and the control group (p = 0.18), and of limited magnitude (0.1% for the patient 
group and 2.9% for the control group). These differences are unlikely to have a 
clinically significant influence on the measured outcome, as they are minor in 
proportion to the 42.9% and 40% difference in B-B Score between the patient and the 
control group, for the reference system and the smartphone, respectively (Table 3.2). 
Based on these results the hypothesis that there would be no difference between the 
smartphone and the reference device when measuring groups was confirmed, making 
the smartphone a possible substitute to inertial sensor systems for the evaluation of 
groups’ outcomes using the B-B Score. 
An excellent relationship was found between measurements from the devices (ICC 
0.97) (Table 3.3). Moreover, the Bland and Altman analysis demonstrated that the 
systematic error of the smartphone was minor. The ME (0.7%) and SEM (4%) were 
proportionally small compared to the difference observed between the patient and the 
control group, using the reference system (43%) or the smartphone (40%) (Table 3.2). 
Thus, the measurement error related to the device was not expected to interfere 
importantly with the capacity of the B-B Score to classify correctly the participants as 
patients or healthy controls. Conversely, the LoA exceeded the 10% criterion that had 
been selected to define an acceptable threshold (please see sub-section 3.1.1 “Study 
aim and hypotheses”, p. 100-101) (Walter et al., 1998; Portney and Watkins, 2015). 
Thus, the Physilog and the iPod are interchangeable for group measurement, but the 
magnitude of the LoA might preclude the devices’ routine exchange when 
measurements concern individual participants. 
 Groups’ comparison 
The B-B Score difference between the control and the patient groups was highly 
significant (p < 0.01) and large, regardless of the devices (mean (SD) control group 
97.0% (13.8) vs. patient group 54.0% (19.0) for the reference device and mean (SD) 
control group 94.1% (11.1) vs. patient group 54.1% (18.3) for the smartphone) (Table 
3.2). Hence, the B-B Score clearly discriminated the performance of the patient group 
from that of the healthy group.  
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These results are in line with the hypothesis that there would be a significant 
difference between the B-B Score outcomes of the patient and the control groups, 
which confirmed the capability of the Score to discriminate groups for which a 
difference is expected (please see sub-section 3.1.1 “Study aim and hypotheses”, p. 
100-101). 
 B-B Score intra- and inter-rater reliability 
The intra- and inter-rater reliability was excellent (0.92 – 0.93) and comparable 
between devices (Table 3.3). The hypothesis that the B-B Score ICCs would be higher 
than the level recommended for clinical measurement (≥ 0.90) for inter-device, intra-
rater and inter-rater comparisons was met, regardless of the device used for the 
measurement (Portney and Watkins, 2015).  
As shown by the small bias derived from the Bland and Altman analyses (≤ 1.5%, 
while the threshold defined for clinical utility was ≤ ±  5% in this study) (Table 3.3 and 
Figure 3.4), the B-B Score’s biases related to the device, measurement and the rater 
were relatively minor, indicating that the systematic errors were not likely to interfere 
significantly with clinical measurements.  
Conversely, for both devices, the LoA for the intra- and inter-agreement of the B-B 
Score had exceeded an arbitrary ≤ ± 10% threshold defining the upper 95% 
confidence limit for measurement error associated with its clinical utility (please see 
sub-section 3.1.1 “Study aim and hypotheses”, p. 100-101). The limits of agreement 
ranged from ± 18.5% to ± 19.4% on both sides of the bias Table 3.3 and Figure 3.4). 
The visual inspection of the Bland and Altman graphs showed an increase of the error 
at higher scoring, due to the technical aspects of scoring. This is related to the formula 
used for the determination of the B-B Score, which expresses the shoulder function 
as the ratio of the performance of the affected side relative to the healthy side (or the 
dominant side relative to the non-dominant side for healthy controls), reported as a 
percentage. Thus, variations in the affected shoulder (denominator in the formula) 
have proportionally more influence on the score when its performance is near from 
that of the healthy shoulder (numerator). Thus, the B-B Score tends to be more stable 
for patients who perform at a low functional level. 
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Thus, the results are comparable between replications and between raters for 
measurements focusing on the performance of a group, but excessive variations and 
divergence amongst repeated assessments of the B-B Score are possible even when 
the outcome is derived from the mean of three repetitions, as has been used in this 
study’s protocol. Measurements relating to the assessment of a single patient is still 
feasible but would be expected to require acquiring the mean of more than three 
replications in order to counteract inflated error and establish the requisite precision 
of measurement (Mercer and Gleeson, 2002), as the variability and error in a 
measurement mean score decreases with the square root of the repetitions’ number 
(assuming a normal distribution of error). The simplicity of the procedure for assessing 
the B-B Score facilitates measurement repetition and largely overcomes this 
limitation.  
 Comparison with PROMs for criterion validity 
determination  
The kinematic measurements were also compared to currently-used PROMs for 
benchmarking. The PROMs included estimates of shoulder function (Constant, 
Relative Constant, SST and QuickDASH), pain (VAS) and quality of life (EQ-5D). 
In healthy participants, both the PROMs and the kinematic B-B Score had indicated 
near to the maximum performance, showing that the reference population had almost 
perfect shoulder function. For patients, the observed importance of shoulder function 
loss was globally comparable between the PROMs and the B-B Score, with all scores 
indicating a substantial function’ loss in the measured sample (from Table 3.4, 
42.8/100 points for the Constant Score, 55.5%/100% for the relative Constant Score, 
4.6/12 points for the SST and 42.8/100 points for the QuickDASH). Thus, it appeared 
that in this study the B-B Score (54.0% using the reference system and 54.1 using 
the smartphone) produces coherent results to those from the shoulder function 
PROMs in terms of measured loss of function, regardless of the device used. 
These results were in line with previously published results on the relationship 
between the B-B Score and PROMs, which showed moderate to high correlations of 
the B-B Score with scores from the Constant and SST and moderate correlations with 
the QuickDASH for various shoulder pathologies (Pichonnaz et al., 2015a). The 
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relationship between the B-B Score and the PROMs will be further explored and 
detailed in Phase 3 specifically for each included shoulder pathology. 
 Shoulder function evaluation by body-worn sensors   
in the literature 
Most previous studies that had investigated the measurement properties of body-worn 
sensors for shoulder function scores used dedicated inertial-based systems (Coley et 
al., 2007a; Korver et al., 2014a; Korver et al., 2014b; Pichonnaz et al., 2015c; Jolles 
et al., 2011; Duc et al., 2013; Duc et al., 2014; Luinge and Veltink, 2005; Cutti et al., 
2008; de Vries et al., 2016). All of these studies concluded that the inertial-based 
systems produced a valid evaluation of shoulder function. However, no comparison 
with a concurrent wearable system has been reported. To the best of our knowledge, 
the present study was the first to investigate the concordance and the relationship of 
a smartphone-based and a reference inertial-based system for shoulder function 
evaluation. The results are valuable for research and clinics, as they demonstrate that 
the validity of the B-B Score measurement is not altered when using a simple and 
accessible device. 
 Study limitations and further developments 
This study provided a novel comparison of a smartphone with a reference device for 
the measurement of the B-B Score but did not yet provide a complete insight into the 
measurement properties of the B-B Score, with the exception of its focus on the 
reliability of measurements associated with intra- and inter-evaluator assessments. 
Although both devices (reference and smartphone) might have been deemed capable 
of offering equivalent measurement reliability characteristics for the assessment of 
the B-B Score, based on the results from the current Phase 2 study, it was still 
plausible that the B-B Score might not appropriately reflect shoulder’ function status 
and its change over time. Furthermore, the definition of a norm and interpretability 
aspects was still lacking to support the correct interpretation of the B-B Score and of 
its change over time. Thus, further research was conducted within the next phase of 
the thesis to investigate the latter issues and to compare the B-B Score with 
alternative measurement methods. 
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The results thus far apply to a situation in which the measurements had been 
performed under supervision and at the patient’s self-selected speed of movement. 
Further investigations are needed to determine the validity of the B-B Score in other 
conditions. For example, the relationship between assessment devices might be 
different if the patients perform movements associated with the B-B Score at their 
maximum speed, due to the difference in sensors’ characteristics. Measurement’ 
reliability might also be different if the patient performs the test without supervision, 
as would be the case in telemedicine applications. 
The results were not detailed separately for each pathological subgroup within this 
Phase 2 study. This might be considered a minor limitation with regard to the study’s 
objectives, as the relationship between devices is likely to be far more influenced by 
the testing conditions rather than by the pathology. Conversely, the use of a larger 
patient group had the advantage of providing more precise estimations of the reliability 
of the B-B Score’s measurements. 
Despite the widespread use and the convenience of smartphones, there are also 
limitations in their use for scientific measurement. The precise features of the device 
are not fully disclosed by manufacturers due to commercial sensitivities. The users 
should remain conscious that the characteristics may differ according to the 
smartphone version and brand. In view of these potential issues, it seemed 
reasonable to have chosen an accessible middle-segment smartphone model in order 
to offer insight into its performance' characteristics for the type of measurements that 
the B-B Score requires. The B-B Score would probably remain robust when faced with 
minor variations in smartphone’ technology, as it would have compared the 
performance of the affected shoulder with that of the healthy one, with the score 
unaffected by systematic errors in measurement affecting both sides (Pichonnaz et 
al., 2015c). However, a study comparing the performance amongst smartphones 
should be conducted to investigate this assumption.  
Based on the findings from this Phase 2 study and the body of literature on the subject, 
it appears that smartphones most likely offer measurement properties that are 
compatible with research requirements for measurements comparing both sides and 
for range of motion measurements (Shin et al., 2012; Werner et al., 2014; Mitchell et 
al., 2014). Nevertheless, the validity of using smartphones for more complex 
measurements, for example those associated with 3D kinematic analysis of sport 
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activities, remains unknown to date. In addition, the aforementioned variations in 
smartphones’ features imply that further research is needed to investigate and 
quantify the influence of variations in the measurement context on the B-B Score’s 
outcome before its clinical implementation.  
The duration required to conduct the whole procedure to assess a B-B Score using 
the smartphone was around two minutes. All things being equal, the advantage of the 
measurement approach used in this study mainly resides in its clinical practicality and 
low cost. Further research may extensively investigate the smartphone B-B Score’s 
specific measurement properties including convergent validity, responsiveness and 
interpretability aspects specifically in different shoulder pathologies. Thus, it was 
planned to address these issues in the Phase 3 study of the thesis, in order to provide 
a broad overview of the measurement properties of the smartphone B-B Score for 
potential users.  
As part of a general approach by the B-B Score’s research team within the DAL-CHUV 
and Laboratory of Movements Analysis and Measurement of the Swiss institute of 
Technology (LMAM-EPFL) to improve access to this approach to the assessment of 
shoulder function by clinicians and patients, an android version of the application has 
been developed and made available to the public (Gait Up, 2018). The latter offered 
an important adjunct to this thesis, facilitating research into the further development 
of the smartphone approach to assessing shoulder’ function in order to accrue 
maximum benefits from it in situations where that might be warranted. A presentation 
of the B-B Score application features is available in Appendix XI. 
This type of smartphone application might also underpin future developments 
facilitating the communication of clinically-relevant results between stakeholders, 
producing progression curves of functional improvements and comparing the patient's 
change of performance during care-pathways to benchmark results on a routine 
basis. 
For recall, Phase 2 study aimed to investigate the validity and reliability of a 
smartphone-assessed kinematic shoulder function B-B Score, and to compare the 
performance of the smartphone to that of a reference inertial sensor system. Further 
developments that will be conducted in Phase 3 study will aim at the determination of 
the measurement properties of the smartphone B-B Score for the assessment of 
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current shoulder pathologies (rotator cuff condition, capsulitis, proximal humerus 
fracture and shoulder instability).   
 Conclusion 
This study aimed at the technical and clinical validation of a B-B Score smartphone 
application for the evaluation of the functional capabilities of the shoulder. Either the 
assessments acquired using a smartphone or a reference inertial sensor system 
displayed comparable measurement properties across a wide-range of clinimetrics. 
This comparison is to the advantage of the smartphone, which is more accessible, 
cheaper and more user-friendly than dedicated movement analysis inertial sensor 
systems. 
The results showed that the B-B Score acquired by means of a smartphone, was 
valid, reliable and reproducible for the measurement of shoulder function of groups of 
patients including those presenting with rotator cuff conditions, proximal humerus 
fractures or adhesive capsulitis. It displayed excellent intra- and inter-rater reliability 
and discriminative power. Conversely, single assessments of the B-B Score, even 
when involving the mean of three measurements, may offer reduced precision in 
some circumstances. 
Thus, the B-B Score measured with a smartphone allows valid, user-friendly and low-
cost evaluation of shoulder function for research and clinical work. This could facilitate 
the use of objective measurement methods for shoulder function evaluation in routine 
practice and thus improve the quality of patient follow-up. Further research is needed 
to investigate extensively the smartphone B-B Score’s specific measurement 
properties in various patient populations, which will be addressed in the next phase 
of this thesis. It may also investigate the influence of the specific characteristics of 
various smartphone’ models on results. Further technological developments are also 













 Study context 
Research results are strongly influenced by the quality of measurements. In addition, 
important decisions concerning patients are taken based on measured outcomes. 
Thus, the establishment of the measurement properties of an evaluation tool is 
paramount before it is used in clinical conditions.  
The Phase 2 study demonstrated that the transfer of the B-B Score to a smartphone 
did not alter the measured score or its reliability compared to the score measured 
using a dedicated inertial measurement system. In isolation, these results support the 
use of smartphones over dedicated movement analysis IMU systems, due to their 
accessibility, user-friendliness and low-cost.  
Nevertheless, the fact that the measurements were comparable between devices 
does not necessarily imply that the B-B Score had acceptable measurement 
properties in the target populations of patients exhibiting different types of frequent 
shoulder conditions such as rotator cuff conditions, capsulitis, shoulder instability or 
proximal humerus fracture. It was therefore necessary to undertake further analyses 
to investigate if the smartphone B-B Score measurement properties were acceptable 
under a wider range of assessment challenges. 
The Phase 3 study was undertaken to investigate the measurement properties of the 
B-B Score acquired using a smartphone and focused attention on the important issue 
of the latter’s capability for delivering high-quality assessments of shoulder function 
amongst varied types of clinical conditions. Considering that measurement properties 
are population-dependent, they were to be established specifically for each of the 
main shoulder pathologies encountered in physiotherapy (Robertson et al., 2017; 
Riddle and Stratford, 2013; Collins and Roos, 2016). 
As a reminder of information offered in Chapter one (subsection 1.1.2.4 “Thesis aim” 
p. 11 – 12), the data of Phase 2 and 3 were collected simultaneously. The first step, 
corresponding to Phase 2, presented in Chapter three, aimed at the assessment of 
the smartphone measurement capacities compared to an inertial sensor system used 
as a reference device, regardless of pathology. The second step, encompassing the 
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work of this Chapter, aimed at the extensive investigation of the B-B Score 
measurement properties for several frequent shoulder conditions, using the most 
efficient device, i.e. the smartphone as concluded from Phase 2 results. This phase 
implied a more detailed and targeted data analysis and the collection of follow-up data 
in order to investigate the B-B Score change over time. 
Aspects of the findings of this Phase 3 study have been published in the peer-
reviewed open-access journal Sensors (Thomson Reuters 2017 impact factor 2.48) 
(Pichonnaz et al., 2015a) (Appendix XII). 
 Definition of the target populations 
The targeted populations included patients with rotator cuff conditions treated 
conservatively, shoulder instability treated conservatively, proximal humerus fracture 
treated surgically or conservatively, and capsulitis treated conservatively. 
Conservatively treated populations were investigated because they represent much 
larger populations than the surgically treated ones. Overall, only one in every 10 
patients presenting with shoulder pain requires surgery (Colvin et al., 2012). 
Moreover, some results were already available for the postsurgical context, as the B-
B Score was developed in a population who had undergone rotator cuff and 
arthroplasty surgery (Pichonnaz et al., 2015c). In addition, it had been previously 
established that the B-B Score produced comparable results to the kinematic P Score, 
which has itself demonstrated to be valid and responsive following shoulder surgery 
(Coley et al., 2007a; Coley, 2007; Jolles et al., 2011). 
Patients with rotator cuff conditions, proximal humerus fractures, adhesive capsulitis, 
and shoulder instabilities are frequently encountered in shoulder consultations (van 
der Windt et al., 1996; Yamamoto et al., 2010; van der Windt et al., 1995; Court-Brown 
and Caesar, 2006; Liavaag et al., 2011; Owens et al., 2007). It was thus essential to 
investigate the measurement properties of the B-B Score for these conditions. The 
characteristics of these conditions have been previously developed in sub-section 




 Measurement properties to be investigated 
Multiple qualities are expected from a measurement instrument to ensure that the 
result gives a correct representation of the reality. These qualities are encapsulated 
by the concepts of validity, reliability and responsiveness, which all encompass 
several aspects that contain specific measurements properties (Mokkink et al., 
2010d). In addition, the determination of normal performance and interpretability 
aspects is of importance for the interpretation of the results (Tubach et al., 2007). 
These notions are not hereby detailed, as they have been extensively developed in 
sub-section 1.1.3.4 “Clinimetrics”, within Chapter one, p. 29 - 50.  
Content and construct validities were not addressed in this thesis, because the 
rationale underlying the design of the B-B Score had been investigated and justified 
in a previous research, that aimed at the selection of essential movements for the 
evaluation of movement analysis-based shoulder function (Pichonnaz, 2010; 
Pichonnaz et al., 2015c). Conversely, criterion validity was investigated in this Phase 
3 study, as it was still to be established in the targeted populations. In the absence of 
a universally recognised PROM for shoulder function evaluation, criterion validity but 
no gold standard validity could be established (McDowell, 2006). 
Notwithstanding the aforementioned exceptions, the Phase 3 study protocol was 
designed to investigate as extensively as possible the B-B Score’s measurement 
properties and to provide users with the information they need to apply the Score with 




Table 4.1: Investigated measurements properties and their aspects (where 







Validity Concurrent Correlation with PROMs 
 Discriminative power Difference between groups  
Difference between stages 
Area under the ROC curve, sensitivity-
sensibility for the discrimination between 
patients and controls  
Responsiveness Responsiveness Area under the ROC curve, sensitivity-
sensibility for shoulder function change 
detection 
  Change score correlation 
  Effect size (comparison between 
outcome measures) 
  Standardised response mean 





  MDC 
Interpretability  Normal performance range 
  MCII/MCID 
  PASS 
  LoA 
Abbreviations: SEM: standard error of measurement; MDC: Minimal detectable 
change; MCII: Minimal clinically important improvement, MCII: Minimal clinically 





 Study aim and hypotheses 
This study was aimed at the determination of the measurement properties of the 
smartphone B-B Score for the assessment or the progression of current shoulder 
pathologies (rotator cuff condition, capsulitis, proximal humerus fracture and shoulder 
instability). 
Based on two assessments acquired over a six-month period, it was hypothesised 
that: 
- the B-B Score would remain stable in the control group (p > 0.05), while it would 
progress significantly (p < 0.05) over time in each pathological subgroup, 
- the responsiveness assessed using effect sizes (ES) and standardised response 
means (SRM) would be comparable to that of validated PROMs, 
- the area under the receiver operating characteristic (ROC) curve indicative of 
discriminative power between patients and controls, and the ROC curve indicative 
of discriminative power between improved and unimproved patients at the 6 
months follow-up, would be at least adequate (AUC ≥ 0.70) and comparable to that 
of validated PROMs (De Vet et al., 2011c; McDowell, 2006; Jimerson, 2007), 
- the correlations with PROMs and the correlation between change scores would be 
at least moderate (r ≥ 0.50) (Munro, 2005; Portney and Watkins, 2015), 
-  no floor and ceiling effect would be detected  
No hypothesis was made about the MDC, MCII, and PASS values as these 
investigations primarily aimed at the determination of these values for the needs of 
clinical evaluation. For the definition of the used methods and the rationale that 
underpin their use in this study, please see sub-section 1.3.4.1.3 Construct validity 
p.35 - 37 and 1.1.3.4.3 “Responsiveness” p. 44 - 49. 
 Methods 
As data for Phase 2 and Phase 3 were collected in the same time and had an intrinsic 
commonality, the measurement protocol used in both Phases were identical to that of 
Phase 2, which was reported within Chapter three section 3.2 “Methods” p. 101 – 109. 
Only the data collected using the smartphone have been analysed and are reported 
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hereafter, as this device has previously demonstrated its efficiency for the B-B Score 
calculation in the Phase 2 study. An additional measurement session was conducted 
six months after the baseline measurement, using the same measurement protocol 
as the Phase 2 baseline session, with the exception that only one rater collected the 
data and that the patient had to assess his or her progress on an anchoring 
questionnaire designed for the determination of the MCII and the PASS.  
The 6 months’ time interval had been chosen, as it constituted elapsed time that could 
realistically be considered as sufficient for most of the patients to have an evolution 
of their shoulder condition, whether spontaneous or induced by treatment. This was 
required to enable the assessment of the responsiveness to change of health state 
over time. No standardisation (e.g. of treatment or patient’s activity) was implemented 
between the initial and follow-up evaluation session. This was not considered as being 
necessary, as these elements are not expected to have an important influence on the 
measurement properties of a score, which were the focus of the thesis. 
On this anchor questionnaire, the patient had to rate the state of his/her shoulder in 
the last 48 hours compared to 6 months earlier, as worse, unchanged or better. If the 
answer was “better”, he/she had to rate the change as unimportant, light, moderate 
or very important. He/she had then to rate whether he/she considered his/her present 
state acceptable or unacceptable. 
Eligible patients residing in the canton, as indicated by the inspection of their medical 
records, were contacted by phone in the order in which they attended the medical 
consultation in the department (for authorisation to screen patients’ medical records, 
please see Appendix X Accord éthique accès Soarian). With the exception of patients 
with humerus fractures, patients who gave their consent underwent a baseline 
measurement session within two weeks following the medical consultation, and a 
second session six months later. For patients with humerus fractures, measurements 
were performed six weeks post-stabilisation and six months later, provided that the 
radiological control showed normal healing. 
The Phase 3 study was registered under ClinicalTrials.gov Identifier: NCT01431417 
simultaneously to Phase 2 study (Appendix IX). 
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Conversely to the aims of the Phase 2 study, involving inter alia, the capability of the 
smartphone B-B Score to discriminate globally between patients for which the Score 
can be used in the future and healthy controls, the results of patients with shoulder 
instability have also been specifically reported hereafter within the Phase 3 study, in 
addition to the specific results for patients with rotator cuff conditions, proximal 
humerus fracture and capsulitis. The measurement procedure was strictly the same 
for patients with shoulder instability than for other patients, with the exception that 
they completed in addition the WOSI, a specific shoulder function PROM for shoulder 
instability (Kirkley et al., 1998). The selection of this PROM was made based on the 
same criteria than other PROMs, i.e. the fact that published literature reviews 
investigated the frequency of its use and the existence of a formal investigation 
process underlying the PROM validity. The WOSI was preferred to the Rowe score, 
which is frequently used but did not meet the second criterion (Gartsman et al., 2015; 
Makhni et al., 2015; Fayad et al., 2004; Longo et al., 2011; Kirkley et al., 2003; Huang 
et al., 2015; Rouleau et al., 2010). Moreover, several versions of the Rowe Score 
have been produced, without it being clearly established which version should be 
presently used (Jensen et al., 2009).  
 Study sample 
A specific sample size calculation was made for the Phase 3, to sustain the 
soundness of the calculation of subgroups by conditions. Calculations were based on 
the data of the Phase 1 study that had included seven controls and 16 patients. 
The rationale underpinning the power calculation was to include a sufficiently high 
number of patients to ensure a 0.80 power for each one of the statistical tests of 
hypotheses at the study’s primary end-point, when a sample size calculation method 
existed and data were available to estimate the sample size. Thus, the sample size 
calculations were made for correlations, for difference between groups and for ROC 
curves. 
The calculation was made so that, with a significance level at p < 0.05, the power of 
0.80 was reached when the minimal standards for acceptable properties of the B-B 
Score were met. For convergent validity, 18 patients per group were needed for a 
significant correlation when the correlation was moderate (r ≥ 0.50), as expected in 
the study hypotheses (sub-section 4.1.4 “Study aim and hypothesis, p.130). For 
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discriminative power for improvement and for diagnostic purposes, 11 patients were 
required for an area under a ROC curve of 0.80 with a standard error of 0.1 ensuring 
that the power was at least adequate (AUC ≥ 0.70), as expected in the study 
hypotheses (Chang, 2014). For discriminative power between groups, nine patients 
were required for a significant difference between the patients and the control group, 
based on the same ‘pilot’ effect sizes shown in the Phase 1 study (Soper, 2004; Lenth, 
2010). According to these estimations, 20 patients were enrolled in each subgroup of 
pathology and 20 healthy controls in the control group. As these estimations applied 
to baseline and to 6 months measurements, patients lost at follow-up were 
compensated by including an equivalent number of additional patients to reach the 
required sample size at 6 months.  
 Analysis 
Descriptive statistics including mean, standard deviation (SD) were performed for 
participants’ characteristics and outcomes (B-B Score and PROMs) for the control 
group and each subgroup of patients at baseline and at six months. Box plots were 
also generated to illustrate the B-B Score outcomes for the control group and each 
subgroup of patients at baseline and at six months. 
The assumptions for the use of parametric tests were checked, using the Shapiro-
Wilk test for the assumption of normal distribution and the Levene’s test for equality 
of variance for the assumption of homoscedasticity (Yap and Sim, 2011). Based on 
these verifications, non-parametric tests were used because the assumption of 
normal distribution was not met in several cases (p < 0.05). The differences between 
pathological subgroups and the control group were analysed using the Mann-Whitney 
(Wilcoxon rank-sum test) or the chi-square tests as applicable, and the differences 
between stages were tested for each pathological subgroup and the control group 
using the Wilcoxon signed-rank test.  
The responsiveness for the baseline- six months change was calculated using the 
Cohen’s d effect sizes (ES) with a 95% confidence interval, the standardised response 
mean (SRM) with a 95% confidence interval, the Spearman correlations between 
change scores and the area under the receiver operating characteristic curve (AUC). 
The sensitivity, specificity and optimal detection threshold (highest sensitivity-
specificity ratio) were also derived from the ROC curve analysis. The discriminative 
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power between patients and controls was calculated using the same ROC curve 
analyses.  
It was considered that a floor effect existed if > 15.0% of patients scored lower than a 
threshold set at 0 + MDC at baseline. This threshold account for the fact that patients 
scoring slightly above zero but within the error limits around zero might possibly have 
got the lowest possible score, and should therefore be taken into account in the 
calculation of the floor effect (Terwee et al., 2007; McHorney and Tarlov, 1995). 
Considering the ceiling effect the B-B Score has theoretically no upper limit. However, 
we investigated the number of patients reaching more than 100%, because, though 
some patients might exceed this result following treatment, this is not likely to be 
frequent.  
For convergent validity assessment, the Spearman correlations were used to assess 
the strength of relationship between the B-B Score and the PROMs for each of the 
pathologies. Concerning the interpretability aspects, the MCII and PASS were 
determined for the patient group using the anchor-based method as described in 
Tubach et al. 2007) and presented in sub-section 4.2 “Methods” within this Chapter 
p. 130, and sub-section 1.1.3.4.3.6 “MCID/MCII” and 1.3.4.3.7 PASS, within Chapter 
one p. 48 - 50.  
Concerning measurement errors, the MDC95 (was calculated using the formula 
MDC(95% confidence level) = 1.96 * √2* SEM, (Beaton et al., 2001a), where the SEM was 
determined using the formula SEM = pooled SD * 1-ICC. The pooled SD was 
calculated from the data of the four measurements that were done for each patient at 
baseline, which represented the most precise evaluation of the real performance of 
each pathological subgroup. The ICC value used in the calculation was 0.92, this 
value being valid both for intra- and inter-evaluator reliability, as determined in Phase 
2 study. 
The results were reported separately for each pathology and for the control group. 
When relevant for the comparison with the existing literature, the results were also 
reported for the whole patients sample, called “All patients” group (n = 88) and for the 
sample of patients with pathologies for which the use of the B-B Score is indicated, 
called “Indicated pathologies” subgroup (n = 65) (i.e. rotator cuff conditions, capsulitis 
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and proximal humerus fractures, but not instability, as will be demonstrated by the 
discriminative power analysis made in this phase). The ROC curve for 
improved/unimproved patients, the MCII value and the PASS value were calculated 
for the whole patient group only, because their calculation methods imply to 
dichotomise the group into two smaller groups (improved/unimproved for the MCII 
and ROC curve, acceptable/not acceptable state for the PASS). Therefore, the 
calculation of these values for each pathological subgroup would have been based 
on too few patients, especially in the unimproved group, to be precise. 
 Results 
 Study sample 
One hundred and eight participants were tested at baseline (20 healthy controls, 20 
patients with rotator cuff condition, 23 with fracture, 22 with capsulitis and 23 with 
shoulder instability). The participants were measured again six months after the 
baseline measurement. Four patients could not be contacted at six months and four 
refused to participate for reasons without relationship with the study (1 patient with 
rotator cuff condition, 3 with fracture, 1 with capsulitis and 3 with instability). Dropout 
rate was low (7%). Recruitment continued until the planned sample was enrolled at 
for the 6 months measurement, so that the expected statistical power could be 
reached. 
The population characteristics and the significance of the differences between groups 




Table 4.2: Participants’ characteristics for each pathological subgroup and the control 
group, with indications of significant difference with the control group. 
 
Rotator Cuff 
(n = 20) 
Fracture    
(n = 23) 
Capsulitis   
(n = 22) 
Instability   
(n = 23) 
Control     
(n = 20) 
Age mean (SD), years 63.5 * (10.6) 60.1 * (15.6) 52.5 * (13.8) 32.1 (14.1) 28.2 (6.2) 
Sex, % Women 50 78 60 43 50 
Weight mean (SD), kg 78.3 (18.2) 69.6 (15.1) 78.3 (15.1) 70.8 (12.9) 74.7 (17.4) 
Body mass index 
mean (SD), kg/m2 
29.0* (6.4) 24.6 (4.2) 26.7 (6.4) 23.7(3.2) 24.2 (3.9) 
Height mean (SD), m. 164.0* (7.4) 167.7* (9.7) 172.4 (10.9) 172.6 (9.4) 175.0 (10.3) 
Hand dominance,       
% Right-handed 
90 87 100 87 90 
Affected side,              
% Dominant side 
70 25 45 52 - 
Legend: * significant difference with control group. 
Significant differences were found for age between the control group and the rotator 
cuff (Z = 5.30, p < 0.01), fracture (Z = 5.37, p < 0.01) and capsulitis (Z = 4.85, p < 
0.01) subgroups of patients, using the Wilcoxon rank-sum test. Significant differences 
were also found for height between the control group and the rotator cuff (Z = - 3.02, 
p < 0.01) and the fracture (Z = - 2.14, p < 0.05) subgroups, and for BMI between the 
control group and the rotator cuff (Z = 2.69, p < 0.01) subgroup.  
Non-significant differences were found for weight and sex between the control group 
and the pathological subgroups, though the p value for sex was at the threshold for 
the fracture group (χ2(1) = 3.76, p = 0.05).  
 Discriminative power 
The outcomes of the B-B Score for the control group and for the patient subgroups by 
pathologies are presented in Table 4.3 and Figure 4.1. Significant differences were 
found at baseline between the B-B Score performances of the control group [mean 
(SD) 94.1 (11.1)] and of the rotator cuff condition [mean (SD) 63.1 (19.7), Z = - 4.24, 
p < 0.01], fracture [mean (SD) 46.3 (17.5), Z = - 5.36, p < 0.01] and capsulitis [mean 
(SD) 54.4 (14.6), Z = - 5.49, p < 0.01] patient subgroups. The difference between the 
shoulder instability subgroup and the control group was non-significant [mean (SD) 
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84.5 (22.6), Z = - 1.88, p = 0.06]. Similar results, not detailed here for the sake of 
concision, were found at 6 months, despite the positive change in the pathological 
subgroups. 
Table 4.3: Mean and standard deviation of the B-B Score, with the number of 
participants measured in the control group and each pathological subgroup, at 
baseline and 6 months. Unit of scores are % representing the performance of the 
pathological side compared to the healthy side. 
Pathology Control  Rotator Cuff  Fracture   Capsulitis  Instability 
Baseline 
Mean (SD)  
Sample size (n) 
94.1 (11.1)  
20 
63.1 (19.7)*  
20 
46.3 (17.5)*  
23 




6 months Mean (SD)  Sample size (n) 










Legend: SD: Standard Deviation; n: number; * Significant difference with the control 
group (p < 0.01); † Significant difference with baseline (p < 0.01). 
The difference between the baseline [mean (SD) 94.1 (11.1)] and 6 months [mean 
(SD) 96.0 (8.3)] control group B-B Score was non-significant (Z = 0.80, p = 0.42) using 
the Wilcoxon signed-rank test. This confirmed the hypothesis that the B-B Score 
outcome would be stable over time in the control group that is not expected to have 
changed between the baseline and 6 months measurement sessions. 
Conversely, significant differences were found between the baseline and the 6 months 
outcomes in the rotator cuff condition [mean (SD) baseline 63.1 (19.7), 6 months 77.6 
(21.1), Z = 2.63, p < 0.01], fracture [mean (SD) baseline 46.3 (17.5), 6 months 78.9 
(15.1), Z = 3.82, p < 0.01] and capsulitis [mean (SD) baseline 54.4 (14.6), 6 months 
75.3 (20.5), Z = 3.98, p < 0.01] subgroups, but not in the shoulder instability subgroup 
[mean (SD) baseline 84.5 (22.6), 6 months 91.2 (15.6), Z = 0.64, p = 0.53], using the 
Wilcoxon signed-rank test. This confirmed the hypothesis that the B-B Score outcome 
would change over time in populations that are expected to have changed between 
the baseline and 6 months measurement sessions, for the rotator cuff condition, 
humerus fracture and capsulitis subgroups, but not for the shoulder instability 
subgroup. 
The first statements concerning the shoulder instability subgroup highlighted that the 
B-B Score was not efficient to assess the function loss for this pathology. Therefore, 
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some calculations were made for a subgroup of patients that included only the 
pathologies for which the B-B Score could potentially be efficient, i.e. rotator cuff 
conditions, humerus fractures and capsulitis. This subgroup was called “Indicated 
pathologies” in the continuation of this work.  
Also, as a reminder, the Phase 2 study reported in Chapter three of this thesis 
included only patients for whom the score may assess efficiently their shoulder 
function. This option had been chosen because it would have been inconsistent to 
report results on the B-B Score that could have been influenced by the results of 
patients for whom the Score should not be used. 
 
 
Figure 4.1 Traditional box plots showing median, lower and upper quartile, range 
and outliers (open circles, 1.5 interquartile range) B-B Scores, comparing the 
baseline and the six months outcomes for the control (n= 20), the rotator cuff (n=19), 
fracture (n = 20), capsulitis (n = 21) and instability (n= 20) subgroups. **: significant 
difference with the control group (p < 0.01). 
The visual inspection of box plots (Figure 4.1) confirmed that the B-B Score was stable 
between baseline and 6 months in the control group, while it changed positively in the 
rotator cuff, fracture and capsulitis, and to a lower extent in the instability subgroup. 
The smaller difference between the control group and the shoulder instability 
subgroup was also visible. The presence of outliers showed that the outcome could 
vary considerably between patients with the same pathology.  
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The discriminative power analyses using the area under the curve (AUC) with 95% CI 
and the cut-off for optimal sensitivity-specificity ratio are presented in Figure 4.2 and 
Table 4.4. 
Table 4.4: ROC curve analysis results for the discriminative power between patients 
and controls, with AUC, optimal B-B Score threshold for patients vs. controls 











All patients                
(n = 88) 
0.88  
(0.82–0.95) 82.1 95 82 
Indicated pathologies 
(n = 60) 
0.96  
(0.92–1.00) 82.1 95 94 
Rotator Cuff              
(n = 20)  
0.90  
(0.78–1.00) 83.6 90 90 
Humerus Fracture     
(n = 23) 
0.98  
(0.94–1.00) 71.6 100 96 
Capsulitis                 
(n = 22) 
0.99  
(0.98–1.00) 82.1 95 100 
Shoulder Instability   
(n = 23) 
0.67  
(0.50–0.84) 
81.6 95 48 
Legend: AUC Area Under the receiver operating characteristic Curve. 
The AUC, indicative of discriminative power between patients and controls, was 
excellent (AUC ≥ 0.90) for the “Indicated pathologies”, rotator cuff, humerus facture 
and capsulitis subgroups and good for the “all patients” group. Conversely, it was 
below the required standard (AUC ≥ 0.70) for the instability subgroup. This weakness 
was mainly related to a lack of specificity. This implied that the B-B Score was not 
efficient in correctly identifying the patient with shoulder instability, because of an 
excessive proportion of false positive results. The hypothesis that the B-B Score 
discriminated adequately the patients from the controls was refuted for this pathology 
only, and accepted in all other analysed cases. The B-B Score thresholds, indicative 
of the outcome level from which the functional outcome can be considered normal, 
were close to each other (81.6% - 83.6%), with the exception of humerus fracture for 





Figure 4.2: ROC curves representing the discriminative power between patients and 
controls of the smartphone B-B Score (green line), specifically for the rotator cuff 
conditions (n = 20), proximal humeral fracture (n = 23), capsulitis (n = 22) and shoulder 




 Convergent validity 
The correlations amongst the shoulder function PROMs are presented for each of the 
pathologies in Table 4.5. 
Table 4.5: Spearman correlation coefficients amongst the B-B Score and the 
PROMs, for each pathology. 
 
Rotator Cuff 
(n = 20) 
Humerus Fracture 
(n = 23) 
Capsulitis 
(n = 22) 
Shoulder instability 
(n = 23) 
Constant 0.82 ** 0.70 ** 0.68 ** 0.46 * 
Constant 
relative 
0.84 ** 0.69 ** 0.69 ** 0.43 * 
SST 0.63 ** 0.66 ** 0.76 ** 0.52 * 
QuickDASH -0.55 * -0.40 -0.64 ** -0.57 ** 
WOSI - - - 0.58** 
VAS pain -0.50 * -0.07 -0.39 -0.19 
EQ-5D 0.33 0.18 0.63 ** 0.46 * 
EQ-5D VAS 0.16 -0.30 0.44 * 0.47 * 
Legend: SST: Simple Shoulder Test; QuickDASH: Quick Disabilities of the Arm, Shoulder and 
Hand score; WOSI: Western Ontario Shoulder Instability Index; SSV: Subjective Shoulder 
Value; VAS: Visual Analog Scale; EQ-5D: EuroQOL quality of life scale in five dimensions; * 
significant correlation (p < 0.05); ** significant correlation (p < 0.01). 
The correlations between the B-B Score and the PROMs were higher than the 
hypothesised level (r ≥ 0.50), except for the QuickDASH for humerus fractures, and 
the Constant and relative Constant. They were generally lower between the B-B Score 
and the pain VAS, EQ-5D and EQ-5D VAS. 
 Responsiveness 
The effect size and SRM with 95% confidence intervals for the B-B Score, Constant 
and Constant relative score, SST, QuickDASH, and WOSI are presented in Table 4.6 
and 4.7, respectively.  
The magnitude of the effect sizes varied from one subgroup to the other, as a function 
of the importance of change over time, which is pathology-dependent. Thus, the 
comparison of the ES within the same pathology was more informative of the 
responsiveness of the outcome measures. Overall, the ESs of outcome measures 
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specific to shoulder function was higher than those of generic PROMs were (VAS pain 
and EQ-5D), with the exception of pain for the rotator cuff subgroup. 
The statements made for the ES also apply for the SRM, showing that these two 
calculations are founded on close bases. 
Table 4.6: Comparison of the effect sizes of scores’ changes between the baseline 
and the 6 months measurements (95% confidence intervals) for the B-B Score and 






(n = 19) 
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All patients 
(n = 80) 
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Legend: SST: simple shoulder test; QuickDASH: Quick Disabilities of the Arm, Shoulder and 
Hand score; WOSI: Western Ontario Shoulder Instability Index; SSV: Subjective Shoulder 




Table 4.7: Comparison of the standardised response means of scores’ changes 
between the baseline and the 6 months measurements (95% confidence intervals) for 
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Capsulitis  
(n = 21) 
Instability  
(n = 20) 
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Legend: SST: simple shoulder test; QuickDASH: Quick Disabilities of the Arm, Shoulder and 
Hand score; WOSI: Western Ontario Shoulder Instability Index; SSV: Subjective Shoulder 
Value; VAS: Visual Analog Scale; EQ-5D: EuroQOL quality of life scale in five dimensions. 
 





Table 4.8: Spearman correlation coefficients for baseline to 6 months change 
between the B-B Score and the shoulder function PROMs. 
 


















Constant 0.50 * 0.59 ** 0.41 0.47 * 0.70 ** 0.67 ** 
Relative 
Constant 
0.55 * 0.66 ** 0.47 * 0.50 * 0.71 ** 0.69 ** 
SST 0.37 0.75 ** 0.21 0.48 * 0.67 ** 0.65 ** 
QuickDASH -0.19 -0.56 ** -0.30 -0.28 -0.55 ** -0.47** 
WOSI - - - 0.32   
Legend: SST: simple shoulder test; QuickDASH: Quick Disabilities of the Arm, Shoulder and 
Hand score; WOSI: Western Ontario Shoulder Instability Index; SSV: Subjective Shoulder 
Value; VAS: Visual Analog Scale.  
* significant correlation (p < 0.05); ** significant correlation (p < 0.01). 
Indicated pathologies: pathologies for which the B-B Score showed sufficient validity and 
discriminative power to be reasonably used. 
 
The correlation coefficients for change were above the hypothesised level for the 
humerus fractures subgroup, the “Indicated pathologies” subgroup and the “All 
patients” group. They were lower for capsulitis and the results were mixed for 
rotator cuff and shoulder instability. 
The ROC curves analysis including the area under the ROC curve, sensitivity-
sensibility and threshold for the discrimination between improved and unimproved 
patients are reported in Table 4.9 and Figure 4.3 for the “All patients” group and for 




Table 4.9: ROC curve analysis results for the discriminative power between patients 
who consider themselves as improved or unimproved at the 6 months follow-up, with 
AUC, optimal threshold for improved vs. unimproved discrimination, and sensitivity 













(n = 80) 
B-B Score (%) 0.73 (0.61–0.86) 9.5 0.76 0.65 
Constant (points) 0.82 (0.71–0.92) 10.0 0.80 0.78 
Constant relative (%) 0.83 (0.73–0.93) 13.5 0.80 0.78 
SST (points) 0.80 (0.67–0.89) 1.5 0.71 0.78 
QuickDASH (%) 0.78 (0.67–0.89) 4.5 0.76 0.69 
Indicated 
pathologies 
(n = 60) 
B-B Score (%) 0.70 (0.50–0.90) 15.9 0.66 0.73 
Constant (points) 0.81 (0.64–0.98) 10.0 0.87 0.73 
Relat. Constant (%) 0.83 (0.67–0.98) 17.5 0.81 0.81 
SST (points) 0.77 (0.61–0.94) 1.5 0.74 0.64 
QuickDASH (%) 0.73 (0.58–0.88) 6.8 0.77 0.63 
Legend: AUC: area under the curve; 95%CI: limits of interval at 95% confidence level; Relat. 
Constant: relative Constant Score; SST: simple shoulder test; QuickDASH: Quick Disabilities 
of the Arm, Shoulder and Hand score; WOSI: Western Ontario Shoulder Instability Index; 
SSV: Subjective Shoulder Value; VAS: Visual Analog Scale. * significant correlation (p < 
0.05); ** significant correlation (p < 0.01). 
The AUC, indicative of discriminative power between the patients who consider 
themselves as improved and those who consider themselves as unimproved was 
adequate (AUC ≥ 0.70) for the “All patients” group and exactly at the threshold for the 
“Indicated pathologies” subgroup. The hypothesis that the B-B Score would met this 
standard could thus be accepted. The B-B Score AUC values were somewhat lower 
than those of the shoulder function PROMs were, but were situated within the PROMs 




All patients (n = 80) 
Improved (n = 56); Unimproved (n = 24) 
 
 
Patients with indicated pathologies (n = 60) 
Improved (n = 49); Unimproved (n = 11) 
 
Figure 4.3: ROC curves representing the discriminative power between the patients 
who consider themselves as improved or unimproved, for the smartphone B-B Score 
(black line), Constant Score (green line), relative Constant Score (blue line), SST 
score (purple line) and QuickDASH score (red line). Legend: SST Simple Shoulder 
Test; QuickDASH: Quick Disabilities of the Arm, Shoulder and Hand Score. 
Chapter four 
147. 
 Floor and ceiling effect 
No floor effect was observed, as no patients performed lower than the threshold 
defined for this measurement property, i.e. 0 + MDC (please see sub-section of this 
Chapter, 4.2.2 “Analysis” p. 135 and sub-section 1.1.3.4.3.6 “Minimal Detectable 
Change” within Chapter one, p. 48). The hypotheses that less than 15% of the patients 
would reach a score lower than 0 + MDC (floor effect) was met. Seven patients 
obtained a score > 100% at baseline, of which 5 had shoulder instability (22% of the 
subgroup), ten patients obtained a score > 100% at 6 months, of which five had a 
shoulder instability (25% of the subgroup). The hypotheses that less than 15.0% of 
the patients would reach a score > 100% (ceiling effect) was met, as 7.9% reached 
this performance level considering the “All patients” group and 2.2% considering the 
“Indicated pathologies” subgroup at baseline. This percentage was 12.5% considering 
the “All patients” group and 6.2% considering the “Indicated pathologies” subgroup at 
6 months, but it cannot be excluded that some patients had actually fully recovered at 
this stage. 
 Interpretability aspects 
Based on the observed values in the control group at baseline (94.1 ± 11.1) and 6 
months (96 ± 8.3), the typical performance of healthy controls can be situated at 95%. 
This value could be of use to determine if the performance of a group is consistent 
with what can be expected. 
The MDC was 15.7% for the rotator cuff subgroup, 17.5% for the fracture subgroup, 
14.6% for the capsulitis subgroup and 22.6 for the instability subgroup. These values 
indicate the level above which a measured difference can reasonably be considered 
as real, specifically for each pathology. 
The MCII of the B-B Score, determined for the “All patients” group using the anchor-
based method, was 25.2%. This indicate that patients whose change is higher than 
this value will consider this change as meaningful.  
The PASS of the B-B Score, determined for the “All patients” group using the anchor-
based method, was 77.6%. This indicate that patients whose score is higher than this 




This study aimed at the determination of the measurement properties of the 
smartphone B-B Score in current shoulder pathologies (rotator cuff conditions, 
capsulitis, proximal humerus fracture and shoulder instability. 
 Interpretation of the results 
 Study sample 
Participants younger than 40 years old were purposefully enrolled in the control group 
to prevent the inclusion of people with undetected rotator cuff conditions (Yamaguchi 
et al., 2006; Yamamoto et al., 2010; Moosmayer et al., 2009). As a consequence of 
this difference in age, the significant differences in patient size and BMI (size: between 
rotator cuff subgroup and control group, and between humerus fracture subgroup and 
control group; BMI: between rotator cuff subgroup and control group) reflected the 
known age-related tendencies to decrease in size and to increase in weight (Cline et 
al., 1989; Center for Disease Control, 2012).  
The influence of the observed significant differences in age, BMI or size is hardly 
evaluable. However, based on logical reasoning, they are not likely to have an 
important impact on this study’s results, as they are not likely to influence the side-to 
side symmetry of the power developed during arm movements, which is the 
parameter measured by the B-B Score. Conversely, the enrolment of healthy 
participants the same age than the patients‘ subgroups, with possible age-related 
rotator cuff tears, could have had a significant impact on the determination of the 
normal B-B Score performance from the control group and on the relevance of the 
comparisons between the control group and the pathological subgroups. 
The high, though non-significant, proportion of women in the fracture subgroup is 
representative of gender prevalence in the wider population affected by this shoulder 
disorders (Court-Brown and Caesar, 2006). The low proportion of patients affected on 
the dominant side in the same subgroup can be considered of minor importance, as 
the shoulder fracture functional outcome is not influenced by the fracture side (Torrens 
et al., 2015). Further, the influence of dominance on the B-B Score is minimal, as 
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observed in the control group, in the Phase 1 study and in a previous study 
(Pichonnaz et al., 2015c). 
Due to the lack of discriminative power of the B-B Score specifically for shoulder 
instability (p. 136 - 140 within this Chapter) that will be discussed hereafter, an 
analysis was conducted in a sample including only patients with rotator cuff condition, 
humerus fracture and capsulitis, which was called “Indicated pathologies” subgroup, 
in addition to the “All patient” group and the subgroups by pathologies.  
 Discriminative power 
4.4.1.2.1. Discrimination between groups 
The B-B Score differences between the control and the patient groups were highly 
significant (p < 0.01) with the exception of the shoulder instability subgroup (from 
Table 4.3: 9.6% difference with the control group, p = 0.06). The functional loss was, 
in order of importance, more marked for patient with a fracture (47.8%), a capsulitis 
(39.7%), and a rotator cuff condition (31.0%) than for instability (9.6%). Hence, the B-
B Score clearly discriminated the three first subgroups from the healthy group but 
displayed a lower discriminative power for shoulder instability. Thus, the most basic 
and essential measurement property, i.e. the capacity to make a difference between 
affected and healthy populations, was not adequate for the B-B Score in this 
pathology, while it was for other included pathologies.  
Shoulder instability is characterised by apprehension in the arm positions that 
exposes the patient to a glenohumeral dislocation risk (Rouleau et al., 2010). It might 
be that the B-B Score is not challenging enough for these patients, as it is executed 
in the pain-free ROM and relied upon a self-chosen speed. Thus, the movement of 
the involved shoulder is not affected by the instability in the normal testing conditions 
of the B-B Score. Consequently, the functional loss may remain undetected. 
Nevertheless, a more challenging version of the B-B Score inducing apprehension is 
hardly conceivable for reasons of ethics, as it might put the patient in a situation of 
actual dislocation likelihood. These results highlight that shoulder instability affects 
movement in a different way than other shoulder pathologies and should, thus, be 
evaluated using a specific tool, like the WOSI, for example. 
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4.4.1.2.2. Discrimination between stages 
The non-significant baseline to 6 months progression in the control group indicated 
that the B-B Score was stable over time during which the healthy participant’s 
performance can reasonably be expected to have remained unchanged (from Table 
4.3 : 1.9% change, p = 0.42). Based on this result, the stability of the score for the 
measurement of a healthy population was demonstrated. The norm for a healthy 
population (~ 95.0%, based on the baseline (94.1%) and 6 months (96%) values) was 
also determined, although its value still needs to be refined using a larger sample. 
The significant changes in the mean B-B Score over time observed in the rotator cuff 
condition (14.5%, p < 0.01), humerus fracture (32.6%, p < 0.01), and capsulitis 
(20.9%, p < 0.01) subgroups indicate that it discriminated amongst clinical stages for 
these pathologies. Conversely, no significant change over time was found in the 
shoulder instability subgroup (6.7%, p = 0.53). Therefore, the capacity of the B-B 
Score to capture group change was demonstrated in all pathologies except for 
shoulder instability.  
The 6 months’ time interval had been chosen, as it constituted elapsed time that could 
realistically be considered as sufficient for most of the patients to have an evolution 
of their shoulder condition, whether spontaneous or induced by treatment. It should 
be noted that the treatments were not standardised in this study, as the aim was to 
evaluate the B-B Score’s properties but not the treatment’s efficacy. Standardisation 
of events between measurements was not considered as being necessary, as these 
elements are not expected to have an important influence on the measurement 
properties of a score, which were the focus of the thesis. Thus, the observed results 
reflect the combination of the natural progress and of the individualised treatment 
received by the patients. The results of this thesis’ investigations should therefore not 
be used to characterise the typical evolution of shoulder conditions, as could be done 




4.4.1.2.3. Discrimination between patients and 
controls 
The AUC of the ROC curves for detection of shoulder conditions were adequate 
(≥0.70) for all pathologies, except for shoulder instability. It was even excellent for the 
“Indicated pathologies”, rotator cuff, humerus fracture, capsulitis and shoulder 
instability subgroups (≥ 0.90) (Jimerson, 2007; De Vet et al., 2011c; McDowell, 2006). 
The discriminative power between patients and controls of the B-B Score was higher 
for fractures and capsulitis (0.98 – 0.99) than for rotator cuff conditions (0.90). The 
sensitivity and specificity at the optimal threshold were excellent for these three 
pathologies (≥ 0.90) (Table 4.4). Conversely, the discriminative power between 
patients and controls was insufficient in the instability subgroup, as the AUC was lower 
than the 0.70 threshold, mainly due to a lack of specificity. This implies that the B-B 
Score was not efficient in correctly identifying the patient with shoulder instability, 
because of an excessive proportion of false positive results. (Portney and Watkins, 
2015).  
Consequently, the hypothesis that the B-B Score would have adequate discriminative 
power between patients and controls was met for all pathologies, with the exception 
of shoulder instability. It was highly efficient for detecting loss of shoulder function in 
rotator cuff, fracture, and capsulitis disorders. However, although the B-B Score is 
capable of discriminating whether or not a pathology alters the function of the 
shoulder, it is not possible to infer a diagnosis of the pathology based on the outcome 
measured by the Score. Further research should investigate to what extent alterations 
in specific movement patterns might allow discrimination amongst pathologies. 
4.4.1.2.4. Synthesis on discriminative power 
The discriminative power of the B-B Score was adequate in all respects for rotator 
cuff condition, proximal humerus fracture and capsulitis. Conversely, a lack of 
discriminative power of the B-B Score for shoulder instability was demonstrated, as it 
was neither able to discriminate the patient group from the control group performance, 
nor the baseline from 6 months follow-up shoulder instability subgroup performance, 
nor the patients from the controls. This implies that the B-B Score did not meet the 
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most basic measurement property for this pathology, contrary to the other pathologies 
included in this study.  
The B-B Score can thus not be recommended to evaluate function in shoulder 
instability. The limitation of the score for this pathology was further confirmed by the 
analyses on convergent validity and responsiveness performed in this Phase 3 study. 
For this reason, the results with mixed pathologies were reported both for all four 
included pathologies (to account for the whole sample performance; “All patients 
group”) and excluding patients with shoulder instabilities (i.e. only for all patients for 
which the B-B Score was likely to be used in practice; “Indicated pathologies” 
subgroup).  
 Convergent validity 
The correlations of the B-B Score with the Constant, Constant relative and SST were 
moderate to high (r = 0.63 – 0.82) for rotator cuff conditions, factures, and capsulitis 
(Table 4.5) (Munro, 2005). In contrast, the relationship with the QuickDASH was 
generally lower (r = -0.55 – -0.64 and non-significant for humerus fracture). The 
merely objective nature of the B-B Score and the merely subjective nature of the 
QuickDASH may explain the lower relation with this PROM. The lower correlations 
with the VAS pain scale (significant correlation only for the rotator cuff subgroup, r = 
0.50) and EQ-5D quality of life PROM indicated that the B-B Score is essentially a 
measure of shoulder function.  
Moderate to low correlations were found between the B-B Score and shoulder function 
PROMs when considering instability. These results indicated that the relation to 
function was limited for this pathology. Conversely, the B-B Score actually assessed 
the shoulder function of patients with rotator cuff, fracture, and capsulitis disorders, 
as demonstrated by the moderate to high correlations between the B-B Score and the 
Constant, Constant relative and SST scores.  
The level of correlation found for these pathologies demonstrated that the B-B Score 
can be used to investigate shoulder function according to the same concept as that 
investigated by these PROMs, which supports the convergent validity of the B-B 
Score with regard to them (McDowell, 2006) (for convergent validity please see sub-
section 1.1.3.4.1.4 “Criterion validity”, within Chapter one p. 37 - 39). The hypothesis 
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that the correlation would be ≥ 0.50 was therefore met for these pathologies. It 
suggests that, though it is an objective measurement, the B-B Score is influenced by 
subjective aspects like e.g. kinesiophobia (fear of movement) or patient level of self-
confidence when moving, which are also investigated by PROMs.  
Based on the literature, this level was not expected because objective and subjective 
evaluations are generally claimed to produce different results, and because low 
correlations were found between PROMs and the AR-score, which has similarities 
with the B-B Score (Krueger et al., 2011; Moustgaard et al., 2014; De Baets et al., 
2017; Portney and Watkins, 2015; Korver 2014a). Nevertheless, these results are 
coherent with previous results found for the B-B Score and the P Score during their 
development in surgically treated populations (Pichonnaz et al., 2015c; Jolles et al., 
2011; Coley, 2007). Thus, this study’s results confirmed the stronger link of the B-B 
Score with function than with pain or quality of life, which was expected from an 
assessment tool designed for shoulder function evaluation. 
 Responsiveness 
Several methods (ES, SRM, correlation coefficients for change, AUC) were used to 
assess the responsiveness of the smartphone B-B Score for the “All patients” group, 
the “Indicated pathologies” subgroup and for each specific pathological subgroup. 
This approach provided a large overview of this measurement property but also 
reflected the controversies surrounding the best methods to evaluate responsiveness 
and the fact that the result and the conclusion of a study on measurement properties 
are dependent on the method used to assess responsiveness. (Terwee et al., 2003; 
Mokkink et al., 2010e; Angst, 2011; Stratford and Riddle, 2005). 
4.4.1.4.1. Effect size and standardised response 
mean 
The effect sizes (ESs) (Table 4.6) and standardised response means (SRM) (Table 
4.7) measured in this study should be considered as approximate indications, as their 
confidence intervals were large. As both methods produced results that lead to the 
same conclusions, their interpretation is presented jointly hereafter. The ES and SRM 
were larger, in decreasing order of magnitude, for the humerus fracture (d = 1.25 – 
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2.10; SRM = 1.45 – 2.09), capsulitis (d = 0.55 – 1.16; SRM = 1.07– 2.02) and rotator 
cuff conditions (d = 0.35 – 0.69; SRM = 0.47 – 0.69), than for the shoulder instability 
condition (d = 0.01 – 0.47; SRM = 0.01– 0.41). These differences of magnitudes 
amongst groups were essentially related to the respective baseline to 6 months 
progression in each one of these pathologies. The absolute size of the ES and SRM 
should not be considered as an appropriate indicator of responsiveness, because it 
is relative to the context of measurement (e.g. importance of the change and follow-
up time) (Baguley, 2009; Husted et al., 2000). Therefore, comparison between 
ES/SRM of outcome measures were made within each group, but not across groups. 
The comparison of the ESs and SRMs to concurrent measurement methods for a 
given condition is informative towards the respective responsiveness of several 
outcome measures. Based on comparisons amongst measurements of shoulder 
function, the B-B Score and Constant Score were the most responsive outcome 
measures within the “All patients” group and the ”Indicated pathologies” subgroup 
(Table 4.6 and 4.7). Considering specific pathologies, the ES of the B-B Score was 
highest for the rotator cuff (d = 0.69 vs. 0.35 – 0.54 for PROMs) and capsulitis (d = 1. 
16 vs. 0.55 – 1.05 for PROMs) subgroups and the SRM for the rotator cuff subgroup 
only (SRM = 0.69 vs. 0.47 – 0.58 for PROMs). The Constant and Constant relative 
score displayed the highest ES and SRM for humerus fracture, followed by the B-B 
Score (d = 2.09 and 2.10, respectively vs. 1.94; SRM = 2.02 and 2.09, respectively 
vs. 1.98). The B-B Score nevertheless constitutes a reasonable alternative to the 
Constant Score for fracture evaluation, when the patient is unable to perform the 
strength measurement (as is the case before full fracture consolidation, and more 
generally in 51.9% of patients referred for shoulder surgery), and when the 
administrative burden is of concern (Christie et al., 2009).  
The QuickDASH and, to a lesser extent, the SST globally performed lower than other 
shoulder function outcome measures in all subgroups. All shoulder function 
evaluation methods showed better responsiveness than the EQ-5D generic quality of 
life PROM. This was expected, as this generic quality of this life-focused PROM is 
only marginally influenced by the change in shoulder conditions. The suitable effect 
sizes found for the B-B Score in this study were expected, as the B-B Score or the P 
Score from which it is derived had previously shown comparable or better effect sizes 
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than PROMs in surgically treated shoulder populations (Pichonnaz, 2010; Jolles et 
al., 2011). 
Similarly to the Constant (d = 0.21; SRM 0.19), DASH (d = 0.01; SRM 0.01) and SST 
(d = 0.10; SRM 0.08), the B-B Score demonstrated a poor responsiveness for 
shoulder instability based on ES and SRM analyses. The WOSI displayed the best 
responsiveness for the evaluation of the shoulder instability condition (d = 0.47; SRM 
0.41). The limited responsiveness of the Constant, DASH, and SST for this patient 
population had previously been reported in the literature (Godfrey et al., 2007; Kirkley 
et al., 1998; Dawson et al., 1999). Further comparisons between the ES/SRM of the 
outcome scores used in this study and the ones reported in the existing literature on 
shoulder disorders cannot reasonably be made, due to the high diversity of 
treatments, timeframes, patients’ characteristics and patients’ change that led to the 
reporting of heterogeneous ES and SRM across studies (please see Chapter five 
literature review on this subject). 
4.4.1.4.2. Correlations between change scores 
Considering the responsiveness assessment of the B-B Score based on its 
correlations with the PROMs change in performance scores from baseline to 6 
months, the hypothesis that the correlation value would be r ≥ 0.50 and statistically 
significant was met in most but not all cases (Table 4.8). This level of correlation was 
met for all PROMs when the strength of correlation had been assessed within the “All 
patients” group (absolute r = 0.55 – 0.70) and in the humerus fracture subgroup 
(absolute r = 0.56 – 0.75). The results were mixed for the “Indicated pathologies” 
subgroup (absolute r = 0.47 – 0.69) and the rotator cuff subgroup (absolute r = 0.19 
– 0.55), with some correlations higher and some correlations lower than the 
hypothesised threshold. The correlations between change scores were below the 
threshold for capsulitis (absolute r = 0.21 – 0.47) and instability (absolute r = 0.28 – 
0.50) (Table 4.8).  
The correlation coefficients between change scores found in this study can hardly be 
compared to those of the literature, because of the heterogeneity of the reported 
results (please see Chapter five literature review for detailed comparisons). The 
correlation coefficients between change scores observed in this Phase 3 study in 
samples including mixed pathologies (“All patients” and “Indicated pathologies” 
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tended to be higher than those of shoulder function PROMs in relatively similar 
samples (Lundquist et al., 2014; Negahban et al., 2015; Fayad et al., 2008b; Mintken 
et al., 2009; Schmitt and Di Fabio, 2004). The correlation coefficients between change 
scores tended to be comparable or lower than those found in the literature for 
conservatively treated rotator cuff (de Witte et al., 2012; Rysstad et al., 2017), and 
lower for capsulitis (Staples et al., 2010). However, it should be noted that studies 
frequently rely on Pearson correlations that would have produced higher correlations 
in this study, as stated in exploratory analyses run for this thesis purpose (van de 
Water et al., 2014; van de Water et al., 2016b; Staples et al., 2010; Holtby and 
Razmjou, 2005; Rysstad et al., 2017; de Witte et al., 2012). Pearson correlations were 
not used in this study, because it was estimated that their use was not adequate for 
ordinal data, such as those produced by the selected PROMs.  
These results concerning correlations between change scores have limitations 
because the subgroup sample sizes were too small to get precise values. They were 
nevertheless sufficient to provide realistic estimations that allow a global insight into 
the relation between the B-B Score and the selected PROMs. 
The use of the correlation coefficient change itself has limitations for the assessment 
of responsiveness, especially when none of the instruments for which the change 
score correlation is calculated is a gold standard, as is the case in this study (Angst, 
2011). High change score correlations essentially show that two instruments, of which 
none is perfect but one is considered as a reference criterion, measured change in a 
related way. Low change score correlations may therefore be found both in case the 
investigated instrument is more sensitive or less sensitive to status change than the 
reference instrument. This implies that low change score correlations will be found 
when an instrument under investigation had better responsiveness than the reference 
instrument. 
The correlations associated with the “All patients” groups and the “Indicated 
pathologies” subgroup were higher than those associated with subgroups reflecting 
specific pathologies were. However, it is important to consider that the magnitude of 
correlations tends to increase with data dispersion, which had become larger when 
the pathological subgroups had been amalgamated and the pathologies were 
considered as a single population with “shoulder disorders”. 
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The correlation coefficients between change scores found in this study can hardly be 
compared to those of the literature, because of the heterogeneity of the reported 
results (please see Chapter 5 literature review for detailed comparisons). The 
correlation coefficients between change scores observed in this Phase 3 study in 
samples including mixed pathologies (“All patients” and “Indicated pathologies” 
tended to be higher than that of shoulder function PROMs in relatively similar samples 
(Lundquist et al., 2014; Negahban et al., 2015; Fayad et al., 2008b; Mintken et al., 
2009; Schmitt and Di Fabio, 2004). The correlation coefficients between change 
scores tended to be comparable or lower than those found in the literature for 
conservatively treated rotator cuff (de Witte et al., 2012; Rysstad et al., 2017), and 
lower for capsulitis (Staples et al., 2010) However, it should be noted that studies 
frequently rely on Pearson correlations that would have produced higher correlations 
in this study, as stated in exploratory analyses run for this thesis purpose (van de 
Water et al., 2014; van de Water et al., 2016b; Staples et al., 2010; Holtby and 
Razmjou, 2005; Rysstad et al., 2017; de Witte et al., 2012). Pearson correlations were 
not used in this study, because it was estimated that their use was not adequate for 
ordinal data, such as those produced by the selected PROMs.  
It can mainly be concluded from these analyses that the patients’ change measured 
using the B-B Score is globally related to that of currently used and supposedly 
responsive shoulder function PROMs, but that this relationship is variable across 
shoulder conditions. The hypothesis that the correlation value would be r ≥ 0.50 was 
met for the “All patients” group and the humerus fracture subgroup. It was partially 
met for the “Indicated pathologies” and the rotator cuff subgroups, and rejected for 
the for capsulitis and instability subgroups. 
4.4.1.4.3. ROC curves analysis 
Considering the ROC curve analysis for the discrimination between patients 
considering themselves as improved or unimproved, the hypothesis that the AUC 
would be adequate (AUC ≥ 0.70) was met in the “All patients” group (AUC = 0.73) 
and just met in the “Indicated pathologies” subgroup (AUC = 0.70) (Table 4.9 and 
Figure 4.3). However, the AUC was lower than that of other shoulder function PROMs 
both in the “All patients” group (AUC = 0.78 – 0.82 for PROMs) and the “Indicated 
pathologies” subgroup (AUC = 0.73 – 0.83 for PROMs). Therefore, though adequate 
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according to established standard, the responsiveness of the B-B Score assessed 
using the AUC had a competitive disadvantage with regard to the PROMs selected in 
this study. The values found in this study should be considered as realistic but not 
precise estimations of the true AUC values, since they rely on small numbers of 
patients who considered themselves as unimproved, especially in the “Indicated 
pathologies” subgroup (24 unimproved in the “All patients” group; 11 unimproved in 
the “Indicated pathologies” subgroup) (Figure 4.3). 
The slightly better responsiveness when all patients are included in the analysis (AUC 
= 0.73) than when only patients with indicated pathologies are included (AUC = 0.70) 
was not expected. The visual inspection of the “Indicated pathologies” ROC curves 
shows that the B-B Score curve is indented in its middle portion, what indicates that 
at this point the lack of specificity (specificity = capacity to detect correctly the 
improvement when it happens) importantly increases, while the sensitivity (sensitivity 
= capacity to rule out correctly the improvement when it did not happen) is not 
improved, when raising the improved/unimproved discrimination threshold. The 
indentation is considerably less marked when all patients are taken into consideration. 
Thus, the proportion of patients that were correctly classified as improved was slightly 
better when all patients were included. This indicated that, despite its weaknesses for 
the evaluation of function in shoulder instabilities, the B-B Score correctly classified 
as improved, patients with shoulder instability who had actually improved. When only 
patients with indicated pathologies were considered, a somewhat larger proportion of 
patients who did not consider themselves as improved were misclassified as 
improved using the B-B Score, which decreased the specificity of the score. The 
number considering themselves as unimproved in the dedicated pathologies group 
being small (n = 11), any misclassification strongly affects the results. This might 
explain why the AUC was slightly better when all patients were included in the 
analysis. 
The threshold of Table 4.9 represents the values for which the balance between 
sensitivity and specificity is optimal for the discrimination between the patients who 
estimated to have improved and those who did not. These threshold values were quite 
different between the “All patients” (9.5% improvement on the B-B Score required to 
consider an improvement) and the “Indicated pathologies” sample (15.9% 
improvement on the B-B Score required) (Table 4.9). Using the second threshold 
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would be more recommended, as it has been established in a sample that is more 
related to the population for which the B-B Score is likely to be used.  
Note that these threshold values are sometimes considered as representative of the 
minimal clinically significant improvement (MCII) according to the patient’s perception. 
However, this method is not the most widely accepted because it relies on statistics 
rather than directly on the perception of the patient. This is why the 75th percentile 
MCII, which is the subject of a broader consensus, will be presented below (Tubach 
et al., 2005a; Kvien et al., 2007) (please see sub-section 1.1.3.4.3.2. “MCID/MCII” 
within Chapter one, p. 48 - 49). As reported in the literature, the MCII values obtained 
using the ROC curve method or the 75th percentile method differed significantly in 
this study (please see sub-section 4.4.2 Interpretability aspects”, within this Chapter, 
p. 161 - 162).  
4.4.1.4.4. Synthesis on responsiveness 
In summary, the B-B Score met most but not all of the standards for adequate 
responsiveness. The AUC values criteria (AUC ≥ 0.70) was met with a small margin. 
The criteria for change score (r ≥ 0.50) was met in the “All patients“ group and in the 
humerus fracture subgroup, partially met in the “Indicated pathologies” and the rotator 
cuff condition subgroups and unmet in the capsulitis and the shoulder instability 
subgroups. Considering the ES/SRM, the Constant Score and the B-B score were the 
two most reactive outcome measures, with an advantage for the former or the latter 
depending on the sample analysed. No floor or ceiling effects issues were detected. 
Despite these globally adequate measurement performances of the B-B score with 
regard to established standards, the results did not demonstrate clearly whether its 
responsiveness was superior or not from that of the PROMs. The B-B Score 
compared either favourably or unfavourably with the PROMs selected in this study, 
depending on the method used for the responsiveness assessment. As an illustration, 
the ES/SRM methods were rather favourable to the B-B score, while the AUC values 
favoured the PROMs.  
These controversial results between methods are not surprising, because the 
methods that were used in this study address different aspects of responsiveness: 
the proportion of real change vs. noise for ES and SRM, the capacity to perform a 
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dichotomous classification for AUC, or the relationship with another allegedly 
responsive measurement method for change score correlation. It has already been 
demonstrated in the literature that different methods of assessing responsiveness 
tend to produce different results, which is problematic for researchers and clinicians 
because they cannot rely on consistent scientific information (Stratford and Riddle, 
2005; Husted et al., 2000; Beaton et al., 1997). The analysis conducted in this Phase 
3 study demonstrated that the responsiveness of B-B Score measurements was 
adequate but did not allow drawing conclusions on the superiority or inferiority of the 
B-B Score responsiveness over currently-used shoulder function PROMs. 
A 6 months’ time interval without events standardisation had been chosen between 
measurements. This period was required to enable the assessment of the 
responsiveness to change of health state over time. Events in between 
measurements may have a major influence on the patient’s evolution. Thus, the 
detailed results of this thesis’ investigations about responsiveness should not be 
generalised to other testing conditions. Nevertheless, the comparison of the 
responsiveness between outcome measures that were conducted within this thesis 
were valid for the determination of their relative responsiveness, as all outcome 
measures were evaluated under the same testing conditions. 
 Floor and ceiling effects 
No floor effect was observed for the B-B Score, as no patient performed lower than 
the threshold defined for this measurement property, i.e. 0 + MDC (please see sub-
section of this Chapter, 4.2.2 “Analysis” p. 133 - 134 for floor effect threshold 
definition), indicating that the measurement’ responsiveness was not reduced for 
patients performing at a low functional level.  
Similarly, no problematic issue was observed with ceiling effects. The proportion of 
patients scoring more than 100% on the B-B Score was below the 15% threshold at 
baseline (2.2%) and at six months (6.2%) for the “Indicated pathologies” subgroup. 
The proportion of patients who scored more than 100% was logically higher at 6 
months, because it was possible that the previously affected shoulder had recovered 
beyond the healthy shoulder performance after treatment in some patients.  
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The proportion of patients scoring above 100% was higher in the “All patients” group 
(7.9% at baseline and 12.5% at 6 months). However, most patients who reached a B-
B Score of more than 100% had shoulder instability (seven at baseline and ten at six 
months), which again highlights the limitations of the B-B Score to capture alterations 
in the patient’s capacity for movement in this pathology, conversely to other 
investigated conditions. Based on these results, it can be considered that the 
hypotheses that no floor or ceiling effect would be detected were met. 
 Interpretability aspects 
Some values useful for the interpretation of clinical results (normal performance, 
MDC, MCII and PASS) were also calculated in this study, and were grouped under 
the term "interpretability aspects". Due to the limited subgroups sample sizes, no 
differentiation between pathologies was made for the establishment of these values.  
The results of the control group showed that the mean norm for performance           (~ 
95%) was close to 100%, indicating that healthy controls have a good balance 
between the dominant and non-dominant side considering the power-related 
parameter used in the B-B Score’s calculation. Comparing the magnitude of the 
difference (5.9% at baseline and 4.0% at 6 months) with perfect balance, with regard 
to the balance deficit in patients (36.9% for rotator cuff, 45.6% for capsulitis, 53.7% 
for fracture), it was considered that no adjustment was additionally necessary for the 
B-B Score to operate effectively in side-to-side comparisons of functional capability. 
The MDC reflects the magnitude of change that is needed to consider that the change 
is greater than the measurement error for an instrument (Beaton et al., 2001a). The 
MDC of the B-B Score using a smartphone indicated that the score difference needs 
to be greater than 18.1% to ensure that it is a real variation of a patient’s state.  
The MCII characterises which level of improvement in an outcome measure reflects 
a meaningful progress for the patient (Tubach et al., 2005a). Based on the MCII value 
determined using the 75% percentile method, the B-B Score improvement between 
two stages (in this Phase 3 study, it reflects the period between baseline and 6 months 
of treatment) needs to be greater than 25.2% for the patient’s improvement to be 
considered as meaningful by him/her.  
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The MCII values based on the thresholds for perceived improvement obtained using 
the ROC curve analysis were smaller than those obtained using the 75% percentile 
method and were quite different from each other depending on whether all patients 
were included or only those with indicated pathologies (Table 4.9: 9.5% for the “All 
patients” group, 15.9% for the “Indicated pathologies” subgroup). This discrepancy 
between MCII values determined using one method or the other had previously been 
reported (Beaton et al., 2011). The thresholds identified using the ROC curve analysis 
method cannot be considered as valid indicators of MCII, because both were smaller 
than the 18.1% MDC value. Indeed, the MCII must be larger than the MDC to be 
considered valid, as it would be contradictory to define a value that supposedly is 
important but is actually below the threshold for detecting changes in performance 
capabilities (van der Linde et al., 2017; De Vet et al., 2011a). 
The PASS is the value beyond which patients consider themselves well (Tubach et 
al., 2005b). Patients performing above a level of 77.6% on the B-B Score will usually 
consider that the function loss is acceptable. 
 Limitations and further developments 
Limitations are related to the limited sample size of each patient group. Though the 
group size was sufficient to compare the measurement properties of the B-B Score 
with those of concurrent outcome measures, larger sample sizes would be needed to 
get more precise estimations of measurement properties by pathologies and to be 
able to perform subgroup analyses for all methods used in this study. Notably, the 
AUC for improvement discrimination, MDC, MCII, and PASS could not be calculated 
realistically and separately for each pathology subgroup in this study. 
Though the B-B Score was compared to frequently-used shoulder function PROMs, 
none of them is considered as a gold standard for shoulder function evaluation. Thus, 
the results of this study could only investigate the convergent validity but not the 
validity of the B-B Score by comparison to a gold standard. The use of other outcome 
measures than the selected PROMs would have provided a different benchmark for 
the comparisons. It can nevertheless be considered that the PROMs used in this study 
are fair comparators as no other concurrent PROM has demonstrated its superiority 
over them (Huang et al., 2015). 
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The results found in this study demonstrated that the B-B Score has limitations for the 
evaluation of patients with shoulder instability. The Score discriminated neither the 
instability subgroup from the control group, nor the baseline to 6 months change of 
the disorder within the instability subgroup. Additionally, the responsiveness of the B-
B Score was lower than that of the WOSI and the discriminative power between 
patients and controls was poor (McDowell, 2006). Based on these results, the B-B 
Score should not be used for the evaluation of shoulder function in a shoulder 
instability population. Conversely, all minimum requirements were met for rotator cuff 
conditions, proximal humerus fractures, and adhesive capsulitis. 
Based on the results of this Phase 3 study, it could be considered that the most 
clinically important measurement properties of the smartphone-based B-B Score had 
been defined, but that some still needed to be specified with more precision in 
homogenous pathological populations. The determination of the interpretability 
aspects for the shoulder pathologies considered in this study provided a background 
for adequate interpretation of the results in research and clinics. Future studies are 
needed in patient populations that were not investigated in this study. For example, 
robust validation of the B-B Score is needed within populations experiencing 
glenohumeral osteoarthritis, shoulder arthroplasty, and rotator cuff surgery that have 
been the focus of initial validation studies in the past (Pichonnaz et al., 2015c). 
A middle segment smartphone model was chosen to have an insight into the 
performance of an accessible model. As a wide range of smartphones has similar or 
even better quality sensors, the results from these models should, theoretically, be at 
least comparable to those found in this study. The B-B Score is probably robust to 
variations in devices, as it compares the performance of the affected shoulder with 
that of the healthy one. Thus, systematic errors in measurement affecting both sides 
should not importantly affect the B-B Score. However, the influence of the 
characteristics of each smartphone on the outcome has to be investigated and 
quantified before clinical implementation. 
The scientific value of a novel and objective test of shoulder function, the smartphone 
B-B Score technique, has been endorsed by the findings of this study, but no cost 
analysis was conducted at this stage of development. Further studies reproducing 
routine working conditions should evaluate this aspect. Given the reasonable material 
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costs and the simplicity of the procedure, there would be a reasonable expectation for 
a favourable outcome following scrutiny by a formal cost-analysis. 
Information and communication technologies developments were not considered in 
this study but may be possible at a later stage. The use of a smartphone makes the 
measurement much more accessible for clinicians or even for patients. Thus, larger 
scale data collection could be performed by more raters at a lower cost. The 
smartphone B-B Score measurement might, for example, be used in telemedicine due to 
its simplicity and accessibility. It could also facilitate the centralisation of data collected in 
a large number of settings at an acceptable cost, thus facilitating data collection for 
multicentre studies and registries. 
 Conclusions 
The smartphone B-B Score demonstrated adequate measurement properties in 
populations with a rotator cuff condition, proximal humerus fracture, and capsulitis. 
The diagnostic and discriminative powers were excellent for these populations. The 
correlations with the PROMs indicated that the B-B Score is valid for shoulder function 
evaluation. The responsiveness was globally comparable to that of PROMs although 
the results varied according to the method used to assess this clinimetric 
characteristic. No issues relating to floor or ceiling effects were detected. The 
determination of the MDC, MCII, and PASS for the B-B Score provided a robust basis 
for the clinical interpretation of the outcome. Though adequate, the measurement 
properties were not demonstrated to be superior to those of the selected PROMs. The 
advantage of the smartphone B-B Score resides mainly in the fact that is provides an 
objective measurement of shoulder function that is not affected by the translation, 
culture and items’ interpretation issues, in contrast to clinical questionnaires. 
All of these conclusions about the smartphone B-B Score open interesting 
perspectives for the routine objective shoulder function measurement in clinics, as 
this validated score can quickly be performed using an inexpensive device. The 
affordable measurement of large cohorts of participants may also be facilitated. 
Further investigation is needed to devise a movement analysis-based score for the 
evaluation of shoulder instability in situations where the B-B Score did not meet the 
minimal clinimetric requirements for clinical deployment. Moreover, the measurement 
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properties of the B-B Score should be further investigated in patient populations 
presenting other shoulder conditions such as osteoarthritis, rotator cuff repair, 
arthroplasty or clavicle fracture and in larger homogenous samples for the pathologies 
investigated in this Phase 3 study. Studies could also explore the possibility of using 
the smartphone B-B Score for remote follow-ups and for early detection of suboptimal 
recovery. 
 Further developments within the thesis 
Phase 2 study demonstrated the equivalency of a smartphone and an inertial sensor 
system dedicated to the analysis of human movement, while Phase 3 investigated a 
broad range of measurement properties of the B-B Score in frequent shoulder 
pathologies. These were important steps to increase the body of knowledge on the 
measurement properties of the B-B Score, but they did not allow determining whether 
or not the B-B Score should be preferred to alternative outcome measures for the 
measurement of the shoulder function in various clinical situations. Although the B-B 
Score measurement properties were found to be adequate, it might be that other 
outcome measures have better measurement properties than the B-B Score. 
This issue was addressed in the Chapter five of this thesis, in which a literature review 
was conducted with the aim to challenge the B-B Score clinimetric performances with 







CHALLENGING THE MEASUREMENT 
PROPERTIES OF PATIENT-REPORTED 
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OUTCOME MEASURES FOR 
SHOULDER FUNCTION EVALUATION: 




 Rationale for conducting a literature review 
 Contribution of the literature review to the 
achievement of the thesis objectives 
For an outcome measure to be recommended it must have shown adequate 
measurement properties and must it must stand up to comparison with alternative 
tools. The adequacy of the measurement properties of the B-B Score measured using 
a smartphone was demonstrated in the previous chapter of this thesis (Phase 1, 2 
and 3 studies), but no comparison had been made with the properties of other 
outcome measures at this stage. 
Therefore, a benchmarking for the measurement properties of the B-B Score and its 
alternative outcomes measures is provided in this Chapter five, through the means of 
a systematic literature review. The measurement properties being context-dependent, 
they were compared separately for various shoulder disorders, either surgically or 
conservatively treated (Robertson et al., 2017; Riddle and Stratford, 2013; Collins and 
Roos, 2016; El Gaafary, 2016). As the alternative instruments can be PROMs or, 
similarly to the B-B Score, movement’ analysis-based (MAB) outcome measures, the 
Score was compared to outcomes measures from these two approaches. This review 
was also undertaken because it was estimated that the comparison between PROMs 
and MAB outcome measures for the evaluation of shoulder function would add to the 
innovative aspects of this thesis, as no review had previously been carried out on this 
issue, to the best of this thesis’ author knowledge. 
Importantly, given that aspects of the findings from the preceding studies in this thesis 
have been published within the peer-reviewed literature (Phase 2 study in Pichonnaz 
et al., 2017, Phase 3 study in Pichonnaz et al., 2015a), it was anticipated that these 
articles would be included within the retrieved literature on the subject of interest. It 
was therefore thought that this novel systematic review would help to further highlight 
the characteristics of the B-B Score, as a MAB approach to assessing shoulder 
function and act as a culmination for the aims of the thesis in this respect. 
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As the Phase 2 and 3 results were extensively but not exhaustively published, the 
comparisons of the B-B Score with alternative outcomes measures based on the 
literature data were complemented by the comparisons including unpublished data 
from the thesis. Conducting this literature review also contributed to an appreciation 
of the methodological quality within the thesis’ studies for evaluating clinimetric 
properties of health outcome measures, which will be contextualised by reference to 
the quality of the studies from the literature.  
 Present situation in shoulder function 
evaluation 
To meet the patients’ and societal expectations, clinicians are expected to treat 
patients with optimal efficiency i.e. with maximum efficacy that is matched to both 
affordable financial and temporal investments. They have thus to rely on efficient 
measurement tools to evaluate their patients’ status and to draw appropriate 
conclusions about the relevance of their intended approaches to treatment. PROMs 
(patient-reported outcome measures) and MAB methods are the most frequently-
used approaches to evaluate shoulder function performance. Both approaches have 
proponents that robustly put forward the advantages of each method. However, to the 
authors’ knowledge, the measurement properties of these approaches have never 
been directly compared within a literature review. Such a comparison would help 
clinicians and researchers to opt for the most suitable tool matching the needs of their 
situation, and to highlight the most promising pathways for future developments in the 
evaluation of the functional and performance capabilities of the shoulder. 
 Challenges to PROMs and movement 
analysis based methods 
The shoulder is the second most frequently-treated body region in rehabilitation 
(Picavet and Schouten, 2003). Clinicians are thus very regularly called upon to 
evaluate shoulder’s function in their practices. This situation is challenging as there is 
a plethora of PROMs for assessing the shoulder, but none has been recognised as a 
“gold standard” (Fayad et al., 2004; Harvie et al., 2005; Huang et al., 2015; Wright 
and Baumgarten, 2010). As such, it might be difficult for them to choose the PROM 
offering appropriate clinimetric qualities within a given situation. Moreover, the 
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evidence about the important measurement properties for each measurement tool 
must be synthesised and easily accessible in order for it to be exploitable in current 
clinical practice.  
With simplifications to the measurement process afforded by technological progress, 
and with increasing people' literacy in computer' manipulation, there’s an imperative 
to investigate whether computerised movement analysis-based (MAB) methods could 
represent a viable alternative to traditional questionnaire-based approaches, which to 
date, have been used routinely in clinical settings. Considering the ongoing debates 
on the validity and other measurement properties of PROMs (Roe et al., 2013; Makhni 
et al., 2015; De Baets et al., 2017; Oh et al., 2009; Bot et al., 2004; Fayad et al., 2004), 
and recent developments in shoulder movement analysis, a review comparing their 
respective merits would provide useful knowledge to clarify to which degree both 
approaches’ properties are comparable. 
Thus, the measurement properties of PROM and MAB scoring systems were 
investigated using the contemporary scientific and clinical literature, to evaluate the 
state of the evidence for both approaches and compare the adequacy of their 
measurement properties. This will help understand to which degree, in their present 
stage of development, the MAB evaluation methods are able to complement or 
replace PROMs, and provide orientations for future research that aims at their 
improvement (including the B-B Score, depending on its associated research studies 
meeting inclusion criteria for this review). 
 Literature review scope 
 Limitations of contemporary field-based 
reviews of literature 
A considerable selection of reviews has already accumulated in the literature focusing 
on shoulder function evaluation using PROMS. Thirty of them were retrieved during 
the preliminary bibliographic researches of this review. Most of them addressed 
validity issues but did not differentiate the measurement properties for different 
patients’ populations.  
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The body of knowledge of previous reviews remained very heterogeneous and difficult 
to synthesise, due to the variety of approaches and of quality levels of reviews, which 
lead to inconsistent conclusions amongst articles. Globally, some reviews had 
concluded that no shoulder function PROM was superior to the other ones, while other 
had recommended the use of one or several PROMs, without a common trend across 
reviews emerging in favour of one of them. 
Most reviews did not display clearly the rationale for choosing the included PROMs. 
Moreover, those that included patients with different pathologies did no differentiate 
them in the analysis, though measurement properties are known to be context-
dependent.  
Thus, it was considered useful for raters to have a focused review on measurement 
issues in the various populations currently treated for shoulder disorders, as 
measurement properties are known to be context-dependent (Robertson et al., 2017; 
Riddle and Stratford, 2013; Collins and Roos, 2016; El Gaafary, 2016). As sufficient 
information is available on the validity of shoulder-focused PROMs, it was estimated 
that investigating this topic again would have had little added value, and would 
probably not solve the controversies surrounding the validity of shoulder function 
PROMs (Bot et al., 2004; Fayad et al., 2004). Thus, a pragmatic approach was 
adopted focused on measurement properties only, with the thinking that the clinicians 
cannot wait for a “perfectly valid” outcome measure, and have to rely on existing 
measurement methods to face today’s challenges.  
In contrast to the large number of reviews focused on shoulder PROMs, only one 
recent review was found on the validity and reliability of shoulder function evaluation 
using computerised movement analysis, and more specifically inertial measurement 
units (De Baets et al., 2017). The properties of movement analysis-based 
measurements were investigated in this latter review, but they were not compared 
with those of PROMs. As movement analysis is a growing and promising field in the 
literature, it was estimated that a literature review challenging the traditional approach 
based on PROMs and the innovative approach based on movement analysis would 
be of great use to clarify the respective merits of each approach for the various patient 
populations encountered in clinical practice. 
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Reviews on the measurement properties that are more recent report the methods with 
greater precision. Nevertheless, a large majority of them did not evaluate the quality 
of the literature. Among those who did, only three used the COSMIN checklist 
(Kennedy et al., 2013; Thoomes-De Graaf et al., 2016; Sahinoglu et al. 2019). 
 Scope of included shoulder conditions 
The chosen pathologies were rotator cuff conditions, humerus fracture, adhesive 
capsulitis and shoulder instability, due to the frequency of these conditions in 
rehabilitation.  
Several conditions, which are hardly clinically distinguishable from each other, are 
associated with the shoulder’s rotator cuff, including rotator cuff tendonitis, rotator cuff 
tears, subacromial impingement or bursitis (Mitchell et al., 2005). Altogether, they 
represent the most common source of shoulder pain (65%). 
Shoulder osteoarthritis (OA) is a common cause of shoulder pain and disability, 
particularly in the aging population, which is characterised by radiological narrowing 
of the glenohumeral joint. It affects 5% – 21% of the adult population in the United 
States and Europe (Singh et al., 2010). It may be conservatively treated using active 
and passive joint mobilisations, strengthening and proprioceptive rehabilitation 
methods. The main surgical options are total shoulder arthroplasty (TSA) and 
hemiarthroplasty, with TSA performed in 80% of interventions. Due to aging of the 
population and improvement in surgical outcomes, there was a 3.7-fold increase in 
TSA intervention rate in the last decade (Trofa et al., 2014). 
With a recorded incidence of 22% in the literature, adhesive capsulitis (also frequently 
called frozen shoulder) represents the second most prevalent cause of shoulder pain 
(Yamamoto et al., 2010). This idiopathic pathology of the joint capsule causes mainly 
pain and stiffness that progressively resolves within 12- to 18-months (Kelley et al., 
2013; Mitchell et al., 2005). 
Proximal humeral fractures is another shoulder disorder that is frequently treated in 
rehabilitation. Proximal humeral fractures account for 6% of adult fractures (Court-
Brown and Caesar, 2006). Their incidence is growing due to the increasing age of the 
population in Western countries.  
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Finally, the shoulder instability concerns mainly young adults and is a common cause 
of medical consultation in this population. It is characterised by the tendency of the 
humeral head to slide partially or completely out of its socket in the glenoid fossa. Its 
incidence reaches 2.8% in a physically active young population (Liavaag et al., 2011; 
Owens et al., 2007). 
 Scope of included measurement properties 
This chapter’s clinically-orientated literature review also focused on the properties that 
are of direct interest for measurement interpretation in contemporary real-world 
treatment situations. Thus, the analysed properties were selected as a function of the 
clinical demand that the clinicians have to face, and the issues that are of concern in 
current practice i.e.:  
- Evaluate the present status of the patient: 
- Reference norm for healthy subjects: how far is the patient from normal 
status?  
- PASS (patient acceptable symptoms state): which is the value from which the 
patient considers his/her state as acceptable? 
- Evaluate the patient’s change at follow-up:  
- Effect size and standardised response mean: to what extent does the tool 
capture the status change over time? 
- Specificity, sensitivity, area under the ROC curve for perceived change of 
status: is the tool able to discriminate those who felt that they evolved from 
those who do not? 
- Change correlation: is the change score of the outcome measure under 
investigation related to that of a reference that is assumed to be responsive?  
- Minimal clinically important difference (MCID)/minimal clinically important 
improvement (MCII): which is the value of the status change/improvement 
beyond which the improvement becomes meaningful for the patient? 
- Floor and ceiling effects: does the tool capture the differences in performance 
over time at end range values? 
- Estimate the influence of the measurement variability on an outcome measure’s 




- Intra-rater, inter-rater and test-retest reliability: to what extent would 
measurements taken at several occasion produce closely related results? 
- Limits of agreement (LoA) using Bland and Altman graphs: what range of error 
is associated with a single measurement? Are repeated measurements 
affected by systematic errors such as carry-over effects? 
- Estimate the influence of measurement error on measured change: 
- Standard error of measurement (SEM): what is the typical margin of error of 
the outcome measure? 
- Minimal detectable change (MDC): beyond which threshold can the measured 
change be considered as real, and not caused by random measurement 
variability? 
 Study aim and hypotheses  
This review aimed to collate and compare the measurement properties of currently 
used patient-reported and MAB outcome measures of function in frequent shoulder 
pathologies. This will contribute determining if an approach has advantages over the 
other one, considering their respective measurement properties. It will also help 
identify paths for future research, based on any detected shortcomings and promising 
orientations for the systems of measurement. 
More specifically to this thesis, the literature review aimed at challenging the 
measurement properties of the B-B Score with the measurement properties of 
alternative outcome measures, considering both PROMs and MAB outcome 
measures. This comparison of the B-B Score clinimetric performances with those of 
other outcome measures pursuing the same purpose may contribute to 
circumstantiated recommendations on its use in various clinical contexts. 
It was hypothesised that the measurement properties of the PROMs and the MAB 
outcome measure, including the B-B Score, would comply with recognized standards 
for the adequacy of measurement properties (see sub-section 5.2.6 “Interpretation 
delimitation” and Table 5.2, within this Chapter p. 182 - 185 for detailed definition of 
standards). Based on previous reviews comparing PROMs and in the absence of any 
previous formal comparison between MAB outcome measures, it was also 
hypothesised that the measurement properties of the alternative scores, including 
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those of the B-B Score, would be comparable within in each one of the investigated 
pathologies (Fayad et al., 2004; Harvie et al., 2005; Huang et al., 2015; Wright and 
Baumgarten, 2010). 
Based on these literature review’s aims, the PICOS (Participant, Intervention, 
Comparison, Outcome, Study design) can be formulated as follows:  
• Participants: patients with rotator cuff conditions, osteoarthritis, proximal 
humerus fracture, capsulitis and shoulder instability,  
• Intervention: any kind of surgical or conservative treatment for the 
aforementioned shoulder disorders 
• Comparison: measurement properties of PROMs outcome measures with 
measurement properties of MAB outcome measures, including the B-B Score 
• Outcomes: statistical results for each one of the investigated measurement 
properties (sub-section 5.1.2.3. “Scope of included measurement properties”, 
within this Chapter 172 - 173). 
• Study design: any kind of validation studies. 
Thus, this literature review aimed to answer the following question: 
- What are the specific measurement properties of the shoulder function 
outcome measures for patients with rotator cuff conditions, humerus fracture, 
capsulitis and shoulder instability for PROMS and MAB outcome measures, 
respectively 
- Are the measurement properties of PROMs and MAB outcome measures 
comparable, for each one of the included pathologies? 
 Methods 
 Formal issues 
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 
guidelines were used as a reference for the methodological conception and the 
reporting of this review, as far as items of the list apply for a literature review without 
meta-analysis. Reasons for not undertaking a meta-analysis are developed in sub-
section 5.2.6 ”Interpretation delimitations”, p. 182 - 185). 
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The literature review was registered in PROSPERO under registration number 
CRD42018104508) (Appendix XIII). Prospero is an international database of 
prospectively registered systematic reviews in health care and related fields, where 
there is a health related outcome. It aims to provide a comprehensive listing of 
systematic reviews registered at inception to help avoid duplication and reduce 
opportunity for reporting bias by enabling comparison of the completed review with 
what was planned in the protocol (http://www.crd.york.ac.uk/ PROSPERO/). 
 Search strategy 
The review was constructed in four steps. The first step comprised the identification 
of the existing outcome measures of shoulder function. All MAB outcome measures 
were retained, while selection procedures were used to focus only on currently used 
and valid PROMs, which was necessary for reasons of feasibility given a multitude of 
approaches (Huang et al., 2015) (please see sub-section 1.1.2.1 “Patient-reported 
outcome measures”, within Chapter one, p. 4 - 5 for the presentation of the 
contemporary situation concerning shoulder function PROMs and sub-section 5.2.7 
“Preliminary bibliographic search of the selection of PROMs”, within this Chapter, p. 
186 - 187 for the detailed selection process and results). 
Then, in step two, bibliographic search strategies for relevant databases (Medline, 
Embase, CINAHL, Web of Science, Pedro) were constructed to retrieve the selected 
tools measurement properties, for PROMS and MAB outcome measures. The 
bibliographic search was then completed by a manual search inspecting the 
references list of included articles. Data concerning measurement properties were 
then extracted on an excel spreadsheet and compiled on as a third step. A fourth and 
final step focused on an interpretation of the results based on recognised threshold 
values for sound measurement properties and on benchmarking for the PROMs and 
MAB outcome measures of shoulder function. 
A double-check was operated by a senior physiotherapist and lecturer colleague of 
the thesis’ author at the Haute Ecole de Santé Vaud (HESAV), Pierre Balthazard. The 
checking focused on the terms of the bibliographic strategies on all investigated 
databases, the retrieved references, the retained articles, the extracted data and the 
definition of the levels of evidence. At each stage, the differences were discussed and 
resolved by consensus, taking the objectives and methods of the study described in 
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this protocol as references. It had been planned that this thesis’ supervisor (Prof. Nigel 
Gleeson) would act as an arbitrator in case of disagreements between the two 
involved authors, which was finally not necessary. Finally, the data interpretation was 
discussed and approved by the colleague auditor.  
For feasibility reasons, no article exclusion was made based on literature ratings and 
no meta-analysis was conducted. The specific reasons for these decisions are 
developed in sub-sections 5.2.5 “Rating quality within the literature” p. 180 - 182 and 
sub-section 5.2.6, ” Interpretation delimitations”, p. 182 - 184). 
The literature review selection process, for the PROMs and MAB outcome measures 
is summarized in Figure 5.1 
 
 






















 Selection of shoulder function outcome measures 
For shoulder function PROMs, the selection was based on frequency of use and the 
fact that a validation process had previously been completed. As the validity will not 
be re-evaluated in the present review, it was a necessary to put this second condition, 
because it would not make sense to evaluate measurement properties of a tool that 
may potentially have presented with conceptual shortcomings. A preselection was 
performed based on previous articles that had investigated the frequency of use of 
shoulder function PROMs (Gartsman et al., 2015; Makhni et al., 2015). Then a 
preliminary bibliographic search was conducted to assess the frequency of use of the 
pre-selected articles and therefore be able to proceed to a final selection (please see 
sub-section 5.2.7 “Preliminary bibliographic search of the selection of PROMs”, within 
this Chapter, p. 186 - 187 for the detailed selection process and results). 
For MAB outcome measures assessing shoulder function, the aim had been to 
retrieve all of those that allowed the functional performance of the shoulder to be 
assessed using a scale system. Thus, the articles mentioning solely a difference 
between a healthy control group and a pathological group in one or several 
parameters, were not retained, due to their limited utility for monitoring patients’ 
change, as the clinicians need a scale that allows rating of their patients’ performance 
from totally non-functional to fully functional. The MAB outcome measures were 
considered only if the purpose of the tool was to measure shoulder function as a main 
outcome, e.g. tools that were intended to measure shoulder ROM only were not 
included, because ROM is not sufficient to reflect shoulder function extensively.  
The same measurement properties were extracted for shoulder PROMs and MAB 
outcome measures, to allow for comparison. Additionally, the correlations amongst 
shoulder function PROMs and MAB outcome measures were also extracted, as they 
reflect the degree to which a MAB outcome measure is related to outcome measures 






Inclusion criteria:  
• Any measurement properties study indexed in relevant databases until 
05.05.2017 that investigated the measurement properties of the selected PROMs 
or any MAB outcome measure designed to assess shoulder function. PROMs 
selection was based on a preliminary bibliographic search that aimed to 
determine which were the most commonly used PROMS within the last five years, 
amongst those pre-selected at the beginning of this sub-section 5.2.3.  
• The translated versions of PROMs were included provided that the translation 
process complied with recommendations for the translation of PROMs 
(Eremenco et al., 2017), as reported in the article or stated by an ascertainable 
reference (please see sub-section 5.1.2.3 “Scope of included measurement 
properties” p. 172 - 173 for detailed description of investigated measurement 
properties, and sub-section 5.2.7 “Preliminary bibliographic search of the 
selection of PROMs” for the PROMs selection process, p. 186 - 187). 
Exclusion criteria:  
• Studies that only addressed the discriminative power between a healthy and a 
pathological group, without investigating any other measurement property. 
• MAB outcome measures measurements whose objective was not to measure the 
function of the shoulder. 
• Studies that included patients with shoulder disorders within a broader upper limb 
sample of patients, without providing a separate analysis for shoulder disorders.  
• Studies including paediatric patients. 
 Bibliographic search process 
Bibliographic research strategies were built to retrieve the measurement properties of 
shoulder function outcome measures in the four selected current shoulder pathologies 
presented in sub-section 5.1.2.2 “Scope of included shoulder conditions”, i.e. rotator 
cuff condition, humerus fracture, capsulitis, shoulder instability and glenohumeral 
osteoarthritis. Articles concerning conservative and surgical treatments were included 
to account extensively for the types of patients’ scenarios commonly encountered in 
physiotherapy practice. However, they were analysed separately to account for the 
fact that the populations and context of patient follow-up cannot be aggregated 
because of their inherent differences. 
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The strategy was also built to retrieve all important measurement properties that are 
mentioned in point 1.2.3.” Scope of included measurement properties” 
These measurement properties were retrieved only for the PROMs selected at the 
first step of the review, while they were retrieved for all MAB outcome measures. 
The search was conducted in the main biomedical (Medline, Embase), allied health 
(CINAHL) and interdisciplinary databases (Web of Science). The final search included 
all articles indexed before 05.05.2017 without an inferior time limit, so that all articles 
about an outcome measure could be taken into account. Strategies for all databases 
are available in Appendix XV. In summary, strategies for PROMs properties 
evaluation were constructed to retrieve articles on: shoulder AND selected conditions 
AND measurement properties AND each selected PROMs. The equation for MAB 
outcome measure was similar except for the last operator, which targeted movement 
analysis-based methods applicable for shoulder function evaluation. 
 Rating quality within the literature 
 Possible checklists considered 
5.2.5.1.1. COSMIN checklist and its shortcomings 
for this review 
The use of a rating scale was initially considered to evaluate the quality of the 
literature, but this approach had to be abandoned for reasons of applicability and 
equity in the specific context of this review. The use COSMIN checklist had been 
initially considered for this purpose, as it had specifically been developed to evaluate 
the methodological quality of studies on the measurement properties of health 
measurement instruments (COSMIN, 2010). It was finally not used based on the tests 
conducted in the preliminary try-outs. 
The COSMIN checklist was not used mainly because it was not adapted to rate the 
quality of the methods used to determine several measurement properties considered 
in this review (MIC, MID, floor/ceiling effects and normative values). It would thus have 
been inappropriate to interpret the results of some of the studies based on their 
methodological rating according to the COSMIN checklist, when this could not have 
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been done for the studies that addressed the properties that could not be assessed 
using the checklist. 
Another problem is related to the fact that a considerable number of articles presented 
their research with several aspects of varying methodological quality. For example, 
the same study could have been highly rated for one aspect of the research and poorly 
for another, which could have compromised the interpretability of the results. Also, 
the COSMIN approach for responsiveness evaluation is controversial (Angst, 2011). 
Most studies published to date would have been poorly rated, because ES and SRM 
calculations, which are widely used, are considered in the checklist as inappropriate 
methods for the assessment of responsiveness. 
Another point to consider is the low inter-rater agreement of the checklist, with Kappa 
coefficient below 0.40 for 61% of the checklist items (Mokkink et al., 2010a). 
Therefore, it was decided to proceed to a qualitative analysis of potential biases when 
results were controversial between studies, but not to present quantitative quality 
ratings in this review. 
Some shortcomings of the original COSMIN checklist have been reported by users 
and recognised by its developers (Mokkink et al., 2018). Therefore, a new version of 
the “Risk of Bias checklist for systematic reviews of Patient-Reported Outcome 
Measures” have recently been released, although at a date too late for it to be taken 
into account in this thesis (July 2018) (COSMIN, 2018a). The content of the revised 
checklist has been targeted more specifically on the issues related to the risk of bias 
and the rating procedure have has been clarified to some extent. However, the issue 
mentioned above still remains. 
5.2.5.1.2. Contributions of the COSMIN checklist 
for this review 
Although the COSMIN checklist was not used to assess quantitatively the quality of 
the included studies, its items’ questions were used where relevant for the qualitative 
quality assessment. The considered items addressed the appropriateness of sample 
size and sample characteristics, stability of patients, time interval between 
measurements, statistical approaches, similarity of testing conditions and 
identification of important flaws (COSMIN, 2018a).  
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Based on these criteria, the quality of the evidence for each measurement property 
was estimated using a version of the GRADE approach that had been adapted by the 
COSMIN group to be specific to the evaluation of measurement properties (GRADE 
Handbook, 2013; Prinsen et al., 2018). The criteria used for the assessment of the 
degree of evidence were the risk of bias (i.e., the methodological quality of the 
studies), the inconsistency (i.e., unexplained inconsistency of results across studies), 
the imprecision (i.e., sample size of the available studies) and the indirectness (i.e. 
evidence from a different population than the one of interest). The evidence was 
graded as low when it relied on one study only. When grading the quality of the 
evidence, the overall rating was initially assumed to be of high quality and was 
subsequently downgraded to moderate, low or very low by one or two levels per 
criteria when shortcomings are stated (COSMIN, 2018b) (Table 5.1). 
Table 5.1: Modified GRADE approach for grading the quality of evidence with reasons 
for downgrading the level of evidence. Adapted from: PRINSEN, C. A. C., MOKKINK, 
L. B., BOUTER, L. M., ALONSO, J., PATRICK, D. L., DE VET, H. C. W. & TERWEE, 
C. B. 2018. COSMIN guideline for systematic reviews of patient-reported outcome 
measures. Qual Life Res, 27, 1147-11573.  
Study design Quality of evidence Lower if 
At least one measurement 
properties study 
High Risk of bias 
-1 Serious 
-2 Very serious 
-3 Extremely serious 
Inconsistency 
-1 Serious 
-2 Very serious 
Indirectedness 
-1 Serious 





 Very low 
                                               
3 COSMIN materials on this site may be reproduced in whole or in part in any form for 
educational or non-profit purposes without special permission. 
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So, when applying these recommendations for grading the quality of evidence, the 
evidence is initially considered as high. After analysing if there are available articles, 
the evidence remains high if there is at least one high quality article. It is downgraded 
by one (high  moderate), two (high  low) or thee levels (high very low) each time 
a weakness is stated due to bias, insconsistency or indirectedness.  
As proposed in the guidelines for grading the level of evidence, the measurement 
properties clinimetric performances were rated as “+” sufficient, “-“ insufficient, +/- 
“undetermined” in the tables of results. A question mark (?) was used when a 
measurement property had never been investigated (please see Table 5.2 Rating 
criteria of measurement properties p. 185 for the rating criteria) (COSMIN, 2018b). 
 Considerations about the Evaluating 
Measures of Patient-Reported Outcomes 
(EMPRO) tool 
The Evaluating Measures of Patient-Reported Outcomes (EMPRO) tool was also 
considered for the screening of the measurement properties of the outcome measures 
(Valderas et al., 2008). This tool has not been frequently used to date, as only ten 
publications mentioning its name were retrieved on Medline when searching 
information on this literature rating approach. 
Several limitations were identified regarding the use of the EMPRO for this study’s 
purpose. Although it provides a broad overview of methodological issues, it would 
have not allowed the assessment of all the measurement properties of interest in this 
thesis, similarly to the COMIN checklist. In addition, the EMPRO combines the 
assessment of the methodological quality of the studies with the clinimetric 
performances of outcomes measures, without making a clear distinction between 
these issues. The scoring would therefore have been problematic for this thesis’ 
literature review, in which both aspects needed to be clearly differentiated. Finally, the 
transition from the items’ rating to the final overall recommendation for the use of an 
outcome measure is essentially based on a qualitative appreciation by the rater. The 
EMPRO tools would therefore not have contributed to improve the objectivity of the 
recommendations, compared to a qualitative interpretation of the results without 
relying on this tool. 
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 Interpretation delimitations 
All articles were retrieved in English or French. Translations of PROMs in other 
languages were included provided that the related article had been published in 
English or French and was based on a validated translation of the questionnaire. 
When various upper extremity conditions were analysed and differentiated, the 
articles were retained only if the data for the conditions relating to the shoulder were 
separately reported. 
The measurement properties were extracted separately for each shoulder condition 
of interest (rotator cuff condition, humerus fracture, adhesive capsulitis, shoulder 
instability and glenohumeral osteoarthritis), and differentiated for surgical and non-
surgical interventions. These differentiations were made to account for the fact that 
measurement properties are context and population-dependent (Robertson et al., 
2017; Riddle and Stratford, 2013; Collins and Roos, 2016). For example, the 
responsiveness may be different for patients with shoulder instability or capsulitis, 
which affects function quite differently, as each condition has a very different progress 
pattern over time. Similarly, the properties might be different with or without surgical 
shoulder stabilisation aiming to restore glenohumeral stability. Though studies that 
include a sample with various shoulder pathologies do not account for the context-
dependency of measurement properties, they were nevertheless included in this 
review. This decision was taken because of the frequency of such studies in the 
literature and because studies that include various shoulder pathologies represent 
nevertheless a feasible and useful research option to provide an initial insight into 
measurement properties, until more precise investigations are conducted. 
Similarly to previous authors who had addressed the topic, no meta-analysis was 
conducted within the data of the current selection of studies included in the systematic 
review, because of the heterogeneity of the methods, timeframes and sample 
composition (Kirkley et al., 2003; Oh et al., 2009; Huang et al., 2015; Harvie et al., 
2005; Fayad et al., 2005; Placzek et al., 2004; Roy et al., 2009). An example of several 
problems relating to heterogeneity was that no relevant mean MCID was capable of 
being calculated from any two studies reporting results that differ because of 
variations in methods (e.g. distribution-based or anchor-based approach), follow-up 
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time, pathologies and populations ages. These issues apply equally to the meta-
analysis of the other measurement properties considered in this review. 
An interpretation of the differences between measurement properties was made only 
when a direct comparison between tools was conducted within the same research. 
The differences in measurement properties across studies were not accounted for, as 
the variations in populations, treatment and follow-up period limited the possibility to 
proceed to valuable comparisons.  
Cut-off values were used when they were available to ensure fair interpretation of 
results based on common standards and to allow benchmarking for the measurement 
properties of outcome measures. This was the case for the area under the curve 
(AUC) of the receiver operating characteristic (ROC) curve, correlations, ICCs and 
floor/ceiling effects. As no recognised threshold was found in the literature for the 
limits of agreement (LoA) and the bias, the thresholds used in the Phase 1 and 2 
studies of the thesis were applied (Table 5.2). Therefore, an outcome measure’s 
measurement properties were interpreted according to their adequacy in comparison 
to established standards and to their comparison with concurrent tools. Comparisons 
were made between outcome measures within a study or between several studies 




Table 5.2: Rating criteria of measurement properties. 
Outcome Cut-off values Comments and references 
Area under the 
curve 
0.90-1.00: excellent  
0.80-0.90: good  
0.70-0.80: fair  
0.60-0.70: poor  
0.50: no 
discriminating ability 
Responsiveness was considered as 
adequate when AUC was ≥ 0.70 
(Pines et al., 2012; Terwee et al., 




≤ ± 10% and ≤ ± 5% 
bias 
LoAs were considered as adequate 
when ≤ ± 10% and bias ≤ ±  5%  
Based on clinical utility, no available 
reference was found  
Correlation 0.00 to 0.30 negligible 
0.30 to 0.50 low 
0.50 to 0.70 moderate 
0.70 to 0.90 high 
0.90 to 1.00 very high 
Correlations between outcome 
measures and between change 
scores were considered as adequate 
when r was ≥ 0.50. 
(Hinkle et al., 2003) 
 
ICC ≥ 0.70 minimum 
acceptable threshold 
≥ 0.90 expected 
threshold for clinical 
use 
Reliability was considered as 
adequate when ICC was ≥ 0.90 
(Terwee et al., 2007; Portney and 
Watkins, 2015; Prinsen et al., 2018) 
 
Floor/ceiling effect The effect is present 
when ≥ 15% of the 
respondents achieved 
the highest or lowest 
possible outcome 
measures 
Percentage of patients reaching the 
maximum or minimum scores was 
discussed in the review when 
several outcomes had been 
investigated in the same study 





 Preliminary bibliographic search of the selection of 
PROMs  
 Selection process 
A pre-selection of current tools was made based on those that had been identified in 
previous literature reviews investigating their frequency of use (Gartsman et al., 
2015; Makhni et al., 2015). As a result, the DASH (Disabilities of the Arm, Shoulder 
and Hand) and QuickDASH, Constant Score 4, ASES (American Shoulder and 
Elbow Score), SST (Simple Shoulder Test), SPADI (Shoulder Pain and Disability 
Index) , UCLA (University of California Los Angeles), Shoulder rating scale, Rowe 
score, WOSI (Western Ontario Shoulder Instability Index) and WORC (Western 
Ontario Rotator Cuff Index) were preselected and their frequency of use estimated 
based on the number of articles indexed in Medline for the last 5 years in which the 
tool had been used for shoulder function evaluation (please see Appendix XIV for 
bibliographic strategies)  
The literature search was limited to the last five years to reflect the recent practice of 
shoulder function evaluation. Abstract and Medline data of retrieved references were 
inspected to ensure that the preselected scores were actually used in the articles. 
Despite their frequency of use, the UCLA shoulder score (Fayad et al., 2004; Longo 
et al., 2011; Kirkley et al., 2003; Huang et al., 2015; Gartsman et al., 2015) and the 
ROWE score (Rouleau et al., 2010; Fayad et al., 2004; Kirkley et al., 2003) were not 
retained as it had been consistently stated in hereby mentioned publications that they 
had not undergone a formal validation process. 
  
                                               
4 Constant Score: unless otherwise specified, “Constant Score” refers to the absolute 
Constant Score. It will be specified “relative Constant Score” when the Constant result 




 Results for the selection of PROMs 
The following number of occurrence for the preselected PROMs was found to be: 
1) Constant: 1070 
2) ASES: 605 
3) DASH or QuickDASH: 452 (among them 98 QuickDASH) 
4) SST: 348 
5) SPADI: 199 
6) WOSI: 95 
7) WORC: 79 
The four most frequent PROMs were selected based on these results. Although the 
Constant Score includes a clinical examination, it was incorporated within the 
category of PROMs (Patient-Reported Outcome Measures), as it serves the same 
purpose and is a very current outcome measure of shoulder function. The WOSI was 
also added to the PROMs that would be used within the thesis’ systematic review. 
This was because, similarly to a previous review on shoulder outcomes, it was 
estimated that investigating at least one validated instrument for shoulder instability 
was necessary, due to the specificity of this condition and the poor performance of 
generic shoulder function PROMs for this pathology (Angst et al., 2011). 
 Characteristics of selected shoulder function 
PROMs 
5.2.7.3.1. DASH and QuickDASH scores 
The DASH is a self-assessment PROM of the entire upper extremity symptoms and 
function (Hudak et al., 1996). It provides a whole upper-extremity evaluation including 
the shoulder. Only studies on the measurement properties for shoulder evaluation 
were considered in this review. The original version comprises 30 items among which 
6 are about symptoms (3 pain, 1 tingling, 1 weakness, 1 stiffness) and 24 about 
function (21 physical function, 3 social function) (Angst et al., 2011). Two optional 
additional modules for work and sports/performing arts, exist for specific evaluation of 
manual workers and athletes. Items are scored on 5-point Likert scales ranging from 
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no difficulty to extreme difficulty or symptoms, with a highest score of 100 indicating 
the worst disability.  
A shortened version, the QuickDASH that comprises 11 items only, has been 
developed to limit the evaluation’ burden. The QuickDASH has been designed to 
measure the same concept as the DASH, but its developers estimate that the full 
DASH should be preferred when more precision is needed (American Academy of 
Orthopaedic Surgeons, 2009).  
5.2.7.3.2. Constant Score 
The Constant Score is a composite outcome measure that includes questions on pain 
and activity, and objective measures of range of motion and abduction strength 
(Constant and Murley, 1987). It can be used in various shoulder pathologies. The 
score rates the shoulder function on a 100-point scale, with a higher score indicating 
a better outcome. The relative Constant has been proposed to overcome the gender 
dependency and the decline with increasing age that were observed using the original 
approach of the Constant Score. The relative Constant expresses the performance 
as a percentage of the expected value, based on the comparison of the patient’s 
performance to a sex and age matched group, which facilitates validity when 
comparisons of this type are undertaken (Constant, 1986; Yian et al., 2005; Katolik et 
al., 2005; Fialka et al., 2005; Constant et al., 2008). 
5.2.7.3.3. ASES score 
The ASES is a composite shoulder evaluation tool that can be used in various 
shoulder pathologies. The original version was published in 1994 (Richards 1994), 
and a modified version mASES in 1998 (Beaton and Richards, 1998), to provide a 
more comprehensive evaluation of upper extremity function (Angst et al., 2011; Fayad 
et al., 2004). The ASES includes a physician-assessed part and a patient self-
assessment part. However, the patient-reported section only is generally taken into 
consideration in the scoring (Hettrich CM, 2007). The latter section comprises 
questions on pain, activities of daily living and instability. The patient-reported ASES 
rates the shoulder function on a 100-point scale, with a higher score indicating a better 
outcome. Function is evaluated based on a series of ten 4-point scales for each arm, 
and pain using a 10-point VAS (Slobogean and Slobogean, 2011). 
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5.2.7.3.4. SST score 
The SST is as shoulder function PROM that comprises binary 12 items (yes/no), 
among which two are about function related to pain, seven about function related to 
strength and three about range of motion (Lippitt, 1993; Beaton and Richards, 1998). 
The SST rates the shoulder function on 12 points, which can be converted into 
percentage of “yes” responses, with a higher score indicating a better outcome. 
5.2.7.3.5. WOSI score 
The WOSI is a specific shoulder outcome measure designed for disease-specific 
quality-of-life evaluation in patients with shoulder instability (Kirkley et al., 1998). It 
comprises 21 items in four domains that are scored on a 100-mm visual analog scale: 
ten items on physical symptoms and pain, four items on sports/recreation/work, four 
items on lifestyle and 3 on emotions. The lower score represents the better outcome. 
The score can be reported either as the sum of 21 unweighted items (0 – 2100) or as 
a percentage (0 – 100%). 
 Results 
The results of the main bibliographic search, which aimed to retrieve the articles in 
which the measurement properties of PROMS and MAB outcome measures are 
investigated is reported in this section. 
Concerning PROMs, 4537 references, among which 13 were found by manual 
search, were identified. One thousand eight hundred references were screened after 
removal of duplicates. Following title and abstract reading, 1668 articles were 
excluded. Of the 132 remaining articles, 86 were finally retained after full-text reading. 
The thesis’ authors had initially selected 82 articles and the colleague auditor 58 
articles, of which six had not been retained by the thesis’ author. Most of the articles 
that were not selected by the colleague auditor addressed mainly the measurement 
properties of a PROM that had not been selected for this review but nevertheless 
contained information on one of the selected PROMs. Following discussions, all of 
the thesis’ authors selected articles were retained and four more were added out of 
the six articles that had been selected by the colleague auditor only, which resulted 
in the total of 86 selected articles. 
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Flowchart with detailed reasons for exclusion is available in Figure 5.2. Please see 
Appendix XVI for the references of selected articles. 
Concerning MAB outcome measures, 4996 references were identified of which 1642 
were screened after duplicates removal. Following reading of titles and abstracts, 
1626 articles were excluded. Of the 17 remaining articles, nine were finally retained 
after full-text reading. The thesis’ author had initially selected seven articles. Two 
more articles that addressed the convergent validity between MAB outcome 
measures and one of the selected PROMs were added following the colleague auditor 
check.  
Flowchart with detailed reasons for exclusion is available in Figure 5.3. Please see 







































 Additional records identified 
through other sources 
Article references (n = 13) 
Records screened (title 
and abstract)  
(n = 1800) 
Records excluded 
(n =  1668) 
Full-text articles assessed 
for eligibility 
(n = 132) 
Full-text articles 
excluded, with reasons 
 
No properties of interest 
(n = 10) 
Not exclusively shoulder 
(n = 27) 
Not research article          
(n = 6) 
Conference abstract only 
(n = 3) 
 
Studies included in 
qualitative synthesis 
(n = 86) 
Records after duplicates removed 
(n = 1800)  
Records identified through 
database searching 05.05.17 
Pubmed (n = 1821)  
EMBASE (n = 332) 
Cinahl (n = 431) 
Pedro (n = 0) 
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through other sources 
Article references (n = 0) 
Records screened (title 
and abstract)  
(n = 1642) 
Records excluded 
(n = 1625) 
Full-text articles assessed 
for eligibility 
(n =17) 
Full-text articles excluded, 
with reasons 
No properties of interest 
(n =8) 
Studies included in 
qualitative synthesis 
(n =9) 
Records after duplicates removed 
(n =1642)  
Records identified through 
database searching 05.05 17 
Pubmed (n = 1707) 26.05.17 
EMBASE (n = 662) 
Cinahl (n = 511) 
Pedro (n = 0) 










 PROMs measurement properties 
 PROMs normal performance in a healthy population 
ASES  
Sallay 2003 95.8 (SD 9.0 points) 
Constant  
Yian 2005 Varying according to age and sex from 94 (male 21 - 40 yr.) to 84 points (female 71 - 80 yr.) For all details see table in original publication 
Constant 1986 Varying according to age and sex from 99 (male 21-31 yr. left side) to 50 points (female 91 - 100 yr. left side) For all details see table in original publication 
Katolik 2005 Varying according to age and sex from 96 (male 40 - 49 yr.) to 81 points (female ≥71 - 80 yr.) For all details see table in original publication 
DASH 
Angst 2011 Cut-off scores for “no problem” : < 15 
Aasheim 2014 Whole population mean 13; women (SD) 15 (3), increasing from 5 (9) in their 20s. to 36 (26) in their 80s; men 11 (2), increasing from 5 (9) in their 20s. to 22 (23) in their 80s 
Hunsaker 2002 
Whole population mean (SD) 10.1 (14.7); women (SD) 12.0 (12.0) increasing from 8.4 (13.5) in 19-34 yr. old population to 
22.3 (20.3) in > 75 yr. old population; men 7.4 (12.1), increasing from 1.9 (3.9) in 19-34 yr. old population to 16.1 (16.5) in > 
75 yr. old population 
QuickDASH 
Aasheim 2014 Whole population mean 13; women (SD) 15 (3), increasing from 6 (9) in their 20s. to 36 (27) in their 80s; men 11 (2), increasing from 5 (10) in their 20s. to 23 (23) in their 80s 
Hunsaker 2002 
Whole population mean (SD) 10.9 (15.3); women (SD) 12.0 (12.0) increasing from 8.9 (14.8) in 19-34 yr. old population to 
22.0 (19.1) in > 75 yr. old population; men 7.4 (12.1), increasing from 2.2 (4.7) in 19-34 yr. old population to 14.6 (17.7) in > 
75 yr. old population 
WOSI 




Notes for all tables: 
• Range possible values and units of the PROMs: ASES: 0 – 100 points; 1 – 100 Constant: points (relative Constant: 0 – 100%); DASH: 
0 – 100 points; SST 0 – 12 points or 0 – 100% (as both rating methods are used, the unit is specified in the table for this PROM); 
WOSI: 0 – 2100 points or 0 – 100% (as both rating methods are used, the unit is specified in the table for this PROM). 
• +  above the threshold required to be considered adequate 
+/-  not clear whether above or below the threshold required to be considered adequate  
- below threshold the threshold required to be considered adequate 
• “Change correlations” are coefficient of correlation with change scores of a Global rating of change scale, unless otherwise specified 
• The range of reported values found in the literature is reported when several studies investigated a measurement property, in order 
to avoid an overwhelming level of details in the tables 
• When studies compared the properties of several scales, the results are reported in the “Direct comparison” column. The 
interpretability aspects were not compared between tools, because their comparisons between scales that do not rely on the same 
rating system would not have been relevant 
ES and SRM were reported only when comparisons between outcome measures were made within a study. As ES and SRM values are 
relative to the magnitude of the change and follow-up time, there were of importance for responsiveness assessment only when a 
comparison between outcome measures was made (Baguley, 2009; Husted et al., 2000).
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5.3.1.1.1. Normal performance for PROMs  
General normative values have been reported for the Constant (3 studies), DASH (3 
studies), QuickDASH (3 studies), ASES (1 study) and WOSI (1 study), but without 
consideration for the potential influence of age and gender for the latter two PROMs (Sallay 
and Reed, 2003; Salomonsson et al., 2009). No normative values were found for the SST 
(results sub-section 5.3.1.1 “PROMs normal performance in a healthy population”, p. 195).  
Normative values in the US and in the Norwegian general population stratified by age and 
sex have been defined for the DASH and QuickDASH (Hunsaker et al., 2002; Aasheim and 
Finsen, 2014). Both studies found convergent results and close values for these two 
outcome measures. They also highlighted the dependency of their norms to age and sex, 
with higher scores in females and in older patients (higher score meaning more disability). 
Additionally, Angst has defined a cut-off value between healthy and pathological subjects 
(Angst et al., 2011). 
The norms of the Constant Score have also been shown to be age and gender dependent 
and have been debated (Yian et al., 2005). This dependency had already been mentioned 
in the original Constant’s work (Constant and Murley, 1987) and has also been reported in 
later publications (Katolik et al., 2005; Yian et al., 2005). 
Consequently, a relative Constant Score, that classifies the patients based on an age-and 
gender-matched normal population, has been developed to limit the impact of these factors 
on the Constant outcome. When using the relative Constant, the origin of the reference 
values that are used should be reported in manuscripts, c are available (Yian et al., 2005). 
It should also be noted that a Constant Score revised testing procedure has been 
recommended to improve the precision of the evaluation, but that the norms available in the 
literature might not be fully applicable, because they had been established based on the 
original procedure (Constant et al., 2008). 
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 PROMs measurement properties in a diversified shoulder conditions sample 
Measurement properties established on a diversified shoulder conditions sample 
 Reliability and measurement error Interpretability  Responsiveness Direct comparison 
Non-surgical 
Constant    
DASH ICC 0.86 vs. 
ASES ICC 0.75 
(Moser 2012) 
 
7.5% maximum and 
7.5% minimum score 
for SST vs. 2.5% and 







Expert ICC 0.94 - 0.97 
Non expert ICC 0.80 - 0.95 
Inter-rater :  
ICC 0.84 - 0.95* SEM 6 
MDC 16.4  
Intra-rater LoA* (bias:) 8.6 - 18.6 (0.4 
- 4.3) 
Inter-rater LoA* (bias): 11.0 - 28.0 




DASH    
Lundquist 2014; Moser 2012; 
Negahban 2015  
- Test-retest ICC 0.86 MCID 11.7  
No floor/No 
ceiling effect 
+ AUC (0.76 - 0.77) 
Change correlation: 
0.52 - 0.59  
QuickDASH    
Fayad 2009; Mintken 2009 + Test-retest ICC 0.90 - 0.94  
LoA (bias) 11.8 (3.4) 
SEM : 4.8; MDC 11.2; 
MCII: 8 + AUC 0.82  
Change correlation: 
0.45 - 0.57 





Measurement properties established on a diversified shoulder conditions sample (continued) 
 
Reliability and measurement error Interpretability  Responsiveness Direct comparison 
SST     
Ebrahimzadeh 2016; Neto 
2013; Membrilla-Mesa 2015; 
Robins 2016; Van Kampen 
2012 
+/- Test-retest ICC 0.61 - 0.92  
SEM 1.18 pts; 2.2 - 10.0% 
MDC90: 6.2%; MDC95 3.3 pts (27.5%) 
 No floor/No ceiling effect 
ASES     
Cook 2002; Kocher 2005; 
Moser 2012; Robins 2016; 
Yahia 2011; Piitulainen 2014 
+/- Test-retest ICC 0.75 - 0.96  
LoA (bias) 9.5 (0.7) 
 
No floor/No ceiling effect 
Surgical 
Constant    
AUC 0.84 Constant vs 
0.79 DASH (Christie 
2011) 
ES ASES 0.61 vs. 
Constant 0.57 vs. 0.50 
SST 
SRM 0.77 ASES vs. 
0.58 Constant vs. SST 
0.47  
(Oh 2009) 
SRM 2.24 Constant 
vs.2.17 SST 
(Ge 2013) 
Christie 2009; Rocourt 2008; 
Christie 2011; Oh 2009; Ge 2013 
 MCID 16.6 
PASS 42.0 - 44.0 
+ AUC 0.84 
No floor/No ceiling 
effect 
DASH    
Christie 2009; Schmitt 2004; 
Christie 2011 
+ Test-retest ICC 0.91  
SEM 5.2; MDC 12.2 
MCID 10.1 - 10.2; 
PASS 42.9 - 43.0 
No floor/ceiling 
effect 
+ AUC 0.79  
Change correlation: 0.66 
ASES    
Beaton 1998; Oh 2009; Ge 2013; 
Cook 2002 
+ Test-retest ICC 0.91 - 0.96  
 
 
SST    
Oh 2009 
Beaton 1998 







Measurement properties established on a diversified shoulder conditions sample (continued) 
 
Reliability and measurement error Interpretability  Responsiveness Direct comparison 
Mixed surgical/non-surgical 
DASH    
ICC 0.86 SST vs. 0.85 
QuickDASH vs. 0.83 
DASH (Van Kampen 
2013) 
Van Kampen 2013; Diniz Lopes 
2009; Beaton 2005; Beaton 
2011; Fayad 2008a 
+/- Test-retest ICC 0.83 - 0.95  
LoA (bias) -7.2 - 13.2 (3) 
MCID 3.9 - 15.0*; 
MDC 16.3; MCII: 
12.4 * depends on 
method 
 
QuickDASH   
Van Kampen 2013; Beaton 2005 -   Test-retest ICC 0.85 MDC 17.1 MCII 13.4  
SST    
Roddey 2000; Van Kampen 2013 -   Test-retest ICC 0.86  
SEM 11.65%; MDC 2.8 pts (23.3%); 
MCII 2.2 pts 
(18.3%) 
 
ASES   
Celik 2013; Michener 2002; 
Vroutsou 2016; Cook 2003; 
Sallay 2003 
+/- Test-retest ICC 0.84 - 0.96  
SEM 6.7; MDC 9.94; 
MCID 6.4  
No floor/No ceiling 
effect 





The PROMs’ measurement properties were frequently defined based on samples 
including various shoulder pathologies. Among them, 18 studies reported 
measurement properties in non-surgical treatments, eight following surgery and nine 
in a mixed sample of non-surgical and surgical treatments.  
5.3.1.2.1. PROMs, DCS non-surgical treatment 
(NSu) 
 Constant (NSu-DCS) 
Three studies investigated the properties of the Constant Score (Blonna et al., 2012; 
Celik, 2016; Conboy et al., 1996) (results sub-section 5.3.1.2. “PROMs measurement 
properties in a diversified shoulder conditions sample”, p. 196). Blonna et al. found 
important differences between expert (ICC = 0.93 for absolute Constant and 0.94 for 
relative Constant) and non-expert users (ICC = 0.80 and 0.81) for intra-rater reliability, 
demonstrating that the level of experience influences the reliability of the score (2012). 
They also demonstrated that the degree of standardisation of the procedure 
influences the reliability, especially for the non-expert users (standardized expert ICC 
= 0.97; non-expert 0.95).  
The inter-rater reliability was found to be lower than the intra-rater reliability (Celik, 
2016; Conboy et al., 1996; Blonna et al., 2012). Blonna et al.’s results for reliability 
and LoA were more favourable when experts performed the test, and less favourable 
when non-experts undertook the task.  
The intra- and inter-rater LoAs were within the acceptable ≤ ± 10% threshold only for 
intra-rater reliability, when experts performed the evaluation using the revised 
guidelines of Constant et al. for measurement standardisation (Constant et al., 2008; 
Blonna et al., 2012; Celik, 2016). 
The SEM (6 points) and MDC (16.4 points) were the only interpretability aspects to 
be reported and the absence of floor and ceiling effects is the only available result 




 DASH and QuickDASH (NSu-DCS) 
Four articles addressed the measurement properties of the DASH (results sub-section 
5.3.1.2. “PROMs measurement properties in a diversified shoulder conditions sample, 
p. 196). The test-retest reliability (ICC = 0.86) was slightly under the expected 
standard of 0.90, but higher than that of the ASES (ICC = 0.75) (Moser et al., 2012). 
Real change might have interfered with these results as all patients, including those 
who changed their shoulder status in-between the test and the retest session one 
week later, were considered in the calculations of the ICCs. The MCID (11.7 points) 
was the only reported interpretability aspect (Lundquist et al., 2014).  
Three studies reported convergent results concerning the responsiveness of the 
DASH, with an acceptable AUC (AUC ≥ 0.70) (De vet 2011) for the detection of 
improved patients (AUC = 0.76 – 0.77) and a moderate change correlation ranging 
from r = -0.52 – -0.59 above the defined threshold for adequacy (r ≥ 0.50) (Lundquist 
et al., 2014; Negahban et al., 2015). No floor or ceiling effects were detected 
(Lundquist et al., 2014).  
Test-retest reliability of the QuickDASH was also adequate (ICC = 0.90 – 0.94) (Fayad 
et al., 2009; Mintken et al., 2009). The LoA were slightly above the ± 10% threshold 
(- 8.4 – 15.2), and a 3.4% bias was stated between measurements (Fayad et al., 
2009). The SEM (4.8%), MDC (11.2%) and MCII (8%) but not the PASS were 
determined (Mintken et al., 2009). 
No study directly compared the responsiveness of the DASH with its simplified 
version, the QuickDASH. However, comparisons between studies showed 
comparable change correlation and AUC for the detection of improved patients 
between these PROMs (Lundquist et al., 2014; Negahban et al., 2015; Fayad et al., 
2009; Mintken et al., 2009). 
 SST (NSu-DCS) 
The results of re-retest reliability were conflicting between the four studies that 
addressed this aspect (Ebrahimzadeh et al., 2016; Neto et al., 2013; Membrilla-Mesa 
et al., 2015b; van Kampen et al., 2012) (results sub-section 5.3.1.2. “PROMs 
measurement properties in a diversified shoulder conditions sample, p. 196). Two 
studies (Membrilla-Mesa et al., 2015b; van Kampen et al., 2012) found adequate 
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reliability (ICC = 0.91 – 0.92), but a recall effect cannot be excluded in the first one 
(Membrilla-Mesa et al., 2015b), as the time interval between measurements was 48h 
only. This shorter interval might also have favourably influenced the calculation of the 
SEM (2.21% vs. 10% in Van Kampen et al. 2012). MDCs could not be compared 
between studies as MDC90 was used in one study (Membrilla-Mesa et al., 2015b), 
while the more current MDC95 was used in the other one (van Kampen et al., 2012). 
Two studies found test-retest reliability ≥ 0.90 at a one-week interval (Ebrahimzadeh 
et al., 2016; Neto et al., 2013). However, no procedure was apparently implemented 
in these studies to ensure that patients’ performance remained stable between time 
points. Therefore, part of the test-retest variability might be due to real change in 
patients. One study found no floor or ceiling effect. Nevertheless, 1.8% of patients 
reported the worst possible score and 13.6% the best possible score (van Kampen et 
al., 2012). Another study reported 7.5% floor and 7.5% ceiling effect, defined as the 
percentage of minimum and maximum scores, respectively (Robins et al., 2017). So, 
floor and ceiling effect were considered as being present or absent by the authors, as 
a function of the criteria used to define them, but would have been classified as being 
absent in all studies when the recommended criteria, defined as < 15% of patients 
reaching the minimum or maximum scores, was used (Terwee et al., 2007).  
 ASES (NSu-DCS) 
Five studies investigated the measurement properties of the ASES (Cook et al., 2002; 
Kocher et al., 2005; Moser et al., 2012; Robins et al., 2017; Yahia et al., 2011a) 
(results sub-section 5.3.1.2. “PROMs measurement properties in a diversified 
shoulder conditions sample, p. 196). The ASES reliability results were incongruent 
between studies, with the ICC ranging from 0.96 to 0.75 across studies. The highest 
reliability was obtained in a study in which the time interval was 1-3 days only and the 
patients were questioned by two different raters (Yahia et al., 2011b). The lowest one 
was obtained in a study were all patients, and not only those who reported as 
unchanged, were included in the analysis (Moser et al., 2012). Real change may have 
negatively interfered with this result, but it was nevertheless lower than that of the 
DASH, which had been tested in the same conditions in this study (0.75 vs.0.86).  
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Floor and ceiling effects are the only other reported measurement properties, with no 
floor and no ceiling effects, though 2.5% of patients reached the maximum score 
(Robins et al., 2017). 
Levels of evidence of PROMs measurement properties in samples including 
diversified conditions non-surgically treated are summarised in Table 5.3. 
Table 5.3: Summary table for the level of evidence of PROMs measurement 
properties in samples including diversified conditions non-surgically treated * 
 Reliability 
(ICC and LoAs) 
Responsiveness 








Constant   Inter-: - moderate 




? ? ? 
DASH -  low +  moderate ? 
QuickDASH +  moderate +  moderate +/-  low 
SST +/- low ? +/-  low 
ASES +/- low ? +/-  low 
Comparisons +/- low DASH superior to 
ASES: low 
 
Legend: Inter-: inter-rater; Intra-: intra-rater; DASH: Disabilities of the Arm, Shoulder and Hand 
score SST: Simple Shoulder Test; ASES: American Shoulder and Elbow Surgeons score; ICC: 
intraclass correlation coefficient; LoA: Limits of Agreement; AUC: Area Under the receiver 
operating characteristic Curve; ES: Effect Size; SRM: Standardised Response Mean; SEM: 
Standard Error of Measurement; MDC: Minimal Detectable Change; MCII/MCID Minimal 
Clinically Important Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 




5.3.1.2.1. PROMs DSC surgical treatment (Su) 
 Constant (Su-DSC) 
The five studies that investigated the measurement properties of the Constant Score 
had assessed differing clinimetric properties for the Constant Score, except a shared 
evaluation of the SRM. 
No relevant information on the Constant Score’s reliability was available. One study 
found excellent intra- and inter-tester Pearson correlations (≥ 0.90) (Rocourt et al., 
2008). However, this result was not taken into consideration in the table because ICC 
would have been the recommended statistics as it integrates systematic error in its 
calculation (Weir, 2005). MCID (17 points) and PASS (42 or 44 points according to 
the method) were determined (Christie et al., 2011), but not the LoA, SEM and MDC.  
Considering responsiveness, the AUC (AUC = 0.84) for improved patients detection 
was above the cut-off considered as sufficient (≥ 0.70) and superior to that of the 
DASH (AUC = 0.79) (Christie et al., 2011; De Vet et al., 2011c). SRM at 6 months 
was found to be much higher in the study by Ge et al. than in Oh et al.’s (SRM = 2.24 
vs. 0.58) (Oh et al., 2009; Ge et al., 2013), possibly because these researchers had 
included samples of patients with surgical interventions that cannot be compared 
across studies. These values were thus higher than that of the ASES in Ge et al. 
(SRM = 2.17) and lower than in Oh et al. (SRM = 0.77). No floor and ceiling effect 
were detected (Christie et al., 2009). 
 DASH (Su-DSC) 
The three studies assessing the DASH had each investigated a large panel of 
measurement properties but, other than estimates for MCID, had no properties in 
common. The single-measurement reliability was above the expected threshold (ICC 
= 0.91) when measured using sequenced test-retest trials (Schmitt and Di Fabio, 
2004). All the interpretability aspects were determined: SEM 5.22, MDC 12.2 and 
MCID 10.1 − 10.2 and PASS 42.9 − 43 (Christie et al., 2009; Schmitt and Di Fabio, 
2004). The MCID and PASS values were consistent across the two studies that 
reported them (Christie et al., 2009; Schmitt and Di Fabio, 2004). 
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The correlation coefficient between change score of the DASH and a global rating of 
change scale was moderate (r = 0.66) and the AUC for improvement detection (AUC 
= 0.79) was acceptable (AUC ≥ 0.70) but inferior to that of the Constant (AUC = 0.84) 
(Christie et al., 2011). No floor or ceiling affect was detected (Christie et al., 2009). 
 ASES (Su-DSC) 
Four studies investigated the measurement properties of the ASES. Three of them 
directly compared it to other PROMs, which is convenient to determine the respective 
reliability or the responsiveness of several scores in the same population (Ge et al., 
2013; Beaton and Richards, 1998; Oh et al., 2009). However, no interpretability 
aspects were investigated in these studies. 
Beaton and Cook (Beaton 1996, Cook 2002) both found an adequate reliability (ICC 
≥ 0.90), with 0.96 and 0.91, respectively. This was slightly lower than for the SST (ICC 
= 0.99) (Beaton and Richards, 1998). 
The SRM varied considerably between studies (0.77 – 2.17). No aggregation can be 
made from these results as the sample composition varied across studies (Beaton 
and Richards, 1998; Oh et al., 2009; Ge et al., 2013).  
The comparison of the responsiveness of the SST, Constant and ASES showed a 
lower ES and SRM of the SST (ES = 0.50, SRM = 0.47) and Constant (ES = 0.57, 
SRM = 0.58) at 6 months compared to the ASES (ES = 0.61, SRM = 0.77) (Oh et al., 
2009). The SRM of the ASES was also slightly superior to that of the SST (SRM = 
0.93 vs. 0.87) in another study (Beaton 1998). Conversely, the Constant showed a 
higher SRM in another study (SRM = 2.24 vs. 2.17 for the ASES) (Ge et al., 2013). 
 SST (Su-DSC) 
One study found an excellent test-retest reliability at a one-week interval (ICC = 0.99) 
(Beaton and Richards, 1998). 
One study that compared the responsiveness of the SST to the ASES, found a lower 
ES and SRM for the SST at 6 months for the latter (ES = 0.50, SRM = 0.47 for the 
SST vs. ES = 0.61, SRM = 0.77 for the ASES) (Oh et al., 2009). Beaton found a higher 
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SRM at 6 months (SRM = 0.87) (Beaton and Richards, 1998), but this result cannot 
be compared with Oh et al. due to the differences in sample composition. 
The levels of evidence of PROMs measurement properties in samples including 
diversified conditions surgically treated are summarised in Table 5.4. 
Table 5.4: Summary table for the level of evidence of PROMs measurement 
properties in samples including diversified conditions surgically treated * 
 
Reliability 
(ICC and LoAs) 
Responsiveness 








Constant  ? +  low ? 
Relative 
Constant 
? ? ? 
DASH +  low +  low ? 
QuickDASH ? ? ? 
SST +  low ? ? 
ASES +  moderate ? ? 
Comparisons - DASH superior to 
Constant, low 
ASES superior to 
Constant, low 
ASES superior to SST, 
low 
Constant superior to 
SST, low 
-  
Legend: DASH: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; 
ASES: American Shoulder and Elbow Surgeons score; ICC: intraclass correlation coefficient; 
LoA: Limits of Agreement; AUC: Area Under the receiver operating characteristic Curve; ES: 
Effect Size; SRM: Standardised Response Mean; SEM: Standard Error of Measurement; 
MDC: Minimal Detectable Change; MCII/MCID Minimal Clinically Important 
Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 




5.3.1.2.1. PROMs measurement properties in 
diversified shoulder conditions mixed 
surgical/non-surgical (Mi-DSC) 
 Constant (Mi-DSC) 
No study investigated the Constant Score’s properties in a diversified sample, 
including surgically and non-surgically treated patients. 
 DASH and QuickDASH (Mi-DSC) 
Four studies investigated the measurement properties of the DASH. Two of them 
tested the test-retest reliability and found it to be either lower than required (0.83) (van 
Kampen et al., 2013) or adequate (0.95) (Fayad et al., 2008a).  
One study found test-retest LoAs (bias) of -7.2 - 10.3 points (3 points), which is within 
requires clinimetric standards (Fayad et al., 2008a). One study had determined the 
value of the MDC as 16.3 and MCII as 12.4 (van Kampen et al., 2013). The fact that 
the MDC was higher than the MCII implies that the latter cannot be considered as 
valid because when an individual patient records an apparent change score 
equivalent to the quoted MCII, this score remains within the 95% confidence limits for 
the estimation of random measurement error (MDC), and as such, error and the 
potential effects of an intervention cannot be differentiated with confidence (van der 
Linde et al., 2017; De Vet et al., 2011a). Another study found a MCID value of 11.5 
using an anchor-based method (Beaton et al., 2005) approaching the MCII value 
found by Van Kampen, though MCII considers the change only for patients who 
improved, while MCID considers patients who improved or deteriorated. Interestingly, 
Beaton compared the results obtained from various options for MCID calculation and 
found values ranging from 3.9 to 15, and only moderate agreement between 
approaches (Kappa = 0.47). This reinforces the controversy raised by other authors 
about MCID calculation (Tubach et al., 2005c). 
The responsiveness has been investigated in two studies using ES and SRM. The 
SRM at 3 months was quite different between studies (SRM = 0.85 for Diniz-Lopez 
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and 1.13 for Beaton), but the sample composition was not similar between studies 
(Diniz Lopes et al., 2009; Beaton et al., 2005). 
Two studies investigated the properties of the QuickDASH with the purpose to 
compare its properties to that of the DASH. Van Kampen found values close to that 
of the DASH for single-measurement reliability based on sequenced test-retest trials 
(ICC = 0.83 for the DASH and 0.85 for the QuickDASH), and comparable MDC (17.1 
vs. 16.3 points for the DASH) and MCII (13.4 vs. 12.4 points for the DASH) (van 
Kampen et al., 2013). The ICC value was nevertheless under the ≥ 0.90 threshold. 
Similarly, Beaton found approaching values between the DASH and the QuickDASH 
for the SRM (SRM = 1.08 vs 1.13) (Beaton et al., 2005). 
 SST (Mi-DSC) 
One study investigated the reliability of the SST and found it to be lower than required 
(ICC = 0.86), though comparable to that of the DASH and QuickDASH (van Kampen 
et al., 2013). The SEM (11.65%), MDC (2.8 points; 23.3%) and MCII (2.2 points; 
18.3%) were also determined (Roddey et al., 2000; van Kampen et al., 2013). No 
study investigated the responsiveness of the SST. 
 ASES (Mi-DSC) 
Two studies found the test-retest reliability of the ASES to be meeting expected 
standards (0.94-0.96) (Sallay and Reed, 2003; Celik et al., 2013) and one to be lower 
(0.84) (Michener et al., 2002). These results cannot be directly compared, as the 
sample composition was different in each study. The interpretability aspects SEM (6.7 
points), MDC (9.4 points) and MCID (6.4 points) were determined in one study 
(Michener et al., 2002). 
Variations between studies were observed for the ES (0.80 vs. 1.35) and SRM (0.75 
vs. 1.54), probably due to variations in sample composition and variable timeframes 
(Michener et al., 2002; Vrotsou et al., 2016). The discriminative power for 
improvement determined by the AUC was adequate (0.74 in Cook and 0.82 in 
Michener et al. 2002) in two studies (Michener et al., 2002; Cook et al., 2003). The 
percentages of patient reaching the maximum or the minimum scores were both 8%, 
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which was considered as no floor/ceiling effects as these values are lower than the 
15% considered for threshold (Celik et al., 2013). 
Levels of evidence of PROMs measurement properties in samples including 
diversified conditions either surgically or non-surgically treated are summarised in 
Table 5.5. 
Table 5.5: Summary table for the level of evidence of PROMs measurement 
properties in samples including diversified conditions either surgically or non-
surgically treated * 
 
Reliability 
(ICC and LoAs) 
Responsiveness 








Constant  ? ? ? 
Relative 
Constant 
? ? ? 
DASH +/-  low ? +/-  low 
QuickDASH -   low ? +/-  low 
SST -  low ? +/-  low 
ASES +/-  moderate +  low +/-  low 
Comparisons DASH, QuickDASH 
and SST have 
comparable ICCs < 
0.90 
- -  
Legend: DASH: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; 
ASES: American Shoulder and Elbow Surgeons score; ICC: intraclass correlation coefficient; 
LoA: Limits of Agreement; AUC: Area Under the receiver operating characteristic Curve; ES: 
Effect Size; SRM: Standardised Response Mean; SEM: Standard Error of Measurement; 
MDC: Minimal Detectable Change; MCII/MCID Minimal Clinically Important 
Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 




 PROMs measurement properties in a rotator cuff conditions sample 
 
Reliability and measurement 
error 
Interpretability aspects Responsiveness Direct comparison 
Non-surgical 
Constant 
Change correlation with 
WORC: Constant 0.61 
vs. 0.84 DASH 
ES Constant 0.89 vs. 
0.61 DASH 
SRM Constant 1.16 vs. 
0.68 DASH 
(De Witte 2012) 
No floor effect ASES vs. 
21% SST  
(Beckman 2015) 
Henseler 2015; Holmgren 
2014; Moeller 2014;De Witte 
2012 
+ Intra-rater ICC 0.93 - 0.95 
+ Inter-rater ICC 0.94 SEM 4.1 - 
8.0 pts (relative Constant 10%) 
MDC 11.2 - 23 pts (28% relative 
Constant) LoA intra-rat. ± 11.3 - 
± 12.6 pts 
LoA inter-rat. ± 11.6 pts 
MCII 15 - 19 pts 
No floor/ceiling effect for 
absolute score  
No floor/17% ceiling effect 
relative score  
 





Haldorsen 2014; Mehta 
2015; Michener 2013; 
Rysstad 2017; De Witte 
2012 
+/- ICC 0.86 - 0.91  
SEM 4.3 - 4.7 
LoA -11.9 - 14.1 
MDC 11.8 - 13.1 
MCII 4.4 
No floor/ceiling effect 
 
+ AUC 0.77 
Change correlation: 
0.61 Change 
correlation with WORC 
0.84 
SST 
Beckman 2015; Naghdi 
2015; Tashjian 2010 
+ Test-retest 0.94  
SEM 0.7 pts/5.5% 
MDC 3.7 pts/15.3% 
MCID 2.05 pts  




Beckman 2015; Tashjian 
2010 
 MCID 12.01 - 16.72  









Interpretability aspects Responsiveness Direct comparison 
Surgical 
Constant 
SRM 3 months DASH 
0.50 vs. 0.51 
QuickDASH 
SRM 6 months DASH 
0.75 vs. 0.78 
QuickDASH 
(MacDermid 2015) 
SRM SST 1.79 vs. 1.63 
DASH (MacDermid 
2006) 
SRM absolute Constant 
1.38 vs. relative 
Constant 1.34 vs. ASES 
0.94 (Holtby 2005) 
Christiansen 2015; Holtby 
2005; Kukkonen 2013; 
O'Connor 1999 
 MCID 9.9 - 11.0 pts + AUC 0.85 for Constant and 
0.78 for relative Constant 
Change correlation 0.32 - 0.78 





   
QuickDASH 
Macdermid 2015    
SST 
MacDermid 2006; Godfrey 
2007 
+ ICC Test-retest 0.97 No floor/ceiling effect  
ASES 




5.3.1.3.1. PROMs measurement properties in non-
surgical rotator cuff conditions (RCC) 
samples (NSu-RCC) 
Among the instruments selected in this review, the Constant, DASH, ASES and SST, 
but not the QuickDASH, properties have been investigated in non-surgically treated 
rotator cuff samples. 
 Constant (NSu-RCC) 
Four studies investigated the measurement properties of the Constant Score in this 
population (non-surgically treated rotator cuff samples) (Henseler et al., 2015; 
Holmgren et al., 2014; Moeller et al., 2014; de Witte et al., 2012). 
The intra- rater (0.93 – 0.95) and inter-rater (0.94) reliability was found to be adequate 
(ICC ≥ 0.90) in this population (Portney and Watkins, 2015; Moeller et al., 
2014)(Portney and Watkins, 2015, Moeller et al., 2014)(Portney and Watkins, 2015, 
Moeller et al., 2014). The SEM (8 points; 10% for relative Constant) and MDC (28 
points, 23% for relative Constant) were determined in a sample including patients with 
various diagnoses related to disorders of the rotator cuff, with some variations in 
subgroups (Henseler et al., 2015). The latter indices of clinimetric performance were 
found to be lower in another study, with SEM ranging from 4.1 to 4.7 points and intra-
rater MDC from 11.2 to 13.1 points according to rater, and inter-rater SEM reaching 
11.6 points (Moeller et al., 2014). These differences between studies were observed 
despite the fact that both had used the revised guidelines for the Constant Score use. 
However the study that got the most favourable clinimetric values used a fixed 
isometric dynamometer for strength measurements (Moeller et al., 2014), while a 
hand-held dynamometer was used in the other one (Henseler 2015). The intra-rater 
LoA ranged from ± 11.2 – ± 13.1 points and the inter-rater LoA were ± 11.6 points, 
i.e. larger than the ± 10% defined threshold in the study that used a fixed isometric 
dynamometer (Moeller et al., 2014). 
The responsiveness of the Constant Score had been evaluated using ES (0.89), SRM 
(-1.16) and change correlation with the WORC (r = 0.61) (de Witte et al., 2012). These 
values were higher than those of the DASH were (ES = -0.61; SRM = -0.68), while 
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the WORC had slightly higher ES (-0.96) and lower SRM (-0.91). No ceiling effect was 
observed for the absolute Constant Score, while it was 17% for the relative Constant 
Score, with important variations in subgroups (53% maximum scores for 
impingement, 7% for tear and 15% for massive tear). A floor effect was absent in all 
circumstances (Henseler et al., 2015). No AUC has been reported for 
unimportant/important change discrimination. 
The MCII was 17 points, with some variations according to the rotator cuff integrity 
(intact: 19 points; torn 15 points) (Holmgren 2014). Similar variations were observed 
for the specificity (intact: 76%; torn 91%; overall 91%) and the sensitivity (intact: 97%; 
torn 82%; overall 79%) for unimportant/important change discrimination (Holmgren et 
al., 2014).  
 DASH (NSu-RCC) 
Five studies investigated the properties of the DASH in this population. The three 
studies that investigated the test-retest reliability found ICC values either slightly over 
or under the 0.90 expected threshold (ICC = 0.86 – 0.91) (Haldorsen et al., 2014; 
Mehta et al., 2015; Rysstad et al., 2017). 
All the interpretability aspects were determined except the PASS. The studies that 
investigated the SEM (4.7 – 4.3 points) and the MDC (11.8 – 13.1 points) found 
concordant results (Haldorsen et al., 2014; Mehta et al., 2015; Rysstad et al., 2017). 
The LoA were -11.9 to 14.1 points, but the bias was not reported (Haldorsen et al., 
2014). The reported MCII was 4.4 points, but this value cannot be considered valid, 
as it is smaller than the MDC. 
The two studies that calculated the ES and SRM found results of very different 
magnitudes (ES 2.2 vs. 0.61; SRM 6.1 vs. 0.68) for comparable timeframes between 
measurements (Mehta 2015; de Witte 2012). The comparison with the Constant 
Score showed lower responsiveness for the DASH (ES: 0.61 vs. -0.89; SRM: 0.68 vs. 
-1.16) (de Witte et al., 2012). The change score was moderately correlated with 
perceived recovery (r = -0.61) (Rysstad et al., 2017) and strongly with the WORC (r = 
-0.84) (de Witte et al., 2012; Hinkle et al., 2003). The AUC for improved/unimproved 
discrimination (AUC = 0.71) was just above the threshold considered as acceptable 
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(De Vet et al., 2011c), with sensitivity of 0.77% and specificity of 0.69% (Rysstad et 
al., 2017). 
All the studies investigated the floor and ceiling effects and none of them found one 
of these effects.  
 SST (NSu-RCC) 
Three studies investigated the properties of the SST in this population. The test-retest 
reliability was found to be adequate (ICC = 0.94) in the only article that had reported 
this property (Naghdi et al., 2015).  
The SEM (0.7 points; 5.5%), MDC (3.7 points; 15.3%) and the MCID (2.05 points, 
corresponding to 17% or 2.33 points, corresponding to 19%, for four- and fifteen-point 
anchor method) were reported (Naghdi et al., 2015; Tashjian et al., 2010), but not the 
PASS and the LoA. 
Only the floor and ceiling effects were investigated among responsiveness-related 
properties. One study detected no such effects (Naghdi et al., 2015), while the other 
found that 6.1% of patients reached the maximum score, which was considered as 
no ceiling effect and 21% had reached the minimum score, which was above the 
defined 15% threshold for a floor effect (Beckmann et al., 2015). Comparatively, no 
floor and ceiling effects were found for the ASES in the same study. 
 ASES (NSu-RCC) 
Two studies investigated the properties of the ASES in this population (Tashjian et 
al., 2010; Beckmann et al., 2015) but none of them investigated its reliability. Only the 
MCID was reported among interpretability aspects. Values of 12 and 17 points were 
found for shoulder function MCID using a four- or a fifteen-point anchor, respectively 
(Tashjian et al., 2010). The percentages of patients reaching the maximum and the 
minimum score effects were both 2.3%, which was lower than the 15% defined as the 
threshold for a floor or a ceiling effect. Conversely, the SST showed a floor effect that 
had exceeded the threshold, in the same study (Beckmann et al., 2015). No other 
responsiveness properties have been investigated for the ASES. 
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Levels of evidence of PROMs measurement properties in samples including rotator 
cuff conditions non-surgically treated are summarised in Table 5.6. 
Table 5.6: Summary table for the level of evidence of PROMs measurement 
properties in samples including rotator cuff conditions non-surgically treated* 
 
Reliability 
(ICC and LoAs) 
Responsiveness 








Constant  Inter-: +   low 
Intra-: +  low 
+/- low +/- low 
Relative 
Constant 
? ? ? 
DASH +/- low +  low +/- low 
QuickDASH ? ? ? 
SST +  low ? +/- low 
ASES ? ? +/- low 
Comparisons  Higher ES and SRM 
for Constant than 
DASH: low 
Floor effect for the 
SST vs. none for the 
ASES: low 
Ceiling effect for the 
relative Constant vs. 
no for the Constant 
 
Legend: Intra-: Intra-rater; Inter-: Inter-rater; DASH: Disabilities of the Arm, Shoulder and Hand 
score SST: Simple Shoulder Test; ASES: American Shoulder and Elbow Surgeons score; ICC: 
intraclass correlation coefficient; LoA: Limits of Agreement; AUC: Area Under the receiver 
operating Curve; ES: Effect Size; SRM: Standardised Response Mean; SEM: Standard Error 
of Measurement; MDC: Minimal Detectable Change; MCII/MCID Minimal Clinically Important 
Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 




5.3.1.3.1. PROMs measurement properties in 
surgical rotator cuff conditions (Su-RCC) 
Among the instruments selected in this review, the Constant, DASH, QuickDASH, 
SST and ASES properties have been investigated in surgically treated rotator cuff 
samples. 
 Constant (Su-RCC) 
Four studies investigated the measurement properties of the Constant Score following 
rotator cuff surgery (Christiansen, 2015; Holtby and Razmjou, 2005; Kukkonen et al., 
2013; O'Connor et al., 1999). No usable information is available on the Constant 
Score’s reliability in this population. One study found excellent intra-rater Spearman 
correlations (r = 0.96) and good to excellent inter-rater reliability (r = 0.91 and 0.89) 
(Livain et al., 2007). However, this result was not taken into consideration in the table 
because ICC would have been the recommended statistics as it integrates systematic 
error in its calculation (Weir, 2005).  
The responsiveness was evaluated in three studies. The ES were not comparable as 
one study determined it in all patients (O'Connor et al., 1999) and the other one in 
improved patients only (Christiansen, 2015). Similarly, the SRM was not comparable 
between studies as the type of surgery was different (decompression vs. mix of 
different surgeries related to rotator cuff), which probably led to difference in the 
magnitude of the measured effects (O'Connor et al., 1999; Holtby and Razmjou, 
2005). The change correlations (0.32 – 0.78) were also varying amongst studies as 
they had used different reference tools and time points for comparison (Holtby and 
Razmjou, 2005; Christiansen et al., 2015; O'Connor et al., 1999). The AUC for 
improved/unimproved discrimination was above the required threshold (AUC ≥ 0.70) 
(Terwee et al., 2007; De Vet et al., 2011c) for the absolute (AUC =0.85) and relative 
(AUC = 0.78) Constant Score. Concerning responsiveness, the Constant Score 
displayed higher SRM than the ASES (SRM = 1.38 for absolute score and 1.34 for 
relative score vs. 0.94 for ASES) (Holtby and Razmjou, 2005). 
The MCID is the only interpretability aspect that was investigated. Two studies found 
that its value was considerably influenced by the calculation method (Christiansen et 
al., 2015; Kukkonen et al., 2013). Using the common anchor-based approach, the 
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values were close between studies (10.4 vs. 11 points) (Christiansen et al., 2015; 
Kukkonen et al., 2013). 
 
 DASH and QuickDASH (Su-RCC) 
The only investigated measurement property of the DASH and of the QuickDASH was 
the responsiveness. The SRM values differ considerably between studies, but are not 
comparable because one study considered all patients following cuff repair (SRM = 
0.50 at 3 months; 0.75 at 6 months) (Macdermid et al., 2015), while the other one 
calculated the specific SRM of subgroups with different patterns of progress (positive, 
equivocal, negative) (MacDermid et al., 2006). The comparison of the DASH’s and 
QuickDASH’s SRMs showed close values between these scores (SRM = 0.75 and 
0.78, respectively) (Macdermid et al., 2015). 
 SST (Su-RCC) 
Two studies investigated the measurement properties of the SST in patients 
undergoing surgery. The test-retest reliability was adequate (ICC = 0.97) (Godfrey et 
al., 2007). Two studies evaluated the responsiveness using the SRM, but they were 
not comparable because one study considered all patients following cuff repair post-
surgery without defining a precise timeframe (SRM 1.01; ES 1.08) (Godfrey et al., 
2007), while the other one calculated the specific SRM of subgroups with different 
patterns of progress [positive (SRM = 1.79), equivocal (SRM = 0.17), negative (SRM 
= -0.73)] (MacDermid et al., 2006). The floor (2.1%) and ceiling (5.1%) effects were 
under the 15% defined threshold (Godfrey et al., 2007). No interpretability aspect was 
investigated. 
 ASES (Su-RCC) 
Two studies investigated the responsiveness of the ASES in this population, while the 
other measurement properties were not investigated. One study reported and 
adequate change correlation with the WORC (r = 0.85) (Holtby and Razmjou, 2005), 
while the second one reported no floor or ceiling effects (Kocher et al., 2005). 
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Levels of evidence of PROMs measurement properties in samples including rotator 
cuff conditions surgically treated are summarised in Table 5.7. 
Table 5.7: Summary table for the level of evidence of PROMs measurement 
properties in samples including rotator cuff conditions surgically treated* 
 
Reliability  
(ICC and LoAs) 
Responsiveness 








Constant  ? +  low +/- low 
Relative 
Constant 
? ? ? 
DASH ? ? ? 
QuickDASH ? ? ? 
SST +  low ? ? 
ASES ? +  low ? 
Comparisons  Comparable SRM 
between DASH and 
QuickDASH: low 
SRM of DASH and SST 
are comparable: low 
Constant and relative 
Constant have higher 
SRM than ASES  
 
Legend: DASH: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; 
ASES: American Shoulder and Elbow Surgeons score; ICC: intraclass correlation coefficient; 
LoA: Limits of Agreement; AUC: Area Under the receiver operating Curve; ES: Effect Size; 
SRM: Standardised Response Mean; SEM: Standard Error of Measurement; MDC: Minimal 
Detectable Change; MCII/MCID Minimal Clinically Important Improvement/Difference; PASS: 
Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 
measurement properties (Prinsen 2018) 
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 PROMs Measurement properties in an osteoarthritis shoulder condition sample 
 
Reliability  Interpretability aspects Responsiveness Direct comparison 
Non-surgical 
DASH ES DASH 1.07 vs. WORC 1.33 
SRM DASH 0.90 vs. WORC 1.11. Corona 2016 
 
No floor/No ceiling effect  
Surgical 
Constant  
Angst 2004; Angst 2008; 
Torrens 2016; Sciascia 2017 
 MCID 8 pts 
PASS 78 pts No 
floor/ceiling effect 
+ AUC 0.77 - 0.85  
 
ES Constant 2.23 vs. ASES 2.13 vs. DASH 1.19 
SRM Constant 1.99 vs. ASES 1.81 vs. DASH 
1.22 
AUC Constant 0.77 vs. ASES 0.76 vs. DASH 
0.71 
(Angst 2008) 
SRM 3 months QuickDASH 0.84 vs. DASH 0.82  
SRM 6 months QuickDASH 1.06 vs. DASH 1.07 
(Macdermid 2015) 
ES 1.26 QuickDASH vs. 1.17 DASH  
(Angst 2009) 
ES SST 2.23 vs. DASH 1.41 
SRM SST 1.73 vs. DASH 1.76  
(Roy 2010) 
ES Constant 2.9 vs. ASES 2.5 
SRM Constant 2.4 vs. ASES 2.2 
Ceiling effect: none Constant vs. 21% ASES 
(Sciascia 2017) 
DASH 
Macdermid 2015; Angst 
2004; Angst 2008; Roy 2010 
 No floor/No ceiling effect + AUC 0.71 
Change correlation 
with SST 0.50 
QuickDASH 
Angst 2009; Macdermid 2015    
SST 
Roy 2010; Tashjian 2017 
 
MCID 2.4 - 3 pts +/- AUC 0.66 
Change correlation 
with DASH 0.50 
ASES 
Angst 2004; Angst 2008; 
Sciascia 2017; Goldhahn 
2008; Kocher 2005; Tashjian 





MCID 13.5 - 21 
PASS 73  
No floor/No ceiling effect 
+/- AUC 0.76 - 0.88 
 
Measurement properties established on an osteoarthritis shoulder condition sample (continued) 
Mix of surgical and non-surgical 
Constant and ASES 
SRM Constant 1.21 vs. ASES 1.29 (Lo 2001) 





5.3.1.4.1. PROMs measurement properties in non-
surgical osteoarthritis (NSu-OA) 
The data were very scarce for non-surgical treatment as only one study addresses 
the measurement properties of outcome measures in this population (Corona et al., 
2016). Only the responsiveness of the DASH score has been partially investigated for 
this approach as the effect size, SRM, floor and ceiling effects have been calculated 
at six months interval (ES= 1.07; SRM = 0.90), which were lower than those of the 
Western Ontario Rotator Cuff index (WORC), a condition-specific PROM. No floor 
and ceiling effects were detected.  
5.3.1.4.2. PROMs measurement properties in 
surgical osteoarthritis PROMs (Su-OA) 
The measurement properties of all the selected PROMs have been investigated for 
surgically treated osteoarthritis, with the exception of the relative Constant. 
 Constant (Su-OA) 
The Constant measurement tool’s reliability has not been tested for surgically treated 
OA. The MCID and PASS are the only interpretability aspects that have been 
established (MCID 8 points; PASS 78 points) for the Constant Score (Sciascia et al., 
2017; Torrens et al., 2016). 
The responsiveness of the Constant has been found to be superior to that of the 
DASH based on ES and SRM, and slightly above that of the ASES (Constant ES = 
2.23 vs. 2.13 for ASES vs. 1.19 for DASH; SRM Constant = 1.99 vs. 1.81 for ASES 
vs. 1.22 for DASH) (Angst et al., 2008). Another study also found a slightly better ES 
and SRM for the Constant compared to the ASES (Constant ES = 2.9 vs. 2.5 for 
ASES; Constant SRM = 2.4 vs. 2.2 for ASES) (Roy et al., 2010). Discriminative power 
between improved/unimproved patients was adequate (AUC = 0.77 - 0.85), which 
was close to that of the ASES (AUC = 0.76) and slightly superior to that of the DASH 
(AUC = 0.71) (Angst et al., 2008; Sciascia et al., 2017). No ceiling or floor effects for 
the Constant was shown five to six years after surgery (Angst et al., 2004). 
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 DASH and QuickDASH (Su-OA) 
The reliably and the interpretability aspects of the DASH and QuickDASH have not 
been evaluated. 
The responsiveness of the DASH was acceptable (AUC = 0.71) but slightly inferior to 
that of the Constant and ASES based on AUCs. The responsiveness of the DASH 
was also inferior to that of the Constant and ASES based on ES and SRM (see 
previous sub-section) (Angst et al., 2008). The comparison of the DASH and the 
QuickDASH showed comparable SRM (DASH SRM = 0.82 vs QuickDASH 0.84) and 
ES (DASH ES = 1.07 vs QuickDASH 1.06) (Angst et al., 2009; Macdermid et al., 
2015). The DASH had inferior ES and similar SRM to the SST (ES = 1.41 vs. 2.23; 
SRM = 1.76 vs 1.71) (Roy et al., 2010). Its change correlation with the SST was 
moderate, precisely at the r = 0.50 threshold (Roy et al., 2010). No ceiling or floor 
effects were reported for the DASH five to six years after surgery (Angst et al., 2004). 
 SST (Su-OA) 
The reliability of the SST has not been tested and MCID is the only interpretability 
aspect that has been determined (2.4 – 3 points) (Roy et al., 2010). Though the SST 
had a superior ES and equivalent SRM to the DASH (ES = 2.23 vs. 1.41; SRM = 1.71 
vs. 1.76), it showed a discriminative power lower than the ≥ 0.70 threshold (AUC = 
0.66).  
 ASES (Su-OA) 
The ASES is the only PROM for which the test-retest reliability, which was excellent 
(ICC = 0.93), and has been evaluated in this population (Goldhahn et al., 2008). The 
PASS has been determined to be 73 points (Sciascia et al., 2017) and the MCID 13.5 
– 21 points (Tashjian et al., 2017; Werner et al., 2016). 
The ASES (ES = 2.5, SRM = 2.2, AUC = 0.88) and Constant (ES = 2.9, SRM = 2.4, 
AUC = 0.85) showed similar levels of responsiveness, and discriminative power 
between satisfied and unsatisfied patients (Sciascia et al., 2017). 
The same study of Sciascia et al. (2017) showed a ceiling effect for the ASES at two 
years following arthroplasty, while Angst et al. found no ceiling or floor effects for the 
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Constant, DASH and ASES five to six years after the same surgery (Angst et al., 
2004; Sciascia et al., 2017). 
Levels of evidence for measurement properties of PROMs in samples including 
patients with osteoarthritis surgically treated are summarised in Table 5.8. 
Table 5.8: Summary table for the level of evidence for measurement properties of 
PROMs in samples including patients with osteoarthritis surgically treated* 
 
Reliability 
(ICC and LoAs) 
Responsiveness 








Constant  ? +    moderate +/-   low 
Relative 
Constant 
? ? ? 
DASH ? +  low ? 
QuickDASH ?  +   low 
SST ? +/-   low +/-  low 
ASES +   low +/-   moderate +/-  low 
Comparisons +/- low Constant superior to 
ASES: moderate 
ASES superior to 
DASH: low 
SST comparable to 
DASH: low 
-  
Legend: DASH: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; 
ASES: American Shoulder and Elbow Surgeons score; ICC: intraclass correlation coefficient; 
LoA: Limits of Agreement; AUC: Area Under the receiver operating Curve; ES: Effect Size; 
SRM: Standardised Response Mean; SEM: Standard Error of Measurement; MDC: Minimal 
Detectable Change; MCII/MCID Minimal Clinically Important Improvement/Difference; PASS: 
Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 
measurement properties (Prinsen 2018) 
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5.3.1.4.3. PROMs measurement properties in 
mixed surgical/non-surgical 
osteoarthritis (Mi-OA) 
Only one study investigated this type of composition within a population. It found 
closely matched SRMs for the Constant and the ASES in a mixed sample of non-
surgically and surgically treated patients (SRM = 1.21 vs. 1.29) (Lo et al., 2001). Due 
to the scarce literature, no table is provided to summarize the levels of evidence for 
measurement properties in this subpopulation. No information on the reliability and 
interpretability aspects is available.  Concerning the responsiveness, only the low 
level of evidence for the equivalence between the Constant and ASES can be stated. 
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 PROMs Measurement properties in a shoulder instability sample 




Interpretability aspects Responsiveness Direct comparison 
Non-surgical 
Constant  
Dawson 1999; Kirkley 1998   ES 0.2 
SRM 3 months WOSI 0.93 
vs. DASH 0.71 vs. 
Constant 0.59 vs. ASES 
0.54 
AUC WOSI 0.90 vs. 
Constant 0.76 (Kirkley 
1998) 
ES WOSI 1.57 vs. DASH 
1.47  




Cacchio 2012; Kirkley 1998  MCID 22 pts  
No floor/ceiling effect 
+ AUC 0.76 
 
SST 
Godfrey 2007;  + Test-retest ICC 1.00 No floor/ceiling effect  
ASES    
Kirkley 1998    
WOSI 
Cacchio 2012; Hatta 2011; 
Hofstaetter 2010; Kirkley 
1998; Skare 2013; Van der 
Linde 2014; Wiertsema 
2014; Basar 2017 
+ Test-retest ICC 0.91 
- 0.98 SEM 71 pts 
(3.4%) - 130 (6.2%) 
MDC 196 pts (9.3%) - 
483 (23.0%)  
LoA 333.9 - 344.8 pts 
(15.9% - 16.4%) - LoA 
± 400 pts (19%) 
 
MCID 400 pts (19%) 
No floor/No ceiling effect 













Responsiveness Direct comparison 
Surgical 
WOSI ICC test-retest WOSI 0.84 vs. 
QuickDASH 0.75 
SRM WOSI 1.55 vs. QuickDASH 0.87  
(Gaudelli 2014) 
ES 0.62 vs Rowe 0.46 
SRM WOSI 0.65 vs. Rowe 0.34  
(Oh 2009) 
Gaudelli 2014; Salomonsson 
2009; Oh 2009  
+/- Test-retest 
ICC 0.84 - 
0.94 




Gaudelli 2014    
Mixed surgical non-surgical 
DASH  
Change correlation with WOSI: DASH 
0.75 vs. SST 0.69 (van der Linde 2017) 
van der Linde 2017  
  
SST (van der Linde 2017) 













MCID 294 pts (14%)  
No floor/No ceiling 
effect 
+ AUC 0.82 




5.3.1.5.1. PROMs measurement properties in non-
surgical shoulder instability (NSu-SI) 
Ten studies on the measurement properties of the Constant, DASH, SST and WOSI 
were found, but not on the QuickDASH and the ASES. 
 Constant (NSu-SI) 
Two studies investigated the responsiveness of the Constant using the SRM. Limited 
information can be drawn from these results, as the SRMs were not compared to that 
of other outcome measures. One study found a lower value (SRM = 0.2) (Dawson et 
al., 1999) than the other one (SRM = 0.59) (Kirkley et al., 1998). Based on the global 
rating of change scale that was used in both studies, this difference is influenced by 
the higher proportion of patients who improved in the second study. 
 DASH (NSu-SI) 
Two studies investigated the responsiveness of the DASH, among which one also 
defined the MCID (22 points). The SRM was much higher in one study (SRM = 1.43) 
(Cacchio et al., 2012) than the other (SRM = 0.71) (Kirkley et al., 1998), possibly 
because the patients’ change was influenced by the structured rehabilitation 
treatment applied between measurements that had occurred within the first study 
only. In both studies, the responsiveness was lower than that of the WOSI (SRM = 
1.94 and 0.93, respectively). The AUC was adequate (AUC = 0.76) but lower than 
that of the WOSI (AUC = 0.91-0.98) and mainly due to its lack of sensitivity (61%) 
(Cacchio et al., 2012). The proportion of patients who reported the lowest possible 
score was 1.5% at baseline, which was under the 15% threshold to consider that a 
floor effect had been present, but appeared to be nevertheless higher than for the 
WOSI (0%). No ceiling effect was detected (Cacchio et al., 2012). 
 SST (NSu-SI) 
One studies investigated the measurement properties of the SST (Godfrey et al., 
2007). The reliability was perfect (ICC = 1.00). The SRM was calculated (SRM = 0.63) 
but not compared to that of other PROMs. The proportion of patients reaching the 
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minimal and maximal score was 2.0% and a 9.3%, respectively, which was under the 
15% threshold to consider that a floor or ceiling effect is present.  
 ASES (NSu-SI) 
One studies investigated the measurement properties of the ASES, in a larger study 
that considered several PROMs. The responsiveness was compared to that of the 
other investigated PROMs. Based on the SRM values (SRM = 0.54), it was lower than 
that of the Constant (SRM = 0.59), DASH (SRM = 0.71) and WOSI (SRM = 0.93). 
 WOSI (NSu-SI) 
The WOSI was the most frequently investigated PROM for the evaluation shoulder 
function in instability, as eight studies addressed its measurement properties compare 
to maximum two for other PROMs. All studies found a reliability above the ICC ≥ 0.90 
threshold (ICC = 0.91 – 0.98). 
Among measurement error issues, the SEM and MDC were evaluated in three 
studies. The reported SEMs ranged from 71 – 171 points (3.4% – 8.3%) and the MDC 
from 196 – 483 points (9.3% – 23%) (Cacchio et al., 2012; Wiertsema et al., 2014; 
van der Linde et al., 2014). The examination of methods used in the studies did not 
provide possible explanations for these discrepancies, except that the SEM tended to 
be smaller when the test-retest interval was shorter, which might have been induced 
by recall effects. The LoAs were investigated in two studies. One found them to be -
333.0 – 344 points (-15.9% – 16.4%) (Skare et al., 2013), while the estimation based 
on the graphs presented in the second one was around ± 400 points (19%) 
(Wiertsema et al., 2014). Thus, LoAs were larger than the 10% threshold in any case 
and indicating potentially excessive errors based on single measurements when using 
the SST.  
The SRM was investigated in two studies, with a larger value (SRM = 1.57) in the 
study that calculated it before and after a structured rehabilitation (Cacchio et al., 
2012), than in the one without specific rehabilitation (SRM = 0.93) (Kirkley et al., 
1998). In direct comparisons, the responsiveness of the WOSI was higher than that 
of the DASH (SRM = 1.94 vs. 1.43 and ES 1.57 vs. 1.47 in the first mentioned study, 
and SRM = 0.93 vs. 0.71 in the second one) and of the Constant and ASES (SRM 
0.93 vs. 0.59 for Constant and 0.54 for SST). The AUC was excellent (AUC = 0.90) 
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and superior to that of the Constant (AUC = 0.76), with better sensitivity (92%) than 
specificity (83%) (Cacchio et al., 2012). No floor or ceiling effects were detected in the 
five studies that investigated this aspect using the 15% minimal/maximal score criteria 
(Cacchio et al., 2012; Hofstaetter et al., 2010; van der Linde et al., 2014; Wiertsema 
et al., 2014; Basar et al., 2017). However, when the criteria for floor and ceiling effect 
was based on the patients who performed at the maximum score minus MDC or the 
minimum score plus MDC, respectively, 17% had a score < MDC (floor effect) and 
5% has a score > 100-MDC (ceiling effect) (van der Linde et al., 2014). Levels of 
evidence for measurement properties of outcome measures in samples including 
patients with shoulder instability non-surgically treated are summarised in Table 5.9. 
Table 5.9: Summary for the level of evidence of PROMS measurement properties in 
samples including patients with shoulder instability non-surgically treated * 
 
Reliability  
(ICC and LoAs) 
Responsiveness 









Constant  ? -     low ? 
Relative 
Constant 
? ? ? 
DASH ? -     low +/-    low 
QuickDASH ? ? ? 
SST +    low ? ? 
ASES ? -     low +/-  low 
WOSI +    high 
-  LoA > 10% : 
moderate 
+    high +    moderate 
Legend: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; ASES: 
American Shoulder and Elbow Surgeons score; WOSI: Western Ontario Shoulder Disability 
Index; ICC: intraclass correlation coefficient; LoA: Limits of Agreement; AUC: Area Under the 
receiver operating Curve; ES: Effect Size; SRM: Standardised Response Mean; SEM: 
Standard Error of Measurement; MDC: Minimal Detectable Change; MCII/MCID Minimal 
Clinically Important Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 




5.3.1.5.1. PROMs measurement properties in 
surgical shoulder instability (Su-SI) 
Only four studies investigated the measurement properties of the PROMS in surgical 
shoulder instability treatment. Only the DASH and the WOSI outcome measures were 
concerned by these studies. 
 QuickDASH (Su-SI) 
One study investigated the properties of the DASH. The test-retest reliability’s ICC 
was under the 0.90 threshold (ICC = 0.75). The SRM (SRM = 0.87) was considerably 
lower than for the WOSI (SRM = 1.55) at one year (Gaudelli et al., 2014). 
 WOSI (Su-SI) 
Three studies investigated the measurement properties of the WOSI. Concerning the 
reliability, one found an ICC above the defined ≥ 0.90 threshold (ICC = 0.94) 
(Salomonsson et al., 2009), while the other one found a lower value (ICC = 0.84), 
which was nevertheless higher than that of the QuickDASH (ICC = 0.75) (Gaudelli et 
al., 2014). The questionnaire was administrated by means of telephone conversation 
in the study in which lower values were found. No interpretability aspects were 
determined for surgical treatment.  
Concerning the WOSI measurement tool’s responsiveness, one study found much 
lower SRM at 6 months (SRM = 0.65) (Oh 2009) than the two other ones that 
investigated this parameter (SRM = 1.40 at 6 months and 1.55 at 1 year) 
(Salomonsson et al., 2009; Gaudelli et al., 2014), respectively. The SRM and ES 
(SRM = 0.66; ES = 0.62) were nevertheless higher than those of the concurrent Rowe 
score for shoulder instability (SRM = 0.34; ES 0.46) (Oh et al., 2009) and of the 
QuickDASH (SRM = 0.87). 
Levels of evidence for measurement properties of PROMs in samples including 
patients with surgically treated shoulder instability are summarised in Table 5.10. 
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Table 5.10: Summary table for the level of evidence for measurement properties of 




(ICC and LoAs) 
Responsiveness 








Constant  ? ? ? 
Relative 
Constant 
? ? ? 
DASH ? ? ? 
QuickDASH -     low -     low ? 
SST ? ? ? 
ASES ? ? ? 
WOSI +    low 
(-   low over phone) 
+    low ? 
Comparisons - WOSI superior to 
QuickDASH: low 
WOSI superior to 
Rowe: low 
-  
Legend: DASH: Disabilities of the Arm, Shoulder and Hand score SST: Simple Shoulder Test; 
ASES: American Shoulder and Elbow Surgeons score; WOSI: Western Ontario Shoulder 
Disability Index; ICC: intraclass correlation coefficient; LoA: Limits of Agreement; AUC: Area 
Under the receiver operating characteristic Curve; ES: Effect Size; SRM: Standardised 
Response Mean; SEM: Standard Error of Measurement; MDC: Minimal Detectable Change; 
MCII/MCID Minimal Clinically Important Improvement/Difference; PASS: Patient Acceptable 
Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 




5.3.1.5.1. PROMs measurement properties in 
mixed surgical/non-surgical shoulder 
instability (Mi-SI) 
Three studies investigated the measurement properties in mixed samples of patients 
with shoulder instability treated either non-surgically or surgically, using the WOSI, 
SST, DASH or ASES (van der Linde et al., 2017; Kocher et al., 2005; Yuguero et al., 
2016). 
 DASH and SST (Mi-SI) 
The DASH and the SST were investigated in the same study (van der Linde et al., 
2017). Their moderate to high change correlations with the global rating of change 
scale [SST (r = 0.69) and DASH (r = 0.75)] are indicative of adequate responsiveness. 
 ASES (Mi-SI) 
Only the responsiveness of the ASES measurement tool was investigated. However, 
little can be inferred from the ES (ES = 0.86) and SRM (SRM = 0.93) in the absence 
of comparison with another outcome measure. No floor effect was found and 1.3% of 
patients reached the maximal score, which is under the 15% defined threshold for a 
ceiling effect (Kocher et al., 2005). 
 WOSI (Mi-SI) 
The reliability of the WOSI was adequate (0.95) (Yuguero et al., 2016). The SRM 
(SRM = 0.61) and ES (ES = 0.25) were determined but not compared to other 
outcome measures. The moderate to high change correlations with the global rating 
of change scale (r = 0.64), SST (r = 0.69) and DASH (r = 0.75) are indicative of 
adequate responsiveness. The discriminative power for improved/unimproved 
discrimination was adequate (AUC = 0.82) (van der Linde et al., 2017). The MCID 











Responsiveness Direct comparison 
DASH     
Staples 2010 
  
+   Active treatment AUC 0.71 
+   Improved patients AUC 0.82 
+   Markedly improved patients AUC 0.86 




5.3.1.6.1. PROMs in non-surgically treated 
capsulitis (NSu-C) 
Only the DASH Score’s measurement properties have been partially evaluated, 
following arthrographic joint distension or oral prednisolone (Staples et al., 2010). No 
data are available for test-retest reliability and no interpretability aspects have been 
defined. 
The responsiveness has been differentiated between the “receiving treatment of 
known efficacy”, the “improved” and the “markedly improved” groups. The AUC was 
higher than the 0.70 threshold in all of these groups (AUC = 0.71 – 0.86). The 
possibility of interpreting the magnitude of the ES and SRM results is nevertheless 
limited as no comparison with other PROMs was performed. Due to the scarce 
literature, no table is provided to summarize the levels of evidence for measurement 
properties in this subpopulation. It could only be stated that the DASH display 
adequate responsiveness, with a low level of evidence.  
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Interpretability aspects Responsiveness Direct comparison 
Non-surgical 
Constant 
   
Test-retest ICC Constant 
0.91 vs. 0.87 DASH 
Change correlation with 
SSV: Constant 0.66 vs. 
DASH - 0.68 
(Van de Water 2014) 
ES Constant 0.31 vs. 
DASH 0.44 
(Van de Water 2016) 
Van de Water 2014; 
Van de Water 2016 
+ Test-retest ICC 0.91 
SEM 4.5  
LoA ~ ± 10 pts (bias ~5%) 
(from graph) 
MCID 5.1 - 11.4  
 
Change correlation with SSV 
0.66; with DASH - 0.72 
DASH 
   
Fayad 2008b; Van de 
Water 2014; Van de 
Water 2016 
-  Test-retest ICC 0.87 
SEM 6.5  
LoA ~ ± 15 pts (bias ~5%) 
(from graph) 
MCID -8.1 - -13.0  
 
Change correlation with SSV 
0.68 ; with Constant -0.72 
Change correlation with 
handicap scale 0.33 
Mixed surgical/non-surgical  
Constant 
   
 
Mahabier 2016 SEM 6.4 
MDC 17.7 
MCID 6.1  
No floor/ceiling effect 
- AUC 0.59 
Change correlation with 
DASH -0.60 
 
AUC DASH 0.66 vs. 
Constant 0.59 
ES Constant 1.71 vs. 
DASH -1.55 
SRM DASH -1.63 vs. 
Constant 1.60 
Ceiling effect DASH 




   
Slobogean 2010; 
Mahabier 2016  
+ Test-retest ICC 0.93 
SEM 6.9 
MDC 19.0 LoA 15.2 - 
15.9 (bias 0.4) 
MCID 6.7 (95% CI, 5.0-15.8) 
No floor/31.1% ceiling effect 
- AUC 0.66 






5.3.1.7.1. PROMs measurement properties in non-
surgical humerus fracture (NSu-F) 
Three studies investigated the measurement properties of  the DASH and Constant 
PROMs for the assessment of function in patients with fractures of the shoulder (van 
de Water et al., 2014; van de Water et al., 2016a; Fayad et al., 2008b). Among them, 
two compared the DASH and Constant outcome measures (van de Water et al., 2014; 
van de Water et al., 2016a) . 
The reliability of these outcome measures were found to be within the specified 
requirement for the Constant (ICC = 0.91), but slightly under it for the DASH (ICC = 
0.87) (van de Water et al., 2014). 
Concerning interpretability aspects, the SEM, MCID and LoAs were reported for both 
the Constant and DASH outcome measures, but not their MDC and PASS 
measurement characteristics (van de Water et al., 2014). The SEM was lower for the 
Constant (4.5 points) than for the DASH (6.5 points). For both outcome measures the 
MCID magnitude was quite different if the anchor-based (Constant 11.4 points; DASH 
-13.0 points) or the distribution-based method (Constant 5.1 points; DASH -8.1 points) 
was used. The LoAs were not numerically reported but could be estimated from 
graphical inspection. The LoAs (~ 10%) were at the limits defined as acceptable in 
this review for the Constant and larger for the DASH (~15%). A ~ 5% test-retest bias 
was visible for the two PROM-derived assessment tools, which it at the limit defined 
as acceptable in this review. 
Two studies investigated the responsiveness of the Constant and the DASH. Both 
were correlated to the change score of the SSV, as well as to each other’s change 
score, with a similar strength (r = 0.68 – 0.72) (van de Water et al., 2014). The effect 
size of the Constant (ES = 0.31) was somewhat lower than that of the DASH (ES = 
0.44) (van de Water et al., 2016a). One research study reported a considerably higher 
ES (ES = 1.2), at a stage of recovery when progress is expected to be more marked, 
but did not compare it to that of the Constant (Fayad et al., 2008b). 
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5.3.1.7.1. PROMs measurement properties in 
surgical humerus fracture (Su-F) 
No PROM has been evaluated in this population. 
5.3.1.7.2. PROMs measurement properties in 
mixed surgical/non-surgical humerus 
fracture (Mi-F) 
Two studies investigated the measurement properties of PROMs in patients with 
fractures, among which, one had compared the DASH’s and Constant’s measurement 
properties. 
 Constant and DASH (Mi-F) 
As most of the results originate from one study that investigated the measurement 
properties of the Constant in this population, the measurement properties of the two 
Score are presented together in the same sub-section to avoid repetitions (Mahabier 
et al., 2017). The reliability of the outcome measures has not been evaluated in this 
study, but has been evaluated for the DASH only in another study (ICC = 0.93). The 
SEM (Constant 6.4 points; DASH 6.9 points), MDC (Constant 17.7 points; DASH 19.0 
points) and MCID (Constant 6.1 points; DASH 6.7 points), but not the LoAs and PASS 
have been evaluated among the interpretability aspects. However, the MCID value 
found in this study cannot be considered as a valid threshold for the determination of 
the change that matters to the patient, because it was smaller than the MDC (van der 
Linde et al., 2017; De Vet et al., 2011a). 
For the Constant, the specificity (58%) and the sensitivity (61%) were only fair, so that 
the area under the curve (AUC = 0.59) was lower than the defined threshold (≥ 0.70). 
For the DASH, the sensitivity (45%) was lower than the specificity (81%), so that the 
area under the curve (AUC = 0.68) was slightly lower than the defined threshold. 
However, the criterion was the discrimination between patients who scored “a little 
better” and patients who did not change, which was a more stringent criterion that the 
most frequently used “improved/unimproved” discrimination. The Constant and DASH 
SRM (Constant SRM = 1.60; DASH SRM = -1.63) and ES (Constant ES = 1.71; DASH 
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SRM = -1.55) were evaluated six and 12 months after the injury. The change 
correlation between the Constant and DASH was r = -0.60 (Mahabier et al., 2017). 
No floor and ceiling effects were detected for the Constant, which contrasted to the 
DASH, for which 31.1% ceiling effect was detected 12 months after the fracture. 
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  Movement analysis-based outcome measures results 
  Presentation of movement analysis-based outcome measures  
Presentation of movement analysis-based outcome measures 
Article Pathology Measurement method Convergent validity NOTES 
Duc 2014 Rotator cuff non-
surgical 
Three scores : 
Duration of muscular activation (TEMG), duration 
of arm movement (Tmov) and Temg/mov (relative 
electromyography (EMG) time over movement 
time) measured with inertial sensor system and 
EMG 
Absolute correlation between 
the DASH, SST and 
Constant and the Tmov, upper 
trapezius TEMG, and Temg/mov 
ranged 0.45 - 0.79 in 
laboratory setting and non-
significant in other cases. 
Best correlations with the 
DASH, SST and Constant in 
daily condition was found for 
the Temg/mov of upper 
trapezius (0.56 - 0.62); lower 
and mostly non-significant in 
other cases 
More scores have been 
explored in this study: 
only those which showed 
a significant difference 
between patient and 
control groups are 
reported here 
Jolles 2011 Mixed sample of 
patients with rotator 




Between-sides balance for power-related metric 
(Power score), range of angular velocity (RAV 
Score) and moment (Moment Score) measured 
with an inertial sensor system during a series of 
seven movements at a self-selected speed 
Absolute correlation with 
DASH, SST, ASES and 
Constant 
Power score 0.69 - 0.80 
RAV Score 0.67 - 0.76 
Moment Score 0.61 - 0.70 
Power Score (equivalent 
to P Score) is the parent 





Presentation of movement analysis-based outcome measures (continued) 




Rotator cuff Two Scores : 
ARS: angular rate signal (equivalent to above 
mentioned RAV score) 
COMP: combination of angular rate signal and 
acceleration signal (equivalent to above 
mentioned P Score) 
Measured with inertial sensor system during two 
selected movements (hand to the back and to 
the ceiling) at self-selected speed 
Weakly correlated with 
functional score DASH and 
SST < 0.25  captures a 
different aspect of shoulder 
function than PROMs 
Completion time < 5min  
Two movements : ‘arm to 
the back’ and ‘arm 
behind the head’ 
Mean of 3 repetitions 
No between-sides 









Smartphone B-B Score : between side balance 
of for power-related metric measured with a 
smartphone inertial sensor system during 2 
selected movements (hand to the back and to 
the ceiling) at self-selected speed 
Absolute correlations with 
Constant, relative Constant, 
SST, QuickDASH and WOSI: 
Rotator cuff: 0.55–0.84 
Humerus fracture: 0.66 – 
0.70, no correlation with 
QuickDASH 
Capsulitis: 0.64 – 0.76 
Instability: 0.46 – 0.58 
Completion time 2 - 3 
minutes 
Mean of 3 repetitions of 
the two movements used 





Pathological arm underuse percentage in 
everyday life environment compared to 
population with the same hand dominance, 
measured with an inertial sensor system  
Non-significant correlation 
with clinical scores except 
with Constant 3 months 0.46 
 
*  Publication based on the MSc dissertation of the thesis’s author, in which the B-B Score conception was developed 





Presentation of movement analysis-based outcome measures (continued) 
Article Pathology Measurement method Convergent validity NOTES 
Pichonnaz 
2015c 
Mixed sample of 
patients with rotator 
cuff conditions and 
osteoarthritis, 
surgically treated 
Study on the conception of the B-B Score (see 
Pichonnaz 2015a for description of the B-B 
Score  
Absolute correlations with 
DASH, SST and Constant 







B-B Score (please see above) 
Inertial sensor system B-B Score (please see 
above) 
Smartphone and inertial 
sensor system equivalent 
Study demonstrated the 
equivalency of 
smartphone and inertial 
sensor system for B-B 
Score measurement 
Yang 2014 Capsulitis Shoulder physical activity (SPA): accelerometer 
net vector magnitude data counts; higher counts 
represent more complex strategies caused by 
pain and discomfort  
Correlation with Flexilevel 







 Measurement properties of movement analysis-based outcome measures  
Measurement properties of movement analysis-based outcome measures 




Responsiveness Normal performance 












Effect size between patients with abnormal 
and normal pain  
Power Score -1.91 
RAV Score -1.90 
Moment Score -1.72 
(vs. 1.01 DASH; -0.96 ASES; -1.09 
Constant; -1.13 SST) 
Power score mean (SD) 
91% (7%) 
RAV score 92% (5%) 










Tmov: ICC 0.74 
Temg upper trapezius: 
ICC 0.83 
Temg/mov upper 
trapezius: ICC 0.81 
  Please see original 
publication for details of 








ARS: ICC 0.94 
COMP: ICC 0.95 
Inter-tester 
ARS: ICC 0.90 
COMP: ICC 0.91 
Inter-tester DASH ICC 
0.63  
Inter-tester SST ICC 
0.70 
 
Discriminative power patient/healthy: 
Specificity: 
ARS asymmetry 81.0% 
COMP asymmetry 85.0% 
Sensitivity: 
ARS asymmetry 98.0% 
COMP asymmetry 84.0% 
Floor effect: no 
Asymmetry between 
shoulder 14.6% for 
COMP and 9.6 for ARS 
Healthy/pathological cut-
off 27% difference 
between sides for 
COMP and 16% for 
ARS  
Vector magnitude 
data counts  
(Yang 2014) 
Capsulitis   AUC 0.83   
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Measurement properties of movement analysis-based outcome measures (continued) 
Score Pathology Reliability and measurement error Interpretability 
aspects 








Correlation change with Constant 
0.47, DASH, 0.49, SST no 
correlation (3-6 months, NS at other 
stages) 
Mean (SD) of 
dominance arm use: 
Right handed: 61.2% 
(6.6%) 


















(n = 65) 
Intra-rater ICC  
Smartphone 0.92 
Reference System 0.92 
 
Inter-rater ICC  
Smartphone 0.92 
Reference System 0.93 
 
Inter-devices ICC: 0.97 SEM: 
Intra-rater: Smartphone 6.6%; Inertial 
sensor system 6.6% 
Inter-rater: Smartphone 6.6%; Inertial 
sensor system 6.4% 
LoA (bias): 
Intra-rater: Smartphone -17.4 - 20.3% 
(1.5%) Inertial sensor system -19.3 - 
19.6% (0.1%) 
Inter-rater: Smartphone - 16.9% - 
20.0% (1.5%); Reference System - 
18.1 - 20.0% (1.0%)  




AUC (patients-controls): all patients 
0.88; indicated pathologies 0.96 
AUC (improved/unimproved): 
all patients 0.73; indicated 
pathologies 0.70 
ES/SRM for all patients: 0.90/0.90 
ES/SRM for indicated pathologies: 
0.81/1.18 
Change correlation with PROMs for 
all patients: 0.55 – 0.71 
Change correlation with PROMs for 
indicated pathologies: 0.47 – 0.69 
No floor/ceiling effect 
 
Healthy/pathological 




Measurement properties of movement analysis-based outcome measures (continued) 




Responsiveness Normal performance 






Healthy mean Score 
95% (mean of baseline 
and 6 months 
measurements) 
Rotator cuff 
(n=20)  No floor/ceiling effect 
AUC (patients-controls): 0.90  
Healthy/pathological cut-off: > 83.6 
ES/SRM: 0.69/1.98 (> Constant, 
QuickDASH, SST) 





 No floor/ceiling effect 
AUC (patients-controls): 0.98 
Healthy/pathological cut-off: > 71.6 
ES/SRM: 1.94/1.98 (< Constant; > 
QuickDASH, SST) 
Change correlation with PROMs: 0.56 – 0.75 
 
Capsulitis 
(n=22)  No floor/ceiling effect 
AUC (patients-controls): 0.99  
Healthy/pathological cut-off: > 82.1 
ES/SRM:1.16/1.68 (> Constant, 
QuickDASH, SST) 





 No floor/ 22% ceiling effect 
AUC (patients-controls): 0.67 
Healthy/pathological cut-off: > 81.6 
ES/SRM: 0.10/0.13 (< WOSI and Constant; 
> QuickDASH and SST) 




5.3.2.2.1. Normal performance for MAB outcome 
measures 
Normative values have been defined systematically for all selected MAB outcome 
measures, except for the shoulder physical activity determined by net vector 
magnitude data count (Yang et al., 2014). However, the samples were small in all 
studies (≤ 100 participants), which prevented any sample’ stratification. The influence 
of age, sex amongst factors that could potentially influence the outcome is thus 
presently unknown. 
Normative values and healthy-pathological cut-off values were determined for the 
ARS and COMP scores (Korver et al., 2014a), arm underuse score (Pichonnaz et al., 
2015b), EMG muscular activity duration (Duc et al., 2014), Power Score, RAV Score, 
Moment Score (Jolles et al., 2011) and B-B Score for inertial sensor system and 
smartphone measurement (Pichonnaz et al., 2015a) 
5.3.2.2.2. MAB outcome measures in diversified 
shoulder conditions mixed surgical/non-
surgical (NSu- and Su-DSC) 
Three studies on kinematic shoulder function outcome measures relied on a patients 
of patient with diversified pathologies (Jolles et al., 2011; Pichonnaz et al., 2017; 
Pichonnaz et al., 2015a). One study included patients operated on for rotator cuff 
repair or total shoulder arthroplasty (Jolles et al., 2011) and two other ones non-
surgically treated patients with rotator cuff, adhesive capsulitis, humerus fracture or 
shoulder instability (Pichonnaz et al., 2015a; Pichonnaz et al., 2017).  
 P, RAV and Moment Scores (Su-DSC) 
Jolles et al. investigated the properties of three MAB outcome measures (Power 
score, RAV score and Moment score) that displayed a close similarity amongst 
measurement properties (Jolles et al., 2011). The criterion-based validity indicated 
that the MAB outcome measures were actually indicative of shoulder function for the 
P, RAV and M Scores (r = 0.61 – 0.80 with the DASH, SST, ASES and Constant 
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PROMs). The effect sizes for the difference between the patients with abnormal and 
normal pain at follow-up was in favour of the three MAB outcome measures (absolute 
ES = 1.72 – 1.91), compared to the DASH (ES = 1.01), SST (ES = - 1.13), Constant 
(ES = 1.09) and ASES (ES = - 0.96) shoulder function PROMs (absolute ES 0.96 – 
1.13). The authors also highlighted that the MAB outcome measures were able to 
detect treatment failures at an earlier stage than PROMs. It can be considered that 
the three investigated MAB outcome measures reflected shoulder function as they 
were moderately to highly related to PROMs pursuing the same purpose (r = 0.61 – 
0.80). 
 B-B Score (NSu-DSC) 
Previous research has shown that the B-B Score had convergent validity with the 
DASH, SST and Constant (r = 0.51 – 0.77) in a sample with diversified pathologies 
(Pichonnaz et al., 2015c). 
The thesis Phase 2 and 3 studies provided material for the comparison of the 
measurement properties of outcomes measures investigated in a sample including 
diversified pathologies. This subsequent literature review was therefore an 
opportunity to conduct a comparative analysis of the measurement properties of the 
B-B score. In the Phase 2 study that compared the measurement properties of the 
MAB shoulder function B-B Score, measured with an inertial sensor system or a 
smartphone, the reliability was above the required cut-off (ICC ≥ 0.90), with intra-rater 
ICCs reaching 0.92 and inter-tester ICCs 0.92-0.93, regardless of device (Pichonnaz 
et al., 2017). The SEM ranged from 6.4% – 6.6% for intra- and inter-tester 
measurements regardless of device. The intra- and inter-tester agreements were 
comparable, with LoAs ranging from ± 18.8% to ± 19.5%, i.e. higher than the ± 10% 
threshold. Separate analyses were conducted for each pathological subgroup in the 
Phase 3 study, but some statistics were also calculated for the whole patient group 
including all pathologies (“All patients” group) or for the whole patient group excluding 
patients with shoulder instabilities, for whom the B-B Score is known to be inadequate 
(“Indicated pathologies group”) (see sub-section 4.2.2 Analysis, within Chapter four, 
p. 133 - 134). It was determined that the AUCs were adequate for the discrimination 
between controls and patients (AUCs = 0.88 “All patients” and 0.96 “Indicated 
pathologies”) (see Table 4.4 in sub-section 4.3.2 “Discriminative power”, within 
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Chapter four, p. 139). The ES (ES = 0.81 “All patients” and 1.21 “Indicated 
pathologies”) and SRM (SRM = 0.90 “All patients” and 1.26 “Indicated pathologies”) 
were comparable to those of the Constant and relative Constant and superior to those 
of the SST and QuickDASH (see sub-section 4.3.4 “Responsiveness”, within Chapter 
4, Table 4.6 p. 142 and 4.7 p. 143). The change score correlations with the Constant, 
relative Constant, and SST were adequate (r = 0.65 – 0.71), but below the required 
threshold for the QUICKDASH in the “Indicated pathologies” subgroup only (“All 
patients r = 0.55; “Indicated pathologies r = 0.45) (same sub-section, Table 4.8 p. 
144). The AUCs for the discrimination between improved and unimproved patients 
were adequate (AUC = 0.73 “All patients” and 0.70 “Indicated pathologies”), but lower 
than those of the Constant, relative Constant, DASH, SST, QuickDASH (AUC = 0.78 
– 0.83 “All patients” and 0.73 – 0.83 “Indicated pathologies”) (same sub-section, Table 
4.9 p. 145). The interpretability aspects of the B-B Score were 18.1% for the MDC, 
25.2% for the MCII and 77.6% for the PASS). No issues related to floor and ceiling 
effects was detected (sub-section 4.4.2 “Interpretability aspects”, within Chapter four, 
p. 147) (Pichonnaz et al., 2015a). 
Levels of evidence of MAB outcome measures measurement properties in samples 




Table 5.11: Summary table for the level of evidence of MAB outcome measures 


















+  low +  low +  low +  low 
P Score (Su) ? +  low ? +  low 
RAV Score 
(Su) 
? +  low ? +  low 
Moment Score 
(Su) 
? +  low ? + low 
Comparisons - ES of P, RAV and M 
superior to Constant, 
DASH, ASES and SST 
ES and SRM of the B-B 
Score comparable to 
Constant and relative 
Constant, and superior to 
QuickDASH and SST 
- - 
Legend: P Score: Power Score; RAV Score Range of Angular Velocity Score; M Score 
Moment Score; ICC: intraclass correlation coefficient; Disabilities of the Arm, Shoulder and 
Hand score SST: Simple Shoulder Test; ASES: American Shoulder and Elbow Surgeons 
score; LoA: Limits of Agreement; AUC: Area Under the receiver operating Curve; ES: Effect 
Size; SRM: Standardised Response Mean; SEM: Standard Error of Measurement; MDC: 
Minimal Detectable Change; MCII/MCID Minimal Clinically Important Improvement/Difference; 
PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence for 
measurement properties 




5.3.2.2.3. MAB outcome measures measurement 
properties in surgical and non-surgical 
rotator cuff conditions (NSu- and Su-
RCC) 
Four studies investigated the measurement properties of MAB outcome measures for 
rotator cuff conditions, among which three had focused on non-surgical treatment 
(Korver et al., 2014a; Pichonnaz et al., 2015a; Duc et al., 2014), and one on surgical 
treatment (Pichonnaz et al., 2015b). 
 ARS and COMP Scores (NSu-RCC) 
Korver investigated two scores, the ARS (peak-to-peak difference in the angular rate 
signal for the three axes) and the COMP (area described by combining the angular 
rate signal and acceleration signal), measured during two basic shoulder movements 
(arm to the back and arm behind the head). Both scores had adequate intra- and inter-
rater reliability (ICC ≥ 0.90) (ARS ICC = 0.94 and 0.90; COMP ICC = 0.95 and 0.91, 
respectively), which was better than the DASH’s (ICC = 0.63) and SST’s (ICC = 0.70) 
reliability reported in this study. No interpretability aspect was reported for these 
scores. The specificity (ARS 81%; COMP 84%) and sensitivity (ARS 98%; COMP 
84%) were high for the discrimination between patients and healthy controls. 
However, such results were indicative of discriminative power between patients and 
controls rather than responsiveness of the outcome measure, as the specificity and 
sensitivity did not address the score’s improved/unimproved discrimination power. 
The negligible correlation (r < 0.25) (Hinkle 2003) with the DASH and SST indicated 
that the ARS and COMP scores had limited convergent validity, as they did not 
capture the same dimension of shoulder function as these PROMs. Interpretability 
aspects and responsiveness were not reported for these scores, except for no floor 
effects. 
 Tmov, Tmov and TEMG/mov Scores (NSu-RCC) 
A study investigated shoulder muscle activation during active movements, using a 
combination of inertial sensors and EMG (Duc et al., 2014). Several alternative scores 
were tested among which the duration of arm movement (Tmov), duration of the upper 
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trapezius activation (TEMG]) and the upper trapezius percentage of muscular activation 
time over movement time (TEMG/mov[%]) were able to show a significant difference in 
performance between healthy controls and patients. The reliability of these three 
scores (ICC = 0.74-0.81) was lower than the threshold defined in this review (ICC ≥ 
0.90). The absolute correlations with the DASH, SST and Constant PROMs ranged 
from r = 0.46 – 0.79 in laboratory settings and from   (r = 0.56 – 0.62) for the TEMG/mov[% 
for measurements undertaken in everyday conditions. The responsiveness and 
interpretability aspects were not determined. 
 Arm underuse (NSu-RCC) 
One study investigated some measurement properties of a score that quantified arm 
underuse following rotator cuff surgery (Pichonnaz et al., 2015b). This score 
significantly differentiated the patients from the healthy controls three months after 
surgery and showed the recovery pattern of arm usage over time. However, no 
correlation was found with the DASH and the SST at several post-surgical stages and 
a significant correlation with the Constant was found only three month after surgery (r 
= 0.49), indicating that the arm underuse score did not capture the same dimension 
of shoulder function as these PROMs. Correlations between change scores were 
found only between three and six months for the DASH (r = 0.49) and the Constant (r 
= 0.47). 
The change score correlation was the only measurement property that was 
investigated in this study. It showed no correlation between change scores for the 
SST and low correlations for the Constant (r = 0.47) and the DASH (r = 0.49).  
 B-B Score (NSu-RCC) 
The Phase 3 study and its related article allowed for the investigation of the B-B Score 
measurement properties in a non-surgical sample (Pichonnaz et al., 2015a). The 
moderate to high correlations with the Constant (r = 0.82), relative Constant (r = 0.84), 
SST (r = 0.63) and QuickDASH (r = -0.55) indicated that the B-B Score measures a 
dimension close to the shoulder function PROMs (see sub-section 4.3.3 “Convergent 
validity”, Table 4.5, within Chapter four p. 141). The reliability and interpretability 
aspects were not specifically determined for rotator cuff conditions (Pichonnaz et al., 
2017). The ES/SRM six months after baseline measurement were SRM = 0.69/ ES = 
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0.69, which was superior to the Constant (SRM = 0.54/0.58), relative Constant (SRM 
= 0.50/ ES = 0.57), SST (SRM =0.52/ ES = 0.48) and QuickDASH (SRM = 0.35/ ES 
= 0.47) (see sub-section 4.3.4 “Responsiveness”, Table 4.6 and 4.7, within Chapter 
4 p. 142 - 143). The AUC (AUC = 0.90) was excellent for the discrimination between 
patients and healthy controls, with an affected-non affected cut-off at 83.6. The 
specificity (90%) and sensitivity (90%) were high for rotator cuff conditions. 
Conversely, the AUC for the improved/unimproved discrimination was not determined 
specifically for rotator cuff conditions (see same sub-section, Table 4.9, p. 145). The 
change correlation was moderate with the Constant (r = 0.51) and relative Constant 
(r = 0.55) but non-significant with the SST and QuickDASH (see same sub-section, 
Table 4.8, p. 144). 
Levels of evidence for measurement properties of outcome measures in samples 
including patients with non-surgical rotator cuff conditions are summarised in Table 
5.12. 
Table 5.12: Summary table for the level of evidence of MAB outcome measures 


















B-B Score  ? +  low ? +  low 
RAV and 
COMP Scores 
+ low +  low ? -  low 
Tmov,TEMG and 
TEMG/mov Scores 
? ? ? -  low 
Arm underuse ? +  low ? -  low 




5.3.2.2.1. Measurement properties of MAB 
outcome measures in osteoarthritis (OA) 
No MAB outcome measure has been validated specifically for OA. Thus, no table is 
provided to summarize levels of evidence for measurement properties in this 
subpopulation. 
5.3.2.2.1. Measurement properties of MAB 
outcome measures in non-surgical shoulder 
instability (NSu-SI) (OA) 
One study evaluated the measurement properties of a MAB outcome measure (B-B 
Score) for non-surgical shoulder instability evaluation (Pichonnaz et al., 2015a). The 
specific interpretability aspects were not reported in this study. 
The B-B Score was correlated with the WOSI (r = 0.58), the QuickDASH (r = -0.57), 
the SST (r = 0.52), the Constant (r = 0.46) and the relative Constant (r = 0.43). This 
indicates adequate convergent validity for the evaluation of shoulder function (see 
sub-section 4.3.4 “Convergent validity”, within Chapter 4, Table 4.5 p. 141 - 142). 
The ES and SRM for a change of baseline until three months was small (ES = 0.10; 
SRM = 0.13). When directly compared to PROMs, these value were lower than the 
ES and SRM of the WOSI (ES = 0.47; SRM = 0.41) and, to a lesser extent, lower than 
that of the relative Constant (ES = 0.27; SRM = 0.22) and Constant (ES = 0.21; SRM 
= 0.19), but equivalent to the ES of the SST (ES = 0.10; SRM = 0.08) and superior to 
that of the QuickDASH (ES = 0.01; SRM = 0.01). The AUC for the discrimination of 
patients with shoulder instability from healthy controls was under the 0.70 threshold 
(AUC = 0.67). The specificity was excellent (98%) but the sensitivity was low (48%). 
No floor and ceiling effects were detected (Pichonnaz et al., 2015a) (see sub-section 





Table 5.13: Summary table for the level of evidence for measurement properties of 
MAB outcome measures in samples including patients with shoulder instability non-
surgically treated * 
 
Reliability  
(ICC and LoAs) 
Responsiveness 









B-B Score ? -     low - 
Comparisons - WOSI superior to generic 
shoulder PROMs 
Constant, DASH, ASES: 
high 
WOSI and to a lower 
extent  Constant superior 
to B-B Score: low 
-  
Legend: DASH Disabilities of the Arm, Shoulder and Hand score ASES: American Shoulder 
and Elbow Surgeons score; WOSI: Western Ontario Shoulder Disability Index; ICC: intraclass 
correlation coefficient; LoA: Limits of Agreement; AUC: Area Under the receiver operating 
Curve; ES: Effect Size; SRM: Standardised Response Mean; SEM: Standard Error of 
Measurement; MDC: Minimal Detectable Change; MCII/MCID Minimal Clinically Important 
Improvement/Difference; PASS: Patient Acceptable Symptom State. 
+ sufficient, +/- undetermined, - insufficient, ? non-investigated measurement properties 
* Evidence graded using the modified GRADE approach for grading the quality of evidence of 
measurement properties (Prinsen 2018) 
 
5.3.2.2.1. Measurement properties of MAB 
outcome measures in capsulitis (NSu-C) 
One study evaluated the measurement of a MAB outcome measure (kinematic B-B 
Score) for the non-surgical treatment of a capsulitis (Pichonnaz et al., 2015a) (results 
sub-section 5.3.2.2 “Measurement properties of movement analysis-based outcome 
measures”, p. 239). The correlation strength was moderate to high with the SST (r = 
0.76), relative Constant (r = 0.69), Constant (r = 0.68) and QuickDASH (r = -0.64) 
(Hinkle et al., 2003), indicating adequate convergent validity for shoulder function 
evaluation. No specific reliability and interpretability aspects for capsulitis were 
determined in this study (see sub-section 4.3.4 “Convergent validity”, within Chapter 
4, Table 4.5 p. 141). 
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Concerning responsiveness preceding investigations conducted within this thesis 
(Phase 3 study) showed that ES and SRM were ES = 1.16 and SRM = 1.68 for the 
baseline until three months change. When directly compared to PROMs, the B-B 
Score ES and SRM were higher than those of the SST were (ES = 0.86; SRM = 1.24) 
and QuickDASH (ES = 0.55; SRM = 1.07), which were used for comparison. 
Concerning the Constant, the ES and SRM provided divergent results concerning the 
superiority or the inferiority of one outcome measure over the other, with higher ES 
for the B-B Score and higher SRM for the Constant (ES = 1.05; SRM = 1.98) and 
relative Constant (ES = 1.04; SRM = 2.02). The AUC was calculated for the 
discrimination between patients with or without a capsulitis. Its value (AUC = 0.99) 
was excellent, largely above the 0.70 threshold, with an affected-non-affected side 
cut-off value at 82.1%. The specificity was nominally perfect (100%) and the sensitivity 
was excellent (95%). No floor and ceiling effects were detected (see sub-section 4.3.4 
“Responsiveness”, within Chapter 4, Table 4.6 p. 142, Table 4.7 p. 143 and 4.8 p. 
144). Due to the scarce literature, no table is provided to summarize the levels of 
evidence for measurement properties in this subpopulation. It can only be stated that 
the B-B Score displays adequate responsiveness, with a low level of evidence, and 
that its comparison with PROMs shows lower responsiveness than the Constant and 
better responsiveness than the SST and QuickDASH, with a low level of evidence. 
5.3.2.2.1. Measurement properties of MAB 
outcome measures in mixed surgical/non-
surgical humerus fractures (Mi-F) 
The Phase 3 study was the only measurement properties study on MAB outcome 
measures following proximal humeral fracture. In this study, the measurement 
properties of the B-B Score have been partially investigated, in a mixed sample of 
surgically and conservatively treated patients. The reliability and interpretability 
aspects of this outcome measure have not been reported specifically in this 
population. Concerning the convergent validity with PROMs, the B-B Score 
correlation was moderate with the Constant (r = 0.70), relative Constant (r = 0.69), 
SST (r = 0.66) and low with the QuickDASH (r = - 0.40). 
Concerning responsiveness, the ES (ES = 1.94) and SRM (SRM = 1.98) were slightly 
inferior to that of the Constant (Constant ES = 2.09 and SRM = 2.02; relative Constant 
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ES = 2.10 and SRM = 2.09) but superior to that of the SST (ES =1.65; SRM = 1.70) 
and the QuickDASH (ES = 1.25; SRM = 1.07). The discriminative power between 
affected and non-affected participants was excellent (AUC = 0.98), with an affected-
non-affected cut-off at 71.6%, due to high specificity (96%) and perfect sensitivity 
(100%) No floor effect, defined as 0 + MDC, was found. The absolute change 
correlations were moderate to high (r = 0.61 – 0.78). No ceiling effect was detected, 
as no patient reached 100% in this subgroup (see sub-section 4.3.4 
“Responsiveness”, within Chapter 4, Table 4.6 p. 142, Table 4.7 p. 143 and 4.8 p. 
144). 
 Discussion 
 Overview of the literature review process 
This review collated and compared the measurement properties of currently used 
patient-reported and MAB outcome measures of function in frequent shoulder 
pathologies. It aimed therefore at determining if an approach has advantages over 
the other one, considering their respective measurement properties.  
More specifically to this thesis, the literature review aimed at challenging the 
measurement properties of the B-B Score reported in Phase 2 and Phase 3 of the 
thesis with the measurement properties of alternative outcome measures, considering 
both PROMs and MAB outcome measures. This comparison of the B-B Score 
clinimetric performances from Phase 2 and 3 with those of other outcome measures 
pursuing the same purpose has aimed at laying the foundation for circumstantiated 
recommendations on its use in various in various clinical contexts. 
The investigation of the specific measurement properties of several PROMs and MAB 
outcome measures for several treatment approaches in several pathologies was 
necessary to avoid the inappropriate aggregation of data that were produced in 
obviously different testing conditions. Although this detailed approach may in fine 
increase the specificity of recommendations and allow a thorough and fair comparison 
of the Phase 2 and 3 results of the B-B Score with alternative outcome measures, it 
implied that the results should be reported and hereafter discussed with a 
considerable level of details.  
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The results were reported separately for each one of the selected common shoulder 
pathologies (rotator cuff condition, capsulitis, osteoarthritis, proximal humerus fracture 
and shoulder instability) and for studies including samples with diversified shoulder 
pathologies. The results of each one of these groups were reported separately for 
surgical samples, non-surgical samples and mixed surgical/non surgical samples 
according to the treatment approach applied to the patients included in the study. This 
detailed reporting was required to account for the context-dependency of the 
measurement properties (Robertson et al., 2017; Riddle and Stratford, 2013; Collins 
and Roos, 2016; El Gaafary, 2016). It was implemented with the purpose of providing 
the foundations for targeted recommendations concerning the choice of outcome 
measures for the types of patients’ scenarios commonly encountered in 
physiotherapy practice.  
For feasibility reasons, the measurement properties were investigated only for the 
most commonly used PROMs, based on the published literature, while all MAB 
outcome measures were considered. The double-check that was conducted at all 
stages showed that the initial bibliographic search was near from exhaustive, 
considering the investigated databases. Only four additional articles were retrieved 
following this checking process. 
 Score selection  
It was crucial to limit the number of PROMs to ensure the feasibility of the review and 
its adequacy in reflecting actual clinical practice in shoulder function measurement. 
The number of investigated outcome measures was thus limited to five frequently 
used and considered as valid PROMs (Makhni et al., 2015; Gartsman et al., 2015).  
The PROMs’ selection based on the frequency observed in our bibliographic search 
was in line with other reviews that had investigated the use of PROMs in the literature. 
Gartsman and al. (2015) found a close ranking for the frequency of use of PROMs for 
the articles published from 2004 to 2014 in The Journal of Bone & Joint Surgery, 
except for the DASH, which was found to be more used than the SST in the 
bibliographic investigations conducted for this review. The UCLA was frequently used 
according to Gartsman and al., but these authors had estimated that this score could 
not be considered as a validated. Makhni et al. also found a similar PROM-use’ 
ranking specifically for rotator cuff evaluation in a review that encompassed six major 
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journals publishing articles on shoulder issues (Makhni et al., 2015). They reported 
that the Constant, ASES, UCLA, SST were the most commonly used, while the DASH 
only ranked 9th for rotator cuff conditions in this publication. The minor differences in 
selection between these reviews and the present one are explainable by the fact that 
the latter’s scope was larger, as the frequency of use was considered for four 
pathologies in all Medline/Pubmed indexed journals.  
The inclusion of a condition-specific tool for instability (WOSI) was necessary because 
it is recognised that generic tools perform lower than specific tools for this condition. 
This had been reported for the Constant (Conboy et al., 1996; Kemp et al., 2012; 
Dawson et al., 1999; Oh et al., 2009), UCLA (Romeo et al., 1996; Oh et al., 2009), 
ASES (Kemp et al., 2012; Romeo et al., 1996; Goldhahn et al., 2008; Oh et al., 2009), 
SST (Oh et al., 2009) and QuickDASH (Gaudelli et al., 2014). Though frequently used 
in shoulder instabilities, the ROWE was not retained because it had not previously 
undergone a full validation process (Rouleau et al., 2010; Fayad et al., 2004; Kirkley 
et al., 2003; Gartsman et al., 2015). 
Several versions of the DASH, the Constant and the ASES were available. The DASH 
and the QuickDASH PROMs were both considered and were compared to help users 
to make an informed choice between these two very similar instruments. As the 
burden is lighter using the QuickDASH, equivalent measurement properties were 
considered as advantageous for this PROM (Kolber et al., 2013; Institute for Work & 
Health). 
For the Constant Score, the relative Constant approach, which compares the patient’s 
performance to a sex and age matched group, has been developed to overcome the 
gender dependency and the decline with increasing age that were observed using the 
original approach of the Constant Score (Constant, 1986; Yian et al., 2005; Katolik et 
al., 2005; Fialka et al., 2005). Both approaches were included in this review due to 
their frequent use and because both the absolute and the relative performance to a 
matched group are of interest. Age and sex dependency of the outcome have also 
been reported for the DASH and QuickDASH, but no relative score has been found 
for these PROMS (Aasheim and Finsen, 2014; Hunsaker et al., 2002). 
Although that several versions of the ASES have been developed (Fayad et al., 2004; 
Angst et al., 2011), with different measurement properties (Beaton and Richards, 
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1998), the specific version that had been used was not always specified in the articles. 
This was an important limitation in the interpretation of the results and might explain 
controversial measurement properties for this score.  
 Overview of the retrieved literature 
The number of retrieved articles was roughly comparable for PROMs (1800) and MAB 
outcome measures (1642). Conversely, a much lower number of articles (9 vs. 85) 
could be included for the latter category. Most of the research on movement analysis 
was focused on phenomena’ analyses, and very little on the development and 
validation of interpretable outcome measures for clinicians. In addition, numerous 
articles stated solely a difference between a patient group and a healthy group for a 
given kinematic or kinetic parameter, but did not report a more extensive validation 
process. These articles were not retained within this review, as the mere statement of 
a difference between a patient and a healthy control groups is not sufficient to allow 
the monitoring of patients’ progress. 
Several factors limited the ability to compare the measurement properties more 
rigorously in this review. First, few researchers compared directly several outcome 
measures in the same population and context. The performances of outcome 
measures were not compared between articles in this review because it was hardly 
possible to determine if the variations in properties were caused by the measurement 
conditions or actually by the clinimetric performances of the outcome measures. More 
specifically, only three original studies comparing directly PROMs and MAB 
approaches were identified (Korver et al., 2014a; Jolles et al., 2011; Pichonnaz et al., 
2015a), though such studies would be of great interest to contrast their measurement 
properties in strictly identical conditions. 
In addition, the possibility to proceed to comparisons between studies was limited by 
the heterogeneity of the methodological approaches used to determine measurement 
properties. For example, eleven methods, each leading to a different result, have been 
listed to calculate the MCID in shoulder function (Beaton et al., 2011). Similarly, 
considering the responsiveness, the AUCs were calculated at different follow-up times 
and according to varying reference criteria (e.g. improvement, important 
improvement, satisfaction, perceived handicap). Likewise, heterogeneous reference 
instruments were used for calculation of correlations associated with changes in 
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performance over time. Conversely, the ES and SRM were commonly reported 
estimators of responsiveness throughout studies, though they are not recommended 
by the authors of the COSMIN checklist (Mokkink et al., 2010b). The ESs or SRMs of 
were nevertheless compared amongst outcome measures, provided that they had 
been calculated in the same study under the same conditions. Between-studies 
comparisons of ESs or SRMs were not made, due to the heterogeneity of testing 
conditions between studies. All these examples illustrate the lack of consensus that 
surrounds the methods for measurement properties’ determination.  
Additionally, the descriptions of the tested populations were frequently imprecise. This 
is an important limitation to the application of the research results to a population of 
interest, which had previously been reported by the EQUATOR Network for quality 
and transparency of health research (Yamato et al., 2016). A considerable number of 
articles investigated the measurement properties in a sample with various shoulder 
problems, of which respective proportions were not reported. These articles were 
nevertheless retained in this review because this approach is sustainable to run 
exploratory investigations at the initial stage of an outcome measure development. 
However, the use of a diversified sample limits the possibility of applying the results 
to a patient, who has by definition, a specific and not a generic shoulder condition. 
Although 82 articles were included for PROMs, it appeared that some conditions, such 
as capsulitis, surgically treated fractures or conservatively treated osteoarthritis, had 
been scarcely investigated or not investigated at all. Considering these literature 
limitations, studies with large sample sizes, specific populations and comparative use 
of several tools by independent researchers would be required to improve the ability 
to compare outcome measures and to increase the precision of estimation of their 
clinimetric capabilities. 
 Interpretation of the results 
 Normal performance definition 
The determination of a given aspect of performance capability in a healthy population 
is of importance for determining from which level of performance it should be 
considered that a shoulder condition has a functional impact, or for ascertaining 
whether a patient’s shoulder completely recovered or not at the end of a treatment. 
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Norms have to be evaluated for each outcome measure, as it cannot be taken for 
granted that all healthy people are capable of reaching the maximum score, especially 
when accounting for the loss of physiological function due to aging. Additionally, the 
determination of a cut-off value for the discrimination between a normal a pathological 
performance is useful to account for the variably of the performance in healthy 
people.. 
It might seem relatively straightforward to determine an outcome measure normative 
value, but the literature review showed that the normal performance varies across 
subpopulations, according at least to age and sex. Thus, the norm can be subject of 
controversies, as it may vary with regard to the subpopulation in which it was 
determined (Yian et al., 2005). It would be recommended to derive normative values 
from large populations to allow stratified analyses, at least according to gender and 
age. As only the normative values of the Constant Score, DASH and QuickDASH 
were based on a stratified analysis among all the outcome measures investigated 
within the context of this review, the influence of the age and sex is unknown for the 
other outcome measures. The stratified analyses has led to the development of a 
version of the outcome measure accounting for age and sex for the Constant only (i.e. 
the relative Constant), but not for the DASH and the QuickDASH. The determination 
of cut-off values is useful to define the value of the outcome measure that 
differentiates a pathological from a healthy performance, accounting for the variability 
of normal performance within the healthy population.  
The determination of a normal score has been frequently performed for MAB outcome 
measures at a developmental stage, but never in large populations. Thus, the 
reported values might be relatively imprecise and do not account for the influence of 
age and sex, due to the small size of the investigated samples.  
The definition of the normal performance and of the healthy-pathological cut-off 
values of the B-B Score have been defined in the Phase 2 and 3 studies of this thesis 
based on a small sample size (n = 20) (Pichonnaz et al., 2015a). Though the side-to-
side symmetry of the power-related metric measured in the Score was not likely to be 
age and sex-dependant, further investigations in larger samples are needed to test 
this hypothesis and to provide a precise estimation of the normal performance and of 
the healthy-pathological cut-off values. 
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 Outcome measures for shoulder function in 
diversified condition populations 
5.4.4.2.1. PROMs for non-surgical treatment of 
diversified condition populations (NSu-
DCS) 
The PROMs’ measurement properties were frequently defined based on samples 
including various shoulder pathologies. As the validity of a measurement method is 
relevant only for the population in which it has been tested, this raises questions about 
the possibility of applying these results to a specific population that might be outside 
of the scope of the populations that were included in studies. As each pathology 
potentially affects shoulder function in a different way, it may be more appropriate to 
validate measurement properties in a sample with a single diagnosis, although this 
might complicate the validation process for practical reasons related to the 
recruitment of a precise target population.  
Moreover, the possibilities to compare studies between them remains limited because 
the sample composition may differ from one study to the other, the main common 
point being merely the heterogeneity of shoulder conditions.  
The formulation of recommendations associated with non-surgical treatments of 
shoulder disorders that could be based on the direct comparison between PROMs 
remains limited and indirect evidence can only be extrapolated cautiously from studies 
investigating diversified shoulder condition samples.  
Concerning reliability, the Constant, SST and ASES had a mix of ICCs above and 
under the expected threshold, while the QuickDASH had ICCs above the ≥ 0.90 
threshold. The only direct comparison for test-retest reliability favours the DASH over 
the ASES score (Moser et al., 2012), but the DASH’s ICC remains nevertheless under 
the required ≥ 0.90 ICC value when single measurement reliability is considered 
(Portney and Watkins, 2015).  
The complete set of interpretability aspects has not been determined for any PROM. 
However, only the PASS was missing for the QuickDASH. The only study comparing 
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the floor and ceiling effects of the SST and ASES was in favour of the ASES for which 
no patients obtained the maximum or the minimum score, though the percentage of 
patients reaching maximum/minimum scores was lower than the defined <15% 
threshold for both outcome measures (Robins et al., 2017). 
In case the Constant Score is chosen for use in clinical practice, it should be 
considered that precise adherence to the recommended procedure for its use and 
previous training of the assessor are prerequisites to the tool’s application under 
optimal conditions, as its measurement properties have been shown to be better 
under these conditions (Blonna et al., 2012). This PROM is probably more sensitive 
than the other ones to these aspects, as the completion of some items (e.g. strength 
and range of motion) requires clinical skills. 
As the comparison of the DASH and the QuickDASH showed no disadvantage for the 
QuickDASH in non-surgical treatment, the latter one should be preferred in this 
context for its convenience. Although no firm recommendation can be formulated 
based on the literature, the use of this score is justifiable as it showed adequate ICC 
and AUC characteristics, and has had most of its interpretability aspects determined.  
5.4.4.2.2. PROMS for surgical treatment of 
diversified condition populations (Su-
DSC) 
No information was found on the properties of the QuickDASH. The reliability was 
adequate for all tested PROMs. Concerning, the ASES performed better than the SST 
based on ES/SRM characteristics, and also better than the Constant but to a lesser 
extent. The Constant showed adequate and slightly superior AUC compared to the 
DASH. The DASH was the only one for which all interpretability aspects were 
available (SEM, MCID, MDC, PASS), which can facilitate the clinical interpretation of 
results. 
Thus, while investigated properties had reached required thresholds, no clear 
recommendation can be formulated based on measurement properties in surgically- 
treated but diversified populations. The latter was due to missing information about 
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some PROMs and some conflicting results concerning the few direct comparisons 
that had been performed.  
5.4.4.2.3. PROMS for mixed surgical/non-surgical 
treatment of diversified conditions 
populations (Mi-DSC) 
The DASH, QuickDASH, SST and ASES, but not the Constant have been investigated 
in mixed samples of surgically or non-surgically treated patients.  
When compared in the same study, the DASH, QuickDASH and SST had comparable 
test-retest ICCs ranging from 0.83 to 0.86, which is lower than the 0.90 required 
threshold (van Kampen et al., 2013). In contrast the DASH’s test-retest reliability, was 
found to be adequate (ICC = 0.95) in a study in which it was not compared to other 
PROMs (Fayad et al., 2008a). For the ASES, one study found also insufficient test-
retest reliability (ICC = 0.84), (Michener 2002) while another other ones found 
adequate reliability (Sallay and Reed, 2003; Celik et al., 2013). Bias due to real 
change that induced systematic variability’ intrusion cannot be excluded as no study 
clearly reported that only stable patients were included in the test-retest evaluation. 
The PASS had never been calculated, and the SEM had been calculated only for the 
SST (Roddey et al., 2000). The MDC and the MCID or MCII had been calculated for 
the DASH, QuickDASH, SST and ASES (van Kampen et al., 2013; Beaton et al., 
2005; Michener et al., 2002). However, these reported MCID or MCII were of little 
interest as they were systematically lower than the MDC. This implies that when a 
clinician measures an improvement at the MCII/MCID level, he cannot be sure that 
the measured change is not due to measurement error (van der Linde et al., 2017). 
In these cases, the MDC should be considered as the threshold from which a clinically 
meaningful change happened. 
Little can be said on the responsiveness, as no comparison was possible between 
studies using various similar methods for its evaluation. It could only be stated that 
the DASH was slightly more responsive than the QuickDASH at 3 months when both 
PROMs were compared in the same study (Beaton et al., 2005). It should thus be the 
first choice among them when the patient change is of concern. 
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Based on analysed results, no recommendation can be made about the choice of a 
PROM for the evaluation in a diversified sample including surgically and 
conservatively treated patients, beyond this specific point concerning the use of the 




5.4.4.2.4. MAB outcome measures for surgical and 
non-surgical diversified shoulder 
conditions (NSu- and Su-DSC) 
To date, the research on the measurement properties of MAB outcome measure of 
shoulder function in diversified samples is scarce. Four outcome measures (P Score, 
RAV Score, M Score and B-B Score) were investigated in three studies, of which two 
are related to the Phase 2 and 3 of this thesis (Jolles et al., 2011; Pichonnaz et al., 
2015a; Pichonnaz et al., 2017). 
The reliability of the P Score, RAV Score and M Score was not reported in the 
literature, while the Phase 2 study had demonstrated adequate properties for intra- 
and inter-rater reliability.  
Concerning responsiveness, the comparison of SRM and ES was globally in favour 
of the MAB outcome measures, except for the Constant and relative Constant that 
compared to the B-B Score. The AUC demonstrated adequate discriminative power 
between improved and unimproved patients, though they were lower than those of 
the PROMs to which the B-B Score was compared.  
Based on Phase 2 results, the kinematic B-B Score’s measurement properties were 
equivalent between an inertial sensor system and a smartphone, while this 
equivalency has not been demonstrated for the P, RAV and Moment Scores 
(Pichonnaz et al., 2017). This is advantageous for the latter that is cheaper and more 
accessible and is of interest for the accessibility of clinicians to the necessary 
technology. The LoAs were higher than the 10% threshold defined in this thesis, which 
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indicates that divergences between the outcome and the real performance are 
possible for single measurements. 
Based on the few studies that have investigated the measurement properties of MAB 
outcome measures in diversified samples, this approach demonstrated convergent 
validity and adequate measurement properties. The B-B Score was the only MAB 
outcome measure that had undergone an extensive validation both previously within 
the literature and now having received further critical scrutiny with Phase 1, 2 and 3 
studies within this thesis. However, the level of evidence about this score’s 
measurement properties remains limited, as the results have not been replicated in 
other studies to date.  
In the present state of the literature, it can be stated that the existing MAB outcome 
measures display adequate measurement properties, but the body of knowledge is 
insufficient to conclude that they might have superiority or inferiority compared to the 
analysed PROMs. Levels of evidence of MAB outcome measures measurement 
properties in samples including diversified conditions are summarised in Table 5.6. 
 
5.4.4.2.5. Benchmarking of measurement 
properties of all outcome measures 
determined in diversified populations 
samples (NS-, S- and Mi-DSC) 
The use of samples including patients with various pathologies is very frequent in 
validation studies. This is understandable due to the difficulty of recruiting samples of 
patients with precisely determined pathologies. The latter represents high 
administrative workloads to achieve the separate validation of an outcome measure 
in a variety of precisely defined shoulder conditions. However, this situation raises 
several concerns with regard to the reported results, all other things being equal.  
There is first a conceptual problem about the definition of the target population. 
“Patients with shoulder conditions” cannot be considered as a homogenous 
population, as each separate pathology potentially impairs function in a different way 
and affects people having different characteristics, (e.g. when the pathology is related 
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to aging or lifestyle). For example, day-to-day variation and change over time will 
obviously influence test-retest reliability and responsiveness, respectively. 
Moreover, the possibility of comparing studies including diversified pathologies in 
various proportions remains limited. In fact, the common point between the research 
samples is essentially that they are heterogeneous.  
Thus, researchers including diversified samples within their studies should mainly 
have the goal of running exploratory studies to offer a first insight into measurement 
properties, unless they include large enough samples to conduct more targeted 
analyses of subgroups. Though this thesis’ author is aware of this limitation, statistics 
including a mix of several pathologies were conducted to allow for the subsequent 
comparisons of the B-B Score measurement properties in this literature review. 
No clear recommendation can be made for the choice of a shoulder function PROM 
in diversified populations involving non-surgically treated or surgically treated patients 
or a mixture of both. No PROM showed consistently superior reliability or 
responsiveness across studies. The DASH was the most extensively investigated 
outcome measure for surgically treated patients, and the QuickDASH for 
conservatively treated patients, which can facilitate the clinical interpretation of results 
in these populations when these outcome measures are used.  
The information on MAB outcome measures was incomplete, which might restrict 
possibilities for the users to interpret the results of their measurements in some 
circumstances. However, the reliability of MAB outcome measures was consistently 
within required standards. MAB outcome measures’ responsiveness was adequate 
considering AUC and change correlation values, and their ES was even superior to 
that of the PROMs for the Power, RAV and Moment Scores, as reported by Jolles et 
al. (2011). However, the data are not sufficient in scope yet to draw conclusions on 
the superiority or inferiority of their responsiveness compared to PROMs. The overall 
level of evidence remains low due to the lack of replication studies to date. 
Despite research that is emerging from the literature and added to by the results of 
Phase 1, 2 and 3 studies in this thesis, it would seem that the MAB outcome measures 
represent a promising but still to be fully-investigated alternative to PROMs for 
shoulder function evaluation in samples, including those involving diversified 
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pathologies. Their superiority or inferiority over PROMs cannot presently be 
established due to the lack of data. 
 Outcome measures for shoulder function in 
rotator cuff conditions (RCC)  
5.4.4.3.1. PROMs measurement properties in non-
surgical rotator cuff (NSu-RCC) 
The Constant showed adequate reliability. There is a controversy about the 
magnitude of the interpretability aspects, which is problematic for clinical 
interpretation of results, as the values considerably vary from one study to single-
measurement another. It might be that the use of a fixed isometric dynamometer 
produces more stable values than a hand-held dynamometer but this should be 
confirmed by a dedicated study.  
A ceiling effect was observed for the relative Constant only. This ceiling effect might 
be due to the fact that rotator cuff does not always induce an important functional loss 
and some undetected tears are also present in the general population (Sher et al., 
1995). The distinction of the function of patients and supposedly healthy subjects may 
thus be difficult. This may explain why the Constant discriminative power is lower in 
rotator cuff conditions when the cuff is intact compared to when the cuff is torn 
(Holmgren et al., 2014). 
The DASH score’s reliability was below or above the threshold for acceptable 
reliability according to the findings of a specific study (ICC ≥ 0.90). Though reported, 
its MCID cannot be considered as valid as the MDC is considerably higher than the 
MCID. The DASH score’s responsiveness was found to be adequate (AUC = 0.77) 
(De Vet et al., 2011c). No study has investigated yet if the QuickDASH could efficiently 
replace the DASH for the evaluation of conservative treatment of rotator cuff 
conditions. 
As little information is available on the ASES clinimetric qualities, this PROM cannot 
be recommended for non-surgical rotator cuff evaluation. The SST showed adequate 
reliability and most of its interpretability aspects were investigated, but little is known 
about its responsiveness. Caution is warranted when interpreting the score of patients 
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performing low on the SST, as there is a controversy on the presence or absence of 
a floor effect. 
The comparison between the SST and the ASES was advantageous for the ASES 
that showed no floor effect while the SST did when both scores were investigated in 
the same testing conditions (Beckmann et al., 2015; Tashjian et al., 2010). The study 
that compared the responsiveness of the Constant and the DASH showed lower 
responsiveness for the latter (de Witte et al., 2012).  
The DASH and the Constant Score were the most extensively investigated outcome 
measures, while limited information was available on the SST’s responsiveness and 
the ASES’s reliability and responsiveness. The Constant should be preferred in 
situations where the responsiveness is paramount, and the DASH when the 
interpretation is to be based on consensual interpretability aspects and this approach 
is of prime importance.  
5.4.4.3.2. PROMs measurement properties in 
surgical rotator cuff (Su-RCC) 
The data on measurement properties were sparse following rotator cuff surgery, as 
none of the selected PROMs has been extensively investigated. The reliability has 
been investigated for the SST only, with an excellent result for this outcome measure. 
Only the MCID of the Constant Score has been investigated. Using the common 
anchor-based method, value around 10 – 11 points represents a clinically useful 
change for the patient using the Constant Score. However, the two studies that 
investigated the MCID emphasised more generally that the MCID value is highly 
dependent of the method used to determine it (Christiansen et al., 2015; Kukkonen et 
al., 2013). 
The responsiveness was the most frequently investigated property. However, 
separate analysis of the studies provided little specific and usable information on ES 
and SRM magnitude, due to the variations in sample composition, timeframe and 
applied treatments. Similarly, change correlations were not comparable, as the 




Direct comparison amongst PROMs within the same study showed that the 
QuickDASH and the DASH have similar responsiveness (Macdermid et al., 2015). 
This result was favourable for the latter score, which is simpler in its administration. 
The comparison of the DASH’s and SST’s responsiveness in improved, equivocal and 
negative response to treatment subgroups showed no clear advantage of one score 
over the other (MacDermid et al., 2006). The Constant Score showed adequate ability 
to discriminate patients who improved or not (Christiansen et al., 2015), but various 
change correlations (O'Connor et al., 1999). The comparison of the Constant and the 
ASES responsiveness was in favour of the Constant Score, when considering 
responses for either the absolute or for the relative Constant Score (Holtby and 
Razmjou, 2005).  
No strong recommendation as to which might be the best PROM amongst those 
selected for the assessment of patients’ shoulder function following rotator cuff 
surgery can be made based on the retrieved data, due to the inherent limitations of 
research within the literature. The Constant Score has a slight advantage over the 
other PROMs in the present state of knowledge, as it showed superior 
responsiveness to ASES in a direct comparison and its MCID has been determined 
in this population, which is useful for interpreting the meaning of a change in the 
function of the shoulder for the patient. However, its reliability has not been 
investigated in this population.  
5.4.4.3.3. Measurement properties of MAB 
outcome measures in surgical rotator 
cuff conditions (NSu- and Su-RCC) 
A limited number of studies investigated the measurement properties of MAB 
outcome measures for shoulder function evaluation in rotator cuff conditions. Two 
studies, assessing arm underuse and muscular activation time were essentially 
exploratory and provided limited information on measurement properties. In both 
studies, the scores from the MAB outcome measures were poorly correlated to those 
derived from shoulder function PROMs. Thus, further research is needed to determine 
more specifically the concepts that these outcome measures are measuring.  
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Several properties were investigated for the ARS and COMP. However, the 
convergent validity of these scores was limited, as shown by their low correlations 
with the shoulder function PROMs.  
The discriminative power between patients and healthy controls was investigated for 
the ARS, the COMP and the B-B Score, which all showed good to excellent 
discrimination capacity. The B-B Score showed better specificity and lower sensitivity 
than the ARS and better specificity and sensitivity than the COMP (B-B Score: 
specificity 90%, sensitivity 90%; ARS: specificity 81%, sensitivity 98%; . COMP: 
specificity 85%; sensitivity 84%). In contrast to the other MAB outcome measures, the 
B-B Score was related to PROMs, and can thus be considered as a specific 
measurement of shoulder function. 
The literature review showed that the B-B Score discriminative power and 
responsiveness had been extensively investigated in non-surgical rotator cuff 
conditions. In addition, it highlighted some limitations, as the ICCs for intra- and inter-
rater reliability and the clinical values had not been specifically defined for this 
pathology, either to avoid overwhelming details in the reporting of results, or because 
the statistics required large samples to be conducted. Nevertheless, more information 
was available for the B-B Score, than for other MAB outcome measures. It was also 
shown to be the only MAB outcome measure that was consistently related to shoulder 
function PROMs, though the COMP Score rely on the same metric and almost the 
same movements (hand to the back + hand behind the head vs. hand to the back + 
hand to the ceiling as to change a bulb for the B-B Score). Both Score are simplified 
versions of the P Score, but the systematic approach that had been used at the 
conception stage of the B-B Score appears to have preserved the relationship to 
shoulder function during the simplification process (Coley et al., 2007a; Pichonnaz et 






5.4.4.3.4. Benchmarking of measurement 
properties of outcomes measures in 
surgical rotator cuff conditions (NSu- 
and Su-RCC) 
No general recommendation can be formulated for the informed choice of an outcome 
measure for the evaluation of patients with rotator cuff conditions, as none 
demonstrated superior measurement properties over the other ones. Users should 
refer to the above intermediate syntheses (PROMs non-surgical p. 265 - 266, PROMs 
surgical p. 266 - 267, MAB outcome measures p. 267 - 268 and Benchmarking of 
measurement properties of outcomes measures in rotator cuff outcome measures p. 
269 - 270) to choose the best tool for their specific needs. 
No PROM demonstrated globally superior measurement properties, either for non-
surgical or for surgical treatment of patients. On the other hand, the research on MAB 
outcome measures validation in this field is still in its infancy. Few MAB outcome 
measures exist and their measurement properties have not been exhaustively 
investigated for this population. The thesis Phase 3 study was useful in this respect, 
as the B-B Score is presently the only MAB outcome measure that has demonstrated 
convergent validity with the PROMs and can therefore claims to assess shoulder 
function.  
Most studies reported an adequate reliability of outcome measures, with comparable 
ICC values for MAB outcome measures and PROMs. When a direct comparison was 
made between PROMs and MAB outcome measure, the latter outcome measures 
(ARS and COMP) showed better reliability than the DASH and SST. No interpretability 
aspects have been specifically determined in surgically or conservatively treated 
rotator cuff populations for MAB outcome measures, which limits the possibility to 
interpret the results of clinical measurements. The B-B Score showed superior 
responsiveness to that of four currently used shoulder function PROMs, when this 
characteristic was assessed using ES and SRM. However, more research is needed 
before making conclusions about responsiveness, because the B-B Score change 
correlation was adequate with the Constant and relative Constant Scores only. 
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Globally, the lack of data prevents conclusions on the respective 
advantages/limitations of the PROMs or the MAB approach in rotator cuff pathologies. 
However, although the body of knowledge on them is still limited, the MAB outcome 
measures represent a promising path for further exploration as they displayed 
equivalent or superior properties when direct comparisons were performed. 
 Outcome measures for shoulder function in 
glenohumeral osteoarthritis (OA)  
5.4.4.4.1. PROMs measurement properties in 
osteoarthritis (Su-, NS- and Mi-OA) 
Conversely to the situation for non-surgical treatments, some properties have been 
calculated for all the selected outcome measures concerning the evaluation of 
shoulder functional capabilities after surgical treatments. Most of the studies 
proceeded to direct comparison between scores, which allows for comparison 
between tools’ measurement properties tested under the same conditions. The 
responsiveness has been tested for all outcome measures, and five studies have 
performed a comparison between several of the selected outcome measures (Angst 
et al., 2004; Angst et al., 2008; Angst et al., 2009; Sciascia et al., 2017; Roy et al., 
2010; Macdermid et al., 2015). Yet, little information was available for reliability and 
interpretability aspects following surgery, which limits the interpretability of the score 
value or score change in patients.  
Although the responsiveness and discriminative power of the Constant and the ASES 
are closely matched, Sciascia et al. calculated a better relative efficiency for the 
Constant (0.8) (Sciascia et al., 2017). Comparable responsiveness was found 
between the DASH and the QuickDASH, which is advantageous for the QuickDASH, 
which is simpler to complete. 
The DASH was less responsive than the SST, Constant and ASES when directly 
compared to them. These three PROMs constitute preferable options for the 
evaluation of shoulder function following surgery to address shoulder OA, in the 
present state of knowledge. However, these recommendations might need to be 
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refined based on future research to determine the reliability and interpretability 
aspects of these scores.  
 Outcome measures for shoulder function in 
shoulder instability (SI) 
5.4.4.5.1. PROMs measurement properties in non-
surgical shoulder instability (NSu-SI) 
The WOSI was the most extensively validated PROMs for shoulder function in non-
surgically treated shoulder instability, while the data were patchy or absent for the 
other PROMs. Its single-measurement reliability was unanimously found to be 
adequate. All the interpretability aspects have been investigated except the PASS. 
However, there is a controversy on the exact magnitude of the SEM and MDC, which 
is a limitation for the clinical interpretation of results.  
c The comparisons were consistently favouring to the WOSI, which always displayed 
larger SRM than the other score outcome measures and significantly higher 
discriminative power between improved and unimproved patients. No floor or ceiling 
effects were detected using the reference 15% threshold for these aspects of 
measurement properties. 
Therefore, the WOSI appears to be the first choice for the evaluation of non-surgical 
shoulder instability among the tested PROMs. The WOSI has adequate measurement 
properties, though LoAs should warrant caution in outcome interpretation when 
analysing the performance of a patient on one occasion. The latter controversies 
about interpretability aspects may also render the need for clinical interpretations to 
be undertaken with caution. Another review should compare the WOSI measurement 
properties to that of other outcome measures that are specific to shoulder instability, 
in order to compare this PROMs to other measurement tools that were designed 
exactly for the same purpose (e.g. the Oxford Shoulder Instability Score (OSIS), 
Melbourne Instability Shoulder Score (MISS) and the Rowe instability score) 
(Plancher and Lipnick, 2009).  
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5.4.4.5.2. PROMs measurement properties in 
surgical shoulder instability (Su-SI) 
Three studies investigated the measurement properties of PROMs for surgical 
shoulder instability treatment (Gaudelli et al., 2014; Salomonsson et al., 2009; Oh et 
al., 2009). Only the WOSI and QuickDASH were involved. It appears from the study 
that investigated their measurement properties that the WOSI was more responsive 
and more reliable than the QuickDASH, though its ICC was lower than required when 
the questionnaire was administered and completed remotely by telephone.  
The clinical interpretation’ possibilities are limited as no interpretability aspect was 
determined in this context. Based on these limited results, the only conclusion that 
can be stated was that the WOSI offers advantages over the QuickDASH for the 
evaluation of surgical shoulder instability treatments and that the outcome measure 
completion over the phone has insufficient reliability.  
5.4.4.5.3. PROMs measurement properties in 
mixed surgical/non-surgical shoulder 
instability (Mi-SI) 
Little information was available, so that no direct comparison can be made between 
outcome measures. In this suboptimal situation to propose recommendation, the 
WOSI showed adequate reliability (at a low level of evidence) and responsiveness (at 
a low level of evidence), but no interpretability aspect is available for the clinical 
interpretation of the score in this population, except for the MCID. Due to the scarce 
literature, no table is provided to summarize the levels of evidence for measurement 
properties in this subpopulation 
5.4.4.5.4. Measurement properties of MAB 
outcome measures in non-surgical 
shoulder instability (NSu-SI) 
Little attention has been given to the validation of MAB outcome measures for the 
evaluation of shoulder instability, as only one study had evaluated the measurement 
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properties of a kinematic outcome measure for non-surgical shoulder instability 
(Pichonnaz et al., 2015a). The Phase 3 study that investigated the B-B Score 
measurement properties specifically in this population was innovative, in the sense 
that it was the first study that intended to develop and investigate a score specifically 
for these pathologies, according to the literature retrieved on MAB outcome scores 
and to the best of the author’s knowledge. 
The strength of its correlations with PROMs showed that the B-B Score had a 
moderate relationship to the other outcome measures of shoulder function, when 
instability was considered. The direct comparison between the B-B Score and several 
PROMs showed that it was considerably less responsive than the WOSI, and to a 
lesser extent the Constant Score for shoulder instability evaluation. Moreover, its 
discriminative power between patients and controls was insufficient, essentially 
because of a lack of specificity. Therefore, the score was not efficient for identifying 
correctly the patients with shoulder instability, because of an excessive proportion of 
false positive results.  
In summary, the WOSI was superior to the B-B Score for shoulder instability 
evaluation in a sample of conservatively treated patients and no other MAB outcome 
measure was available to date for shoulder instability evaluation.  
The Phase 2 study highlighted the poor measurement properties of the B-B Score for 
conservatively treated shoulder instability. The aim of this thesis (i.e. validate the 
simplest possible kinematic shoulder function scoring procedure applicable in clinical 
practice and research) was therefore not reached specifically for this condition, as the 
B-B Score clinimetric weaknesses prevent its application for shoulder instabilities. By 
contrast, this result highlight that the detailed analysis of pathological subgroups 
provided in this thesis was required to offer a realistic picture of the B-B Score 
measurement properties in each investigated shoulder pathology. Analyses of the 
complete sample of patients were useful for the comparison between the B-B Score 
clinimetric performance and its alternative outcome measures. They made it possible 
to use the abundant literature that relies on study samples including diversified 




5.4.4.5.5. Benchmarking of measurement 
properties of outcome measures in 
shoulder instability (Su-, NS- and M-SI) 
The WOSI was the most frequently evaluated PROM in nonsurgical, surgical and 
mixed nonsurgical/surgical samples. It consistently showed higher clinimetric 
performance when compared to concurrent alternatives, whether it is PROMs or MAB 
outcome measures. This result highlights that a specific tool for shoulder function 
evaluation in instability is better performing than any generic tool for shoulder function. 
Several authors had previously put forward that the WOSI is the most rigorously 
validated instability outcome measure and that it has thus become the most used in 
recent years (Rouleau et al., 2010; Angst et al., 2011; Wylie et al., 2014). 
Thus, the WOSI is presently the first choice for shoulder instability among selected 
PROMs and MAB outcome measures. The WOSI has however, some limitations 
related to the difficulty to interpret the clinical meaning of results due to some 
controversial or missing interpretability aspects. An interpretation of results based on 
a single measurement may also be compromised by the variability of measurement, 
as indicated by the relatively inflated magnitude of the LoA.  
Very little attention has been put on the development of a valid MAB outcome 
measure for instability evaluation. The only the properties of the B-B Score have been 
partially investigated, with diminished results for this particular pathology (shoulder 
instability). This is contrary to the other shoulder pathologies for which the B-B Score 
had been tested (Pichonnaz et al., 2015a). 
The results of the researches conducted in this thesis were further reinforced by the 
subsequent literature review. This might indicate that a specific approach to shoulder 
instability should be used to develop an outcome measure able to capture the 
function-related movement alterations in this condition. Shoulder instability is actually 
mainly characterised by apprehension of movements at risk of dislocation, while the 
other shoulder pathologies retained in this review are essentially characterised by the 
association of pain, stiffness and weakness, in various proportions. A MAB outcome 
measure for shoulder instability should thus ideally be able to challenge the patient’s 
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range of motion that causes apprehension during shoulder movements, but which 
does so without compromising the patient’s safety. 
 Outcome measures for shoulder function in 
capsulitis (C) (frozen shoulder)  
Measurement properties of outcome measures in capsulitis (NSu-C) 
Little focus has been put on the evaluation of PROMs and MAB outcome measures 
for assessing function capabilities in capsulitis. Only one study was found for each 
approach. 
The DASH demonstrated an adequate discriminative power between 
improved/unimproved patients and the B-B Score demonstrated an excellent 
discriminative power between affected/healthy controls. These values cannot be 
compared as the discrimination criteria were not the same. 
The B-B Score’s convergent validity was adequate considering its correlation with 
PROMs. Conversely, the change correlations were lower, indicating that the 
evaluation of change had limited relationship to that measured using PROMs. 
The BB Score’s ES compared favourably, and its SRM equivalently, with those of 
PROMs, when a direct comparison was performed in similar conditions. 
Based on the limited evidence available, it was stated that the B-B Score displayed 
adequate responsiveness. Nevertheless, the direct comparison of responsiveness of 
the B-B Score and that derived from PROMs favoured the B-B Score considering ES’ 
responses, and equivalent when considering the SRM’s responses.  
Provided that the other measurement properties are adequate, these results suggest 
that a MAB outcome measures may have the potential to challenge the PROMs for 
effective functional assessment of this pathology. However, relevant data were scarce 
and more research is needed to complete the knowledge on both approaches for 




 Outcome measures for shoulder function in 
humerus fracture (F) 
5.4.4.7.1. PROMs measurement properties in non-
surgical humerus fracture (NSu-F) 
Limited evidence was available on the measurement properties of PROMs in non-
surgical treatment of proximal humerus fracture. From the available results, it appears 
that the DASH is slightly less reliable, but also slightly more responsive than the 
Constant. Thus, the Constant has an advantage as an outcome measure when a 
measure at a given time point is required, due to its superior reliability, while the DASH 
is more efficient for detecting the patient’s change amongst several time points. Due 
to the scarce literature, no table is provided to summarize the levels of evidence for 
measurement properties in this subpopulation. 
5.4.4.7.2. PROMs measurement properties in 
mixed surgical/non-surgical humerus 
fracture (Mi-F) 
There is limited evidence on the measurement properties of the PROMs in mixed 
samples of non-surgically and surgically treated patients. Only two outcome 
measures were partially investigated and compared, i.e. the DASH and the Constant. 
No information was available on the reliability of the Constant, while the DASH’s 
reliability was adequate. The defined interpretability aspects (SEM, MDC, MCID) were 
closely matched amongst them. The LoAs were also evaluated for the DASH only, 
but they were larger than the ± 10% threshold used in this review.  
Concerning responsiveness, the change scores of both PROMs were moderately 
correlated. The ES and SRM were of comparable magnitude between scores, but the 
DASH showed a better ability to discriminate the patient who improved by a small 
amount better from those who did not improve. However, it showed a marked ceiling 
effect at 12 months that was not present for the Constant. 
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The DASH should be preferred to the Constant at an early stage of recovery, because 
it demonstrated a higher ability to detect improvement and more interpretability 
aspects were determined for this score than for the Constant. However, it should not 
be used at a late stage of recovery, due to its consequent ceiling effect.  
The reliability still needs to be compared between these scores to be able to formulate 
more informed recommendations for the preferred use of one or other PROM. 
5.4.4.7.3. Measurement properties of MAB 
outcome measures in humerus fracture 
(NS- and Mi-F) 
Little research has been conducted on MAB outcome measures in patients with 
proximal humeral fracture, as only the study related to this thesis was found in a mixed 
sample of surgically and non-surgically treated patients (Pichonnaz et al., 2015a). 
The strength of the correlations with the selected PROMs showed that the B-B Score 
evaluated a shoulder function concept that is related to those underpinning the 
Constant and SST, and to a lesser extend the QuickDASH. The reliability and critical 
the outcome measure in this population were not determined. Thus, no comparison 
with PROMs can be made on these aspects. The responsiveness was adequate, as 
only the Constant showed a slightly higher ES and SRM. Moreover the change 
correlations showed a good relationship with the selected PROMs for the evaluation 
of shoulder function’ change.  
5.4.4.7.4. Benchmarking of measurement 
properties of outcome measures in 
humerus fractures (NSu- and Mi-F) 
Little research has been conducted to investigate the clinimetric properties of outcome 
measures for shoulder function assessment following humerus fracture. However, 
some of the researches compared several outcome measures, so that conclusions 
can be drawn on some issues. 
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The Constant and the DASH were the only scores that were investigated and 
compared, in non-surgically treated and in mixed of surgically/non-surgically treated 
samples. Their measurement properties were globally comparable, with a better 
reliability for the Constant in non-surgically treated shoulders and a better 
responsiveness for the DASH at an early stage, which revealed an advantage 
clinimetrically but was later diminished by a consequent ceiling effect at one year 
following fracture. 
Only one MAB outcome measure, the B-B Score was investigated and compared to 
PROMs in mixed samples of surgically/non-surgically treated patients. This score was 
correlated to shoulder function PROMs and can be thus considered as a shoulder 
function focused outcome measure. Its responsiveness was slightly lower than that of 
the Constant and higher than that of the QuickDASH, and to a lower extent, the SST 
based on ES and SRM. Its change correlations with PROMs showed that the 
evaluation of change using this score is comparable to that using PROMs.  
Based on these statements and on the compared measurement properties, it would 
appear that the Constant and B-B Score perform comparably concerning the 
responsiveness following shoulder fracture, but that the literature was insufficient to 
draw firm conclusions. 
 Synthesis on the measurement properties of 
PROMs and MAB outcome measures in 
shoulder disorders, with emphasis on the 
thesis achievements  
The synthesis of the results of the literature review provides an opportunity to address 
general considerations on methods for measuring function of the shoulder. It also 
allows a certain distance to be taken with the results of the studies carried out in the 
thesis, which is why it was carried out at the end of the work, and not upstream, as is 
traditionally the case. 
The corpus of research on PROMs and MAB outcome measures was substantial and 
approximately equivalent in scope considering the number of publications. However, 
the research on MAB outcome measures has rarely led to a basis from which an 
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effective scoring system can be developed, and even less so in the pursuit of a tool 
that is applicable within clinical practice.  
Based on this statement from the literature, the developments undertaken in this 
thesis can be considered as innovative in that they rely on MAB methods, while taking 
advantage of technological opportunities (use of a smartphone) and possibilities to 
simplify the measurement procedure (use of the B-B Score) to propose an approach 
that can be applied for routine clinical assessment. The interdisciplinary collaboration 
between physiotherapists, medical doctors and engineers has helped to reduce the 
gap between the conception of an efficient movement analysis method and its clinical 
application. 
Measurement properties were frequently determined in diversified patient samples 
and, to a lower extent, within rotator cuff populations. Conversely, little research had 
addressed the measurement properties in fractures and even less in capsulitis. This 
is problematic for the clinical transference of useful information, as the measurement 
properties are context-dependent (Riddle and Stratford, 2013; Robertson et al., 2017; 
El Gaafary, 2016; Collins and Roos, 2016) and the patient, who presents with a 
defined pathology and with specific consequences to shoulder function, is not always 
comparable to the population that has been the target for research. The thesis’ data 
were gathered and analysed separately for various common shoulder disorders to 
allow a circumstantiated interpretation of the investigated measurement properties. 
The Constant and the DASH/QuickDASH were the most extensively investigated 
PROMs. Based on the results of this review, no PROM can considered as globally 
superior to the other ones, and thus none can be recommended as a generic standard 
for shoulder function’ measurement. These results were in line with previously 
published systematic reviews on PROMs measurement properties standard (Fayad 
et al., 2005; Oh et al., 2009; Placzek et al., 2004; Roy et al., 2009).  
Nevertheless, some PROMs might have demonstrated an equivalency or an 
advantage compared to the others when a direct comparison was performed in a 
given target population. The WOSI is the only one PROM that demonstrated overall 
superior measurement properties to the other and in comparison to MAB outcome 
measures as well, when shoulder instability was considered. The good measurement 
properties of the WOSI had previously been reported by other authors (Angst et al., 
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2011; Salomonsson et al., 2009). As the WOSI was the only condition-specific 
outcome measure amongst the selected ones, this finding raises the question of 
whether specific outcome measures should be developed to improve the quality of 
shoulder function assessment, although this option would further increase the already 
high number of shoulder function outcome measures.  
Despite the substantial body of literature on shoulder movement analysis, few MAB 
outcome measures exist. Furthermore, the development and the clinical application 
of most of them has not been continued beyond the initial studies. Conversely, this 
thesis’ work was oriented toward clinical applicability. Much communication, 
marketing and technical work would still be necessary for its routine application to 
become a reality, but the smartphone B-B Score has nevertheless been designed to 
make it technically feasible. 
Some of MAB outcome measures (B-B Score and P Score) are correlated to PROMs 
and can thus be considered to investigate the same concept of shoulder function. As 
a consequence, they might concur with the PROMs for shoulder function’ evaluation. 
Other ones (ARS, COMP, arm underuse, Temg/mov), that were hardly correlated with 
PROMs, investigate different concepts of shoulder function compared to PROMs. 
More research is needed to understand better what encompasses the concepts 
captured by these MAB outcome measures. A large variety of biomechanical 
parameters can be measured using MAB methods. However, they cannot be a priori 
considered to reflect shoulder function until their convergent validity has been 
demonstrated by an adequate correlation between them and recognised shoulder 
function measurement tools (de los Reyes-Guzman et al., 2014).  
The B-B Score relationship to PROMs was expected, because the measured power-
related parameter [(deg/s)*(m/s2)] had precisely been selected due to its relationship 
to shoulder function from the conception of the P Score (the parent score from which 
the B-B Score was derived) and of the B-B Score (Coley et al., 2007a; Pichonnaz et 
al., 2015c). The Phase 3 study confirmed the adequacy (r ≥ 0.50) of the B-B Score 
for shoulder function evaluation of patients’ populations with rotator cuff condition, 
humerus fracture or capsulitis, but not for shoulder instability. Again, these results, 
which are differentiated according to pathologies, highlight the context-dependency 
of the measurement properties of outcome measures. 
Chapter five 
281. 
More research is needed to investigate exhaustively the measurement properties of 
MAB outcome measures in various populations with shoulder conditions. The thesis 
aimed at an extensive validation of the B-B Score and, consequently, it came up as 
the most extensively validated MAB outcome measures to date. For recall, its normal 
performance, its reliability and interpretability aspects in a diversified sample and its 
convergent validity and responsiveness for the pathologies selected in this review 
have been investigated in Phase 3 study and published (Pichonnaz et al., 2015a). 
Additionally, it had been demonstrated in Phase 2 study  and its related article that 
the B-B Score measurement can be performed using a smartphone, with similar 
properties to a dedicated IMU device (Pichonnaz et al., 2017).  
It would be worth developing more the exploration and validation of MAB outcome 
measures, as well as their transfer into clinical practice, provided that they display 
sound measurement properties at the initial stage of testing. On this latter point, the 
systematic step-by-step validation approach has been effective, since it demonstrated 
that the use of a smartphone did not lead to a degradation of the measurement 
properties of the B-B Score, compared to an inertial measurement system, which is 
the tool used for all other selected MAB outcome measure. Though the practicality 
was not a formally investigated aspect of the literature review, it appears that the B-B 
Score is the only MAB Score that was designed to be measured with a cheap and 
accessible device. However, to date no score, including the B-B Score, has been 
exhaustively tested, including reliability and interpretability aspects for specific 
shoulder conditions. The literature review highlighted additional patients’ population 
for which validation studies would be useful to extent the knowledge about the B-B 
Score measurement properties. 
It was striking to state in this review, that the development of the few existing MAB 
outcome measures have very rarely been followed by applications in treatment 
outcome studies, as could be observed during the inspection of titles and abstracts of 
articles. This is a limitation to the acquisition of experience on these outcome 
measures. This situation highlights the lack of focus on clinical applicability at the 
development stage of MAB outcome measures, as well as the shortcomings of the 
knowledge transfer from research into professional practice. Though the B-B Score 
was designed to be easily applicable in clinical practice and research, mainly in the 
study of Phase 3 that tested the measurement capacities of the smartphone, the lack 
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of actual clinical applications also apply to this MAB outcome measure to date. Its 
actual use in the future, if possible in conjunction with other outcome measures to 
allow for comparison, will be necessary to gain more knowledge on the B-B Score 
clinical capabilities.  
The Phase 2 and 3 studies demonstrated that, except for shoulder instability, the B-B 
Score measurement properties were appropriate, to the exception of the LoAs that 
were larger than the ≤ 10% arbitrary defined threshold. The literature review confirmed 
that the B-B Score compared equally and sometimes favourably to PROMs in direct 
and indirect comparisons with alternative outcome measures to the exception of LoAs 
that were larger. Although LoAs ≥ 10% were frequently reported in this review, this 
appeared as a shortcoming of the B-B Score. Future work could address this issue 
for example by modifying the testing instructions in order to increase the movement 
repeatability (e.g. by using targeted movement or setting a pace) or increasing the 
number of replications. Three replications had been defined in Phase 1 study as an 
optimal number to contain measurement variability while limiting measurement 
constraints. Nevertheless, further investigations on the use of a higher number of 
replications might be conducted with the aim to improve the B-B Score reliability for 
single measurements.  
More generally, it was stated that the measurement properties of MAB outcome 
measures generally and adequately complied with requirements. In the long run, they 
might thus represent a viable alternative to overcome the controversies surrounding 
shoulder function evaluation with PROMs for most current shoulder pathologies, 
provided that more research is conducted to extensively validate and improve the 
existing MAB outcome measures, and that greater emphasis is placed on clinical 
applicability and knowledge transfer. 
 Study limitations 
For clinical interest and feasibility reasons, this review was conducted on the most 
frequently used PROMs in the most frequent shoulder pathologies. Thus, the results 
do not apply to all PROMs and are not transferable to other less frequent shoulder 
pathologies. The fact that the investigated PROMs are frequently used reflects the 
present practice, but does not imply that the selected outcome measures are 
necessarily the ones with the best measurement properties. New PROMs that have 
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been recently developed may have been developed based on presently 
recommended standards but scarcely diffused to date. The fact that the WOSI Score 
stood out for shoulder instability raise the question if conditions-specific PROMs 
would have obtained better measurement properties that generic shoulder PROMs in 
this review. 
As explained in the introduction, the conditions were not met to proceed to a formal 
quality analysis of the literature. Thus, it was not possible to present a hierarchical 
analysis of the quality of the articles. Other authors, who have conducted literature 
reviews where the COSMIN checklist could potentially be used, have chosen either 
not to rely on this checklist, or to use it without indicating how the difficulties were 
overcome, or to adapt the assessment in a transparent manner (Andreopoulou et al. 
2018; Zanudin et al. 2017). However, a selective qualitative analysis of the 
methodology was undertaken when conflicting results were found in order to 
determine the factors explaining the discrepancies. The inability to make a 
quantitative assessment of the quality of the studies prevented a comparison between 
the studies conducted in this thesis and those found in the literature. 
Differences in results were frequently induced by a lack of consensus about the 
methods to be used. This was for example, the case for the AUC criteria for 
responsiveness’ evaluation, the reference scores used for change correlations and 
the MCID/MCII determination methods. No meta-analysis could be conducted 
because of the heterogeneity of the methods, timeframes and sample composition. 
Moreover, no well-established quantitative meta-analysis methods were found to 
aggregate the data of some measurement properties. The qualitative synthesis of the 
results did not allow robust conclusion to be drawn from statistical inferences 
concerning the differences in measurement properties of the selected outcome 
measures. Similarly, previous reviews that had addressed this topic had also 
proposed a qualitative synthesis of the data (Kirkley et al., 2003; Oh et al., 2009; 
Huang et al., 2015; Harvie et al., 2005; Fayad et al., 2005; Placzek et al., 2004; Roy 
et al., 2009). The inability to perform a meta-analysis prevented drawing generalizable 
conclusions on the clinical performance of the B-B score compared to alternative 
outcome measures. 
The languages of the included articles were limited to English and French. Some 
validation studies of PROMs in a translated language might therefore have been 
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ignored. Validation studies of translations published in the two aforementioned 
languages were nevertheless included.  
In some cases, several versions of testing instructions exist for a PROM. Whenever 
possible, observed discrepancies between studies were checked to assess whether 
they might have originated because of the use of different versions or testing 
procedures. However, this was not always possible because the used version was 
not systematically reported.  
The validation studies that were only presented in congresses or in academic works 
were not retrieved in this review, because they had not undergone a full peer-reviewed 
process. However, this most likely would have had a marginal impact of the results, 
as no scientific communication of this nature was identified during the manual search 
in the articles’ references and in the websites that compile outcome measures’ 
properties. Globally, the search conducted within the retained databases was near to 
exhaustive, as the manual search elicited only a small number of additional articles. 
This review investigated the measurement properties of the measurements tools. 
Validity issues were not exhaustively investigated, except for the convergent validity 
between MAB outcome measures and PROMs, and for the floor and ceiling effects, 
which are part of content validity. This aspect was essential to address in order to 
determine whether a MAB outcome measures should be considered as an indicator 
of shoulder function or not. Other validity issues were not investigated in order to avoid 
adding to the complexity of this work. Relevant information about the validity of 
measurement tools for the assessment of shoulder functional capabilities can be 
found in other reviews (Roe et al., 2013; Makhni et al., 2015; De Baets et al., 2017; 
Oh et al., 2009; Bot et al., 2004; Fayad et al., 2004), and this should clearly be taken 
into account also when choosing a measurement tool. 
A strong point of this review was that it differentiated the measurement properties in 
several selected populations of patients and for surgical and non-surgical treatment. 
It addressed separately the issues about measurement properties known to be 
context-dependent (Robertson et al., 2017; Riddle and Stratford, 2013; Collins and 
Roos, 2016), which had not been addressed in most previous systematic reviews. 
The analysis accounting for the specificity of each pathological population added to 
the complexity of the work, but contributed to the precision and relevance of the 
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results. However, some limitations inherent in the literature have been identified in the 
implementation of this approach. The population pathologies were often defined 
succinctly, compromising the possibilities to apply the results to a single patient during 
the clinical encounter. This was especially the case when a sample with diversified 
shoulder pathologies was enrolled in a study. The latter studies were nevertheless, 
not excluded from analysis, as they represented a considerable part of the body of 
knowledge on the subject. 
Considering the substantial body of knowledge on shoulder movement analysis, it had 
been unexpected that only seven articles on the measurement properties of MAB 
outcome measures would have been retrieved. This paucity limited the possible 
comparisons with PROMS, particularly for OA, humerus fracture and capsulitis. 
Moreover, six of these articles originated from the same laboratory, with which this 
thesis’ author had collaborated. The origin of the developed MAB outcome measures 
was expected to be much more diversified at the initiation of this review. Although 
actions have been taken to ensure a fair analysis based on previously defined 
objective criteria, the author’s methodological background and experience might have 
influenced the results’ interpretation against his intentions. 
 Conclusion 
This systematic review allowed for the comparison of the measurement properties of 
the B-B Score with alternative outcome measures. It provided therefore an opportunity 
to challenge its clinimetric performance investigated in the Phase 2 and 3 studies with 
those of outcome measures using a questionnaires-based approach (PROMs) and 
those using also a MAB approach. 
More generally, it added to the body of knowledge on the outcome measures of 
shoulder function, as it was the first literature review that compared measurement 
properties of frequently-used shoulder function PROMs (Constant, DASH, SST, 
ASES and WOSI) and MAB outcome measures to the best of the author’s knowledge. 
It reported the outcome measures’ respective measurement properties separately for 
current shoulder conditions, to account for the context dependency of measurement 
properties. 
Similarly to previous systematic reviews, it stated that no PROM was globally superior 
to the other ones for shoulder function evaluation, except for the WOSI that performed 
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better than generic shoulder function PROMs for shoulder instability’ evaluation. In 
other shoulder conditions, a PROM may merely display particular advantages over 
the other ones only for a given set of conditions of evaluation. Thus, the choice of a 
PROM should be oriented by its specific measurement properties for the target 
population, and not based on general considerations. 
Concerning the retrieved body of literature, it was stated that despite the considerable 
amount of literature on PROMs, little information about the clinimetric performance of 
outcome measures was found for capsulitis and fracture evaluation. The Constant 
and DASH/QuickDASH were the most extensively investigated PROMs. Although 
they cannot be considered as superior to concurrent outcome measures in all aspects, 
they nevertheless possess a more consistent body of knowledge about their 
clinimetric characteristics to better orientate the potential user’s choice.  
The review of MAB outcome measures showed that despite the consistency of 
research on shoulder movement analysis, few investigations had resulted in the 
development of an outcome measure for shoulder function evaluation. All MAB 
outcome measures, with the exception of the B-B Score, had had their measurement 
properties investigated in one sample of population only at the development stage of 
the measurement tools. It can thus be considered that the development of MAB 
outcome measures for shoulder function assessment is still in its infancy.  
Nevertheless, the investigated properties of MAB outcome measures were generally 
adequate for their intended purposes. Also, they compared equally and sometimes 
favourably to PROMs in direct comparisons within pathologies. The B-B Score was 
the most extensively investigated MAB outcome measures to date, though its 
reliability and interpretability aspects have still to be defined in specific populations.  
This literature review allowed for an extended benchmarking for the measurement 
properties that had been previously investigated in Phase 2 and 3 studies of the 
thesis. It showed that the shortcomings of the B-B Score concerned specifically the 
clinimetric performances for the assessment of function in shoulder instability and the 
variability of single measurements highlighted by large LoAs. All other measurement 
properties were comparable to those of concurrent scores, with slight nuances for 
each testing conditions, and complied with the established standards for adequate 
measurement. The literature review highlighted that further researches on the B-B 
Score should primarily investigate the influence of modified measurement procedures 
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on the variability of single measurements, so that it performs comparably to alternative 
outcome measures with regard to this specific shortcoming. Concerning shoulder 
instability, a condition-specific approach, which differs considerably from the B-B 
Score is probably needed to asses shoulder function.  
Based on the results of this review, it appears that MAB shoulder function evaluation 
is still an emerging field. The results are presently too limited to be conclusive on their 
superiority or inferiority over PROMs. Nevertheless, studies on measurement 
properties conducted to date showed that they constitute, including for the B-B Score, 
a sustainable alternative or complement to frequently used PROMs. However, it 
would be worth investigating if devices that are more accessible can substitute inertial 
sensor systems to facilitate the widespread application of MAB outcome measures in 
clinical conditions, as was done for the B-B Score in Phase 2 study. Future researches 
are needed to investigate exhaustively the measurement properties of existing MAB 
outcome measures and optimise their testing procedures, as well as attempting to 
develop ones that are more efficient. The clinical applicability and the knowledge 











 General achievements 
 Conception of a founded measurement method 
This thesis has endeavoured to explore, based on contemporary clinical need, an 
alternative path for shoulder function evaluation, in order to provide, if possible, the 
clinicians with a valid, cheap and straightforward shoulder outcome measure. The 
research underpinning these ambitions took place in a context where there is an 
ongoing controversy about the best shoulder PROM to use and where transfer of 
laboratory-based movement analysis into clinical practice has remained scarce due 
to its technical complexity (Kirkley et al., 2003; Oh et al., 2009; Huang et al., 2015; 
Harvie et al., 2005; Aminian and Najafi, 2004; Clark et al., 2017). Concurrently, 
technological progress and the widespread diffusion of sensors within daily-life’ 
objects has revealed pathways for the exploration of new opportunities to improve the 
efficiency of shoulder function’ evaluation in clinical practice (Ciuti, 2015).  
Based on these statements and considering that access to suitable devices, time 
constraints and familiarity with technology are important barriers that could potentially 
be overcome, it was decided to explore to what extend a very simple movement 
analysis-based outcome measure using a smartphone, met the requirements of a 
valid/efficient measurement tool of shoulder function. During the initial phases of the 
PhD research programme (Phase 1, 2 and 3 studies) involving ‘proof of this concept’, 
everything was focused towards keeping the measurement procedure and 
instrumentation to their simplest expressions, while preserving measurement 
properties, in order to develop an efficient outcome measure. 
The kinematic B-B Score was chosen for focused explorations because it had been 
designed to capture shoulder function using only two essential movements, i.e. “hand 
to the back” + “hand to the ceiling as to change a bulb”. Initial research suggested 
that this score had potentially sound measurement properties, though this remained 
to be established with more precision in specific conservatively treated shoulder 
conditions (Pichonnaz et al., 2015c). 
Initial research conducted by the author for the purpose of his MSc dissertation 
(Pichonnaz, 2010; Pichonnaz et al., 2015c) suggested that this score had potentially 
sound measurement properties, though the measurement process remained to be 
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optimised, the practicalities and the measurement properties had to be further 
investigated and specified for common conservatively treated shoulder conditions. 
Having addressed these issues, it was then necessary to compare the clinimetric 
performance of the optimised version of the B-B Score to the alternative outcome 
measures for shoulder function evaluation, in order to provide a substantiated insight 
into its contribution to the measurement of shoulder function. 
Incremental steps from the first to the third Phase of the thesis addressed these 
issues. The Phase 1 study, which explored various possible alternatives for the 
delivery and calculation of the B-B Score, resulted in the definition of optimal testing 
and calculation procedures, amongst tested possibilities. The Phase 2 study, which 
investigated the influence of the use of a dedicated IMU system or a smartphone on 
the measured values, established that the B-B Score could be acquired with greater 
simplicity without deterioration of the measurement properties using a smartphone 
(Pichonnaz et al., 2017). The Phase 3 study, in which the detailed measurement 
properties of the smartphone B-B Score using the optimised procedure were 
investigated, resulted in their specific determination in several common shoulder 
pathologies (Pichonnaz et al., 2015a). Following these studies, it was necessary to 
consider the defined measurement properties of the B-B Score within a larger scope, 
which was done by means of a systematic literature review that included a wide range 
of alternative PROMs and MAB outcome measures for shoulder function evaluation 
 Scoring method optimisation 
 Achievements of the B-B score optimisation 
study (Phase 1)  
Phase 1 provided the foundations to underpin the choice of a justifiable calculation 
method for the B-B Score among several theoretically relevant ones. A summary of 
the clinimetric performance for the measurement properties of the B-B Score 




Table 6.1: Summary of the clinimetric performance for the measurement properties 
of the B-B Score investigated in the Phase 1 study 
Measurement property Clinimetric performance 
Discriminative power Significant difference between patient and 
control groups p < 0.01 
Large ES for difference between healthy and 
groups (Cohen’s d 1.60 – 1.70) 
Stability between replications Non-significant 1.8% increase over replications 
(p  = 0.06 in patient group, 0.16 in control group) 
ICC between replications 0.90 
Intra-rater reliability  ICC: 1st measurement 0.93   
2nd measurement 0.97 
Bias (LoA): 1st measurement 1.2% (± 12.7%) 
2nd measurement 2.3% (± 16.7%) 
Inter-rater reliability  ICC: 1st rater 0.94  
2nd rater 0.96 
Bias (LoA): 1st rater  - 0.9% (± 13.3%) 
2nd rater - 2.6% (± 16.6%) 
Legend: ES: effect size; LoA: limits of agreement; ICC: intraclass coefficient of correlation 
These results were sufficiently encouraging to support further research on the 
measurement properties of the B-B Score for measuring shoulder function in 
conservatively treated patients, who represent much larger populations than the 
surgically treated ones (Colvin et al., 2012). The adequacy of these first results with 
current standards for clinimetric performance was of importance for the good 
continuation the thesis’ project. As the Phase 1 study was the first investigation of the 
B-B Score in a population that had not been surgically treated, it was not a priori 
obvious that the measuring properties would be adequate.    
The exploration of the relevance of the “area” computation method as an alternative 
to the original “range” method did not allow improving the B-B Score measurement 
properties. The investigations rather confirmed that the results using the original 
“range” method was not importantly influenced by possible peak measurements. This 
reinforces the results on the P Score developments published by Coley et al. (Coley 
et al. 2007a)  
Chapter six 
292. 
The results of the Phase 1 study complied with the standards for adequate 
measurement properties (please see Table 5.2, within sub-section 5.2.6 
“Interpretation delimitation”, within Chapter five, p. 185), except for the LoAs that were 
≥ ± 10%. Although this threshold is not widely recognised, as it has been defined 
based on clinical considerations for the needs of the subsequent literature review, 
LoAs ranging from ± 12.7% to ± 16.7% were indicative of a level of variability that this 
might affect the precision of single measurements.  
At the Phase 1 advancement stage of the thesis, the magnitude of the LoAs were 
attributed to the inexperience of the raters in the B-B Score delivery, as close data 
inspection had revealed the influence of a limited number of divergent values on the 
LoAs (please see sub-section 2.3.3.3 “B-B Score determined by mean or median of 
replications”, Figure 2.5 and 2.6 Bland and Altman graphs for 1 replication, within 
Chapter two, p. 86 - 87). However, this assumption could be a posteriori invalidated, 
because the LoAs of the Phase two were found to be larger than that of the Phase 1 
(Smartphone intra-rater LoAs ± 18.8%; inter-rater LoA ± 18.5%), though the data had 
been collected by trained users. The origin of the variability lies probably more in the 
difficulty for participants to perform exactly the same movement several times than in 
the inaccuracy in the placement of the sensors or the imprecision of the sensors 
themselves.  
As the intra- and inter-rater magnitudes of the LoAs stated in Phase 2 study 
represents the main shortcoming of the B-B Score for the shoulder function 
measurement in rotator cuff conditions, capsulitis and proximal humerus fracture, it is 
questionable whether the choice of only three replications in the subsequent thesis’ 
phases was adequate. Taking a larger number of replications into consideration for 
the calculation of the B-B Score should mathematically decrease the LoAs, but would 
be of interest only if this modified procedure does not induce any carry-over effects 
(like warm-up or fatigue effect) (Mercer, 2002).  
In addition, the chosen measurement procedure was optimal only within the 
investigated alternatives. Other modifications could be explored, to determine 
whether they improve the ability of the measured persons to execute the score’s 
movements in a consistent manner. Amongst other factors, the use of targeted 
movements, the specification of a speed, the wearing of a light weight or the provision 
of a cadence might influence the consistency of executed movements, and therefore 
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the magnitudes of the LoAs. These alternatives were not tested in the context of this 
thesis, because it was aimed to keep the scoring procedure at its simplest expression. 
The results from the Phase 1 study also provided information to ensure the feasibility 
of the research protocol and the implementation of an efficient recruitment procedure. 
The information was precious for the subsequent studies, as a more efficient 
recruitment procedure could be implemented and the experience acquired by the 
raters ensured the collection of proper data in the next research phases. The fact that 
a pilot study had been undertaken also proved to be an advantage when applying for 
the Swiss National Science Foundation funding.  
It could thus be considered that the issues related to the definition of optimal testing 
and calculations procedures, amongst tested possibilities, were addressed in Phase 
1, but that issues related to the instrumentation and to the B-B Score’s measurement 
properties were still to be investigated, which was addressed in the Phase 2 and 3 
studies. 
 Development and testing of a smartphone approach 
 Achievements of the smartphone evaluation 
study (Phase 2)  
Phase 2 dealt with the issues related to the simplification of the B-B Score’s 
instrumentation. It compared the respective measurement properties of a middle-
segment smartphone and a dedicated movement analysis IMU system, used as a 
reference for the B-B Score measurement. 
 A summary of the clinimetric performance for the measurement properties of the B-





Table 6.2: Summary of the clinimetric performance for the measurement properties 
of the B-B Score investigated in the Phase 2 study 
Measurement property Clinimetric performance 
Discriminative power Significant difference between control and 
patient groups p < 0.01 
Intra-devices reliability  ICC: 0.97   
Bias (LoA): - 0.6 (± 12.6) 
ME: 0.7 
SEM: 4.0 
Intra-rater reliability  ICC: reference device 0.92   
smartphone 0.92 
Bias (LoA): reference device 0.1 (± 19.4) 
smartphone 1.5 (± 18.8) 
ME: reference device: 0.8 
smartphone: 0.7 
SEM: reference device: 6.6 
smartphone: 6.6 
Inter-rater reliability  ICC: reference device: 0.92  
Smartphone: 0.93 
Bias (LoA): reference device: 1.5 (± 19.0) 
smartphone: 1.0 (± 18.4) 
ME: reference device: 0.7 
smartphone: 0.7 
SEM: reference device: 6.4 
smartphone: 6.6 
Legend: ES: effect size; LoA: limits of agreement; ICC: intraclass coefficient of correlation; ME 
measurement error; SEM standard error of measurement. 
The Phase 2 study investigated essentially the influence of the measurement device 
on the quality of the measurement and provided an insight into the measurement 
properties of the B-B Score using a sample that included various shoulder conditions 
(rotator cuff conditions, proximal humerus fracture and capsulitis).  
The results of the device comparison highlighted that the IMU system and the 
smartphone were interchangeable for group measurements, but that the magnitude 
of the LoA might preclude the devices’ routine exchange when measurements 
concern individual participants. This makes the smartphone a possible substitute to 
Chapter six 
295. 
inertial sensor systems that can be used with confidence for the group evaluation of 
shoulder function using the B-B Score. Previous research had already shown that 
smartphone measurements are adequate for shoulder ROM evaluation, but no study 
had investigated the validity of smartphone measurement for shoulder function 
evaluation up to now (Cuesta-Vargas, 2016; Johnson et al., 2015; Shin et al. 2012). 
This result was of importance to overcome the tendency for movement analysis-
based methods to be confined to laboratory settings, as was highlighted by the 
subsequent literature review on the measurement properties of outcome measures of 
shoulder function. 
This result was also important with regard to the aims of the thesis, which intended to 
validate the simplest possible kinematic shoulder function scoring procedure 
applicable in clinical practice and research. Following the Phase 2 study, the process 
of simplification of the testing procedure could be considered as successfully 
achieved, as the combination of a score that includes only essential movements and 
a device whose use has entered into daily life reduces the testing procedure to its 
simplest expression. Conversely to other previously tested simple procedures for 
shoulder function evaluation, the B-B Score was related to alternative outcome 
measures of shoulder function, which demonstrated its convergent validity (Korver et 
al. 2014a; Korver et al. 2014b). 
However, caution is warranted when interpreting the measured outcome of a single 
measurement that concern an individual patient. It should be considered that the 
typical error is ± 6.6% based on the SEM, and that errors of up to ± 18.6 % may 
occasionally occur based on the limits of agreement. Individual measurements at 
regular intervals can be used to overcome the disadvantages associated with the 
variability of a single measure, as the follow-up curve of the patient’s performance will 
be correct, due to the random distribution of errors. Due to the lack of comparable 
investigations available in the literature, it was not possible to determine if this degree 
of variability was specific to the B-B Score, or more generally related to ability of 
participants to perform consistently shoulder movements over measurements. 
The Phase two results confirmed the measurements properties that had been 
previously explored in the Phase 1 study, concerning the discriminative power and 
the reliability of the B-B Score. The results were slightly more favourable in Phase 1 
than in Phase 2 (intra- and inter-rater ICC range 0.94 – 0.96 vs. 0.92 – 0.92 in Phase 
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2, LoA range ± 12.7% – ± 16.7% vs. 18.8% – ± 19.5%), but the Phase 2 results should 
be considered as the reference, because they were derived from data acquired by 
experienced raters in considerably larger samples of patients and controls. The intra- 
and inter-rater measurement properties were comparable, indicating that the B-B 
Score measurement had negligible dependency on the person performing the 
measurement. Previous studies had already shown the adequate reliability of 
smartphones for shoulder ROM evaluation, but none had previous investigated their 
reliability for shoulder function evaluation (Cuesta-Vargas, 2016; Johnson et al., 2015; 
Lim, 2015). 
The development of an accessible and quickly delivered measurement method was 
required to allow for the implementation of movement analysis in routine clinical 
practice. It was nevertheless not enough to meet all the requirements of measurement 
in professional practice, as the use of an outcome measure is only warranted to the 
extent that the user is assured of the quality of its measurement properties. Therefore, 
the subsequent investigations undertaken in the Phase 3 study of the thesis aimed at 
an in-depth assessment of the measurement properties of the smartphone B-B Score, 
in order to be able to provide the necessary information to users. 
 Extensive investigation of measurement properties  
 Achievements of the study on the 
measurement properties of the smartphone 
B-B Score (Phase 3) 
The Phase 3 study was aimed at the investigation of the measurement properties of 
the B-B Score in four current shoulder conditions. The measurement properties were 
analysed by the yardstick of established references for the quality of outcome 
measures and compared to those of frequently used PROMs that are considered as 
current standards for shoulder function evaluation. 
A summary of the clinimetric performance for the measurement properties of the B-B 




Table 6.3: Summary of the clinimetric performance for the measurement properties 
of the B-B Score investigated in the Phase 3 study 
Measurement 
property 
Clinimetric performance for rotator cuff conditions, 
proximal humerus fracture and capsulitis* 
Convergent validity r ≥ 0.50, except for the QuickDASH for humerus 
fractures (r = - 0.40). 
Discriminative power Significant difference between patient and control group 
(p < 0.01)  
Significant difference between baseline and 6 months 
stage (p < 0.01) 
AUC for patients vs. control discrimination: 0.90 - 0.96 
Responsiveness  ES and SRM: B-B Score, Constant Score and relative 
Constant Score show close responsiveness, and 
superior responsiveness to QuickDASH and SST 
Change correlation with Constant, relative Constant, 
QuickDASH and SST: 
- Humerus fractures, “Indicated pathologies” and “All 
patients” group: r > 0.50 
- Rotator cuff Constant and relative Constant r > 0.50; 
QuickDASH and SST: no correlation 
- Capsulitis: r < 0.50 
AUC for improved vs. unimproved discrimination:  
- 0.73 All patients 
- 0.70 Indicated pathologies  
vs. AUC 0.73 – 0.83 for Constant and relative 




- Rotator cuff:15.7% 
- Humerus fracture: 17.5% 
- Capsulitis: 14.6% 
MCII: 25.2% 
PASS: 77.6% 
* The measurement properties of the B-B Score for shoulder instability evaluation 
were demonstrated to be inadequate in this study: the B-B Score should not be 
used for the evaluation of shoulder function in this patients’ population 
Legend: QuickDASH: Quick Disabilities of the Arm, Shoulder and Hand score; AUC Area 
Under the operator receiving Curve; ES: Effect Size; SRM: Standardised Response Mean; 
SST: Simple Shoulder Test; MDC: Minimal Detectable Change; PASS: Patient Acceptable 
Symptoms State. 
The Phase three study allowed for the extensive determination of the measurement 
properties of the B-B Score in four common shoulder pathologies. The measurement 
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properties were found to be in line with the established standards for clinimetric 
performance for the assessment of patients with rotator cuff conditions, capsulitis and 
proximal humerus fractures, but not for patients with shoulder instabilities. As no 
alternative kinematic shoulder function score exists, to the best of our knowledge, it 
is not possible to determine is this is weakness is related to an intrinsic shortcoming 
of MAB methods or is specific to the B-B Score. The subsequent literature review 
highlighted that following the Phase 2 and 3 studies, the B-B Score was the MAB 
outcome measure of shoulder function with the highest number of properties 
investigated. 
The B-B Score clearly demonstrated adequate discriminative power as it was able to 
differentiate groups, stages and types of study participants. The interpretation of the 
results with reference to the responsiveness was less straightforward. Although the 
clinimetric performance globally complied with the standards for adequate 
responsiveness, the comparison of the smartphone B-B Score’s responsiveness with 
that of PROMs provided mixed results, depending on the shoulder condition and the 
methods used (ES, SRM, correlations between change scores, AUC). Thus, neither 
the superiority nor inferiority of a shoulder function evaluation method over the others 
could be established in this phase of the PhD’s research programme. This result was 
expected for PROMS, as several previous reviews had reached the same conclusion, 
but is new concerning the current equivalency of MAB outcome measures and 
PROMS, as no previous review comparing them had been conducted so far, to the 
best of our knowledge (Fayad et al., 2005; Oh et al., 2009; Placzek et al., 2004; Roy 
et al., 2009). Based on the findings of the Phase 3 study of the thesis, the only 
conclusion that can be drawn is that the B-B Score performs equivalently to other 
established measurement methods, as long as patients with shoulder instability are 
not the target population.  
Although the subgroups’ sample size was sufficient to provide an insight into the B-B 
Score’s measurement properties within specific shoulder conditions, ultimately 
studies with larger homogeneous groups will be needed to establish with more 
precision, the measurement properties of the smartphone B-B Score in various 
shoulder conditions and to compare them more definitively with current standards. 
Studies about the relevant parameters and testing procedures to evaluate shoulder 
function in shoulder instability will also be required. 
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Interpretability aspects that are important for results’ interpretation were also defined 
in this Phase 3 study. This study offered novel information that was of importance to 
provide the users with the necessary information to determine if a performance is 
normal, if a difference is real, if it is meaningful for a patient and if the patient’s present 
state if acceptable for him/her. 
Although all B-B Score’ measurement properties could not be established with 
precision for all investigated shoulder pathologies within the Phase 3 study, 
nevertheless, a novel and quite extensive validation process has been conducted, 
laying the important foundations for a sound interpretation of results by clinicians and 
researchers. The literature review showed that, despite the limitation stated above for 
subgroup analysis, the measurement properties of the B-B Score were established 
on a larger sample than the alternatives scores, of which none had been tested on 
large samples following the score development study (Duc et al., 2014; Coley et al., 
2007a; Korver et al., 2014a; Korver et al.; Yang et al., 2014). 
Further research using larger samples should be undertaken to increase the precision 
of the results and to establish the B-B Score measurement properties in other patients 
populations (e.g. osteoarthritis, shoulder arthroplasty or, rotator cuff tears repair). It 
should also explore the potential of MAB outcome measures for the assessment of 
function in shoulder instability, as the B-B Score clinimetric performances were clearly 
insufficient for the assessment of shoulder function in this pathology. A MAB outcome 
measure for shoulder instability should ideally be able to challenge the patient’s range 
of motion that causes apprehension during shoulder movements, but without 
compromising the patient’s safety. No such investigation has been conducted to date 
on this issue, to the best of our knowledge. 
After the establishment of the B-B Score’s measurement properties accumulated by 
means of Phase 1, 2 and 3 studies, it was possible to offer a culmination to the thesis, 
which focused on an up-to-date contextualising the B-B Score’s performance from a 
broader perspective and critically-evaluating it against presently-used, concurrent 
PROMs and against any other alternative movement analysis-based outcome 
measure. This aspiration was achieved by means of a review of literature that was 
conducted following the Phase 3 study. 
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 Benchmarking of the measurement properties of the 
smartphone B-B Score with concurrent methods 
 Achievements of the systematic literature 
review comparing the properties of PROMs 
and MAB outcome measures 
In order to appraise the soundness of the research orientations taken in this thesis, it 
was of importance to determine globally, to what extent might movement analysis 
represent a viable alternative approach to the contemporary reliance on PROMs, in 
attempting to overcome the issues of assessing changes to functional capacity of the 
shoulder, and more specifically, to critically-appraise the strengths and weaknesses 
of the B-B Score compared to all other approaches.  
A summary of the key points of the literature review comparing the measurement 
properties of PROMs and MAD outcome measures is available in Table 6.4 
Table 6.4: Summary of the key points of the literature review comparing the 
measurement properties of PROMs and MAD outcome measures 
- First literature review comparing the measurement properties of PROMs 
- Lack of a tool for quantitative evaluation of the literature that would be 
adapted to the review purpose 
- Consequent but heterogeneous body of literature on PROMs measurement 
properties prevents meta-analysis 
- Scarce body of knowledge on MAB outcome measures for shoulder function 
assessment 
- No retrieved PROM or MAB outcome measure superior to any other, except 
for the WOSI for non-surgically treated shoulder instability 
- Investigated properties of MAB outcome measures were generally adequate 
for their intended purposes.  
- MAB outcome measures, including the B-B Score compared equally to 
PROMs in direct comparisons within pathologies.  




Specifically considering the benchmarking of the outcome measure developed in this 
thesis, the B-B Score appeared to be the most extensively validated MAB outcome 
measure to date. It is the only MAB Score for which the reliability, measurement error, 
interpretability and responsiveness have all been evaluated (Duc et al., 2014; Coley 
et al., 2007a; Korver et al., 2014a; Korver et al.; Yang et al., 2014). This statement 
does not imply that its measurement properties are superior to those of current - or 
yet to be developed - MAB outcome measures, but allows potential users to rely on 
the information available in the literature to use the B-B Score and interpret its 
outcome. As stated in the Phase 3 study’s research findings, it was confirmed that its 
measurement properties were comparable to those of currently used PROMs, except 
for function evaluation in shoulder instabilities for which the WOSI score was superior 
to the other investigated outcome measures. This finding reinforces those of previous 
literature reviews that reported that the measurement properties of the WOSI were 
superior to those of generic shoulder function outcome measures for shoulder 
instability (Cacchio et al., 2012; Kirkley et al., 1998; Kirkley et al., 1998). 
Concerning practicalities and accessibility, the B-B Score was the only one that had 
proven to be possibly measured using a smartphone, with similar properties to a 
dedicated IMU device. Despite the need for future possible improvements, the B-B 
Score appeared to be well positioned among MAB outcome measures, as it has 
undergone an extensive validation process in four shoulder pathologies and has 
practical advantages on its alternative MAB outcome measures. Due to its moderate 
to high correlation with currently used PROMs and comparable measurement 
properties, it also appears to be a viable alternative to shoulder function PROMs for 
the evaluation of rotator cuff conditions, proximal humerus fractures and capsulitis, 
but not for shoulder instability. This good convergent validity was also found for the P 
Score, if which the B-B Score is extracted, but not for the accelerometer net vector 
magnitude data counts, arm underuse percentage, COMP Score, TEMG, Tmov and 
Temg/mov (Duc et al., 2014; Coley et al., 2007a; Korver et al., 2014a; Korver et al.; 
Pichonnaz et al. 2015a ; Yang et al., 2014). This highlights the need for MAB outcome 
measures to respond to certain features to capture shoulder function rather mere 
movement alterations.  
The realisation of the review was a complex issue, due to the need to retrieve a large 
range of measurement properties for several outcome measures in four pathologies. 
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This detailed classification was thought to be necessary for the sake of precision and 
comprehensiveness, as measurement properties are valid only in the context in which 
they were measured. However, it is questionable to what extent it is necessary to 
detail the properties of measurement properties for each possible context, as this may 
make it impossible to synthesize the results and may ultimately calls into question the 
possibility of generalizing the results. 
The difficulties encountered in carrying out the literature review highlighted some 
inherent limitations to the subject that could not be overcome using current 
approaches. No quantitative rating of the articles could be performed, due to the lack 
of an instrument that would have allowed doing so for all investigated measurement 
properties. The comparison between tools could not be performed based on precise 
objective criteria, due to the nature of the literature, as only a small proportion of 
articles directly compared the properties of several PROMS within the same study, 
and even less directly compared the properties of PROMs and MAB methods. 
Importantly, the heterogeneity amongst the studied populations that had been 
investigated, follow-up times and the methods used to calculate measurement 
properties, had prevented the aggregation of results into a meta-analysis. Therefore, 
the quality of the body of literature and the results concerning measurement properties 
could be qualitatively but not quantitatively discussed and critically evaluated. Other 
authors who had previously addressed the topic also renounced proceeding to a 
meta-analysis and reported the heterogeneity of the literature (Kirkley et al., 2003; Oh 
et al., 2009; Huang et al., 2015; Harvie et al., 2005; Fayad et al., 2005; Placzek et al., 
2004; Roy et al., 2009). Most of them renounced to conduct a meta-analysis, while 
Roy et al. have undertaken a weighting of measurement properties across studies. 
However, this approach was not adopted in this thesis’ review, as it does not allow 
overcoming the issues related to data heterogeneity. 
When viewed collectively, all these issues explain why the controversy surrounding 
the evaluation of shoulder function using PROMs continues to exist despite decades 
of research on the topic. The characteristics of the current body of literature and the 
shortcomings of the literature evaluation methods for validation studies make it 
difficult to provide a clear synthesis on the respective strength and weaknesses of the 
outcome measures for shoulder function evaluation. This situation is problematic for 
users, who lack easily interpretable information to make a well-grounded and 
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informed decision on the choice of a shoulder function outcome measure adapted to 
their specific needs.  
This review nevertheless highlighted some useful issues for the orientation of future 
research and measurement practice. Despite the substantial number of publications 
addressing movement analysis, very few have led to the development, let alone the 
clinical validation of a MAB outcome measure for shoulder function assessment. The 
body of knowledge remains thus limited in this area, so that the development of 
shoulder function MAB outcome measures can still be considered as an emerging 
field. A previous literature review had previously concluded that more research was 
needed to develop more MAB outcome measures that related to shoulder function 
(De Baets et at., 2017). 
An overall illustration of the thesis accomplishments, which highlights the extent of 
the thesis achievements compared to the initial process illustrated in Figure 1.4, 
“Structure of the thesis process”, p. 54, is available in Figure 6.1” Achievements of 




Achievements of the thesis process 
 Equivalency of devices demonstrated 
 Equivalency of discriminative power 
and reliability demonstrated 
 Smartphone measurement valid 
• Controversies around 
shoulder function PROMs 
• Cumbersomeness of 
laboratory measurement 
Technological progress 
• Shoulder function using   
IMU system (P Score) 
• Simplified measurement:     
B-B Score (MSc  dissertation) 
Smartphones include 
built-in 3D accelerometers 
and gyroscopes 
Opportunities for a simple shoulder 
function score using a daily-life object 
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 Convergent validity demonstrated 
 Condition-specific measurement 
properties investigated 
 Measurement properties adequate 
 Equivalency with PROMs 
demonstrated 
 Equivalency with MAB outcome 
measures demonstrated 
 B-B Score compares to current 
outcome measures 
 Alternatives explored and compared 
 Optimal scoring procedure defined 
 Initial results justify continuation  
 
Figure 6.1: Achievement of the thesis process, to compare with Figure 1.4: “Overview 
of the planned thesis process” within sub-section 1.1.4.4 “Implication of practical 
issues for the thesis, p. 54. 
 Implications of the thesis’ findings for clinics and research 
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 Scope of application of the B-B Score  
The main outcome of this thesis centres on in the demonstration that the use of a 
cheap, accessible, valid and straightforward MAB outcome measure is justifiable for 
clinical and research purposes in rotator cuff conditions, proximal humerus fracture 
and capsulitis. Previous research had already shown that smartphone measurements 
are adequate for shoulder ROM evaluation, but this thesis was the first to demonstrate 
the validity of smartphone measurement for shoulder function evaluation up to now 
(Cuesta-Vargas, 2016; Johnson et al., 2015; Shin et al. 2012). 
The main limitation of the B-B Score for use with these pathologies was the rather 
large LoAs. As errors were randomly distributed, this might affect the precision of 
single measurements, but not necessarily of groups’ measurements or of the mean 
outcome of repeated measurements. Due to the lack of data in the literature, it is not 
possible to interpret if this is a specific shortcoming of the B-B Score, or a more 
general characteristic of MAB shoulder function outcome measures. Thus, the most 
suitable applications for the B-B Score concern group-based measurements and the 
definition of a recovery trend in the follow-up of patients. 
As the B-B Score is the only computerised MAB outcome measure applicable for 
routine measurement, it is of particular interest in situations where laboratory 
measurements are not possible or where the ‘paper and pencil’ approach shows 
limitations (i.e. whenever language, item interpretation, or data communication issues 
are involved). Thus, the smartphone B-B Score could for example be especially suited 
for multicentre studies over several countries.  
 Decision making about shoulder function evaluation  
The literature review confirmed the value of computerised MAB outcome measures 
for shoulder function evaluation, but also highlighted that little research had 
addressed the conception of clinically usable scores to date. The conclusions of this 
review might underpin further research in this field. Concerning shoulder function 
PROMs, the review confirmed the current impossibility to make strong 
recommendations for the use of one tool over another in a given situation, due to the 
dispersion of results caused by the heterogeneity of research and calculation 
methods. The same limitation was reported by previous authors that had conducted 
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literature reviews on the topic (Kirkley et al., 2003; Oh et al., 2009; Huang et al., 2015; 
Harvie et al., 2005; Fayad et al., 2005; Placzek et al., 2004; Roy et al., 2009).  
This thesis did not bring new solutions on this point. This outcome had been 
somewhat expected and confirms one of the fundamental issues raised within the 
thesis’ introduction i.e. that the investigation of new pathways is needed to overcome 
the controversy surrounding shoulder function PROMs. This situation remains 
problematic for users, who have to rely on inconclusive findings to underpin the choice 
of an outcome measure. The tables of measurement properties elaborated and 
detailed within the review, may help them to make an informed choice when selecting 
a tool for shoulder function evaluation in rotator cuff conditions, humerus fracture, 
capsulitis, instability and glenohumeral osteoarthritis.  
In the present situation, the association of several outcome measures represent the 
most robust approach. Although any chosen recommendation on this topic may be 
debated, the use in conjunction of the DASH (extensively validated subjective score), 
Constant (extensively validated mix of clinical measurements and subjective 
questions) and B-B Score (objective MAB score) might represent a justifiable 
approach for research purposes in rotator cuff conditions, proximal humerus fractures 
and capsulitis. The complementary nature of these outcome measures may provide 
an effective large-scale overview of shoulder function. For instability, the WOSI was 
superior to all the other outcome measures evaluated in this thesis. However, further 
research should still challenge this score with concurrent shoulder instability scores 
like the Rowe score, Melbourne Instability Shoulder Score (MISS) or Oxford Shoulder 
Instability Score (OSIS) (Plancher and Lipnick, 2009).  
 Suggestions for practice and future research work 
 Reconsideration of initial assumptions 
The basic assumptions underlying this thesis were based on a limited number of 
available studies, most of which reported results from a small sample. Though these 
studies constituted the best available evidence at the time of the thesis’ conception, 




The P Score had been taken as a reference for the conception of the B-B Score. This 
approach was sustainable, as this score had demonstrated promising measurement 
properties and was the most advanced in its development at the time of the thesis’ 
inception (Coley et al., 2007a; Jolles et al., 2011; Pichonnaz et al., 2015c). The 
investigations run in the thesis confirmed that the approach of the P Score - using a 
power-related metric for the evaluation of shoulder function - was sound, as the 
measurement properties of the B-B score were within expected standards for rotator 
cuff condition, capsulitis and humerus fracture. As the sample size of the thesis was 
considerably larger and included conservatively treated patients, contrary to the 
studies that aimed at the development of the P and B-B Score, the results of the thesis 
reinforced and extended the basis for the use of a power-related metric for the 
evaluation of shoulder function. 
The soundness of the choice of the two B-B Score movements (hand to the back and 
hand to the ceiling) and their weighting based on principal component analysis and 
multiple regressions was also confirmed. Actually, Korver et al. studies, which used 
the same metric but slightly different movements (hand behind the head instead of 
hand to the ceiling) and did not weight them, found weak correlations with shoulder 
function PROMs. This indicated limited ability of this score to capture shoulder 
function, conversely to the B-B Score (Korver et al., 2014a; Korver et al., 2014b). 
This approach had also inherent limitations in that, when taking the P Score as a 
reference for the conception of the B-B Score, it was at best possible to design a score 
that closely matched the P Score, but not a score that would have superior 
measurement properties. Some suggestions for the improvement of the B-B Score 
will be made in the next subsection. However, it might also be of interest to challenge 
the background of the B-B Score conception, in order to overcome the limitations of 
the basic assumptions on which it relies. 
Coley’s work found that a power-related metric was a better indicator of shoulder 
function than ROM, especially when the patient is able to reach full ROM but with 
difficulty (Coley, 2007). However, it would be interesting to investigate if a combination 
of a power-related metric and ROM would further increase the relationship with other 
outcome measures of shoulder function. 
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The B-B Score movements are representative of the difficulties that are reported by 
patients suffering shoulder function loss (van der Windt et al., 1995; Magermans et 
al., 2005). Nevertheless, the two movements do not cover all possible shoulder 
movements. A recent approach that has been investigated consists in taking the hand 
reachable space to capture shoulder function. This approach has been used either 
considering the active ROM in various directions based on clinical observation (Riley 
and al. 2018) or based on computerized movement analysis (LMAM-EPFL, 2018). 
The observation-based approach showed a relationship with the SPADI shoulder 
function PROM, while no publication is yet available for the movement analysis based 
approach. 
Instead of making two movements interrupted by a pause in the rest position, it might 
also be possible to link the two movement in a row and calculate the B-B Score on a 
single large movement that goes from hand to the back to hand to the ceiling. This 
would make the test even simpler to perform. 
Another possible simplification that deserves investigations could be to perform the 
movements holding the smartphone in the hand instead of attaching it to the arm with 
an armband. It should then be checked whether the elbow and wrist movements 
interfere substantially with the evaluation of shoulder function, but this would save the 
time used for fixing the armband, which represent approximately half the time required 
to perform the B-B Score. This would also facilitate the self-evaluation of the patient 
without supervision. 
 B-B Score improvement 
Further researches may address shortcomings of the B-B Score reported in this 
thesis, i.e. the magnitude of the LoAs and the lack of validity for shoulder instability 
measurement. 
Concerning the first issue, several investigations could be conducted to contain the 
extent of measurement variability. The simplest approach could investigate the 
influence of the number of replications on the B-B Score variability. The variability 
should theoretically decrease with the square root of the repetitions’ number (Mercer 
and Gleeson, 2002). Although the use of three replications had been retained based 
on Phase 1 study investigations, because most of the decrease in measurement-to-
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measurement variability occurred within this number of replications, it might 
retrospectively still be of interest to use a higher number of replications.  
The optimal number of replications to contain the single measurement variability 
within the level previously defined as acceptable for clinical measurements                
(LoA ≤ ± 10%) cannot be inferred from the data collected in the studies conducted for 
the purpose of the thesis. Based on the above-mentioned theoretical considerations, 
the single measurement variability should decrease with each added replication, but 
in a progressively lower proportion for each added replication. Although no carry-over 
effect between replications was stated in the Phase 1 study (non-significant 
progressive mean increase of measured values reaching 1.8% between the first and 
the fifth replication), such effect cannot be excluded using more replications, making 
that the results might not be in line with the theoretical expectations. For example, it 
cannot be excluded that a warm-up or a fatigue effect interferes with the results of the 
measurements when more than five replications are used. The influence of a 
selectively-used number of the replications should also be explored, like for example 
discounting the highest and lowest values, taking the mean of the three central values 
out of a higher number of replications, or omitting the first replication, followed by a 
reasonable (yet to be determined) number of replicates reflecting random variability. 
With regard to the second shortcoming of the B-B Score, investigations concerning 
the evaluation of shoulder function in shoulder instability would imply to reconsider 
the Score conception. While the B-B Score was conceived to detect shoulder function 
alterations at a self-chosen speed in essential movements, these movements are 
obviously not challenging enough to induce apprehension of dislocation, which is 
pathognomonic of shoulder instability. The so-called ‘squaring of the circle’ would be 
to find a solution to generate apprehension without putting the patient at risk of 
dislocation. The examination of the end of active range of motion in the shoulder 
instability position (typically combination of flexion, abduction and lateral rotation), e.g. 
when throwing a ball, could be of particular interest in this situation. This difficulty may 
explain why no other MAB shoulder function outcome measure has been proposed to 
date, to the best of our knowledge.  
Other Score’s refinements of the B-B Score may be possible using IMU systems but 
not smartphone-based measurements. The addition of an IMU module on the 
acromion in order to capture the scapula movement might allow a more precise 
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location of the source of shoulder dysfunction, because the B-B Score as it conceived 
currently, captures only the resultant of all involved body segments. This might 
increase the clinical relevance of measurements as it would allow targeting more 
precisely the treatment goals according to the degree of involvement of the scapula 
(De Baets et al., 2017). The reliability of this approach is yet to be demonstrated, 
because the scapular motion capture using IMU remains a complex issue, especially 
at the end range of humerus elevation (Coley, 2007; Lempereur et al., 2014). The 
addition of an IMU module on the trunk might also be of interest to record the 
movements of the trunk interfering with the shoulder function measurement, and thus 
be able to discard them from the analyses in order to obtain a purer outcome (Duc et 
al., 2013).  
The study samples have been designed in order to determine the measurement 
properties of the B-B Score in different shoulder pathologies, but were not large 
enough to investigate the possible influence of subgroup characteristics on the score. 
The performance of the healthy population has thus been determined based on a 20-
participant sample, which was sufficient to reach the thesis’ aims, but not to 
investigate the possible specificities of subgroups.  
Typically, age, sex and dominance might potentially influence the results. As an 
illustration, such influences have been stated for the Constant, the DASH and the 
QuickDASH scores, concerning age and sex (Constant, 1986; Yian et al., 2005; 
Katolik et al., 2005; Aasheim and Finsen, 2014; Hunsaker et al., 2002).  
The influence of these two characteristics is less likely for the B-B Score, which 
compares the performance of the two shoulders. It is theoretically not likely that age 
or sex might influence mean population symmetry between sides in one of these 
subpopulation, as aging and sex affects both shoulders in a similar way.  
However, the variability in asymmetry might potentially be different within one of the 
subpopulations, which would affect the range of the score that is considered as 
normal. For example, the variability of the symmetry might potentially be larger in an 
older population, due to a possible interaction between age and dominance, which 
could hypothetically lead to a different age-related performance decline according to 
shoulder side. This could have an impact on the discriminative power of the score. 
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Also, the effect on dominance has been considered as negligible in this thesis, due to 
the absence of a significant difference between sides and to the limited magnitude of 
the between-side difference observed in the healthy group. However, the 
establishment of a more precise norm based on a large sample would be of interest 
to increase the accuracy of the evaluation, as possible population-related factors 
could be taken into account in the performance assessment. This investigation could 
rather easily be conducted due to the practicality of the B-B Score.  
 Possible future research pathways 
In the context of this research, movement variability was considered as a drawback 
that negatively influenced the B-B Score precision. However, movement variability 
might also be investigated as a parameter of interest for shoulder evaluation. A 
parallel can be made with the investigations on gait variability that revealed that it was 
indicative of fall risk (Hausdorff, 2005). Concerning the shoulder, the precise meaning 
of movement variability still needs to be clarified, though some recent studies have 
already investigated its relationship with pain and motor control strategies (Mehler et 
al., 2017; Major et al., 2014; Lopez-Pascual et al., 2017b). 
Another pathway could concern the development of MAB outcome measures of 
shoulder function. As stated in the literature review, only a small fraction of the studies 
on the shoulder movement was extended by further works to lead to the development 
of a scoring system. Future researches in this direction may investigate the relevance 
of either measurements over a short span of time in controlled conditions or several 
hours’ measurements in a free-living environment. For instance, these investigations 
might be a continuation of the previous works on the area of functional reach, the 
used arm position in daily life or the shoulder muscular activity in daily life (Hurd et al., 
2014; Clement et al., 2018; Duc et al., 2013; Duc et al., 2014; Coley et al., 2008a; 
Coley et al., 2009). 
A recent literature review that included the B-B Score suggested several possible 
research path for MAB outcome measures, of which certain appear to be relevant to 
the author of the thesis (De Baets et al., 2017). It was proposed to investigate also 
‘movement smoothness’, ‘movement path’ and ‘trajectory length’ to represent the 
functional status of a joint. It would actually be of interest to investigate if these 
parameters are mere indicators of movement alterations or more largely indicators of 
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shoulder function. The review’s authors also suggest that taking the thoraco-humeral 
movement into consideration is not sufficient to capture shoulder function. This 
statement is questionable, as the relationship of the B-B Score, and of the P Score as 
well with shoulder function PROMS, could be demonstrated. This was expected as 
the thoraco-humeral movements is the resultant of the whole shoulder joint complex. 
The addition of scapulo-humeral movement into the algorithm would surely be of 
interest to locate more precisely the location of shoulder function alteration, though 
as the expense of an increased complexity of the testing and analysis procedures. 
Moreover, this can be more conveniently achieved based on clinical evaluation of 
each joint of the shoulder complex, as scapulo-humeral movement is itself the 
resultant of several joints (scaplulo-thoracic, acromio-clavicular, sterno- costo-
clavicular joints) that can hardly be analysed separately using computerised 
movement analysis.  
Future researches may also address the on-going controversy on the validity and 
measurement properties of shoulder function PROMs, though no simple solution is 
likely to solve the problem. A first useful step would consist of the elaboration of a 
consensual definition of shoulder function (Roe et al., 2013). A larger consensus 
should also be reached concerning the recognised methods for establishing 
measurement properties (Mokkink et al., 2010). To ensure objectivity and 
admissibility, these consensuses should be developed by large panels of experts 
under the patronage of an independent organisation. These panels should also 
recommend orientations for future research on PROMS. Nowadays, it is not clear if 
the most promising path consists of the improvement of present PROMs or the 
development of new ones based on a still to be elaborated consensual approach. The 
degree of specificity of the new PROMs to be developed should also be stipulated, 
knowing that tools that are more specific will tend to be more valid for the evaluated 
condition, but that their development would most likely lead eventually to a plethora 
of shoulder function outcome measures (Michener and Leggin, 2001; Longo et al., 




 Possible future development pathways 
Some technological development projects can also be envisioned. The B-B Score 
software application stores the data on the smartphone only, in order to prevent all 
undesired outcome’ communication. The results can be communicated only using an 
email address, typically that of the patient or of a stakeholder that the patient has 
given permission to be contacted. This simple approach was chosen to prevent the 
contravention of data protection and professional confidentiality issues during the 
application’s development. Provided that these issues are correctly handled and only 
with the patient’s agreement, further development of the application may improve the 
possibilities to communicate and centralise the results. For example, it might be 
possible to inform concerned stakeholders or construct a centralised database for the 
establishment of norms (e.g. the expected recovery trend or final outcome for various 
shoulder conditions) or for benchmarking. 
Another possible technological development may address the construction of a more 
comprehensively featured smartphone application oriented toward the health 
professionals’ needs, in which numerous useful and well-validated applications would 
be accessible in a coordinated interface. The development of smartphone health 
applications is a growing field, so that it becomes arduous for the user to select the 
most reliable ones and to find in a timely manner, the ones they have downloaded on 
their smartphone. Such an application should allow the straightforward activation of 
meaningful applications for various pathologies, outcomes and body regions, and an 
easy transfer toward the patient’s file. In this context, the B-B Score would be one of 
the possible applications integrated within the section for shoulder evaluation. 
Importantly, the conception of such an application should be guided by public health 




 Final conclusion 
The situation concerning shoulder function evaluation is currently not optimal for 
clinicians and researchers. On one hand, PROMS have intrinsic limitations and none 
of them has demonstrated its superiority over the others. On the other hand, no easily 
accessible MAB outcome measure is available for routine assessment. Thus, this 
thesis was initiated with the aim to develop and assess the simplest possible MAB 
shoulder function scoring procedure for clinical measurement. 
Following optimisation of the testing procedure and extensive investigations of the 
measurement properties of the B-B Score, the research’ findings allowed the 
conclusion that this score met the current standards for adequate measurement 
properties for the evaluation of rotator cuff, shoulder capsulitis or humerus fracture 
function, either using a dedicated inertial sensor system or a smartphone for 
measurement. It was concluded from the benchmarking of the B-B Score with the 
other existing measurement methods that its measurement properties are globally 
comparable to those of alternative shoulder function measurement methods. 
The shortcomings of the B-B Score concerned specifically the clinimetric 
performances for the assessment of function in shoulder instability and the variability 
of single measurements. Further research should investigate these issues, either by 
further refining the B-B Score or by investigating alternatives using simple testing 
procedures for the evaluation of shoulder function. 
Though it can still be improved, the B-B Score already represents a sustainable 
measurement method for the evaluation of shoulder function in rotator cuff, shoulder 
capsulitis or humerus fracture. These thesis’ results thus demonstrated that a valid 
MAB shoulder function evaluation can be achieved using a simple procedure and an 
accessible device. This constitutes a useful contribution to facilitating routine objective 
evaluation of shoulder function in clinical and research conditions, which is one of the 
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Enhancing clinically-relevant shoulder function 
assessment using only essential movements  
 
Abstract 
Kinematic functional evaluation with body-worn sensors provides discriminative 
and responsive scores after shoulder surgery, but the optimal movements’ 
combination has not yet been scientifically investigated. The aim of this study 
was the development of a simplified shoulder function kinematic score including 
only essential movements. The P Score, a seven-movement kinematic score 
developed on 31 healthy participants and 35 patients before surgery and at 3, 6 
and 12 months after shoulder surgery, served as a reference. 
Principal component analysis and multiple regression were used to create 
simplified scoring models. The candidate models were compared to the 
reference score. ROC curve for shoulder pathology detection and correlations 
with clinical questionnaires were calculated. 
The B-B Score (hand to the Back & hand upwards as to change a Bulb) showed 
no difference to the P Score in time*score interaction (p > .05) and its relation 
with the reference score was highly linear (R2 >.97). Absolute value of 
correlations with clinical questionnaires ranged from 0.51 to 0.77. Sensitivity 
was 97% and specificity 94%. 
The B-B and reference scores are equivalent for the measurement of group 
responses. The validated simplified scoring model presents practical 
advantages that facilitate the objective evaluation of shoulder function in clinical 
practice.  




The assessment of functional outcome of shoulder treatments remains a 
controversial issue. Although many questionnaires exist, none has been 
universally recognized as a standard to date (Fayad et al., 2005, Oh et al., 2009, 
Placzek et al., 2004, Wilcox et al., 2005). Alternatively, the effectiveness of 
embedded kinematic measurement to assess shoulder function has not yet 
been extensively explored. Measurements based on body-worn sensors may 
potentially represent a well-balanced compromise between the practicality of 
questionnaires and the measurement precision and reliability of laboratory-
based movement analysis (Pandyan et al., 2002). 
However, the most efficient testing procedure for the evaluation of shoulder 
function has not yet been defined. An approach to assessment that captures the 
essence of the complex patterns of movement comprising shoulder function 
may offer further progress towards an effective clinical tool. A simplified scoring 
procedure involving only essential movements would facilitate the use of 
movement analysis for outcome evaluation. Thus, this study focused on the 
development of an efficient and simple assessment model that should 
demonstrate content validity, relationship to shoulder function and ease of 
application. 
Body-worn inertial sensors have been applied with promising results to measure 
shoulder movement in various conditions (Zhou et al., 2006a, Coley et al., 2007, 
Luinge et al., 2007, Wong et al., 2007, Coley et al., 2008, Teece et al., 2008, 
Duc et al., 2013). Their results are highly correlated to laboratory 
measurements, and display adequate accuracy (Bernmark and Wiktorin, 2002, 
Coley et al., 2007, Zhou et al., 2006b, Luinge and Veltink, 2005, Cutti et al., 
2008). Among these authors, Coley et al. (2007) proposed a shoulder kinematic 
score based on the P Score, which compares injured vs. healthy arm power 
measured by accelerometers and gyroscopes. A power-related metric [(deg/s) * 
(m/s2)] was used as it demonstrated more discrimination than angle 
measurements for shoulder outcome evaluation (Coley et al., 2007). The clinical 
inference was that the ability of the patient to deliver energy and useful work in a 
timely manner during arm movements is typically reduced in shoulder 
pathologies (Bunker, 2002, Murrell and Walton, 2001). 
The P Score procedure relied on a sequence of seven movements extracted 
from the Simple Shoulder Test (SST) and therefore included movements 
representative of daily life activities (Lippitt et al., 1993, Coley et al., 2007). The 
testing procedure requires around 20 minutes for completion. This approach 
demonstrated clinical relevance as the P Score discriminated healthy from 
pathological subjects, identified early treatment failure, was correlated to clinical 
scores and displayed good responsiveness after shoulder surgery (Coley et al., 
2007, Jolles et al., 2011, Coley, 2007). 
Körver et al (2014b, 2014a) proposed a kinematic score including only the 
movements “arm to the back” and “arm behind the head”. This simplified 
approach improved clinical applicability by reducing measurement time to less 
than 5 minutes. It demonstrated high intra- and inter-evaluator reliability, 
diagnostic sensitivity and specificity, but weak correlations with the DASH and 
SST clinical scores (Jester et al., 2005, Lippitt et al., 1993). Conversely to the P 
Score, its validity for shoulder function evaluation was thus limited. 
It is of interest to explore if a simplification of the P Score procedure, based on a 
systematic approach, would ensure that measurement properties observed for 
the P Score are not compromised by the simplification process. The primary aim 
of this study was to design a simplified kinematic shoulder scoring model based 
on a selection of essential movements among the seven movements of daily life 
comprised in the reference P Score. It was hypothesized that the number of 
movements could be reduced based on components identified by principal 
component analysis (PCA). Multivariate regression (MR) was then used to 
combine the defined principal components into a simplified scoring model.  
The secondary aim was to compare the results of the new simplified scoring model 
with those of the reference P score. It was hypothesized that the results of the 
simplified score would be comparable to those of the reference score in terms of 
descriptive statistics, linear relation, evolution pattern and agreement. The strength of 
the relationship with the shoulder function questionnaires was evaluated for the 
reference and the new kinematic scores. This evaluation aimed at estimating their 
concurrent validity relative to commonly used clinical questionnaires but not at 
validating the kinematic scores against a gold standard. 
2 METHODS 
2.1 Reference Score 
This study was based on a secondary analysis of data gathered for the 
development of the P Score, which is detailed above (Coley et al., 2007).  
 
The sample (Table 1) was made of participants from a prospective cohort study 
between 2005 and 2008 at the Department of Traumatology and Orthopaedic 
Surgery of the University Hospital of [added]. Ethical approval was granted by 
the local ethical board [added]. Patients gave their informed and signed consent 
for the secondary use of data for research purposes. 
The included patients were adults with rotator cuff disease involving a 
supraspinatus rupture of at least 1 cm2, as determined by an MRI, or with a 
gleno-humeral osteoarthritis stage II or III according to the radiologic criteria 
published by Koss (1997). The criteria considered for rotator cuff surgery were 
significant pain or dysfunction affecting quality of life (American Academy of 
Orthopaedic Surgeons, 2010). Exclusion criteria were previous shoulder surgery 
or arthroscopy, intra-articular injection in the last six months, contralateral 
painful shoulder or malignant disorder. All patients were operated on by the 
same surgeon. The healthy participants, measured for normal usage 
characterization, were people without history of shoulder condition/pain and 
were purposefully younger than the patients to avoid bias related to the high 
prevalence of asymptomatic rotator cuff tear above 40 years old (Sher et al., 
1995).  
Patients were measured before surgery, and at 3, 6 and 12 months after 
surgery. The participants were asked to perform the following movements as 
showed by the evaluator:  
 1 - Back: place hand to the back  
 2 - Head: reach the back of the head with the hand  
 3 - Flexion: lift the arm upwards to reach 90° flexion 
 4 - Abduction: lift the arm on the side to reach 90° abduction 
 5 - Shoulder: touch the opposite shoulder with the hand 
 6 - Bulb: lift the hand upwards as to change a bulb 
 7 - Rotation: rotate the arm laterally with a 90°elbow flexion 
The participants were instructed before the test to perform the movements at 
their natural speed in the pain free range of motion. They were told that they 
should stop the movement in case of pain. The initial position was standing in 
front of the evaluator, with arm along the body in a relaxed position. The 
participants performed each of the 7 movements and got back to the initial 
position, as demonstrated by the evaluator. The movements were performed at 
20 seconds intervals. The movements were performed on the affected side first 
for the patients and on the dominant side first for the healthy participants. 
The movements’ performance was assessed using the P Score, a metric related 
to the power of movement computed as the product of accelerations by angular 
velocities. 
To measure this score, participants were equipped with two inertial sensors 
including a triaxial accelerometer and a triaxial gyroscope, placed on each 
humerus, 3 cm above the midpoint of the line connecting the lateral epicondyle 
(EL) and medial epicondyle (EM). The sensor’s axes were aligned to the 
humerus anatomical frame following the ISB recommendations (Wu et al., 
2005): Yh on the line connecting the gleno-humeral (GH) joint and the midpoint 
of EL and EM, pointing to GH; Xh on the line perpendicular to the plane formed 
by EL, EM and GH, pointing forward; Zh on the line perpendicular to Xh and Yh, 
pointing to the right (Figure 1). 
Accelerations and angular velocities were amplified and low-pass filtered (cutoff 
frequency: 17Hz) to remove noise (Aminian et al, 2006; Mathie et al., 2004) 
before being recorded by a data-logger (Physilog®, BioAGM, CH), at 200Hz. A 
power-related parameter was extracted from the recorded signals: the range of 
acceleration was multiplied by the range of angular velocity, with a 
measurement unit of (deg/s) * (m/s2), for each movement (Figure 2). This 
parameter was calculated for each axis and then averaged, separately for each 
side. The P Score was then computed as the ratio of the performance of the 
affected side relative to the healthy side, expressed in percentage (Coley et al., 
2007). For example, while a typical healthy person performs near to 100%, the 
average patient might reach e.g. 46% before surgery, 67% at 3 months and 
71% at 6 months. For healthy subjects, the P Score reflects the performance of 
the dominant side compared to the non dominant side. 
Participants also completed questionnaires to establish the relationship between P 
Score and respectively pain assessed though Visual Analog Scale (VAS) and 
function estimated by clinical questionnaires: Constant score, SST, Disability of Arm, 
Shoulder and Hand (DASH) (Fayad et al., 2008, Lippitt et al., 1993, Constant and 
Murley, 1987).  
The aim of the comparison with clinical scores was not to validate the P Score 
against a gold standard but to estimate the concurrent validity of the P score relative 
to the most commonly used clinical questionnaires. 
2.2 Statistical analysis approach 
The statistical analysis was conducted with PASW Statistics 18 (SPSS Inc, 
Chicago, Illinois). First, the development of a simplified scoring model based on 
selected movements was conducted, initially using data at 3 months after 
surgery. As rehabilitation is most intensive at this stage, it was of primary 
importance that the simplified score would be efficient at this stage. The scoring 
model was then applied to data at all stages to investigate its relevance over 
time. Finally, the reference and the simplified scores were compared. 
PCA was used to identify components that explain most of the variance 
associated with the reference score. Among movements loading on a 
component, one was retained for each respective component for inclusion in a 
MR analysis. This planned linkage between multiple regression and antecedent 
PCA prevents multicollinearity problems that could cause erratic changes in the 
regression coefficients (Portney and Watkins, 2009, Jolliffe, 2002). Several 
simplified scoring models were created based on MR results at 3 months. The 
models were then applied to data at baseline, 6 and 12 months to calculate their 
outcomes over all stages. The latter outcomes were compared with the 
reference score to assess the extent of congruency. 
Then the progression pattern over time, for the reference and simplified scores, 
were compared using separate factorial (model [reference; simplified] x time 
[baseline, 3, 6 and 12 months post-surgery]) two-ways ANOVAs on both factors. 
“Model” was used as factor and “time” as covariate. Assumptions of normality 
and homoscedacity were verified using, respectively, the Shapiro-Wilk and the 
Levene’s test. Results of the reference and simplified scores were reported 
using descriptive statistics (mean, standard deviation, 95% confidence interval, 
standard error, difference with reference score). The effect of arm dominance on 
score outcome was evaluated using a one-sample t-test against a test value of 
100, indicating perfect symmetry. Simple linear regressions and Bland and 
Altman’s limits of agreement (LOA) were performed at each stage of 
rehabilitation for the score which displayed the closest pattern of congruency to 
the reference score. The relationships between reference and simplified scores 
with clinical questionnaires were investigated using Spearman correlations. 
Type I error rates were set at P<.05, where applicable. Diagnostic power for 
shoulder pathology detection at baseline was calculated using receiver 
operating characteristic (ROC) analysis. 
3 RESULTS 
3.1 Development of simplified scores 
3.1.1 P Score and score for each movement 
Mean and SD of the P Score at 3 months for each movement included in the 
PCA are presented in Table 2.  
3.1.2 Principal component analysis 
The PCA highlighted two components. Arm movements related to the first 
component represented a dimension of “elevation” while those related to the 
second component represented “rotation”. This model was constant over all 
stages of rehabilitation. The movement 1 (Back) was systematically related to 
the rotation component. The movements 2 to 6 (Head, Flexion, Abduction, 
Shoulder, Bulb) were systematically related to the elevation component, with 
varying strength over stages. The movement 3 was excluded from the model at 
3 months, as it was a complex variable i.e. correlated above .40 with several 
components. The movement 7 (Rotation) was related to one or the other 
component according to the stage. 
The factor loadings and explained variance are presented in Table 3. 
3.1.3 Multiple regression at 3 months 
Based on the two components identified by the PCA at 3 months, the MR 
included scores from two movements as independent variables. The first 
variable was the movement 1 that represented the rotation component. The 
movement 2, 4, 5, and 6 were alternatively included as a second variable in MR 
to represent the elevation component. The movement 7 was excluded from the 
candidate MRs as its relation to a component was erratic over time. Thus, four 
MRs were conducted with pairs of isolated movements as predictive variables: 
Back-Head (Movements 1 and 2), Back-Abduction (Movements 1 and 4), Back-
Shoulder (Movements 1 and 5) and Back-Bulb (Movements 1 and 6) (Table 4)  
The regression equations from these four potential simplified scoring models 
were applied to data at all stages of rehabilitation. Shapiro-Wilk tests confirmed 
normality for all scores except for the Back-Abduction scoring model at baseline 
(P <.05) and this candidate was thus excluded from further analyses. 
3.2 Selection of the simplified scoring model 
The simplified scoring models developed at 3 months were applied to data at 
baseline, 6 months and 12 months. A separate factorial ANOVA with measures 
on both factors was used to compare patterns of each remaining candidate 
scoring model (Back-Head, Back-Shoulder and Back-Bulb) with that of the 
reference score across times of rehabilitation. Assumption of normality and 
homoscedacity were met for all scores at all stages (P > .05 for the Shapiro-Wilk 
and for the Levene’s test). 
The ANOVAs showed that the time-model interactions were significant for the 
Back-Head [F(3, 90) = 7.0; P<.01], the Back-Shoulder [F(3, 78) = 3.0; p <0.05], 
but not for the Back-Bulb score, indicating that the latter model (B-B Score) 
offered better congruency between reference and simplified scoring models over 
the period of rehabilitation and should be selected for further comparative 
analysis on this basis (Figure 3). Congruency was also confirmed by ANOVA 
that showed no significant difference in the model comparison between the 
reference and the simplified B-B Score. 
3.3 Comparison of the simplified score outcome the with 
reference score outcome 
The mean, standard deviation, 95% confidence interval and standard error for 
the reference P Score and the simplified B-B score were calculated at each 
stage of rehabilitation (Table 5). The difference between the mean reference 
and the mean B-B Score ranged respectively from - 2.4 to - 0.2 % according to 
stage in the patient group and was 5.3% in the control group. 
The one sample t-test showed that the healthy group B-B Score of 102.9 was 
not significantly different from a 100% score indicating perfect symmetry 
between arms (P=0.28). Conversely, the 108.2 P score showed a significant 
difference (P<0.01). 
The coefficients of the linear regressions between the reference and the B-B 
Score were significant at P<.01 at all stages. The slope coefficient was 1.03 at 
baseline, 1.01 at 3 months, 1.04 at 6 months and 1.01 at 12 months. Coefficient 
of determination was ≥.97 at all stages.  
Bias and LOA between reference and B-B Scores were - 3.1 % ± 15.8, - 0.7 % ± 
13.3, 1.8 % ± 21.6 and 1.6 % ± 19.6, respectively at baseline, 3, 6, and 12 
months (Figure 4). 
3.4 Relationship with shoulder function questionnaires 
The absolute values of correlations between B-B Score and shoulder function 
assessed by clinical questionnaires (DASH, SST and Constant) ranged from 
0.51 to 0.77 across the period of rehabilitation. The relationship between B-B 
Score and VAS pain (visual analog scale of pain) ranged from 0.35 to 0.50. All 
correlations were significant (P<.05) (Table 6).  
3.5 Diagnostic power for shoulder condition detection 
The area under the ROC curve was 0.99 [95% CI 0.98 – 1.00]. Using a 
threshold score of 78.7, the sensitivity for shoulder pathology detection was 97% 
and the specificity 94%.  
4 DISCUSSION 
4.1 Main results 
This study investigated the possibility of reducing the number of movements 
performed during a reference kinematic test (P Score) and the influence of this 
reduction on the measured outcome following shoulder surgery. 
The first step aimed at the development of a simplified kinematic scoring model 
using PCA and MR. It showed that 82% of the variation provided in the 
reference score involving seven movements was accounted for by the B-B 
Score at 3 months. As loss of information was minor, it should be reasonable to 
substitute this two-movement score for the reference score. The PCA 
highlighted two components, the “elevation” and the “rotation”, which correspond 
to clinically relevant features. It was consistent over the three different 
assessment occasions during rehabilitation. This provided a robust indication 
that the data structure was correctly identified by PCA. 
The PCA and MR did not allow the definition of a unique movement association 
reflecting the “elevation” and the “rotation” components. Therefore, several 
combinations were tested and the best choice was made in the second step of 
the analysis, based on the comparison of outcome with reference score 
outcomes using ANOVA. 
No significant difference was found between the reference score and the 
simplified models. However, the model involving “hand to the Back” and “hand 
upwards as to change a Bulb” movements (B-B Score) displayed the closest 
patterning of minimised differences between simplified and reference models 
across the times of rehabilitation. This model was thus selected for further 
comparison. 
The congruency between the simplified model and the reference model was 
further confirmed by the descriptive statistics that showed little difference 
between reference and B-B Scores outcomes. Similarly, the linear regressions 
between the reference score and the B-B Score showed a close relationship (R2 
> .97). However, standard errors of estimate ranged from 7.0 to 11.1% 
indicating that consistent errors may occur in individual prediction.  
Correspondingly, the Bland and Altman method showed that group results for 
the simplified model were closer to the reference score than those for 
individuals. The systematic error was limited (bias <-3.1%) but the limits of 
agreements between reference score and B-B Score were large (13.3 to 21.6%) 
regardless of the stage.  
The correlation between the B-B Score and the clinical questionnaires 
demonstrated that the outcome of the simplified scoring model is representative 
of the shoulder function and pain, with a closer link to function. 
The mean score of the healthy subjects (102.9) indicated that arm dominance 
had little influence on the outcome. The non-significant one-sample t-test for the 
B-B Score against a test value of 100, indicated that the arm dominance had 
little influence on the outcome. Therefore, no correction was needed to account 
for subjects’ dominance.  
Consequently, no correction factor accounting for handedness was necessary 
when investigating the diagnostic power. The area under the ROC curve was 
0.99, indicating an excellent ability of the B-B Score to distinguish affected from 
non-affected subjects (Hanley and McNeil, 1982). Concordantly, the diagnostic 
sensibility (97%) and specificity (94%) were excellent. The sensibility was 1% 
lower and the specificity was 5% higher than for a measurement method using 
range of angular velocities in subacromial impingement syndrome (Körver et al., 
2014a).  
In summary, despite the possible divergence for single measurements, the 
findings confirm the hypothesis that the reference score and a simplified scoring 
model (B-B Score) provide comparable results for group measurements. It can 
be inferred from these analyses that the B-B Score is a reasonable substitute for 
the reference score during group-based measurements and offers the 
aforementioned characteristics of an efficient model.  
4.2 Clinical interpretation 
Rotation and elevation, as identified by the PCA, are two essential components 
of shoulder function. Seventy-seven and 73 % of patients report difficulty in 
moving to reach the back of the head (elevation and external rotation) and the 
lower back (internal rotation) respectively in commonly occurring shoulder 
conditions (Van der Windt et al., 1995). Some daily activities like perineal care 
require a large internal rotation while combing hair requires a large elevation 
and external rotation (Magermans et al., 2005). Therefore, the inclusion of 
internal rotation and elevation in kinematic scores is underpinned by a close 
relation to shoulder function, and confirmed by the correlations with clinical 
questionnaires. 
4.3 Contribution to clinical practice 
The new model for scoring shoulder function is a contribution to the transfer of 
new technology into clinical practice. Together with progress of hardware 
technology, miniaturisation, wireless transmission, drop in electronic costs and 
development of user-friendly software, the simplification of body-worn sensors 
measurement procedure might render this approach more accessible to health 
professionals (Aminian and Najafi, 2004). 
As it is related to shoulder function questionnaires, the B-B score can be 
considered as a valid measurement tool of shoulder function. Due to its 
excellent sensitivity and specificity, it may be used in clinics to diagnose 
shoulder function alteration caused by rotator cuff tear or shoulder arthritis. 
Nevertheless, though the B-B Score is able to detect pathologies, it is not able 
to discriminate them. 
The development of a simplified kinematic score is also a contribution to an 
objective evaluation of shoulder function. Further research will be necessary to 
better understand the complementarities of objective and subjective approaches 
in shoulder function evaluation. 
4.4 Study strengths and limitations 
The process of analysis in this study implied that the B-B Score can at best 
perform equivalently to the reference score in the assessment of kinematic 
shoulder performance. Due to its consistent resemblance to the reference score 
over the period of rehabilitation, it can be expected that the simplified score 
displays comparable kinanthropometric measurement properties. The 
advantage of the B-B Score over the reference score mainly resides in its 
clinical practicality. 
The simplicity of the B-B Score allows measurement repetition. As the variability 
and error in a measurement mean score decreases with the square root of the 
repetitions number (assuming a normal distribution of error), test replication and 
averaging over intra-individual trials (Winer et al., 1981) may overcome the 
limitation linked to the possible models discrepancy in individual measurements. 
The kinematic scores would be biased toward an overestimation in case of 
bilateral symptomatic shoulder condition. Therefore, the absolute value of the 
score would not be indicative of the real shoulder function in this case. When the 
reference side is not healthy, the score can only be used to follow-up shoulder 
function evolution toward improvement or degradation, provided that the 
reference side is stable.  
The mean age of the patient group was purposefully higher compared to the control 
group, to avoid the inclusion of subjects with asymptomatic rotator cuff as control. 
Thus, the effect of age on the B-B score could not be investigated in this study. 
Theoretically, age-related degradation should have no influence as the subject 
serves as his own control. It must be considered that the B-B score reflects the 
function of the pathological shoulder compared to the normal shoulder function of the 
subject accounting for physiological aging. Further research is needed to investigate 
the possible effect of age on the B-B Score.  
Further studies are warranted to validate exhaustively the B-B Score for various 
shoulder pathologies, with particular consideration given to measurement 
reproducibility, responsiveness and concurrent validity. 
4.5 Conclusion 
The primary aim of this study was to design a simplified kinematic shoulder 
scoring model based on a selection of essential movements among the seven 
movements of daily life comprised in the reference P Score. The secondary aim 
was to compare the results of the new simplified scoring model with the 
reference P score. 
PCA and multiple regression were used to create simplified scoring models. 
Separate factorial ANOVA with measures on both factors were used to select 
the model presenting the best congruency with the reference model. The 
relationship between the reference and the new scoring model was evaluated 
using linear regression. The limits of agreement between models were 
evaluated using the Bland and Altman method. The validity of the new scoring 
model was evaluated calculating the correlations with shoulder function 
validated questionnaires. Finally, diagnostic power for shoulder pathology 
detection was calculated using receiver operating characteristic (ROC) analysis. 
“Elevation” and “rotation” movements were identified as the essential 
components of shoulder function. This study has shown that a measurement 
procedure including only two essential movements can replace a more complex 
seven-movement score without any significant information loss. Among all 
relevant two-movement models, the B-B Score (hand to the Back & hand 
upwards as to change a Bulb) was the best substitute for the reference score, 
due to its congruent evolution pattern across the period of rehabilitation 
compared to those of the reference model and to its clinical relevance for 
shoulder function evaluation. 
The B-B Score and the reference score produced comparable outcomes as far 
as group measurement is concerned, but as might be expected, they could 
produce differing results during the assessment of individual patients. 
The new score is a valid measurement method of shoulder function for the study 
population. It is able to discriminate accurately healthy subjects from patients 
suffering from rotator cuff or arthritis and is correlated to clinical questionnaires. 
The B-B Score is a contribution to objective evaluation of the shoulder function 
and to its routine application in physiotherapy, surgery and rehabilitation. 
The practicality of the B-B Score allows for completion of repeated 
measurements, which could prove useful to decreasing measurement variability 
and establishing requisite measurement precision for effective intra-subject 
evaluations. Application of this new model to shoulder conditions other than 
those considered in this study should be validated prior to use. Further studies 
are warranted for an extensive validation of the B-B Score. 
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Patient group Control group 
Sample 35 participants 31 participants 
Gender 25 male /10 female 15 male/16 female 
Age mean (SD) 58 (9.6) years old 33.2 (8.1) years old 
Weight mean (SD) 79.6 (14.7) kg. 68.8 (10.4) kg. 
Height mean (SD) 1.70 (0.1) m. 1.72 (0.1) m. 
BMI mean (SD) 27.2 (3.8) kg / m2 23.2 (3.1) kg / m2 
Dominance 33 right-handed//2 
left-handed 
24 right-handed/7 left 
handed 
Surgery side dominant/ side 23 dominant /12 non 
dominant 
- 








P Score  








































Table 2: Mean and SD of the reference score (P Score) and details for all performed 
movements for patients at 3 months. Unit of scores are % representing the 








Factor loading per movement 
Explained 
variance 




3.0 - 0.72 0.62 0.83 0.72 0.80 - 43% 
62% 





3.4 - 0.74 - 0.85 0.81 0.85 0.69 57% 
73% 





3.3 - 0.88 - 0.73 0.86 0.82 0.63 56% 
72% 





2.1 - - 0.80 0.90 - - - 51% 
76% 
2nd rotation 1.0 0.76 - - - - - 0.91 25% 
Legend : 1. Hand to the back, 2. Hand behind the head, 3. Reach object ahead (90° flexion), 4. Carry 
4kg in abduction (90° abduction with load), 5. Touch opposite shoulder with hand, 6. Change a bulb 
(elevation), 7. Move hand laterally keeping elbow against the body (external rotation). Loadings are 
presented into brackets.  
Movements which do not appear in the table are complex movements (related to several components) 
that were therefore excluded from analysis. 
 
Table 3: For each stage, the two PCA components are described with the 
eigenvalue, the factor loading to each movement, and the explained variance 
























Back – head 17.71 + (0.27 x back) + (0.47 x head) 10.5 .70 
Back – 
abduction 





7.38 + (0.19 x back) + (0.63 x head) 8.1 .81 
Back – bulb  16.71 + (0.32 x back) + (0.45 x bulb) 8.1 .82 
*All coefficients are significant at P<.01 
Table 4: Details and results on the four candidate scoring models computed by the 
multiple regressions analysis (MR) at 3 months 
  
Table 5 






in mean  
Baseline 
P Score 51.3 20.8 7.2 3.5 
-0.6 
B-B 50.7 15.8 5.8 2.8 
3 months 
P Score 62 19.2 6.7 3.3 
-0.2 
B-B 61.8 16.8 6 3 
6 months 
P Score 71.4 19.9 6.8 3.3 
-2.4 
B-B 69 15.9 6.5 2.7 
12 months 
P Score 81.5 22 7.6 3.7 
-1 
B-B 80.5 21 7.6 3.7 
Controls 
P Score 108.2 15.2 5.7 2.8 
5.3 
B-B 102.9 14.5 5.4 2.6 
Table 5: Descriptive statistics of the simplified scoring model (B-B Score) and the 
reference score (P Score) for patients at all stages and for healthy participants. Unit 
of scores are % representing the performance of the pathological side compared to 
the healthy side. 
  
Table 6 
 Baseline 3 months 6 months 1 year 
DASH 
- .54** - .60** - .64** - .51** 
SST 
  .62**   .62**   .65**   .55** 
CST 
  .57**   .77**   .61**   .54** 
VAS pain 
- .50** - .35* - .48** - .38* 
* p < 0.05 ** p < 0.01 
Legend: DASH: Disabilities of the Arm, Shoulder and Hand questionnaire, SST: Simple Shoulder Test, 
CST: Constant shoulder score, VAS: visual analogic scale. 
 




Captions to illustrations 
 
 
Figure 1: Arm sensors placement during measurement 
Figure 2: Humerus acceleration as a function of its angular velocity for a patient. (a) The 
trace represents the humerus acceleration vs. angular velocity for the healthy 
side. (b) The trace represents the humerus acceleration vs. angular velocity for 
the painful side. The rectangle, which circumscribes the curve corresponds to the 
product of the acceleration range by the angular velocity range (Pr). From: Coley 
et al. 2007. 
Figure 3: Graphs comparing evolution pattern over time of P Score and B-B Score 
(hand to the Back & hand upwards as to change a Bulb) 
 
Figure 4: Bland and Altman plot for the agreement between P Score and B-B Score 
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Quelles personnes sont concernées par l’étude ? 
Les patients présentant des pathologies de l’épaule.  
Des participants sans problème d’épaule seront également mesurés afin d’établir le résultat de 
référence de la personne saine.  
Qui sont les investigateurs de l’étude ?  
Plusieurs institutions collaborent de manière interdisciplinaire à cette étude. Des 
physiothérapeutes de la Haute Ecole Cantonal Vaudoise de Santé (HECVSanté), des 
médecins et des physiothérapeutes du Département de l’Appareil Locomoteur du CHUV, et 
des ingénieurs du Laboratoire de Mesure et d’Analyse du Mouvement de l’EPFL participent au 
projet.  
Quels sont les principes de l’étude ? 
Un capteur qui enregistre les vitesses angulaires et les accélérations du bras est collé par 
système velcro respectivement du côté atteint, puis du côté sain (Fig. 1). L’analyse de 
mesures permet d’avoir une représentation de la manière dont la personne bouge le bras et 
de comparer le mouvement des deux côtés. 
 
 
Figure 1: Exemple de capteur positionné sur le bras 
 
Comment se déroulent les tests ? 
Deux collaborateurs de l’étude prennent le volontaire en charge pour la réalisation du test. 
Chacun des collaborateurs effectuera le test à tour de rôle avec vous.  
Le 1er collaborateur met en place sur votre bras le capteur Physilog, qui communique avec le 
boîtier récepteur, ainsi que l’iPod. Le volontaire effectue cinq répétitions de mouvements 
simples de l’épaule, qui sont enregistrés par le boîtier récepteur. 
Ensuite, le 2ème collaborateur répétera avec vous la même procédure de test que son collègue. 
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Nous vous prierons aussi de remplir des questionnaires qui permettront de mettre en relation 
les résultats obtenus avec ce que vous vivez quotidiennement.  
L’ensemble de la procédure dure environ 60 minutes. 
Combien de séances sont nécessaires ? 
Deux séances de mesure espacées de 6 mois sont nécessaires. Ceci permet ainsi d’évaluer 
votre niveau initial et votre évolution dans le temps. La première séance se déroulera tel que 
décrit ci-dessus. Lors de la 2ème séance, un seul évaluateur vous prendra en charge et les 
tests ne seront donc répétés que deux fois.   
Où se déroulent les tests ? 
Les séances se dérouleront au service de physiothérapie de l’Hôpital Orthopédique, dans la 
cité Hospitalière du CHUV. 
Y a-t-il des risques pour l’épaule ? 
Les tests effectués ne présentent pas un risque supérieur aux mouvements que vous 
effectuez dans la vie courante. Les mouvements seront effectués en-dessous du seuil de 
douleur afin de ne pas augmenter des douleurs préexistantes. 
Que devez-vous encore savoir ? 
Cette étude ne modifie pas le traitement dont vous bénéficierez, qui est identique pour tous les 
patients, qu’ils fassent partie ou non de l’étude. 
L’étude est financée par le Fonds National Suisse de la Recherche Scientifique. Par 
conséquent, aucun frais lié à l’étude n’est facturé aux assurances ou aux participants. 
Le CHUV répond des dommages éventuels que vous pourriez subir dans le cadre de cette 
étude. Si, pendant ou après l’étude clinique, vous souffrez de problèmes de santé ou d’autres 
dommages en relation avec l’étude, vous voudrez bien en faire part à M. Claude Pichonnaz, 
investigateur principal de l’étude, dont les coordonnées sont notées à la fin de cette 
information, qui prendra les mesures adaptées à votre cas.  
La participation à l’étude est volontaire. Vous avez la possibilité de vous retirer de l’étude à 
tout moment sans avoir à vous justifier et sans préjudice d’aucune sorte. 
Toutes les données récoltées seront traitées de façon confidentielle. Elles pourront être 
transmises à des personnes extérieures en relation directe avec le projet de recherche, sous 
une forme anonyme uniquement, ainsi qu’à la Commission d’Ethique de la Faculté de Biologie 
et de Médecine de l’Université de Lausanne et à Swissmedic pour des activités de contrôle. 
Elles pourront être conservées durant 5 ans au maximum. 
 
5. 
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Aucun médicament ne sera utilisé pendant l’étude. 
Votre médecin traitant pourra être informé de votre participation à l’étude. Une copie de votre 
dossier d’étude lui sera envoyée si vous faites part de ce souhait au responsable de l’étude, 
dont vous trouvez les coordonnées ci-dessous. 
Un défraiement vous sera accordé pour compenser les frais de déplacement occasionnés par 
votre participation à l’étude. 
Responsable de l’étude :  
Claude Pichonnaz, Professeur HES-S2, HECVSanté filière physiothérapie 
Avenue de Beaumont 21 
1011 LAUSANNE 




C.P.  04.05.2011 
 
Prof. A. Farron  
Prof. B. Jolles 
FORM
Je soussigné(e) certifie que 
intitulée:  
« Validation d'un score ci
 
- J’ai été informé(e) des buts et
- J’affirme avoir lu attentiveme
propos desquelles j’ai pu sollic
- Je certifie avoir été informé(e)
obligations qui m’incombent p
- Je confirme notamment que j’a
- J’ai été informé(e) du fait qu
étude sans avoir à me justifier
- Je consens à ce que les don
personnes extérieures en rela
qu’à la Commission d’Ethiqu
Lausanne et à Swissmedic po
- Je consens à ce que mon méd
 
J’accepte donc de participer à
Nom, prénom du patient / de l
 
Date :  ...................................
 
Nom du responsable de l’étud
 
Date :   ...................................






ULAIRE DE CONSENTEMENT ECLAIRE 
 
le Docteur ………………… m’a proposé d
nématique fonctionnel de l'épaule incluan
mouvements essentiels » 
 du déroulement de l’étude ci-dessus. 
nt et compris les informations écrites fou
iter toutes les explications nécessaires à la 
 des avantages et des risques éventuels lié
our la participation à l’étude. 
i eu suffisamment de temps pour réfléchir à
e je pouvais interrompre à tout instant ma
 et sans préjudice d’aucune sorte. 
nées recueillies pendant l’étude puissent ê
tion avec le projet de recherche sous une 
e de la Faculté de Biologie et de Médeci
ur des activités de contrôle. 
ecin traitant soit informé de ma participation
 l’étude mentionnée dans l’en-tête. 
a patiente : ....................................................
................ Signature du patient :  ..................
e :  ................................................................








of. Kamiar Aminian 
e participer à l’étude 
t uniquement les 
rnies, informations à 
prise de ma décision. 
s à cette étude et des 
 ma participation. 
 participation à cette 
tre transmises à des 
forme anonyme, ainsi 
ne de l’Université de 





  DATE D ADMINISTRATION: ___/___/ 201 
 
C.P.  04.05.2011  7 
 
A remplir par le clinicien 
Diagnostic (entourez) : 
Pathologie de la coiffe des rotateurs  Fracture Instabilité Capsulite rétractile  
Aucun problème d’épaule 
1
er
 test effectué par : _______________________ 
2
ème
 test effectué par : ______________________ 
3
ème
 test effectué par : ______________________ 
4
ème
 test effectué par : ______________________ 
Taille   __. ____ mètre(s)  
Poids  ____ kilogrammes 
Intensité des douleurs et de la raideur dans l’épaule dominante (= la droite si vous êtes 
droitier, la gauche si vous êtes gaucher): 
VAS 1. Quelle fut l’intensité des douleurs dans votre épaule au cours de la semaine passée ? 
Réglette EVA en mm.: ________ 
VAS 2. Quelle fut l’intensité de la raideur dans votre épaule au cours de la semaine passée? 
Réglette EVA en mm.: ________ 
 
Intensité des douleurs et de la raideur dans l’épaule non dominante (= la gauche si vous êtes 
droitier, la droite si vous êtes gaucher): 
VAS 3. Quelle fut l’intensité des douleurs dans votre épaule au cours de la semaine passée? 
Réglette EVA en mm.: ________ 
VAS 4. Quelle fut l’intensité de la raideur dans votre épaule au cours de la semaine passée? 
Réglette EVA en mm.: ________ 
Remarques (particularité de la situation, déroulement des tests, biais éventuel, 
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DOULEUR / 15 points 
Evaluation d’après échelle EVA (p. précédente) 
calcul : 15 - (valeur EVA 100mm x 1,5/10) (arrondir au point entier le 
plus proche. Si .5, arrondir au point supérieur) 
  
 
NIVEAU D’ACTIVITÉ / 20 points 
1.  Handicap professionnel ou occupationnel  
Evaluation d’après échelle EVA sur 4 points, zone dans 
laquelle se trouve le curseur  (sévère = 0 → aucun = 4) 
2.  Handicap dans les activités de loisirs  
Evaluation d’après échelle EVA sur 4 points  
 (sévère = 0 → aucun = 4) 
3. La gêne dans le sommeil  
(oui = 0 pt ; parfois = 1 pt non = 2 pts) 
4. Le niveau de travail confortable avec la main (10 pts) 
Taille        Xyphoïde       Cou     Tête     Au-dessus 
 2 pts          4 pt             6 pts     8 pts       10 pts 
SUB-TOTAL / 20 points 
 
                   
                   
                   




                   
                   
                   




















MOBILITÉ ACTIVE NON DOULOUREUSE/ 40 points 
Flexion  0-30 /  31-60 /  61-90  /  91-120  /  121-150  / 150-180 
 0 pt 2 pts 4 pts    6 pts   8 pts    10 pts 
Abduction : 0-30 /  31-60 /  61-90  /  91-120  /  121-150  / 150-180 
     0 pt     2 pts     4 pts        6 pts         8 pts    10 pts 
Rotation externe: Main derrière la tête, coude en avant    : 2 pts 
  Main derrière la tête, coude en arrière  : 2 pts 
  Main sur la tête, coude en avant    : 2 pts 
  Main sur la tête, coude en arrière    : 2 pts 
  Elévation complète                            : 2 pts 
Rotation interne – Dos de la main sur : 
 Cuisse latérale     Fesse     Sacro-iliaque     L3         TH 12     TH 7 
  0 pt               2 pts           4 pts            6 pts       8 pts    10 pts 
  SUB-TOTAL / 40 points 
 
 
                   
 
 
                   
 
                   
                   
                   
                   
                   
 




                   
 
 
                   
 
                   
                   
                   
                   
                   
 
                   
 
FORCE MUSCULAIRE / 25 points 
Mesurée avec un dynamomètre, durant 5 sec, le bras à 90° d’élévation dans 
le plan de l’omoplate. Noter le meilleur résultat de la force max. pour 3 
répétitions. Le résultat est donnée en newton, donc diviser par 9.81 pour 
résultats en kg. Pts =nombre de kg. x 2. 








INDICE FONCTIONNEL DE CONSTANT TOTAL / 100 points 
  
Constant, C. R., et al.  2008. A review of the Constant score: Modifications and guidelines for its use. Journal Of 
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Dossier du patient 
 
Cette section vous demande de préciser quelques informations générales vous concernant: 
 
D1. Indiquez svp votre code postal: __ __ __ __ 
 
D2. Indiquez svp votre date de naissance (JJ-MM-AAAA)?  __ __ / __ __ / 19__ __ 
 
D3. Indiquez svp si vous êtes de sexe  (Cochez une case svp)     Féminin [F] 
   Masculin [M] 
 
D4.  Quel est le plus haut niveau d’éducation que vous ayez reçu? (Cochez une seule case svp) 
  Ecole primaire/ cours élémentaire     [P] 
  Ecole secondaire/ collège / apprentissage    [S] 
  Lycée/ université ou équivalent     [U] 
  Autre: _______________________________________________ [O] 
  Ne sait plus        [X] 
 
D5. Avez-vous déjà rempli une demande d’invalidité (AI) concernant l’épaule opérée? 
  Oui, j’ai rempli une demande AI, j’ai reçu une compensation dans  
le passé mais plus actuellement     [1] 
  Oui, j’ai rempli une demande AI, je reçois une rente actuellement [2] 
  Oui, j’ai rempli une demande AI, j’attends la décision  [3] 
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D6. A quel pourcentage travaillez-vous? 
  Plein-temps  [F] 
  Mi-temps  [P] 
  N’a pas d’activité professionnelle rémunérée [N] 
 




D10.  Combien d’heures, en moyenne, travaillez-vous chaque semaine: ____heures  [WH] 
 
D11. Vous considérez-vous comme   
 Droitier [ED]  Gaucher [EG]   Ambidextre  [EA] 
Si vous avez répondu ambidextre (=qui utilise indifféremment la main droite ou gauche), cochez 
quelle main vous utilisez pour : 
- écrire   Droite    Gauche  
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Cette section permet de nous renseigner sur votre état général (EQ-5D): 
 
Veuillez indiquer, pour chacune des rubriques suivantes, l’affirmation qui décrit le mieux votre 
état de santé aujourd’hui, en entourant le numéro approprié. 
 
 
EQ1.   Mobilité 
1. Je n’ai aucun problème pour me déplacer à pied 
2. J’ai des problèmes pour me déplacer à pied 
3. Je suis obligé(e) de rester alité(e) 
 
EQ2.   Autonomie de la personne 
1. Je n’ai aucun problème pour prendre soin de moi 
2. J’ai des problèmes pour me laver ou m’habiller tout(e) seul(e)  
3. Je suis incapable de me laver ou de m’habiller tout(e) seul(e)  
 
EQ3.   Activités courantes (ex. travail, études, travaux domestiques, activités familiales ou loisirs) 
1. Je n’ai aucun problème pour accomplir mes activités courantes 
2. J’ai des problèmes pour accomplir mes activités courantes 
3. Je suis incapable d’accomplir mes activités courantes 
 
EQ4.   Douleurs/gêne  
1. Je n’ai ni douleurs, ni gêne 
2. J’ai des douleurs ou une gêne modérée(s) 
3. J’ai des douleurs ou une gêne extrême(s) 
 
EQ5.   Anxiété/dépression 
1. Je ne suis ni anxieux(se), ni déprimé(e) 
2. Je suis modérément anxieux(se) ou déprimé(e) 
3. Je suis extrêmement anxieux(se) ou déprimé(e) 
 
  DATE D ADMINISTRATION: ___/___/ 201 
 








Afin d'évaluer au mieux votre état de santé,  
nous avons reporté sur cette feuille une 
échelle en forme de thermomètre où la 
valeur de 100 correspond à un état de santé 
le meilleur imaginable et la valeur de 0 cor- 
respondant à un état de santé le moins bon 
imaginable. 
 
Nous vous demandons de tracer une ligne 
à partir de la lettre A et se dirigeant vers 
la valeur de l'échelle correspondant au 


























































































 Pire état de santé 
 imaginable






Valeur subjective de l’épaule 
 
Indiquez sur l’échelle  ci-dessous à combien de % vous coteriez votre épaule atteinte, si une épaule 
complètement normale représente 100%. Cochez une seule case 
                      
 0% 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100% 
 
Indiquez sur l’échelle  ci-dessous à combien de % vous coteriez votre épaule la plus saine, si une épaule 
complètement normale  représente 100%.  
                      
 0% 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100% 
  




Cette section s’intéresse à ce que vous ressentez et à vos possibilités d’accomplir  
certaines activités. (QuickDASH) 
 
Veuillez répondre à toutes les questions en considérant vos possibilités au cours des 7 derniers jours. 
Si vous n’avez pas eu l’occasion de pratiquer certaines de ces activités au cours des 7 derniers jours, 
veuillez entourer la réponse qui vous semble la plus exacte si vous aviez dû faire cette tâche. Le côté 
n’a pas d’importance. Veuillez répondre en fonction du résultat final, sans tenir compte de la façon 
dont vous y arrivez. 
Veuillez évaluer votre capacité à réaliser les activités suivantes au cours des 7 derniers jours. Entourez 










1. Dévisser un couvercle serré 
ou neuf 
1 2 3 4 5 
2. Effectuer des tâches 
ménagères lourdes 
(nettoyage des sols ou des 
murs) 
1 2 3 4 5 
3. Porter des sacs de 
provisions ou une mallette 
1 2 3 4 5 
4. Se laver le dos 1 2 3 4 5 
5. Couper la nourriture avec 
un couteau 
1 2 3 4 5 
6. Activités de loisir 
nécessitant une certaine 
force ou avec des chocs au 
niveau de l'épaule du bras 
ou de la main.                         
















 Pas du tout    Légèrement Moyennement Beaucoup Extrêmement 
7. Pendant les 7 derniers jours, 
à quel point votre épaule, 
votre bras ou votre main vous 
a-t-elle gêné dans vos 
relations avec votre famille, 
vos amis ou vos voisins ? 

















Très limité Incapable 
8. Avez-vous été limité dans 
votre travail ou une de vos 
activités quotidiennes 
habituelles en raison de 
problèmes à votre épaule, 











Veuillez évaluer la sévérité des symptômes suivants durant les 7 derniers jours. (Entourez une réponse 
sur chacune des lignes) 
 Aucune  Légère Moyenne Importante Extrême 
9. Douleur de l'épaule, du bras 
ou de la main 
 
1 2 3 4 5 
10. Picotements ou 
fourmillements douloureux 





















perturbé que je 
ne peux pas 
dormir 
11. Pendant les 7 derniers jours, 
votre sommeil a-t-il été 
perturbé par une douleur de 
votre épaule, de votre bras 
ou de votre main ? (entourez 















La section suivante nous renseignera sur l’état fonctionnel de l’épaule qui vous pose problème 
(Simple Shoulder Test) : 
Veuillez répondre aux rubriques suivantes en marquant d’une croix la bonne réponse. 




Votre épaule est-elle indolore lorsque votre bras 

















3. Pouvez-vous mettre la main dans le dos pour 







4. Pouvez-vous mettre votre main derrière la tête 






5. Pouvez-vous mettre une pièce de monnaie à 






6. Pouvez-vous soulever 500 g (1 boîte de 
conserves) à hauteur de votre épaule sans plier 











Suite Simple Shoulder Test 
Veuillez répondre aux rubriques suivantes en marquant d’une croix la bonne réponse. 




Pouvez-vous soulever 4 kilos (1 baril de lessive) 









Pouvez-vous porter, du côté atteint, une valise 









Pensez-vous être capable de lancer une balle de 
caoutchouc à la façon d’une boule de pétanque 










Pensez-vous être capable de lancer une balle de 
caoutchouc à la façon d’une fléchette à une 









Pouvez-vous laver l’arrière de l’épaule opposée 









Votre épaule vous permet-elle de travailler 
normalement toute la journée dans votre 











A remplir seulement si votre diagnostic est une instabilité d’épaule               
(= tendance à la luxation) : questionnaire WOSI 
 
 Instructions au patient  
 
Dans les sections A, B, C, et D, il vous sera demandé de noter votre réponse en dessinant un trait en 
travers de la ligne horizontale, 
Si vous mettez un trait à l’extrémité gauche de la ligne, tel que représenté ci-dessous,  
                / 
vous signifiez alors que vous n’avez aucune douleur 
 
Si vous mettez un trait à l’extrémité droite de la ligne, tel que représenté ci-dessous,  
                                                               / 
vous signifiez alors que votre douleur est extrême 
 
 
Plus vous mettez le trait à droite, plus le symptôme que vous ressentez est fort 
 
Plus vous mettez le trait à gauche, moins le symptôme que vous ressentez est fort 
 
Veuillez ne pas inscrire de trait en dehors des lignes horizontales s’il vous plaît 
 
Vous êtes appelés à noter dans ce questionnaire l’intensité des symptômes que vous avez ressentis la 
semaine passée à l’épaule qui pose problème. Si vous n’êtes pas sûr de savoir de quelle épaule il 
s’agit ou si vous avez d’autres questions, n’hésitez pas à les poser librement avant de compléter ce 
questionnaire.  
 
Si une question ne s’applique pas à votre situation ou que vous n’avez pas ressenti le symptôme 












Section A : Symptômes physiques 
 
 
Les questions suivantes portent sur les symptômes physiques que vous éprouvez en raison de votre 
problème d’épaule. Pour chaque question, veuillez indiquer l’intensité du symptôme éprouvé au cours 
de la semaine dernière (Inscrivez un trait « l » sur l’échelle horizontale). 
 
1. Quelle intensité de douleur ressentez-vous à l’épaule lors d’activités nécessitant des 
mouvements au-dessus de la tête? 
 
aucune douleur                                                                                                               douleur extrême 
 
2. Quelle intensité de douleur continue ou pulsatile éprouvez-vous à l’épaule? 
 
aucune douleur                                                                                                                    douleur continue ou 
continue ou pulsatile                                                                                                              pulsatile extrême               
 
3. Eprouvez-vous une faiblesse ou un manque de force à l’épaule? 
 
aucune faiblesse                                                                                                               faiblesse extrême 
 
4. Ressentez vous une fatigue ou un manque d’endurance dans votre épaule? 
 
aucune fatigue                                                                                                               fatigue extrême 
 
 
5. Ressentez-vous des craquements ou claquements dans votre épaule? 
 
aucun                                                                                                                              craquements 
craquement extrêmes 




6. Ressentez vous une raideur de votre épaule? 
 
aucune raideur                                                                                                                 raideur extrême 
 
7. Ressentez vous une gêne au niveau des muscles de la nuque en raison de votre épaule? 
 
aucun inconfort                                                                                                                inconfort extrême 
 
8. A quel point ressentez vous votre épaule comme instable? 
 
aucune instabilité                                                                                                             instabilité extrême 
 
9. À quel point compensez-vous la perte fonctionnelle de votre épaule à l’aide d’autres muscles? 
 
aucunement                                                                                                                    extrêmement 
 
10. Quelle est la perte de mobilité au niveau de votre épaule ? 
 
aucune perte                                                                                                                   perte extrême 
  




Section B : Sports, loisirs et travail 
 
 
Les questions suivantes portent sur la manière dont votre problème d’épaule a perturbé le travail, le 
sport et les activités de loisir durant la semaine passée. Pour chaque question, tracez un trait « l » sur 
l’échelle horizontale à l’endroit qui correspond à l’intensité de votre symptôme. 
 
11. À quel point votre épaule limite-t-elle votre capacité de participer à des activités sportives ou 
récréatives? 
 
aucunement                                                                                                                    limitation 
limité extrême 
12. À quel point votre épaule affecte-t-elle le niveau de performance auquel vous pratiquez votre 
sport ou effectuez votre travail? (si votre épaule perturbe le sport et le travail, prenez en 
considération le domaine le plus perturbé) 
 
aucunement                                                                                                             affecté de  
affecté          façon extrême 
13. À quel point ressentez-vous le besoin de protéger votre bras lorsque vous pratiquez une 
activité? 
 
aucunement                                                                                                            extrêmement 
 
14. À quel point éprouvez-vous de la difficulté lorsque vous soulevez un objet lourd au-dessous de 
la hauteur de l’épaule? 
 
aucune                                                                                                                     difficulté 
difficulté   extrême








Les questions suivantes portent sur la manière dont votre problème d’épaule a perturbé ou changé 
votre mode de vie. A nouveau, veuillez tracer pour chaque question un trait « l » sur l’échelle 
horizontale à l’endroit qui correspond à l’intensité de votre symptôme. 
 
 
15. À quel point craignez-vous de tomber sur votre épaule? 
 
aucunement peur                                                                                                            extrêmement peur 
 
16. À quel point éprouvez-vous de la difficulté à maintenir votre niveau de condition physique 
souhaité? 
 
aucune difficulté                                                                                                              difficulté extrême 
 
17. À quel point avez-vous de la difficulté à jouer physiquement (ex : jouer à la lutte, taquiner…) 
avec votre famille ou vos amis? 
 
aucune difficulté                                                                                                              difficulté extrême 
 
18. À quel point avez-vous de la difficulté à dormir à cause de votre épaule? 
 
aucune difficulté                                                                                                              difficulté extrême




Section D : Émotions 
 
 
Les questions suivantes demandent comment vous vous êtes senti au cours de la semaine 
dernière quand à votre problème d’épaule. Veuillez indiquer votre réponse par un trait « l » 
sur l’échelle horizontale à l’endroit qui correspond à l’intensité de votre symptôme. 
 
 
19. À quel point êtes-vous focalisé sur votre épaule? 
 
aucunement                                                                                                                            extrêmement 
focalisé  focalisé 
 
20. À quel point craignez-vous que l’état de votre épaule ne s’aggrave? 
 
aucunement                                                                                                                            préoccupation 
préoccupé extrême 
 
21. À quel point éprouvez-vous de la frustration à cause de votre épaule? 
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The B-B Score is a straightforward kinematic shoulder function score including only two
movements (hand to the Back + lift hand as to change a Bulb) that demonstrated sound
measurement properties for patients for various shoulder pathologies. However, the B-B
Score results using a smartphone or a reference system have not yet been compared. Pro-
vided that the measurement properties are comparable, the use of a smartphone would
offer substantial practical advantages. This study investigated the concurrent validity of a
smartphone and a reference inertial system for the measurement of the kinematic shoulder
function B-B Score.
Methods
Sixty-five patients with shoulder conditions (with rotator cuff conditions, adhesive capsulitis
and proximal humerus fracture) and 20 healthy participants were evaluated using a smart-
phone and a reference inertial system. Measurements were performed twice, alternating
between two evaluators. The B-B Score differences between groups, differences between
devices, relationship between devices, intra- and inter-evaluator reproducibility were
analysed.
Results
The smartphone mean scores (SD) were 94.1 (11.1) for controls and 54.1 (18.3) for patients
(P < 0.01). The difference between devices was non-significant for the control (P = 0.16)
and the patient group (P = 0.81). The analysis of the relationship between devices showed
0.97 ICC, −0.6 bias and −13.2 to 12.0 limits of agreement (LOA). The smartphone intra-
evaluator ICC was 0.92, the bias 1.5 and the LOA −17.4 to 20.3. The smartphone inter-
evaluator ICC was 0.92, the bias 1.5 and the LOA −16.9 to 20.0.
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Conclusions
The B-B Score results measured with a smartphone were comparable to those of an in-
ertial system. While single measurements diverged in some cases, the intra- and inter-
evaluator reproducibility was excellent and was equivalent between devices. The B-B score
measured with a smartphone is straightforward and as efficient as a reference inertial sys-
temmeasurement.
1. Introduction
1.1. Current methods for shoulder function evaluation in clinical settings
The shoulder is the second most frequently affected body site [1]. The quality of tools for the
evaluation of shoulder function is of primary interest to adequately address the problems of
this large population and therefore limit the impact of shoulder pathologies on patients and
society. Shoulder function is usually evaluated using questionnaires. Dozens of evaluation
tools exist but most have not undergone a full validation process [2, 3]. Thus the measurement
of the shoulder functional outcome remains a controversial issue.
Several reviews of literature have concluded that no single questionnaire of shoulder func-
tion offered superiority regarding measurement properties [3–5], while one concluded that the
DASH (Disabilities of the Arm, Shoulder and Hand) score compared favourably to other ques-
tionnaires [6]. As a consequence, a large variety of outcome measurements tools have been
used, hindering the development of scientific evidence about the treatment of shoulder condi-
tions [2].
Clinical questionnaires have the advantages of handiness and low cost. Conversely, they
present intrinsic limitations related to language and cultural issues, respondents’ interpreta-
tions and content validity [7, 8]. The validation of questionnaires’s translations into various
languages is a time-consuming and cumbersome process. Moreover, the delineation between
objective and subjective evaluation is not always clearly defined in questionnaire-based assesss-
ment, with both approaches producing different results [9, 10].
1.2. Computerized shoulder function evaluation
Laboratory-based movement analysis overcomes these limitations and displays high accuracy
and precision. It has thus been largely used in research studies aiming at the characterization
and evaluation of shoulder motion. Most motion analysis studies have addressed the develop-
ment of innovative measurement’ methods mainly and have investigated differences between
healthy and pathological participants’ groups. However, none of them had proposed a shoul-
der function score that could be possibly used to monitor patient clinical evolution, to the best
of our knowledge.
Although 3D laboratory motion analysis systems have assumed a growing importance in
research, it’s their application in clinical settings that has remained likely to be limited by com-
plexity and cost. So, embedded systems, like inertial measurement units (IMU) have also been
developed for shoulder evaluation, as their portability and practicality facilitates the proce-
dures for measurement.
Measurements using embedded systems may provide a well-balanced compromise between
practicality and reliability. They may thus constitute a valuable alternative to questionnaires or
laboratory-based evaluation. The embedded systems’ results are highly correlated to laboratory
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reference system in the study. The other authors
have declared that no competing interests exist.
measurements and display adequate accuracy for clinical evaluation. Also, their use is not
restricted to laboratory settings and the measurement completion is easier [11]. Body-worn
sensors have been applied with promising results, to measure arm and shoulder movement in
various conditions [12–20].
Despite the simplification of the measurement procedures provided by body-worn sensors
their use for shoulder function evaluation has remained limited in clinical settings. Several bar-
riers still hinder the wide-spread use of such devices among health professionals. The require-
ments for the routine application in clinical practice are very demanding as, in addition to
measurement properties, time, practicability, user-friendliness and cost are of concern.
Using a smartphone for evaluation purposes might contribute to meeting these require-
ments and facilitating the regular use of computerized movement analysis in current practice.
Like embedded measurement systems, most smartphones are now fitted with built-in acceler-
ometers and gyroscopes. Using a dedicated application, they can thus be used for movement
analysis.
1.3. Present smartphone applications for shoulder evaluation
Numerous smartphone applications have been developed for patient evaluation, patient educa-
tion or to assist health care professionals in their practice. The applications addressing the
assessment of shoulder range of motion (ROM) generally demonstrated adequate measure-
ment properties [21–23]. However, ROM is only one component of shoulder function and no
smartphone-based assessment score for shoulder function has been validated to our knowl-
edge. The validation of smartphone-based outcomes would be of interest because of the high
prevalence of shoulder conditions and of the existing controversy about shoulder function
questionnaires.
Smartphone-based evaluation in clinical conditions is valuable only provided that the mea-
surement properties have previously been validated. This is mandatory as important decisions
are taken based on clinical outcome. The smartphone results might possibly differ from iner-
tial-based systems as the sensors’ features have not been specifically designed for scientific
measurement. An extensive validation process is thus needed before clinical implementation.
1.4. Inception of a smartphone application for shoulder function
Coley developed a shoulder function scoring system using inertial sensors. He proposed a rela-
tively simple shoulder function score based on three dimensional measurements of a power-
related metric using accelerometers and gyroscopes (P score) [11]. The procedure relied on a
sequence of seven functional movements based on the Simple Shoulder Test functional score
[24]. This approach demonstrated clinical relevance following rotator cuff and arthroplasty
surgery. It clearly discriminated healthy from pathological subjects, was correlated to clinical
scores and displayed good responsiveness [11]. However, the full test procedure required
around 20 minutes, which precluded routine application in clinical settings.
Körver et al. [25, 26] proposed a kinematic score based on angular rate (AR Score). This
score required less than 5 minutes to perform as it included only “arm to the back” and “arm
behind the head” movements. It demonstrated high intra- and inter-evaluator reproducibility,
with intraclass coefficient of correlation (ICC) of 0.95 and 0.91, respectively. The diagnostic
sensitivity was 98% and the specificity 81%. However, the criterion-based validity for shoulder
function evaluation was limited, as correlations with the DASH and SST (simple shoulder test)
clinical scores were weak [24, 27].
The latter weakness was not found for the B-B Score, a simplified version of P Score includ-
ing two movements only (hand to the Back & hand upwards as if to change a Bulb) [28]. This
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score was developed based on principal component analysis and multiple regression of the P
Score original data. The B-B Score results showed no significant difference with the P score
during the first year after shoulder surgery and both scores were highly related (R2>.97). The
diagnostic sensitivity was 97% and the specificity 94% for patients following rotator cuff sur-
gery or shoulder arthroplasty. The correlations with current clinical questionnaires ranged
from 0.51 to 0.77, indicating that the B-B Score had good criterion-based validity for shoulder
function evaluation. Thus, the simplified model is comparable to the P Score but presents prac-
tical advantages that facilitate the evaluation of shoulder function in clinical practice.
Pichonnaz et al. [29] investigated the measurement properties of a smartphone-based ver-
sion of the B-B Score in various shoulder pathologies. Diagnostic power, responsiveness and
concurrent validity with shoulder function questionnaires were insufficient for shoulder insta-
bility, but were appropriate for patients conservatively treated for rotator cuff conditions or
capsulitis, and patients surgically or conservatively treated for proximal humerus fracture,
when compared to accepted clinimetric standards.
Despite these promising results, it remains presently unknown if the measurement obtained
using a smartphone are comparable those obtained using a reference human movement analy-
sis system and display equivalent reproducibility. If so, the use of a smartphone for the B-B
Score measurement might offer a cost-effective and straightforward clinical outcome
measurement.
1.5. Study aim and hypotheses
The aims of this study were to investigate the validity and reproducibility of a smartphone-
assessed kinematic shoulder function B-B Score, and to compare the performance of the
smartphone to a reference inertial system.
Thus, the study hypothesis is that the B-B Score meets the requirements of a valid shoulder
function score. This implies that the differences between the control and the pathological
group but not the difference between devices should be significant, the ICCs 0.80 for inter-
device, intra-evaluator and inter-evaluator reproducibility, the limits of agreement (LOA)
between devices 10% and the bias 5% [30, 31]. The B-B Score results should also be coher-
ent with those of shoulder function questionnaires.
2. Materials andmethods
2.1. Study sample
A prospective cohort study was conducted between August 2011 and May 2014 at the Depart-
ment of Traumatology and Orthopaedic Surgery of the University Hospital of Lausanne. Ethical
approval was granted by the Human Research Ethics Committee of the Canton of Vaud
(CER-VD), protocol number 205/10. Patients gave their signed informed consent for participa-
tion in the study. The study was registered under ClinicalTrials.gov Identifier: NCT01431417.
Three healthy participants where inadvertently measured within the two weeks preceding the
registration date. The measurement protocol was strictly identical for all participants and was in
line with study declaration.
The included patients were adults> 18 year old. They presented with one of the following
shoulder conditions, as recorded during their first medical consultation at the specialized
shoulder consultation unit of the hospital: rotator cuff condition, adhesive capsulitis, proximal
humerus fracture i.e. the pathologies for which the B-B score measurement properties were
known as appropriate [29]. With the exception of patients with fracture, patients who gave
their consent underwent the measurement session within two weeks following medical
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consultation. Measurements were performed 6 weeks post stabilisation for patients with
humerus fracture, provided that the radiological control showed normal consolidation.
For the rotator cuff condition or capsulitis, patients were selected who required only con-
servative treatment. As the B-B Score had previously been validated after rotator cuff and
arthroplasty surgery [28], it was of interest to explore its validity in different populations. Sur-
gical and conservative fracture treatment were included in the same group as the evolution
and functional prognosis is similar in both populations [32].
A group of participants younger than 35 years-old without history of shoulder condition/
pain, was also included to evaluate the performance in a healthy population and the stability of
the score. These participants were selected purposefully to be younger than the patients to
avoid bias related to the high prevalence of asymptomatic rotator cuff tear above 40 years old
[33].
The sample size calculation was based on the data of a pilot study that included 7 controls
and 16 patients. The calculation was made so that, with a significance level at P< 0.05, the
power of 0.80 was reached when the minimal standards for acceptable properties of the score
were met. Fourty-six patients were required considering a lowest acceptable ICC of 0.80, corre-
sponding to a substantial correlation, and an expected ICC of 0.90 for two measurements [31,
34]. Nine patients were required to get the expected power for the difference between the
patients and the control group [35, 36]. A considerably larger sample was enrolled to get pre-
cise estimations of results and to allow subsequent subgroup analysis in further investigations.
Exclusion criteria were bilateral shoulder conditions, any concomitant pain or condition
involving the upper limb or cervical spine, medical contraindication to execute movements
required for score completion, tumour, neurological condition interfering with the test and an
insufficient local language level to give truly informed consent or to understand
questionnaires.
2.2. B-B Score calculation
The B-B Score was calculated according to the method described in Pichonnaz et al. and Coley
at al. [11, 28]. A power-related parameter was extracted from the recorded signals: the range of
acceleration was multiplied by the range of angular velocity, with a measurement unit of
[(deg/s) × (m/s2)], for each movement. This parameter was calculated for each axis and for
each movement of the B-B Score (“hand to the Back” movement and “lift hand as to change a
Bulb” movement) and added, separately for each side and for each movement. The ratio of the
performance of the affected side relative to the healthy side (or the dominant side relative to
the non-dominant side for healthy participants), expressed in percentage, was then calculated
for each of the two movements. The values of the movements were then weighted using the
equation: B-B Score = 16.71 + 0.32 x hand to the Back. + 0.45 x lift hand.
One hundred percent represents a perfect balance in capability between sides and the score
decreases in accordance with the severity of functional loss. For example, while a typical
healthy person performs near to 100%, the average patient might reach 46% before surgery,
67% at 3 months and 71% at 6 months after surgery.
2.3 Experimental system: Smartphone
A smartphone (iPod1, Apple, Cupertino, USA) was chosen as the support device for the devel-
opment of the application. It was fitted with 3D built-in sensors (Accelerometers: ± 2 g preci-
sion: ± 0.02 g; Gyroscopes: ± 500 deg./s precision: ± 0.2 deg./s; Sampling frequency: 100 Hz)
[37]. An application, called iShould (instrumented shoulder test) was programmed in Objec-
tive-C [38, 39]. This application enabled the acquisition of the acceleration and angular
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velocity signals during the movements of the B-B Score and the computation of the B-B Score
value, as described in the Fig 1. Once the application was launched, the smartphone provided
instructions to the user, through the smartphone loudspeaker, when to perform a score move-
ment. For each score movement, the application recorded the acceleration and angular veloc-
ity signals for a predefined period of 10 sec. The movements were first performed with the
healthy side and then repeated with the painful side. At the end of the test, the B-B Score was
directly calculated, displayed on the smartphone screen and then stored on the smartphone.
The application enabled exporting of all saved data to a computer for its direct comparison
with the data from the inertial sensors of the reference system.
2.4 Reference system
The reference system for body-worn movement analysis was composed of 2 inertial sensors
and a datalogger system (Physilog1, Gait Up, Lausanne Switzerland).
Each inertial sensor included three dimensional accelerometers and gyroscopes (Acceler-
ometers: Analog device, ADXL 210, ±5 g, precision: ± 0.2% of Full Scale; Gyroscopes: Analog
device, ADXRS 250, ±400 deg/s, precision: ± 0.1% of Full Scale). The device resolution was 16
bits and the sampling frequency was 200 Hz.
An inertial measurement system was used as a reference in this study because the B-B Score
has been previously developed based on this approach, and because inertial sensors provide
direct measurements of angular velocities and accelerations used in the score calculation. Ini-
tial study try-outs showed that the influence of measurement errors (offset, sensitivity or drift)
was negligible in the study context.
2.5. Measurement procedure
The inertial sensors of the reference system were placed on each humerus, 3 cm above the
midpoint of the line connecting the lateral epicondyle (EL) and medial epicondyle (EM). The
sensor’s axes were aligned to the anatomical frame of the humerus following the ISB recom-
mendations [40, 41]: Yh on the line connecting the gleno-humeral (GH) joint and the mid-
point of EL and EM, pointing to GH; Xh on the line perpendicular to the plane formed by EL,
EM and GH, pointing forward; Zh on the line perpendicular to Xh and Yh, pointing to the
right (Fig 2). The smartphone was also attached to the back of the arm with an armband. The
Fig 1. Schema of the application steps for the recording of a B-B score. From: Pichonnaz C, Duc C, Gleeson N, Ancey C,
Jaccard H, Lecureux E, et al. Measurement Properties of the Smartphone-Based B-B Score in Current Shoulder Pathologies. Sensors
(Basel). 2015;15(10):26801-17.
https://doi.org/10.1371/journal.pone.0174365.g001
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lower edge of the smartphone was set 3 cm above the upper edge of the inertial sensors’ mod-
ule [29]. Similar to previous work angular velocities and accelerations in the sensor frame have
been used to calculate the B-B Score [11, 28].
After setting-up of the systems, the participants watched a video-recorded demonstration
of the execution of the B-B Score. They were instructed to do the movements in the pain free
ROM, at their self-selected speed and in their natural way. The starting position was the arm
alongside the body, in a relaxed position. Movements were executed in a standing position fol-
lowing the smartphone-recorded instructions. The patients undertook first 3 repetitions of the
two B-B Score movements on the healthy side (put hand to the back + hand to the ceiling as to
change a bulb) and then repeated the task on the pathological side. The controls executed the
same procedure beginning on the dominant side.
The measurement procedure was repeated twice alternating between two evaluators. All
evaluators were experienced physiotherapists engaged in the project, who had previously been
trained to the score completion. The first evaluator was randomly assigned. All measurement
systems were detached for inter-evaluator administration of assessments to account for the
variability induced by possible inconsistent sensors’ placement in clinics. The score was calcu-
lated based on the mean of the 3 replications because the pilot study showed that the variability
was not significantly different with a higher number of repetitions.
Clinical questionnaires were also completed. Three currently used shoulder function ques-
tionnaires [Quick Disabilities of the Arm and Shoulder score (QuickDASH), Simple shoulder
test (SST), Constant score and Constant relative score (based on an age- and sex-matched nor-
mal populations)], the EuroQol generic quality of life questionnaire [EQ-5D] and the pain
visual analog scale (VAS) [24, 42–44]. The Constant Score was undertaken according to the
modified guidelines of Constant [45]. The shoulder function questionnaires were selected
because they represent current standards [3, 4, 46, 47]. They allowed the evaluation of the con-
current validity for the B-B Score but not of its validity against a ‘gold standard’, due to the
controversy surrounding shoulder function evaluation.
Fig 2. Inertial sensors and smartphone placement and axes. (a) The inertial sensor module (Physilog®
reference system) attached to the arm with medical tape and connected by cable to the datalogger carried on
wait. The smartphone is attached to the arm with the armband. (b) Test completion of “hand to the ceiling”.
https://doi.org/10.1371/journal.pone.0174365.g002
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2.6. Analysis
Descriptive statistics including mean, standard deviation (SD) and boxplots were performed
for patients’ characteristics and outcomes of both groups. The difference between the B-B
Scores measured by each device was evaluated using theWilcoxon rank-sum test. The relation-
ship between the B-B Scores of each device, and the intra- and inter-evaluator reproducibility
were evaluated using the ICC, measurement error (ME: standard error of the mean differ-





and Altman LOA analysis. Intra-evaluator reproducibility was calculated comparing the 1st
with the 2nd score obtained by the same evaluator, for the two evaluators. Inter-evaluator
reproducibility was calculated comparing the score obtained by one evaluator with the score
by the other evaluator, for the 1st and 2nd evaluator’s measurement. The Shapiro–Wilk test and
Komolgorov-Smirnov tests were used for the normal distribution analysis. The discriminative
power was evaluated by the significance level for the differences between groups (Mann-Whit-
ney) and between stages (Wilcoxon).
3. Results
3.1. Study sample
Twenty healthy participants and 65 patients (20 with rotator cuff condition, 23 with fractures,
22 with capsulitis) were included.
The population characteristics and the significance of the differences between groups are
described in Table 1.
3.2. Score outcome
The outcomes of the control group and the patient group, for the smartphone and the refer-
ence system (Physilog1), respectively, are presented in Table 2 and in Fig 3.
The difference between the control and the patient group was significant for the reference
system and the smartphone (P< 0.01).
The difference between the reference system and the smartphone was non-significant for
the control (P = 0.16) and for the patient group (P = 0.81).
3.3. Measurement reproducibility
The Shapiro-Wilk and Komolgorov-Smirnov tests confirmed the normal distribution of data
(P> 0.05) in the patient and in the control group, regardless of device. The numerical and
graphical presentations of reproducibility of measurement for inter-devices and intra- and
inter-evaluator comparison are presented in Table 3 and Fig 4.
Table 1. Participants’ characteristics.
Patient (n = 65) Control (n = 20)
Age mean (SD), years 58.5 (14.2)** 28.2 (6.2)
Sex (% women) 63 50
Weight mean (SD), kg 75.2 (15.8) 74.7 (17.4)
Body mass index mean (SD), kg/m2 26.6 (5.8) 24.2 (3.9)
Size mean (SD), m. 1.68 (0.10) 1.75 (0.10)
Hand dominance (% right-handed) 92 90
Affected side (% dominant side) 43 -
** Significant difference between groups with p-value < 0.01.
https://doi.org/10.1371/journal.pone.0174365.t001
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3.4. Clinical questionnaires
The results of shoulder function, pain and quality of life questionnaires are presented in Table 4.
4. Discussion
This study focused on the development and validation of the shoulder function B-B Score
measured by means of a smartphone. Using shoulder function scores derived from a dedicated
Table 2. Mean and standard deviation of B-B Score using the smartphone and the reference system.
Unit of scores are % representing the performance of the pathological side compared to the healthy side.
Mean (SD), % Reference system Smartphone
Min;max
Control 97.0 (13.8) 94.1 (11.1)
79.5 ; 125.2 71.9 ; 115.7
Patient 54.0 (19.0) 54.1 (18.3)
21.5; 114.5 21.7; 108.2
Legend: SD: standard deviation; Min: minimummeasured value; Max: maximum
measured value.
https://doi.org/10.1371/journal.pone.0174365.t002
Fig 3. B-B Score outcome in both groups using the reference system (Physilog®) and the
smartphone.
https://doi.org/10.1371/journal.pone.0174365.g003
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smartphone application, the study aimed at the technical and clinical validation of them within
various shoulder pathologies. Provided that the score is valid, it can offer a valuable alternative
to concurrent assessment methods as it is accessible and quickly performed.
4.1. Devices comparison
The reference system (Physilog1) and the smartphone produced comparable B-B Score out-
comes regarding group measurements. Although the specificities of the measurement systems
were different, e.g. sensors noise, sensor ranges and sampling frequency, the smartphone per-
formance appeared to be sufficient for the scores’ proper measurement. The mean differences
between the devices were non-significant and of limited magnitude (0.0% for the patient
group and 2.9% for the control group). These differences are minor in proportion to the 42.9%
and 40% difference between the patient and the control group, for the reference system and
the smartphone, respectively.
An excellent relationship was found between measurements from the devices (ICC 0.97).
Moreover, the Bland and Altman analysis demonstrated that the systematic error of the smart-
phone was minor. TheME and SEMwere acceptable when considered in relation to the mini-
mum-maximum range of the scores in the study sample. Conversely, the LOA exceeded the 10%
criterion that had defined the threshold. Thus, the Physilog and the iPod are interchangeable for
group measurement, but the magnitude of the LOAmight preclude the devices’ routine exchange.
4.2. Groups’ comparison
There were no deviations away from the planned sampling for this study. No significant differ-
ence was observed between the groups, except for age. The control group was purposefully
younger than the patient group as it was of primary importance that the reference population
had healthy shoulders. The patient characteristics were representative of the population com-
monly treated for shoulder pain [1, 48].
The B-B Score difference between the control and the patient groups was highly significant
regardless of the device. Hence, the B-B Score clearly discriminated the patient group from the
healthy group.
4.3. Score reproducibility
The intra- and inter-evaluator reproducibility was excellent (0.92 to 0.93) and comparable
between devices. As shown by the non-significant difference between B-B Scores computed
from reference and smartphone devices and by the small bias (<1.5%) derived from the Bland
Table 3. Inter-devices and intra- and inter-evaluator reproducibility of the measurements.
ICC (95% CI) LOA (%) Bias (95% CI) ME (%) SEM (%)
Inter-devices 0.97 (0.94–0.98) -13.2 to 12.0 - 0.6 (-0.9 to 1.1) 0.7 4.0
Intra-evaluator
Smartphone 0.92 (0.89–0.94) -17.4 to 20.3 1.5 (0.0 to 2.9) 0.7 6.6
Reference System 0.92 (0.89–0.94) -19.3 to 19.6 0.1 (- 1.4 to 1.6) 0.8 6.6
Inter-evaluator
Smartphone 0.92 (0.90–0.94) - 16.9 to 20.0 1.5 (0.1 to 3.0) 0.7 6.6
Reference System 0.93 (0.91–0.95) - 18.1 to 20.0 1.0 (-0.5 to 2.4) 0.7 6.4
ICC: intraclass coefficient of correlation; 95%CI: 95% confidence interval; LOA: limits of agreement; ME: measurement error; SEM: standard error of
measurement
https://doi.org/10.1371/journal.pone.0174365.t003
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and Altman analyses, the B-B Score’ replication and the evaluator biases were relatively minor,
indicating that the systematic errors were negligible.
Fig 4. Bland and Altman graphs for inter-devices, intra- and inter-evaluator limits of agreement. Legend: LOA: limits
of agreement.
https://doi.org/10.1371/journal.pone.0174365.g004
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Conversely, for both devices, the LOA for the repeated measurement of a B-B Score had
exceeded an arbitrary 10% threshold defining its clinical utility. Thus, the results are compara-
ble between replications and between evaluators for group measurement, but divergences are
possible for single measurements when using this study’s protocol, i.e. when taking the mean
of three repetitions. Measurements relating to the assessment of a single patient is still feasible
but would be expected to require acquiring the mean of more than three replications in order
to counteract inflated error and establish the requisite precision of measurement [49], as the
variability and error in a measurement mean score decreases with the square root of the repeti-
tions number (assuming a normal distribution of error). The simplicity of the procedure for
assessing the B-B Score facilitates measurement repetition and largely overcomes this
limitation.
4.4. Comparison with clinical scores
The kinematic measurements were also compared to currently-used clinical scores for bench-
marking. The clinical scores included shoulder function (Constant, Relative Constant, SST
and QuickDASH), pain (VAS) and quality of life (EQ-5D).
In healthy subjects, both clinical questionnaires and the kinematic B-B score were near to
the maximum performance for all scores, showing that the reference population had almost
perfect shoulder function. For patients, the observed importance of shoulder function loss was
also comparable between questionnaires and the B-B score, all scores indicating a substantial
function loss in the measured sample. It appeared thus in this study that the B-B score pro-
duces coherent results to the shoulder function questionnaires in terms of measured loss of
function, regardless of the device used.
These results were in line with published results on the relationship between kinematic
scores and clinical questionnaires, which showed moderate to high correlations of the B-B
score with the Constant and SST scores and moderate correlations with the QuickDASH for
various shoulder pathologies [29].
Table 4. Clinical questionnaires results.
Questionnaires mean (SD) * Patient Control
Min;max (n = 65) (n = 20)
Constant Score (SD), points 42.8 (17.9) 93.7 (6.6)
10 ; 85 80 ; 100
Relative Constant Score (SD), % 55.5 (23.9) 97.6 (7.5)
12 ; 110 82; 108
SST (SD), points 4.6 (3.1) 11.9 (0.2)
0; 12 11; 12
QuickDASH (SD), % 42.8 1.1 (2.5)
0.0; 86.4 0.0; 6.8
VAS pain (SD), mm 40.5 (24.2) 0.9 (2.7)
0; 81 0.0; 10
EQ-5D (SD), index 0.70 (0.19) 1.00 (0.00)
- 0.18; 1.00 1.00; 1.00
EQ-5D VAS (SD), points 74.3 (18.0) 98.4 (44.9)
10.0; 100.0 85.0; 100.0
* Best possible scores: Constant 100 points, Relative Constant theoretically no limit (scores in % based on
an age-and sex-matched normal population for Constant score), SST 12 points; QuickDASH 0, VAS pain 0,
EQ5D 1.00 (index score of a value set derived from the general population sample), EQ5D VAS 100.
https://doi.org/10.1371/journal.pone.0174365.t004
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4.5. Body-worn sensors shoulder function evaluation in the literature
Most previous studies that had investigated the measurement properties of body-worn sensors
for shoulder function scores used dedicated inertial-based system [11, 25, 26, 28, 50–55]. All
these studies concluded that the inertial-based systems produced a valid evaluation of shoulder
function. Similar conclusions have since been drawn by a study using smartphone technolo-
gies [29]. However, no comparison with a reference system was reported. To our knowledge
the present study has been the first to investigate the concordance and the relationship of a
smartphone-based and a reference inertial-based system for shoulder function evaluation. The
results are valuable for research and clinics as they demonstrate that the validity of the B-B
Score measurement is not altered when using a simple and accessible device.
4.6 Study limitations and further developments
The results apply for a situation in which the measurement has been performed under supervi-
sion and at the patient’s self-selected speed of movement. Further investigations are needed to
determine the validity of the score in other conditions. For example, the relationship between
devices might be different if the patients perform movements associated with the B-B Score at
their maximum speed due to the difference in sensors’ characteristics. Measurement’ reliability
might also be different if the patient performs the test without supervision.
The results were not detailed for each pathological subgroup in this study. This is a minor
limitation with regard to the study’s objectives, as the relationship between devices is not likely
to be significantly influenced by the pathology. Conversely, the use of a larger group had the
advantage of providing more precise estimations of the reproducibility.
Despite the widespread use and the convenience of smartphones, there are also limitations
in their use for scientific measurement. The precise features of the device are not fully dis-
closed by manufacturers due to commercial sensitivities. The users should remain conscious
that the characteristics may differ according to smartphone version and brand. An accessible
middle-segment smartphone model had been chosen specifically to offer insight into its per-
formance’ characteristics. The B-B Score would probably remain robust when faced with
minor variations in smartphone technology, as it would have compared the performance of
the affected shoulder with that of the healthy one [28], with the score unaffected by systematic
errors in measurement affecting both sides.
Based on this study and the body of literature on the subject, it appears that smartphones
most likely present measurement properties that are compatible with research requirements
for measurements comparing both sides and for range of motion measurements [21–23].
Nevertheless, the validity of using smartphones for more complex measurements, e.g. those
associated with 3D kinematic analysis of sport activities, remains unknown to date. Also, the
aforementioned variations in smartphones’ features imply that further research is needed to
investigate and quantify the influence of these variations on the outcome before clinical
implementation.
The duration required to conduct the whole procedure using the smartphone was around
two minutes. All things being equal, the advantage of the measurement approach used in this
study mainly resides in its clinical practicality and low cost. Further development of the smart-
phone approach is possible to accrue maximum benefit from it clinically. Thus, an android
version of the application has recently been made available to the public [56]. Future develop-
ment may also consider facilitating the communication of clinically-relevant results between
stakeholders, producing progression curves of functional improvements and comparing the
patient’s evolution of performance during care-pathways to benchmark results on a routine
basis.
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5. Conclusion
This study aimed at the technical and clinical validation of a B-B Score smartphone applica-
tion for shoulder function evaluation. The results showed that the B-B Score acquired by
means of a smartphone was valid and reproducible for the measurement of shoulder func-
tion of groups of patients including those presenting with rotator cuff conditions, proximal
humerus fractures or adhesive capsulitis. It displayed excellent intra- and inter-evaluator
reproducibility and discriminative power. Conversely, single measurements may offer
reduced precision in some circumstances. The assessments acquired using either a smart-
phone or a reference inertial system displayed comparable measurement properties across a
wide-range of clinimetrics.
Thus, the B-B Score measured with a smartphone allows valid, user-friendly and low-cost
evaluation of shoulder function for research and clinical work. This could facilitate the use of
objective measurement methods in routine practice and thus improve the quality of patient
follow up. Further research is needed to investigate the influence of the specific characteristics
of various smartphone models on results. Further technological developments are also re-
quired to achieve maximum benefit from the smartphone approach.
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duration can be 
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patient’s capacities. 
 
The smarphone is 
then attached to the 
back of the arm by 
means of an 
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see Figure 3.2 within 





A description of the 
measurement 
procedure is shown 
before the beginning 
of a new 
measurement. The 
measurement 
begins when the 
“healthy shoulder” 
button is touched.  
 
Three replications of the series of 
movements “hand to the back” and “hand to 
the ceiling” are completed. On ‘launching’ 
and initiating the software application, the 
smartphone provides instructions to the user, 
through the smartphone’s loudspeaker, 
when to perform a B-B Score-related 
movement. For each movement, the 
application records the acceleration and 
angular velocity signals. The movements are 
first performed using the healthy side of the 
body and then repeated with the painful side.  
 
For illustation, the outcomes of a patient treated in physiothepray for a capsulitis (patient’s 
information on the top of the screen have been blinded). The B-B Score change over time 
can be monitored (1st: 56%; 2nd 75%; 3rd 90%). The maximum range of motion of the 
shoulder in elevation on the affected side is also recorded (1st: 104%; 2nd 119%; 3rd 164%).  
Progression curves can be inspected (faded line and numbers on the right scale are related 
to the B-B Score; white line and numbers are related to shoulder elevation). 
The faded cursor at the bottom of the screen allows to navigate the time scale in order to 
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Abstract: This study is aimed at the determination of the measurement properties of the 
shoulder function B-B Score measured with a smartphone. This score measures the 
symmetry between sides of a power-related metric for two selected movements, with 100% 
representing perfect symmetry. Twenty healthy participants, 20 patients with rotator cuff 
conditions, 23 with fractures, 22 with capsulitis, and 23 with shoulder instabilities were 
measured twice across a six-month interval using the B-B Score and shoulder function 
questionnaires. The discriminative power, responsiveness, diagnostic power, concurrent 
validity, minimal detectable change (MDC), minimal clinically important improvement 
(MCII), and patient acceptable symptom state (PASS) were evaluated. Significant 
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differences with the control group and significant baseline—six-month differences were 
found for the rotator cuff condition, fracture, and capsulitis patient groups. The B-B Score 
was responsive and demonstrated excellent diagnostic power, except for shoulder instability. 
The correlations with clinical scores were generally moderate to high, but lower for 
instability. The MDC was 18.1%, the MCII was 25.2%, and the PASS was 77.6. No floor 
effect was observed. The B-B Score demonstrated excellent measurement properties in 
populations with rotator cuff conditions, proximal humerus fractures, and capsulitis, and 
can thus be used as a routine test to evaluate those patients. 
Keywords: shoulder; shoulder function; measurement properties; outcome assessment; 
validation studies; smartphone sensors; body-worn sensors; kinematics 
 
1. Introduction 
1.1. Measurement Properties in Shoulder Function Evaluation 
The prevalence of shoulder pain is estimated at 26.9% [1]. This places the shoulder as the second 
most frequently affected body site behind the lower back. Despite the high occurrence of shoulder 
conditions, there is an on-going controversy about the best methods to evaluate the impact of 
pathologies on shoulder function. Numerous clinical questionnaires exist but the methodological and 
reporting quality of the validation studies is generally low [2]. As a consequence, none has been 
recognized as a universal standard [3–5]. Computerized movement analysis might be an alternative 
due to its precision and reliability. However, the use of computerized systems is restricted to research 
for reasons of cost, training, practicality, and accessibility. The use of smartphones allows these 
limitations to be largely overcome, as they are fitted with built-in movement sensors, working in three 
dimensions but are affordable and have become items of everyday life. However, the use of 
smartphones for scientific purposes requires prior scientific validation. 
Clinicians and clinical researchers need thoroughly validated measurement methods to correctly 
evaluate the patient’s performance and the efficiency of therapeutic interventions. It is essential that the 
measurement properties of evaluation tools are extensively established to allow a correct interpretation of 
the outcome. In addition to the validity and the reliability, the investigation of the responsiveness and the 
definition of the clinically-important values are fundamental to correctly interpret the progress over time. 
This work requires a methodical process as the measurement properties are context-dependent. Thus, the 
investigations have to be performed in a large variety of situations to provide specific values for the 
clinicians to be able to tackle the wide range of conditions encountered in their practice [6]. 
Computer-based kinematic evaluation showed promising results for objective function evaluation 
but has remained too cumbersome for routine clinical application. Based on nine functional tests 
inspired from the Simple Shoulder Test (SST) [7], Coley et al. developed different scores (P, RAV, 
and M scores) using arm acceleration and angular velocity [8]. The kinematics have been recorded 
with arm-attached inertial sensors, with the aim to produce a valid and clinically-applicable kinematic 
score that can be straightforwardly performed in clinical settings. Recently the functional tests were 
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simplified to provide a shoulder function score, named the B-B Score by including only two basic arm 
movements (hand to the Back + hand upwards as to change a Bulb) [9]. 
Considering the simplicity of the B-B Score and the inertial sensing facility provided by 
smartphones, the measurement of this score using a smartphone might make computerized shoulder 
evaluation much more accessible for clinicians and researchers. We have investigated the validity and 
the reliability of the shoulder function B-B Score measured with a smartphone in a preliminary phase 
of the present study. It was demonstrated that a smartphone produced comparable group measurements 
to an inertial sensor-based body-worn system [10]. However, the ability of the score to evaluate the 
patient’s progression and to differentiate the results according to pathologies have not been 
investigated yet. The responsiveness, minimal detectable change (MDC), minimal clinically important 
improvement (MCII), and patient acceptable symptom state (PASS) need to be evaluated to allow a 
well-substantiated interpretation of the results during the patient follow-up [11–13]. The MDC is the 
lowest value that can be considered as above the bounds of measurement error for an instrument [12]. 
The MCII is the smallest change in measurement that signifies an important improvement for the 
patient, and the PASS is the symptom state that the patients consider acceptable [11]. 
1.2. Influence of Shoulder Pathologies on Physiological Movement 
The measurement properties for the B-B Score need to be determined first for conservatively-treated 
shoulder conditions, as they are much more frequent than surgically-treated conditions. Overall, only 
one in every sixteen patients presenting with shoulder pain requires surgery [14]. Moreover, some 
results were already available for the postsurgical context as the B-B Score was developed in a 
population who had undergone rotator cuff and arthroplasty surgery [9]. It has been established that the 
B-B Score produces comparable results to the kinematic P Score, which is valid and responsive 
following shoulder surgery [8,15,16]. 
Patients with rotator cuff conditions, proximal humerus fractures, adhesive capsulitis, and shoulder 
instabilities are frequently encountered in shoulder consultations [17–22]. It is, thus, essential to 
investigate the measurement properties of the B-B Score for these conditions. The validity and 
measurement properties of kinematic analysis may differ according to the type of pathology which 
affects the movement in a specific way. Thus, the B-B Score has to be validated separately for each 
pathology. 
Conditions associated with the shoulder’s rotator cuff musculature are the most common source of 
shoulder pain (65%). They are caused by rotator cuff tendinopathy, rotator cuff tears, subacromial 
impingement or subacromial bursitis [23]. Rotator cuff tendinitis affects 29% of patients presenting 
with shoulder pain in general practice [19]. Rotator cuff tear prevalence is also very high and is strongly 
related to age. Tears are present in 2.5% of the general population in their 30 s, 25% in their 60 s, and 
50% in their 80 s [18]. A painful arc during arm elevation is typical of rotator cuff conditions [24]. 
However, clinical presentation of rotator cuff conditions varies considerably. Range of motion (ROM) 
limitations may or may not be observed, and tears may remain asymptomatic despite the anatomical 
lesions [25]. 
Adhesive capsulitis, also named frozen shoulder, represents the second most prevalent cause of 
shoulder pain (22%) [18]. It is an idiopathic disease of the joint capsule causing mainly pain and  
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stiffness [23]. The adhesive capsulitis is usually considered a 12- to 18-month self-limiting process, 
but mild symptoms may persist longer [26]. 
Proximal humeral fractures are also common, as they account for 6% of all adult fractures [20].  
The incidence of this type of fracture in Western countries is growing due to the increasing age of the 
population. The movement is altered during the rehabilitation phase by pain, stiffness, and loss of 
strength. The recovery at one year is generally good for the conservative and the surgical approach [27]. 
Finally, the shoulder instability is also a frequent cause of medical consultation in younger 
populations. It is characterized by the inability to maintain the humeral head in the glenoid fossa of the 
scapula, so that the humerus slides partially or completely out of its socket. The shoulder instability’s  
one-year incidence is 0.56‰ individuals per year in the general population, but reaches 2.8% in a 
physically active young population [21,22]. Instability is problematic because it frequently leads to 
recurrent shoulder dislocation, apprehension, and loss of quality of life [28,29]. The movement is 
altered in the less stable positions of the glenohumeral joint. Typically, the patient experiences 
apprehension at the end of ROM while undertaking combined movements but can perform activities 
without problem in stable glenohumeral joint positions. 
1.3. Study Aim and Hypotheses 
This study is aimed at the determination of the measurement properties of the smartphone B-B 
Score for the assessment of the progression of current shoulder pathologies (rotator cuff condition, 
capsulitis, proximal humerus fracture, and shoulder instability). 
Based on two assessments acquired over a six-month period, it was hypothesized that: 
- the score would remain stable in the control group while it would progress significantly  
(p < 0.05) over time in each pathological group, 
- the responsiveness would be comparable to that of validated clinical questionnaires, 
- the area under the receiver operating characteristic (ROC) curve indicative of diagnostic power, 
would be at least adequate (≥0.70), 
- the correlations with clinical questionnaires would be at least moderate (r > 0.50) [6,30]. 
No hypothesis was made about the MDC, MCII, and PASS values as these investigations primarily 
aimed at the determination of these values for the needs of clinical evaluation. 
2. Experimental Section 
2.1. Participants 
A prospective cohort study was conducted between August 2011 and May 2014 at the Department 
of Traumatology and Orthopaedic Surgery of the University Hospital of Lausanne. Ethical approval 
was granted by the Human Research Ethics Committee of the Canton of Vaud (CER-VD). Patients 
gave their signed informed consent for the participation in the study. 
Patients were adults (>18 years old). They presented with one of the following shoulder conditions, 
as stated during their first medical consultation at the specialized shoulder consultation unit of the 
hospital: a rotator cuff condition, shoulder instability, adhesive capsulitis, proximal humerus fracture. 
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With the exception of patients with fractures, patients who gave their consent underwent a baseline 
measurement session within two weeks following the medical consultation, and a second session  
six months later. For patients with humerus fractures, measurements were performed six weeks  
post-stabilisation and six months later, provided that the radiological control showed normal healing. 
Only patients who required conservative treatment were selected in the rotator cuff condition, 
capsulitis or instability groups. Patients undergoing surgical and conservative fracture treatments were 
included as the progress and functional prognosis is similar in both populations [27]. 
A group of participants younger than 35 years old without a history of shoulder condition/pain, was 
also included to evaluate the performance in a healthy population and the stability of the score.  
These participants were purposefully younger than the patients to avoid bias related to the high 
prevalence of asymptomatic rotator cuff tear above 40 years old [25]. 
The sample size calculation was based on the data of a pilot study that included seven controls and  
16 patients. The calculation was made so that, with a significance level at p < 0.05, the power of 0.80 
was reached when the minimal standards for acceptable properties of the score were met. Eighteen 
patients per group were needed for a significant correlation when r > 0.50, 11 patients for an area 
under a ROC curve of 0.80 with a standard error of 0.1, and nine patients for a significant difference 
between the patients and the control group [31,32]. According to these estimations, 20 participants 
were enrolled in each group of pathology and in the control group. 
Exclusion criteria were a bilateral shoulder condition, any concomitant pain or condition involving 
the upper limb or cervical spine, medical contraindication to execute movements required for score 
completion, tumour, neurological conditions interfering with the test, and an insufficient local 
language level to give truly informed consent or to understand questionnaires. 
2.2. Measurement Protocol Heading  
Patients were measured using a smartphone (iPod®, Apple, Cupertino, CA, USA) attached to the 
back of the arm with an armband (Figure 1). The lower edge of the smartphone was set 3 cm above the 
upper edge of olecranon. The iPod was fitted with 3D built-in sensors (accelerometers: ±2 g precision:  
±0.02 g; gyroscopes: ±500°/s precision: ±0.2°/s; sampling frequency: 100 Hz) [33]. 
  
Figure 1. iPod® attached to the arm during the test completion. 
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After the setting-up of the system, the participants watched a video-recorded demonstration of the 
execution of the B-B Score. They were instructed to do the movements in the pain free ROM at their 
self-selected speed. Movements were executed in a standing position following smartphone-recorded 
instructions. The patients first undertook three repetitions of the two B-B Score movements on the 
healthy side (put hand to the back + hand to the ceiling as to change a bulb) and then repeated the task 
on the pathological side. The controls executed the same procedure beginning on the dominant side. 
The B-B Score was computed as the ratio of a power-related unit [(deg/s) × (m/s2)] of the affected 
side relative to the healthy side, expressed as a percentage [8]. It was calculated along the method 
described in Pichonnaz [9]. 
An application, called iShould (instrumented shoulder test) was programmed in Objective-C 
[34,35]. This application enabled the acquisition of the acceleration and angular velocity signals during 
the movements of the shoulder, and the computation of the B-B Score value, as described in the  
Figure 2. Once the application had been initiated at the start of the assessment, the smartphone 
provided instructions to the user, through the smartphone loudspeaker, as to when the user should 
perform a movement associated with the B-B Score. For each score’ movement, the application 
recorded the acceleration and angular velocity signals for a predefined period of 10 s. The movements 
were first performed with the healthy side and then repeated with the painful side. At the end of the 
test, the B-B Score was directly calculated, displayed on the smartphone screen, and then stored on the 
smartphone. The application enabled exporting of all saved data to a computer for its direct 
comparison with the data from the inertial sensors of the reference system.  
 
Figure 2. Schema of the application steps for the recording of a B-B Score. 
One hundred percent represented a perfect balance between sides and the score decreases according 
to the severity of the functional loss. The score was calculated based on the mean over the  
three replications. 
Clinical questionnaires were also completed. Four currently-used shoulder function questionnaires 
(Quick Disabilities of the Arm and Shoulder score (QuickDASH), Simple shoulder test (SST), 
Constant score and Constant relative score (based on an age-and sex-matched normal populations)), a 
specific shoulder instability questionnaire (Western Ontario Shoulder Instability Index (WOSI)), the 
EuroQol quality of life questionnaire (EQ-5D), and the pain visual analog scale (VAS) were completed 
[7,36–40]. The Constant Score was completed according to the modified guidelines [41]. The shoulder 
function questionnaires were selected because they represent current standards [5,42–44]. They 
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allowed the evaluation of the concurrent validity for the B-B Score but not of its validity against a 
“gold standard”, due to the controversy surrounding shoulder function evaluation. 
2.3. Analysis 
Descriptive statistics were calculated for the patients’ characteristics and the outcomes at baseline and 
at six months. The differences between groups were analyzed using the Mann-Whitney or the chi-square 
tests as applicable, and the differences between stages were tested for each pathological group using the 
Wilcoxon signed rank test. The responsiveness for the baseline—six months evolution was calculated 
using Cohen’s d effect size with a 95% confidence interval. The diagnostic power for shoulder pathology 
detection was calculated using the ROC curve analysis. The area under the curve (AUC), sensitivity, 
specificity, and optimal detection threshold (highest sensitivity-specificity ratio) were calculated. The 
Spearman correlations were used to assess the strength of relationship between the B-B Score and the 
questionnaires for each of the pathologies. It was considered that a floor effect existed if >15% of 
patients scored less than 0 + MDC at baseline [13,45]. No ceiling effect was calculated as the score has 
theoretically no upper limit. 
The MCII and PASS were determined for the patient group using the anchor-based method as 
described in Tubach et al. [11]. The MDC was calculated as described in Beaton et al. [12]. 
3. Results 
One hundred and eight participants were tested at baseline (20 healthy participants, 20 patients with 
rotator cuff condition, 23 with fractures, 22 with capsulitis, and 23 with shoulder instability). All 
controls were measured at six months. Four patients could not be contacted at six months and four 
refused to participate for reasons without relationship with the study. 
Drop-out rate was low (7%) and the number of patients lost at follow up were compensated to reach 
the planned sample size. 
The population characteristics and the significance of the differences between groups are described 
in Table 1. 




(n = 20) 
Fracture  
(n = 23) 
Capsulitis  
(n = 22) 
Instability  
(n = 23) 
Control  
(n = 20) 
Age mean (SD), Years 63.5 * (10.6) 60.1 * (15.6) 52.5 * (13.8) 32.1 (14.1) 28.2 (6.2) 
Sex, % Women 50 78 60 43 50 
Weight Mean (SD), kg 78.3 (18.2) 69.6 (15.1) 78.3 (15.1) 70.8 (12.9) 74.7 (17.4) 
Body Mass Index Mean (SD), 
kg/m2 
25.8 (5.4) 25.8 (5.4) 25.8 (5.4) 25.8 (5.4) 24.2 (3.9) 
Size Mean (SD), m. 164.0 * (7.4) 167.7 (9.7) 172.4 (10.9) 172.6 (9.4) 175.0 (10.3) 
Hand Dominance, % Right-Handed 90 87 100 87 90 
Affected Side, % Dominant Side 70 25 45 52 - 
* Significant difference with control group. 
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The outcomes of the B-B Score for the control group, and for the patient group by pathologies are 
presented in Table 2 and Figure 3. The differences between the control group and the rotator cuff 
condition, fracture, and capsulitis patient groups were significant (p < 0.01). The difference between 
the shoulder instability group and the control group, was non-significant (p = 0.06). 
Table 2. Mean and standard deviation of the B-B Score. Unit of scores are % representing 
the performance of the pathological side compared to the healthy side. 
Pathology Control Rotator Cuff Humerus Fracture Capsulitis Shoulder Instability 
Baseline 
Mean (SD)  
Sample size 
94.1 (11.1) *  
20 
63.1 (19.7) *  
20 
46.3 (17.5) *  
23 
54.4 (14.6) *  
22 
84.5 (22.6)  
23 
6 months 
Mean (SD)  
Sample size 
96.0 (8.3) *  
20 
77.6 (21.1) *,†  
19 
78.9 (15.1) *,†  
20 
75.3 (20.5) *,†  
21 
91.2 (15.6)  
20 
* Significant difference with the control group (p < 0.01); † Significant difference with baseline (p < 0.01). 
 
Figure 3. Outcome of the B-B Score for the control group and the pathology groups.  
**: significant difference with the control group p < 0.01. 
The effect size and 95% confidence intervals are presented in Table 3 for the B-B Score, Constant 
and Constant relative score, the SST, QuickDASH, and WOSI. The area under the curve (AUC) with 
95% CI and the cut-off for optimal sensitivity-specificity ratio are detailed in Table 4. The correlations 
between the shoulder function questionnaires are presented for each pathologies in Table 5. 
Table 3. Effect Size (95% CI) for each score and each pathology. 
Outcome 
Measure 
Rotator Cuff Fracture Capsulitis Instability 
Effect Size (95% CI) 
B-B Score 0.69 (0.02–1.33) 1.94 (1.14–2.67) 1.16 (0.49–1.79) 0.10 (−0.52–0.72) 
Constant 0.54 (−0.12–1.18) 2.09 (1.26–2.83) 1.05 (0.38–1.67) 0.21 (−0.42–0.82) 
Relative Constant 0.50 (−0.15–1.14) 2.10 (1.27–2.84) 1.04 (0.38–1.67) 0.27 (−0.36–0.89) 
SST 0.52 (−0.13–1.16) 1.65 (0.89–2.35) 0.86 (0.22–1.48) 0.10 (−0.53–0.71) 
QuickDASH 0.35 (−0.30–0.98) 1.25 (0.53–1.91) 0.55 (−0.08–1.16) 0.01 (−0.61–0.63) 
WOSI - - - 0.47 (0.17–1.09) 
EQ-5D 0.23 (−0.42–0.86) 0.76 (0.09–1.40) 0.34 (−0.27–0.94) 0.37 (−0.26–0.99) 
EQ-5D VAS 0.07 (−0.57–0.70) 0.37(−0.26–0.99) 0.06 (−0.55–0.66) 0.11 (−0.51–0.73) 
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Rotator Cuff  0.90 (0.78–1.00) 83.6 90 90 
Humerus Fracture 0.98 (0.94–1.00) 71.6 100 96 
Capsulitis 0.99 (0.98–1.00) 82.1 95 100 
Shoulder Instability 0.67 (0.50–0.84) 81.6 95 48 
Table 5. Spearman correlation coefficients between B-B Score and clinical questionnaires. 
 Rotator Cuff Humerus Fracture Capsulitis Shoulder Instability 
Constant 0.82 ** 0.70 ** 0.68 ** 0.46 * 
Relative Constant 0.84 ** 0.69 ** 0.69 ** 0.43 * 
SST 0.63 ** 0.66 ** 0.76 ** 0.52 * 
QuickDASH −0.55 * −0.40 −0.64 ** −0.57 ** 
WOSI - - - 0.58 
VAS pain −0.50 * −0.07 −0.39 −0.19 
EQ5D 0.33 0.18 0.63 ** 0.46 * 
EQ5D-VAS 0.16 −0.30 0.44 * 0.47 * 
SST: simple shoulder test; QuickDASH: Quick Disabilities of the Arm, Shoulder and Hand score; WOSI: 
Western Ontario Shoulder Instability Index; SSV: Subjective Shoulder Value; VAS: Visual Analog Scale.  
* significant correlation (p < 0.05); ** significant correlation (p < 0.01). 
The MDC was 18.1%. The MCII of the B-B Score was 25.2% and the PASS was 77.6. No floor 
effect was observed as all patients performed above the MDC. 
4. Discussion 
This study aimed at the determination of the measurement properties of the smartphone B-B Score 
in current shoulder pathologies (rotator cuff conditions, capsulitis, proximal humerus fractures, and 
shoulder instabilities). 
4.1. Results Interpretation 
Participants younger than 40 years old were purposefully enrolled in the control group to prevent 
the inclusion of people with undetected rotator cuff conditions [25]. Thus, the significant difference in 
patient size between the rotator cuff group and the control group reflects the age-related decrease in 
size [46]. It is not likely to have an impact on this study’s results as age is not known to have an 
influence on symmetry in arm movement, as measured by the B-B Score. The high proportion of 
women in the fracture group is representative of gender prevalence in the wider population [20]. The 
low proportion of patients affected on the dominant side in the same group is of minor importance, as 
the outcome is not influenced by the fracture side [47]. Further, the influence of dominance on the B-B 
Score is minimal, as observed in the control group and in a previous study [9]. 
The B-B Score differences between the control and the patient groups were highly significant with 
the exception of the shoulder instability group. The functional loss was, in order of importance, more 
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marked for patient with a fracture, a capsulitis, and a rotator cuff condition than for instability. Hence, 
the B-B Score clearly discriminated the three first groups from the healthy group but displayed a lower 
discriminative power for shoulder instability. 
Shoulder instability is characterised by apprehension in the arm positions that exposes the patient to 
a glenohumeral dislocation risk [29]. It might be that the B-B Score is not challenging enough for these 
patients, as it is executed in the pain-free ROM and involved a self-chosen speed. Thus, the movement 
of the involved shoulder is not affected by the instability in the normal testing conditions of the B-B 
Score. Consequently, the functional loss may remain undetected. A more challenging version of the 
score inducing apprehension is hardly conceivable, as it might put the patient in a situation of actual 
dislocation likelihood. These results highlight that shoulder instability affects movement in a different 
way than other shoulder pathologies and should, thus, be evaluated using a specific tool, like the 
WOSI, for example. 
The non-significant baseline to six-month progression in the control group indicated that the B-B 
Score is stable over time during which the participant’s performance can reasonably be expected to 
have remained unchanged. The significant differences over time observed in the rotator cuff condition, 
humerus fracture, and capsulitis groups indicate that the B-B Score discriminates amongst  
clinical stages for these pathologies. Conversely, no significant difference was found in the shoulder  
instability group. 
It should be noted that the treatments were not standardized in this study as the aim was to evaluate 
the score properties but not the treatment’s efficacy. Thus, the observed results reflect the combination 
of the natural evolution and of the individualized treatment received by the patients. 
The effect size measured in this study should be considered as indicative, as the confidence 
intervals were large. The effect sizes were larger, in order of importance, for the rotator cuff, humerus 
fracture, and capsulitis conditions, than for the shoulder instability condition. These results are 
essentially related to the respective baseline to six-month progression in each one of these pathologies. 
As a consequence, the absolute value of the effect size is relative to the context of measurement and, 
hence, the reference to cut-off values can be misleading [48]. 
Conversely, the comparison of the effect sizes of concurrent measurement methods for a given 
condition is informative towards the respective responsiveness of a score. The B-B Score was the most 
responsive score for the rotator cuff and capsulitis groups. The Constant and Constant relative score 
displayed the better responsiveness for humerus fracture, followed by the B-B Score. The B-B Score 
nevertheless constitutes a reasonable alternative to the Constant score for fracture evaluation, when the 
patient is unable to perform the strength measurement (as is the case in 51.9% of patients referred for 
shoulder surgery), and when the administrative burden is of concern [4]. All shoulder function 
evaluation methods showed better responsiveness than the EQ-5D generic quality of life questionnaire. 
No floor effect was observed for the B-B Score as all patients performed above the MDC value. 
Similarly, to the Constant, DASH, and SST, the B-B Score demonstrated a poor responsiveness for 
shoulder instability. The WOSI displayed the best responsiveness for the evaluation of the shoulder 
instability. The limited responsiveness of the Constant, DASH, and SST for this patient population has 
previously been reported in the literature [40,49,50]. 
The AUC were excellent (≥0.90) for all pathologies except shoulder instability. The diagnostic 
power of the B-B Score was higher for fractures and capsulitis (0.98 to 0.99) than for rotator cuff 
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conditions (0.90). The sensitivity and specificity at the optimal threshold were excellent for these three 
pathologies. Conversely, the diagnostic power was insufficient in the instability group as the AUC was 
lower than the 0.70 threshold [51]. Thus, the B-B Score is highly efficient for detecting loss of 
shoulder function in rotator cuff, fracture, and capsulitis. However, although the score is able to detect 
that pathology impairs shoulder function, it is not able to differentiate amongst pathologies. Further 
research should investigate to what extent alterations in specific movement patterns might allow 
discrimination amongst pathologies. 
The correlations for the B-B Score with the Constant, Constant relative, and SST were moderate to 
high (0.63 to 0.82) for rotator cuff conditions, factures, and capsulitis [30]. In contrast, the relationship 
with the QuickDASH was generally lower (0.36–0.64) and non-significant in some cases. The merely 
objective nature of the B-B Score and the merely subjective nature of the QuickDASH may explain the 
lower relation with this questionnaire. The lower correlations with the VAS pain scale indicated that 
the B-B Score is essentially a measure of shoulder function. 
Moderate to low correlations were found between the B-B Score and shoulder function 
questionnaires when considering instability. These results indicated that the relation to function was 
limited for this pathology. Conversely, the B-B Score adequately captured shoulder function for rotator 
cuff, fracture, and capsulitis. The absence of a floor effect indicated that the responsiveness was not 
altered for patients performing at a low functional level. 
Some clinically useful values (MDC, MCII, and PASS) were also calculated in this study.  
No differentiation between pathologies was made due to the limited sample size. The MDC reflects the 
magnitude of change that is needed to consider that the change is greater than the measurement error 
for an instrument [12]. The MDC of the B-B Score using a smartphone indicated that the score 
difference needs to be greater than 18.1% to ensure that it is a real variation of a patient’s state. The 
MCII characterizes which level of score improvement reflects a meaningful progress for the  
patient [52]. Based on the MCII value, the B-B Score improvement between two stages needs to be 
greater than 25.2% for the patient to consider the improvement as meaningful. The PASS is the value 
beyond which patients consider themselves well [53]. Patients performing above the 77.6% will 
usually consider that the function loss is acceptable. 
4.2. Limitations and Further Developments 
Limitations are related to the limited sample size of each patient group. Though the group size was 
sufficient to compare the measurement properties of the B-B Score with those of concurrent scores, 
larger sample sizes would be needed to get more precise estimations. Additionally, the MDC, MCII, 
and PASS could not be calculated separately for each pathology group. 
Though the B-B Score was compared to frequently-used shoulder function questionnaires, none of 
them is considered as a gold standard for shoulder function evaluation. Thus, the results of this study 
could solely investigate the concurrent validity but not the validity of the new score by comparison to a 
gold standard. The use of other questionnaires would have provided a different benchmark for the 
comparisons. It can nevertheless be considered that the questionnaires used in this study are fair 
comparators as no concurrent questionnaire has demonstrated its superiority over them [2]. 
Sensors 2015, 15 26812 
 
 
The results found in this study demonstrated that the B-B Score has limitations for the evaluation of 
patients with shoulder instability. The score discriminated neither the instability from the control 
group, nor the stages within the instability group. Additionally, the responsiveness was lower than that 
of the WOSI and the diagnostic power was poor [54]. Based on these results, the B-B Score should not 
be used for the evaluation of shoulder function in a shoulder instability population. Conversely,  
all minimum requirements were met for rotator cuff conditions, proximal humerus fractures, and  
adhesive capsulitis. 
Based on this study, it can be considered that clinically-important measurement properties of the 
smartphone-based B-B Score have been defined. The determination of the clinically useful values for 
the shoulder pathologies considered in this study provides a background for adequate interpretation of 
the results in research and clinics. However, a benchmark with a reference measurement system has 
not been provided in this study. Future studies should compare the results, reproducibility, and 
diagnostic power of a smartphone and a scientific measurement device. More research is also needed 
in patient populations that were not investigated in this study. For example, robust validation of the  
B-B Score is needed within populations experiencing glenohumeral osteoarthritis, shoulder 
arthroplasty, and rotator cuff surgery that have been the focus of validation studies in the past [9]. 
A middle segment smartphone model was chosen to have an insight into the performance of an 
accessible model. As a wide range of smartphones have similar or better quality sensors, the results 
from these models should, theoretically, be comparable to those found in this study. The B-B Score is 
probably robust to device variations, as it compares the performance of the affected shoulder with that 
of the healthy one. Thus, systematic errors in measurement affecting both sides will not affect the 
score. However, the influence of the characteristics of each smartphone on the outcome has to be 
investigated and quantified before clinical implementation. 
The scientific value of a novel and objective test of shoulder function, the smartphone B-B Score 
technique, has been endorsed by the findings of this study, but no cost analysis was conducted at this 
stage of development. Further studies reproducing routine working conditions should evaluate this 
aspect. Given the reasonable material costs and the simplicity of the procedure, there would be a 
reasonable expectation for a favorable outcome following scrutiny by a formal cost-analysis. 
Information and communication technologies developments were not considered in this study but 
may be possible at a later stage. The use of a smartphone makes the measurement much more 
accessible for clinicians or event patients. Thus, larger scale data collection could be performed by 
more evaluators at a lower cost. The smartphone B-B Score measurement might, for example, be used in 
telemedicine due to its simplicity and accessibility. It could also facilitate the centralization of data 
collected in a large number of settings at an acceptable cost, thus facilitating data collection for multicentric 
studies and registries. 
5. Conclusions 
The smartphone B-B Score demonstrated excellent measurement properties in populations with a 
rotator cuff condition, proximal humerus fracture, and capsulitis. The diagnostic and discriminative 
power were excellent for these populations. The correlations with the clinical questionnaires indicated 
that the B-B Score is valid for shoulder function evaluation. The responsiveness compared favourably 
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with clinical questionnaires and no floor effect was detected. The determination of the MDC, MCII, 
and PASS provided a robust basis for the clinical interpretation of the outcome. 
This opens interesting perspectives for routine objective shoulder function measurement in clinics, 
as this validated score can quickly be performed with an inexpensive device. The affordable 
measurement of large cohorts of participants may also be facilitated. However, the performance of the 
smartphones should first be compared to that of scientific measurement devices. Further investigation 
is also needed to devise a kinematics smartphone-based score for the evaluation of shoulder instability 
where the B-B Score did not meet the minimal requirements. Moreover, the measurement properties of 
the B-B Score should be further investigated in patient populations presenting other shoulder 
conditions. Studies could also explore the possibility to use the smartphone B-B Score for remote 
follow-ups and for early detection of suboptimal recovery. 
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Systematic review
Please complete all mandatory fields below (marked with an asterisk *) and as many of the non-mandatory
fields as you can then click Submit to submit your registration. You don't need to complete everything in one
go, this record will appear in your My PROSPERO section of the web site and you can continue to edit it until
you are ready to submit. Click Show help below or click on the icon 
to see guidance on completing each section.
This record cannot be edited because it has been rejected
 
1. * Review title.
 
Give the working title of the review, for example the one used for obtaining funding. Ideally the title should
state succinctly the interventions or exposures being reviewed and the associated health or social problems.
Where appropriate, the title should use the PI(E)COS structure to contain information on the Participants,
Intervention (or Exposure) and Comparison groups, the Outcomes to be measured and Study designs to be
included.
Comparison of patient-reported outcome measures (PROMs) and kinematic scores’ measurement
properties for shoulder function evaluation: a systematic review
2. Original language title.
 
For reviews in languages other than English, this field should be used to enter the title in the language of the
review. This will be displayed together with the English language title.
Comparison des propriétés de mesure des scores subjectifs et des scores cinématiques de la fonction de
l'épaule: une revue systématique
3. * Anticipated or actual start date.
 
Give the date when the systematic review commenced, or is expected to commence.
18/07/2018
4. * Anticipated completion date.
 
Give the date by which the review is expected to be completed.
31/12/2018
5. * Stage of review at time of this submission.
 
Indicate the stage of progress of the review by ticking the relevant Started and Completed boxes. Additional
information may be added in the free text box provided.
Please note: Reviews that have progressed beyond the point of completing data extraction at the time of
initial registration are not eligible for inclusion in PROSPERO. Should evidence of incorrect status and/or
completion date being supplied at the time of submission come to light, the content of the PROSPERO
record will be removed leaving only the title and named contact details and a statement that inaccuracies in
the stage of the review date had been identified.
This field should be updated when any amendments are made to a published record and on completion and
publication of the review.
 
The review has not yet started: No
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Review stage Started Completed
Preliminary searches No Yes
Piloting of the study selection process No Yes
Formal screening of search results against eligibility criteria No No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
Provide any other relevant information about the stage of the review here (e.g. Funded proposal, protocol not
yet finalised).
 
6. * Named contact.
 
The named contact acts as the guarantor for the accuracy of the information presented in the register record.
Claude Pichonnaz
Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence:
Professor Pichonnaz
7. * Named contact email.
 
Give the electronic mail address of the named contact. 
claude.pichonnaz@hesav.ch
8. Named contact address
 
Give the full postal address for the named contact.
HESAV\Av. de Beaumont 21\1011 Lausanne\Switzerland
9. Named contact phone number.
 
Give the telephone number for the named contact, including international dialling code.
++41 21 318 81 26
10. * Organisational affiliation of the review.
 
Full title of the organisational affiliations for this review and website address if available. This field may be
completed as 'None' if the review is not affiliated to any organisation.
Haute Ecole de Santé Vaud (HESAV)
Organisation web address:
http://www.hesav.ch/
11. Review team members and their organisational affiliations.
 
Give the title, first name, last name and the organisational affiliations of each member of the review team.
Affiliation refers to groups or organisations to which review team members belong.
 
Professor Claude Pichonnaz. Haute Ecole de SantÃ© Vaud (HESAV)
Professor Nigel Gleeson. Queen Margaret University
Mr Pierre Balthazard. HESAV
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12. * Funding sources/sponsors.
 
Give details of the individuals, organizations, groups or other legal entities who take responsibility for
initiating, managing, sponsoring and/or financing the review. Include any unique identification numbers
assigned to the review by the individuals or bodies listed.
None
13. * Conflicts of interest.
 
List any conditions that could lead to actual or perceived undue influence on judgements concerning the





Give the name and affiliation of any individuals or organisations who are working on the review but who are
not listed as review team members.
 
15. * Review question.
 
State the question(s) to be addressed by the review, clearly and precisely. Review questions may be specific
or broad. It may be appropriate to break very broad questions down into a series of related more specific
questions. Questions may be framed or refined using PI(E)COS where relevant.
Are the measurement properties of currently used shoulder function PROMs and kinematic shoulder function
scores comparable for current shoulder pathologies evaluation?
16. * Searches.
 
Give details of the sources to be searched, search dates (from and to), and any restrictions (e.g. language or
publication period). The full search strategy is not required, but may be supplied as a link or attachment.
Databases: PubMed/MEDLINE, Web of Science, Embase, CINAHL, Pedro
Languages: English and French
No time limitation
17. URL to search strategy.
 
Give a link to the search strategy or an example of a search strategy for a specific database if available
(including the keywords that will be used in the search strategies).
  
Alternatively, upload your search strategy to CRD in pdf format. Please note that by doing so you are
consenting to the file being made publicly accessible.
  
Do not make this file publicly available until the review is complete
18. * Condition or domain being studied.
 
Give a short description of the disease, condition or healthcare domain being studied. This could include
health and wellbeing outcomes.




Give summary criteria for the participants or populations being studied by the review. The preferred format
includes details of both inclusion and exclusion criteria.
Included: studies on the measurement properties of PROMs or kinematic scores for patients with cuff tear,
proximal humerus fracture, capsulitis, osteoarthritis, glenohumeral instability, conservatively or surgicaly
treated
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Excluded: any other study
20. * Intervention(s), exposure(s).
 
Give full and clear descriptions or definitions of the nature of the interventions or the exposures to be
reviewed.
No intervention, only shoulder function outcome measurement
21. * Comparator(s)/control.
 
Where relevant, give details of the alternatives against which the main subject/topic of the review will be
compared (e.g. another intervention or a non-exposed control group). The preferred format includes details
of both inclusion and exclusion criteria. 
Measurement properties of currently used shoulder function PROMs vs. measurement properties of shoulder
function kinematic scores for similar conditions and treatment
22. * Types of study to be included.
 
Give details of the types of study (study designs) eligible for inclusion in the review. If there are no
restrictions on the types of study design eligible for inclusion, or certain study types are excluded, this should
be stated. The preferred format includes details of both inclusion and exclusion criteria.
Included: any published study that aimed at the determination of one or several measurement properties of
currently used shoulder function PROMs or kinematic scores. Currently used PROMs have been selected
based on an exploratory bibliographic search : Constant score and relative Constant score,
DASH/QuickDASH, SST, ASES, WOSI
Excluded: studies on other PROMs, validation studies that do not adress any of the measurement properties
mentioned in primary outcomes below, studies on kinematic parameters not related to shoulder function,




Give summary details of the setting and other relevant characteristics which help define the inclusion or
exclusion criteria.
There is an ongoing controversy on the validity and measurement properties of shoulder function PROMs. In
parallel, a lot of research on kinematic evaluation of shoulder function has been conducted. Thus, kinematic
scores might be a possible alternative to PROMs, but their respective properties have never been compared.
24. * Primary outcome(s).
 
Give the pre-specified primary (most important) outcomes of the review, including details of how the outcome
is defined and measured and when these measurement are made, if these are part of the review inclusion
criteria.
The following measurement properties of current PROMs and kinematic shoulder function scores specificaly
for rotator cuff tear, proximal humerus fracture, capsulitis, osteoarthritis and glenohumeral instability, and
specificaly for surgical or conservative treatment
- Reliability : test-retest, intra- and inter-evaluator reproducibility
- Responsiveness: effect size, standardised response mean, floor and ceiling effect, area under the ROC
curve
- Critical values: standard error of measurement, minimal detectable change, minimal clinically important
change/improvement, patient acceptable symptoms state, limits of agreement
- Normal performance
Timing and effect measures
25. * Secondary outcome(s).
 
List the pre-specified secondary (additional) outcomes of the review, with a similar level of detail to that
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required for primary outcomes. Where there are no secondary outcomes please state ‘None’ or ‘Not
applicable’ as appropriate to the review
None
Timing and effect measures
26. Data extraction (selection and coding).
 
Give the procedure for selecting studies for the review and extracting data, including the number of
researchers involved and how discrepancies will be resolved. List the data to be extracted.
Titles and/or abstracts of studies retrieved using the search strategy and those from additional sources will
be screened independently by two review authors (CP and PB) to identify studies that potentially meet the
inclusion criteria outlined above. The full text of these potentially eligible studies will be retrieved and
independently assessed for eligibility by two review team members (CP and PB). Any disagreement between
them over the eligibility of particular studies will be resolved through discussion with a third reviewer (NG).
No fromal assessment of study quality and no quantitative evidence synthesis will be conducted, due to the
lack of a study assessement method suitable to the review specific context and the lack of well-established
methods for measurement properties meta-analyses. A qualitative study assessement will be conducted to
explain results discrepancies between studies. Ranges of extracted measurement properties will be provided
when several studies investigated a measuremnt property.
A standardised previously conceived spreadsheet will be used to extract data from the included studies 
Two review authors (CP and PB) will extract data independently, discrepancies will be identified and
resolved through discussion (with a third author (NG) where necessary). 
27. * Risk of bias (quality) assessment.
 
State whether and how risk of bias will be assessed (including the number of researchers involved and how
discrepancies will be resolved), how the quality of individual studies will be assessed, and whether and how
this will influence the planned synthesis. 
Risk of bias assessment is not applicable using a checklist that would be suitable to all investigated
measurement properties. Methods of retrieved articles will be inspected by two authors (CP and PB) and
potential sources of bias will be noted. Disagreements between the review authors over the risk of bias in
particular studies will be resolved by discussion, with involvement of a third review author where necessary.
28. * Strategy for data synthesis.
 
Give the planned general approach to synthesis, e.g. whether aggregate or individual participant data will be
used and whether a quantitative or narrative (descriptive) synthesis is planned. It is acceptable to state that a
quantitative synthesis will be used if the included studies are sufficiently homogenous.
Ranges of extracted measurement properties will be reported, and the reasons for results diverging between
studies will be discussed. The results will not be aggregated because inhomogeneity in methods is expected
and well-established methods do not exist for each investigated measurement property.
29. * Analysis of subgroups or subsets.
 
Give details of any plans for the separate presentation, exploration or analysis of different types of
participants (e.g. by age, disease status, ethnicity, socioeconomic status, presence or absence or co-
morbidities); different types of intervention (e.g. drug dose, presence or absence of particular components of
intervention); different settings (e.g. country, acute or primary care sector, professional or family care); or
different types of study (e.g. randomised or non-randomised). 
None
30. * Type and method of review.
 
Select the type of review and the review method from the lists below. Select the health area(s) of interest for
your review. 
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There is an English language summary.
32. Country.
 
Select the country in which the review is being carried out from the drop down list. For multi-national
collaborations select all the countries involved.
 Scotland
 Switzerland
33. Other registration details.
 
Give the name of any organisation where the systematic review title or protocol is registered (such as with
The Campbell Collaboration, or The Joanna Briggs Institute) together with any unique identification number
assigned. (N.B. Registration details for Cochrane protocols will be automatically entered). If extracted data
will be stored and made available through a repository such as the Systematic Review Data Repository
(SRDR), details and a link should be included here. If none, leave blank.
None
34. Reference and/or URL for published protocol.
 
Give the citation and link for the published protocol, if there is one
None
 
Give the link to the published protocol. 
 
Alternatively, upload your published protocol to CRD in pdf format. Please note that by doing so you are
consenting to the file being made publicly accessible.
 
No I do not make this file publicly available until the review is complete
 
Please note that the information required in the PROSPERO registration form must be completed in full even
if access to a protocol is given.
35. Dissemination plans.
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Give brief details of plans for communicating essential messages from the review to the appropriate
audiences.
Publication in peer-reviewed journal and congress presentation





Give words or phrases that best describe the review. Separate keywords with a semicolon or new line.
Keywords will help users find the review in the Register (the words do not appear in the public record but are
included in searches). Be as specific and precise as possible. Avoid acronyms and abbreviations unless
these are in wide use.
Shoulder; measurement tool; measurement properties; function; patient-reported outcome measure;
kinematics
37. Details of any existing review of the same topic by the same authors.
 
Give details of earlier versions of the systematic review if an update of an existing review is being registered,
including full bibliographic reference if possible.
None
38. * Current review status.
 
Review status should be updated when the review is completed and when it is published.
Please provide anticipated publication date
 
Review_Ongoing
39. Any additional information.
 
Provide any other information the review team feel is relevant to the registration of the review.
40. Details of final report/publication(s).
 
This field should be left empty until details of the completed review are available. 
 
Give the link to the published review.
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Reliability") OR (MH "Interrater Reliability") OR 
"responsiv*" OR (MH "Intraclass Correlation 
Coefficient") OR "intraclass" OR "discrimina*" OR 
"propert*" OR "clinimetric*" OR "metrolog*" OR 
Search 
modes - 




“responsiveness” OR "floor effect*" OR "ceiling 
effect*"OR minimal detectable change* OR "MDC" OR 
"standard error of measurement*" OR "SEM" OR 
"minimal clinically important improvement*" OR "MCII" 
OR "minimal clinically important difference*" OR 
"MCID" OR "detect*" OR "correlat*" OR "accura*" OR 
"precis*" 
S3  (MH "Validation Studies") OR (“Instrument Validation”) 
OR (MH “Measurement Issues and Assessments”) OR 
"valid*" OR (MH "Clinical Assessment Tools+") OR 
"assessment tools" OR (MH "Outcome Assessment") 
OR (MH "Reliability and Validity") OR (MH "Research 
Measurement") OR (MH "Reproducibility of Results") 
OR (MH "Sensitivity and Specificity")   
Search 
modes - 




S2  (MH "Shoulder Pain") OR (MH "Pain+") OR (MH 
"Shoulder Impingement Syndrome") OR 
"impingement" OR “subacromial” OR (MH 
"Tendinopathy+") OR "tendinitis" OR "tendon*" OR 
(MH "Bursitis+") OR (MH "Rotator Cuff Injuries") OR 
(MH "Tears") OR “rotator cuff tear” OR "tear" OR 
"repair" OR (MH "Arthritis") OR (MH "Arthroplasty+") 
OR “arthroplasty” OR “prosthesis” OR (MH "Joint 
Instability+") OR (MH "Shoulder Dislocation") OR 
"instability" OR "dislocation" OR (MH "Adhesive 
Capsulitis+") OR "frozen shoulder" OR (MH "Shoulder 
Injuries+") OR (MH "Shoulder Fractures+") OR (MH 
"Fractures+") OR "fracture*" OR (MH "Pathology+") 
OR (MH "Disease+") OR (MH "Trauma+") OR 
"condition" OR "disorder*" OR "surgery" OR 
"surgical"(MH "Shoulder Pain") OR (MH "Pain+") OR 
(MH "Shoulder Impingement Syndrome") OR 
"impingement" OR “subacromial” OR (MH 
"Tendinopathy+") OR "tendinitis" OR "tendon*" OR 
(MH "Bursitis+") OR (MH "Rotator Cuff Injuries") OR 
(MH "Tears") OR “rotator cuff tear” OR "tear" OR 
"repair" OR (MH "Arthritis") OR (MH "Arthroplasty+") 
OR “arthroplasty” OR “prosthesis” OR (MH "Joint 
Instability+") OR (MH "Shoulder Dislocation") OR 
"instability" OR "dislocation" OR (MH "Adhesive 
Capsulitis+") OR "frozen shoulder" OR (MH "Shoulder 
Injuries+") OR (MH "Shoulder Fractures+") OR (MH 
"Fractures+") OR "fracture*" OR (MH "Pathology+") 
OR (MH "Disease+") OR (MH "Trauma+") OR 
"condition" OR "disorder*" OR "surgery" OR "surgical" 
Search 
modes - 




S1  (MH "Shoulder") OR "shoulder" OR (MH "Shoulder 
Joint+") OR (MH "Glenohumeral Joint") OR (MH 
"Upper Extremity+") OR (MH "Arm") OR ("upper limb") 
OR (MH "Rotator Cuff+") OR (MH "Rotator Cuff+") OR 
"rotator cuff" OR (MH "Humerus") OR "Humer*"   
Search 
modes - 


















modes - Find 










Search Screen - 




S7  S5 OR S6   Search 
modes - Find 
all my search 
terms  
 
S6  TX "motion analysis*" OR TX "motion capture" OR TX 
"motion tracker*" OR TX "movement analysis" OR TX 
magnetomet* OR TX "magnetic system*" OR TX 
"angular velocit*" OR TX fluidity OR "infrared 
camera*"   
Search 
modes - Find 
all my search 
terms  
 
S5  TX acceleromet* OR TX accelerat* OR TX 
smartphone* OR MH monitoring, physiologic OR 
"monitoring, physiologic" OR TX torque OR TX 
"inertial sensor*" OR TX "inertial measurement unit" 
OR imu OR "wearable sensor*" OR TX ultrasound OR 
TX video   
Search 
modes - Find 
all my search 
terms  
 
S4  (MH "Sensitivity”) OR (MH "Specificity") OR "sensitiv*" 
OR "specific*" OR "likelihood ratio*" OR (MH "ROC 
Curve") OR "roc curve*" OR "reproduci*" OR (MH 
"Psychometrics") OR "psychometric" OR "clinimetric" 
OR "metrolog*" OR (MH "Validity+") OR (MH 
"Reliability+") OR "reliab*" OR "test-retest" OR (MH 
"Measurement Error") OR (MH "Test-Retest 
Reliability") OR (MH "Intrarater Reliability") OR (MH 
"Interrater Reliability") OR "responsiv*" OR (MH 
"Intraclass Correlation Coefficient") OR "intraclass" 
OR "discrimina*" OR "propert*" OR "clinimetric*" OR 
"metrolog*" OR “responsiveness” OR "floor effect*" 
OR "ceiling effect*"OR minimal detectable change* 
OR "MDC" OR "standard error of measurement*" OR 
"SEM" OR "minimal clinically important improvement*" 
OR "MCII" OR "minimal clinically important 
difference*" OR "MCID" OR "detect*" OR "correlat*" 
OR "accura*" OR "precis*" OR "discrimin*"(MH 
"Sensitivity”) OR (MH "Specificity") OR "sensitiv*" OR 
"specific*" OR "likelihood ratio*" OR (MH "ROC 
Curve") OR "roc curve*" OR "reproduci*" OR (MH 
"Psychometrics") OR "psychometric" OR "clinimetric" 
OR "metrolog*" OR (MH "Validity+") OR (MH 
"Reliability+") OR "reliab*" OR "test-retest" OR (MH 
"Measurement Error") OR (MH "Test-Retest 
Search 
modes - Find 
all my search 
terms  
 
Reliability") OR (MH "Intrarater Reliability") OR (MH 
"Interrater Reliability") OR "responsiv*" OR (MH 
"Intraclass Correlation Coefficient") OR "intraclass" 
OR "discrimina*" OR "propert*" OR "clinimetric*" OR 
"metrolog*" OR “responsiveness” OR "floor effect*" 
OR "ceiling effect*"OR minimal detectable change* 
OR "MDC" OR "standard error of measurement*" OR 
"SEM" OR "minimal clinically important improvement*" 
OR "MCII" OR "minimal clinically important 
difference*" OR "MCID" OR "detect*" OR "correlat*" 
OR "accura*" OR "precis*" 
S3  (MH "Validation Studies") OR (“Instrument Validation”) 
OR (MH “Measurement Issues and Assessments”) 
OR "valid*" OR (MH "Clinical Assessment Tools+") 
OR "assessment tools" OR (MH "Outcome 
Assessment") OR (MH "Reliability and Validity") OR 
(MH "Research Measurement") OR (MH 
"Reproducibility of Results") OR (MH "Sensitivity and 
Specificity")   
Search 
modes - Find 
all my search 
terms  
 
S2  (MH "Shoulder Pain") OR (MH "Pain+") OR (MH 
"Shoulder Impingement Syndrome") OR 
"impingement" OR “subacromial” OR (MH 
"Tendinopathy+") OR "tendinitis" OR "tendon*" OR 
(MH "Bursitis+") OR (MH "Rotator Cuff Injuries") OR 
(MH "Tears") OR “rotator cuff tear” OR "tear" OR 
"repair" OR (MH "Arthritis") OR (MH "Arthroplasty+") 
OR “arthroplasty” OR “prosthesis” OR (MH "Joint 
Instability+") OR (MH "Shoulder Dislocation") OR 
"instability" OR "dislocation" OR (MH "Adhesive 
Capsulitis+") OR "frozen shoulder" OR (MH "Shoulder 
Injuries+") OR (MH "Shoulder Fractures+") OR (MH 
"Fractures+") OR "fracture*" OR (MH "Pathology+") 
OR (MH "Disease+") OR (MH "Trauma+") OR 
"condition" OR "disorder*" OR "surgery" OR 
"surgical"(MH "Shoulder Pain") OR (MH "Pain+") OR 
(MH "Shoulder Impingement Syndrome") OR 
"impingement" OR “subacromial” OR (MH 
"Tendinopathy+") OR "tendinitis" OR "tendon*" OR 
(MH "Bursitis+") OR (MH "Rotator Cuff Injuries") OR 
(MH "Tears") OR “rotator cuff tear” OR "tear" OR 
"repair" OR (MH "Arthritis") OR (MH "Arthroplasty+") 
OR “arthroplasty” OR “prosthesis” OR (MH "Joint 
Instability+") OR (MH "Shoulder Dislocation") OR 
"instability" OR "dislocation" OR (MH "Adhesive 
Capsulitis+") OR "frozen shoulder" OR (MH "Shoulder 
Injuries+") OR (MH "Shoulder Fractures+") OR (MH 
"Fractures+") OR "fracture*" OR (MH "Pathology+") 
OR (MH "Disease+") OR (MH "Trauma+") OR 
"condition" OR "disorder*" OR "surgery" OR "surgical" 
Search 
modes - Find 
all my search 
terms  
 
S1  (MH "Shoulder") OR "shoulder" OR (MH "Shoulder 
Joint+") OR (MH "Glenohumeral Joint") OR (MH 
"Upper Extremity+") OR (MH "Arm") OR ("upper limb") 
OR (MH "Rotator Cuff+") OR (MH "Rotator Cuff+") OR 
"rotator cuff" OR (MH "Humerus") OR "Humer*"   
Search 
modes - Find 







#7  #6 AND ('article'/it OR 'review'/it) 332
#6  #1 AND #2 AND #3 AND #4 AND #5 AND [1-1-1800]/sd NOT [7-5-2017]/sd 372
#5  
'disabilities of the arm, shoulder and hand (score)'/exp OR 'disabilities of the 
arm, shoulder and hand (score)' OR 'quickdash'/exp OR quickdash OR 
'constant murley (score)'/exp OR 'constant murley (score)' OR 'constant 
score'/exp OR 'constant score' OR 'cs score' OR 'csm score' OR 'simple 
shoulder test'/exp OR 'simple shoulder test' OR sst OR 'western ontario 
shoulder instability index'/exp OR 'western ontario shoulder instability index' 
OR 'western ontario shoulder instability score' OR wosi OR 'american 
shoulder and elbow surgeons score'/exp OR 'american shoulder and elbow 
surgeons score' OR 'american shoulder and elbow surgeon score'/exp OR 
'american shoulder and elbow surgeon score' OR 'ases score'/exp OR 'ases 
score' OR ases 
10929
#4  
'specificity'/exp OR specificity OR 'sensitivity and sensibility'/exp OR 
'sensitivity and sensibility' OR 'reproducibility'/exp OR reproducibility OR 
'receiver operating characteristic'/exp OR 'receiver operating characteristic' 
OR 'psychometry'/exp OR psychometry OR 'psychometric properties'/exp 
OR 'psychometric properties' OR 'validation'/exp OR validation OR 
'validity'/exp OR validity OR 'measurement precision'/exp OR 'measurement 
precision' OR 'measurement properties' OR 'clinimetrics'/exp OR clinimetrics 
OR 'metrology'/exp OR metrology OR 'reliability'/exp OR reliability OR 'test 
retest reliability'/exp OR 'test retest reliability' OR 'test retest variability'/exp 
OR 'test retest variability' OR 'responsiveness'/exp OR responsiveness OR 
responsiv* OR 'minimal detectable change'/exp OR 'minimal detectable 
change' OR mdc OR 'standard error of measurement'/exp OR 'standard 
error of measurement' OR 'sem'/exp OR sem OR 'minimal clinically 
important difference'/exp OR 'minimal clinically important difference' OR 
'minimal clinically important improvement'/exp OR 'minimal clinically 
important improvement' OR mcii OR mcid OR 'likehood ratio' OR 'roc curve*' 
OR 'detection'/exp OR detection OR 'correlation coefficient'/exp OR 
'correlation coefficient' OR 'accuracy'/exp OR accuracy OR 'precision'/exp 
OR precision OR discern* OR 'discrimination'/exp OR discrimination OR 
'floor effect' OR 'ceiling effect'/exp OR 'ceiling effect' 
3289470
#3  
'evaluation study'/exp OR 'evaluation study' OR 'evaluation 
methodology'/exp OR 'evaluation methodology' OR 'symptom 
assessment'/exp OR 'symptom assessment' OR 'validation study'/exp OR 
'validation study' OR 'validation'/exp OR validation OR 'reproducibility'/exp 
3059475
No. Query Results
OR reproducibility OR 'outcome assessment'/exp OR 'outcome assessment' 
OR 'measurement'/exp OR measurement 
#2  
'fracture'/exp OR fracture OR 'dislocation'/exp OR dislocation OR 'limb 
disease'/exp OR 'limb disease' OR 'bursitis'/exp OR bursitis OR 'pain'/exp 
OR pain OR 'joint instability'/exp OR 'joint instability' OR 'tendinitis'/exp OR 
tendinitis OR 'tendon injury'/exp OR 'tendon injury' OR 'arthritis'/exp OR 
arthritis OR 'arthroplasty'/exp OR arthroplasty OR 'pathology'/exp OR 
pathology OR 'diseases'/exp OR diseases OR 'injury'/exp OR injury OR 
'tear'/exp OR tear OR 'condition'/exp OR condition OR 'repair'/exp OR repair 
OR surg* OR 'humeroscapular periarthritis'/exp OR 'humeroscapular 
periarthritis' OR 'frozen shoulder'/exp OR 'frozen shoulder' OR dysfunction* 
OR 'prostheses and orthoses'/exp OR 'prostheses and orthoses' 
21433437
#1  
'shoulder' OR 'shoulder'/exp OR shoulder OR 'arm' OR 'arm'/exp OR arm 







#7  #6 AND ('article'/it OR 'review'/it) AND [1-1-1800]/sd NOT [6-5-2017]/sd 662
#6  #1 AND #2 AND #3 AND #4 AND #5 925
#5  
'acceleromet*' OR 'smartphone*' OR 'physiologic monitoring' OR 'torque' OR 
'inertial sensor*' OR 'inertial measurement unit*' OR 'ultrasound-based' OR 
'video' OR 'motion capture' OR 'gyroscope*' OR 'wearable sensor*' OR 
'infrared camera*' OR 'motion analysis' OR 'movement analysis' OR 'motion 
tracker' OR 'magnetometer*' OR 'magnetic system' OR 'acceleration*' OR 
'angular velocit*' OR 'fluidity' 
232314
#4  
'specificity'/exp OR specificity OR 'sensitivity and sensibility'/exp OR 
'sensitivity and sensibility' OR 'reproducibility'/exp OR reproducibility OR 
'receiver operating characteristic'/exp OR 'receiver operating characteristic' 
OR 'psychometry'/exp OR psychometry OR 'psychometric properties'/exp 
OR 'psychometric properties' OR 'validation'/exp OR validation OR 
'validity'/exp OR validity OR 'measurement precision'/exp OR 'measurement 
precision' OR 'measurement properties' OR 'clinimetrics'/exp OR clinimetrics 
OR 'metrology'/exp OR metrology OR 'reliability'/exp OR reliability OR 'test 
retest reliability'/exp OR 'test retest reliability' OR 'test retest variability'/exp 
OR 'test retest variability' OR 'responsiveness'/exp OR responsiveness OR 
responsiv* OR 'minimal detectable change'/exp OR 'minimal detectable 
change' OR mdc OR 'standard error of measurement'/exp OR 'standard 
error of measurement' OR 'sem'/exp OR sem OR 'minimal clinically 
important difference'/exp OR 'minimal clinically important difference' OR 
'minimal clinically important improvement'/exp OR 'minimal clinically 
important improvement' OR mcii OR mcid OR 'likehood ratio' OR 'roc curve*' 
OR 'detection'/exp OR detection OR 'correlation coefficient'/exp OR 
'correlation coefficient' OR 'accuracy'/exp OR accuracy OR 'precision'/exp 
OR precision OR discern* OR 'discrimination'/exp OR discrimination OR 
'floor effect' OR 'ceiling effect'/exp OR 'ceiling effect' 
3316791
#3  
'evaluation study'/exp OR 'evaluation study' OR 'evaluation 
methodology'/exp OR 'evaluation methodology' OR 'symptom 
assessment'/exp OR 'symptom assessment' OR 'validation study'/exp OR 
'validation study' OR 'validation'/exp OR validation OR 'reproducibility'/exp 
OR reproducibility OR 'outcome assessment'/exp OR 'outcome assessment' 
OR 'measurement'/exp OR measurement 
3086036
#2  
'fracture'/exp OR fracture OR 'dislocation'/exp OR dislocation OR 'limb 
disease'/exp OR 'limb disease' OR 'bursitis'/exp OR bursitis OR 'pain'/exp 
OR pain OR 'joint instability'/exp OR 'joint instability' OR 'tendinitis'/exp OR 
21551637
No. Query Results
tendinitis OR 'tendon injury'/exp OR 'tendon injury' OR 'arthritis'/exp OR 
arthritis OR 'arthroplasty'/exp OR arthroplasty OR 'pathology'/exp OR 
pathology OR 'diseases'/exp OR diseases OR 'injury'/exp OR injury OR 
'tear'/exp OR tear OR 'condition'/exp OR condition OR 'repair'/exp OR repair 
OR surg* OR 'humeroscapular periarthritis'/exp OR 'humeroscapular 
periarthritis' OR 'frozen shoulder'/exp OR 'frozen shoulder' OR dysfunction* 
OR 'prostheses and orthoses'/exp OR 'prostheses and orthoses' 
#1  
'shoulder' OR 'shoulder'/exp OR shoulder OR 'arm' OR 'arm'/exp OR arm 
OR 'rotator cuff'/exp OR 'rotator cuff' OR 'upper extremit*' OR 'upper limb*' 
430398
  







Save History / Create Alert Open Saved History  
# 6 1,822  (#5) AND LANGUAGE: (English OR French)  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 5 1,915  #1 AND #2 AND #3 AND #4  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 4 28,562  TS=(DASH) OR TS=(QuickDASH) OR TS=("Disabilities of the arm, shoulder 
and hand") OR TS=("Constant Score") OR TS=("CS Score") OR 
TS=("Constant-Murley") OR TS=("CSM score") OR TS=(SST) OR 
TS=("simple shoulder test") OR TS=(WOSI) OR TS=("Western Ontario 
Shoulder Instability Index") OR TS=("ASES score") AND TS=("American 
Shoulder and elbow surgeons score") AND TS=("UCLA Shoulder") AND 
TS=("UCLA score")  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 3 10,818,476  TS=(sensitiv*) OR TS=(specifici*) OR TS=(reproducib*) OR TS=("ROC 
curve") OR TS=(psychometric*) OR TS=(valid*) OR TS=(propert*) OR 
TS=(clinimetric*) OR TS=(metrolog*) OR TS=(reliab*) OR TS=(test-retest) 
OR TS=(responsiv*) OR TS=("minimal detectable change*") OR TS=(MDC) 
OR TS=("standard error of measurement*") OR TS=(SEM) OR TS=("minimal 
clinically important improvement*") OR TS=(MCII) OR TS=("minimal 
clinically important difference*") OR TS=(MCID) OR TS=("likelihood ratio*") 
OR TS=(detect*) OR TS=(intraclass) OR TS=(correl*) OR TS=(accura*) OR 
TS=(precis*) OR TS=(discern*) OR TS=(discrim*) OR TS=("floor effect*") 
OR TS=("ceiling effect*")  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 2 10,090,842  TS=(pain) OR TS=(impingement) OR TS=(bursitis) OR TS=(tendon*) OR 
TS=(tendin*) OR TS=(fracture*) OR TS=(dislocation*) OR TS=(instab*) OR 
TS=(arthritis) OR TS=(arthroplast*) OR TS=(injur*) OR TS=(patholog*) OR 
TS=(disease) OR TS=(trauma*) OR TS=(tear*) OR TS=(condition*) OR 
TS=(disorder*) OR TS=(repair*) OR TS=(surger*) OR TS=(surgical) OR 
TS=("adhesive capsulitis") OR TS=("frozen shoulder") OR TS=(dysfunction) 
OR TS=(prosthes*)  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 1 374,539  TS=(shoulder*) OR TS=(upper extremit*) OR TS=(upper limb*) OR 
TS=(arm*) OR TS=(glenohumeral) OR TS=(humer*) OR TS=(rotator cuff*)  




Set   Results Save History / Create Alert Open Saved History  
# 7 2,076  #4 AND #3 AND #2 AND #1  
Refined by: DOCUMENT TYPES: ( ARTICLE OR REVIEW ) AND 
LANGUAGES: ( ENGLISH OR FRENCH )  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 6 2,104  #4 AND #3 AND #2 AND #1  
Refined by: DOCUMENT TYPES: ( ARTICLE OR REVIEW )  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 5 2,109  #4 AND #3 AND #2 AND #1  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 4 287,283  TS=(acceleromet*) OR TS=(smartphone*) OR TS=("physiologic monitoring") OR 
TS=(torque) OR TS=("inertial sensor*") OR TS=(IMU) OR TS="inertial 
measurement" OR TS=("wearable sensor*") OR TS=("ultrasound-based") OR 
TS=("video-based") OR TS=("motion capture") OR TS=(gyroscop*) OR 
TS=("infrared-camera*") OR TS=("motion analysis") OR TS=("movement analysis") 
OR TS=("motion tracker*") OR TS=(magnetometer*) OR TS=("magnetic system") 
OR TS=(acceleration*) OR TS=("angular velocity") OR TS=(fluidity)  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 3 10,818,476  TS=(sensitiv*) OR TS=(specifici*) OR TS=(reproducib*) OR TS=("ROC curve") 
OR TS=(psychometric*) OR TS=(valid*) OR TS=(propert*) OR TS=(clinimetric*) 
OR TS=(metrolog*) OR TS=(reliab*) OR TS=(test-retest) OR TS=(responsiv*) OR 
TS=("minimal detectable change*") OR TS=(MDC) OR TS=("standard error of 
measurement*") OR TS=(SEM) OR TS=("minimal clinically important 
improvement*") OR TS=(MCII) OR TS=("minimal clinically important difference*") 
OR TS=(MCID) OR TS=("likelihood ratio*") OR TS=(detect*) OR TS=(intraclass) 
OR TS=(correl*) OR TS=(accura*) OR TS=(precis*) OR TS=(discern*) OR 
TS=(discrim*) OR TS=("floor effect*") OR TS=("ceiling effect*")  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 2 10,090,842  TS=(pain) OR TS=(impingement) OR TS=(bursitis) OR TS=(tendon*) OR 
TS=(tendin*) OR TS=(fracture*) OR TS=(dislocation*) OR TS=(instab*) OR 
TS=(arthritis) OR TS=(arthroplast*) OR TS=(injur*) OR TS=(patholog*) OR 
TS=(disease) OR TS=(trauma*) OR TS=(tear*) OR TS=(condition*) OR 
TS=(disorder*) OR TS=(repair*) OR TS=(surger*) OR TS=(surgical) OR 
TS=("adhesive capsulitis") OR TS=("frozen shoulder") OR TS=(dysfunction) OR 
TS=(prosthes*)  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
# 1 374,539  TS=(shoulder*) OR TS=(upper extremit*) OR TS=(upper limb*) OR TS=(arm*) OR 
TS=(glenohumeral) OR TS=(humer*) OR TS=(rotator cuff*)  
Indexes=SCI-EXPANDED, ESCI Timespan=1900-2017 
 
  
PEDro Physiotherapy Evidence Database 
This database does not allow complex combination of search terms. As the “advanced search” feature 
allow several thematic selections, the searches were limited to “clinical trials” and “upper arm, 
shoulder or shoulder girdle”. Then simple keywords combination were used to investigate the content 
of the database.   
PROMs 
Keywords Results 
shoulder DASH 38 
« Disabilities of the Arm, Shoulder and Hand » 36 
shoulder QuickDASH 4 
shoulder Constant 117 
shoulder ASES 7 
« American Shoulder And Elbow Surgeons » 16 
shoulder SST 12 
simple shoulder test 18 
 
None of the retrieved references addressed the measurement properties of shoulder function PROMs 
Kinematic 
Keywords Results 
shoulder kinematic 27 
shoulder movement analysis 25 
shoulder motion analysis 57 
shoulder sensor*  20 
shoulder inertia*  1 
shoudler infrared  7 
shoulder magnet*  22 
shoulder kinematic*  27 
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